1	Lung	NN	O	lung	nn	2	SENT_1	[p1l881t82r942b108],
2	Cancer	NN	O	cancer	_	0	SENT_1	[p1l950t82r1036b103],
3	67	CD	NUMBER	67	number	4	SENT_1	[p1l1044t82r1073b103],
4	(	CD	NUMBER	(	dep	2	SENT_1	[p1l1082t81r1165b108],
5	2010	CD	DATE	2010	dep	4	SENT_1	[p1l1082t81r1165b108],
6	)	CD	NUMBER	)	num	7	SENT_1	[p1l1082t81r1165b108],
7	355-360	CD	NUMBER	355-360	dep	2	SENT_1	[p1l1173t82r1284b103],

1	Contents	NNS	O	contents	_	0	SENT_2	[p1l779t188r914b214],
2	lists	NNS	O	list	dep	1	SENT_2	[p1l927t189r986b213],
3	available	JJ	O	available	amod	2	SENT_2	[p1l997t189r1133b214],
4	at	IN	O	at	_	0	SENT_2	[p1l1145t192r1172b213],
5	ScienceDirect	NNP	O	ScienceDirect	prep_at	3	SENT_2	[p1l1184t188r1392b214],

1	Lung	NN	O	lung	nn	2	SENT_3	[p1l925t289r1056b344],
2	Cancer	NN	O	cancer	_	0	SENT_3	[p1l1074t289r1259b333],

1	>	JJR	O	>	_	0	SENT_4	[p1l36t375r86b400],
2	*	NN	O	*	dep	1	SENT_4	[p1l36t375r86b400],
3	'	''	O	'	_	0	SENT_4	[p1l100t378r126b396],
4	7	CD	NUMBER	7	dep	2	SENT_4	[p1l100t378r126b396],
5	.	.	O	.	_	0	SENT_4	[p1l100t378r126b396],

1	“	NN	O	“	_	0	SENT_5	[p1l100t378r126b396],
2	;	:	O	;	_	0	SENT_5	[p1l201t375r252b398],
3	;	:	O	;	_	0	SENT_5	[p1l201t375r252b398],
4	"	``	O	"	punct	5	SENT_5	[p1l201t375r252b398],
5	r	NN	O	r	dep	1	SENT_5	[p1l201t375r252b398],
6	ELSEVIER	NN	O	elsevier	nn	8	SENT_5	[p1l12t421r248b456],
7	journal	NN	O	journal	nn	8	SENT_5	[p1l576t418r707b449],
8	homepage	NN	O	homepage	dep	5	SENT_5	[p1l730t418r933b449],
9	:	:	O	:	_	0	SENT_5	[p1l730t418r933b449],
10	www	NN	O	www	amod	8	SENT_5	[p1l949t418r1593b449],
11	.	.	O	.	_	0	SENT_5	[p1l949t418r1593b449],

1	e	LS	O	e	dep	3	SENT_6	[p1l949t418r1593b449],
2	|	SYM	O	|	dep	3	SENT_6	[p1l949t418r1593b449],
3	sevier.com/locate/Iungcan	NN	O	sevier.com/locate/iungcan	_	0	SENT_6	[p1l949t418r1593b449],

1	Predictors	NNS	O	predictor	dep	14	SENT_7	[p1l6t565r271b611],
2	of	IN	O	of	_	0	SENT_7	[p1l291t565r346b611],
3	geﬁtinib	NN	O	geﬁtinib	nn	4	SENT_7	[p1l357t565r577b622],
4	outcomes	NNS	O	outcome	prep_of	1	SENT_7	[p1l596t572r853b611],
5	in	IN	O	in	_	0	SENT_7	[p1l873t566r922b610],
6	advanced	JJ	O	advanced	amod	11	SENT_7	[p1l940t565r1190b611],
7	non	JJ	O	non	amod	11	SENT_7	[p1l1209t565r1477b611],
8	—	NN	O	—	nn	11	SENT_7	[p1l1209t565r1477b611],
9	small	JJ	O	small	amod	11	SENT_7	[p1l1209t565r1477b611],
10	cell	NN	O	cell	nn	11	SENT_7	[p1l1496t565r1585b611],
11	lung	NN	O	lung	prep_in	4	SENT_7	[p1l1605t565r1721b622],
12	cancer	NN	O	cancer	dep	14	SENT_7	[p1l1738t578r1912b611],
13	(	CD	NUMBER	(	num	12	SENT_7	[p1l6t637r234b694],
14	NSCLC	NN	O	nsclc	_	0	SENT_7	[p1l6t637r234b694],
15	)	CD	NUMBER	)	num	14	SENT_7	[p1l6t637r234b694],
16	:	:	O	:	_	0	SENT_7	[p1l6t637r234b694],
17	Study	NNP	O	Study	dep	14	SENT_7	[p1l253t637r403b694],
18	of	IN	O	of	_	0	SENT_7	[p1l420t637r475b682],
19	a	DT	O	a	det	21	SENT_7	[p1l487t650r513b682],
20	comprehensive	JJ	O	comprehensive	amod	21	SENT_7	[p1l532t637r935b694],
21	panel	NN	O	panel	prep_of	17	SENT_7	[p1l955t637r1098b694],
22	of	IN	O	of	_	0	SENT_7	[p1l1117t637r1172b682],
23	molecular	JJ	O	molecular	amod	24	SENT_7	[p1l1185t637r1452b682],
24	markers	NNS	O	marker	prep_of	14	SENT_7	[p1l1469t637r1683b682],

1	Marcello	NNP	PERSON	Marcello	dep	137	SENT_8	[p1l8t741r188b776],
2	Tiseo	NNP	PERSON	Tiseo	dep	137	SENT_8	[p1l201t741r309b776],
3	3	CD	NUMBER	3	dep	137	SENT_8	[p1l317t742r372b782],
4	*	NN	O	*	dep	137	SENT_8	[p1l317t742r372b782],
5	,	,	O	,	_	0	SENT_8	[p1l317t742r372b782],
6	Giulio	NNP	PERSON	Giulio	dep	137	SENT_8	[p1l388t741r511b776],
7	Rossib	NNP	PERSON	Rossib	dep	137	SENT_8	[p1l526t735r667b782],
8	,	,	O	,	_	0	SENT_8	[p1l526t735r667b782],
9	Marzia	NNP	PERSON	Marzia	dep	137	SENT_8	[p1l682t741r825b776],
10	Capellettia	NNP	PERSON	Capellettia	dep	137	SENT_8	[p1l839t741r1072b785],
11	,	,	O	,	_	0	SENT_8	[p1l839t741r1072b785],
12	Giuliana	NNP	PERSON	Giuliana	dep	137	SENT_8	[p1l1088t741r1261b776],
13	Sartorib	NNP	PERSON	Sartorib	dep	137	SENT_8	[p1l1275t735r1450b782],
14	,	,	O	,	_	0	SENT_8	[p1l1275t735r1450b782],
15	Elena	NNP	PERSON	Elena	dep	137	SENT_8	[p1l1466t741r1577b776],
16	Spiritellia	NNP	PERSON	Spiritellia	dep	137	SENT_8	[p1l1592t741r1803b785],
17	,	,	O	,	_	0	SENT_8	[p1l1592t741r1803b785],
18	Alessandro	NNP	PERSON	Alessandro	dep	137	SENT_8	[p1l6t794r236b829],
19	Marchioni	NNP	PERSON	Marchioni	dep	137	SENT_8	[p1l251t794r496b834],
20	°	NN	O	°	dep	137	SENT_8	[p1l251t794r496b834],
21	,	,	O	,	_	0	SENT_8	[p1l251t794r496b834],
22	Cecilia	NNP	PERSON	Cecilia	dep	137	SENT_8	[p1l511t794r647b829],
23	Bozzettia	NNP	PERSON	Bozzettia	dep	137	SENT_8	[p1l661t794r863b835],
24	,	,	O	,	_	0	SENT_8	[p1l661t794r863b835],
25	Giuseppe	NNP	PERSON	Giuseppe	dep	137	SENT_8	[p1l879t794r1072b838],
26	De	NNP	PERSON	De	dep	137	SENT_8	[p1l1087t796r1140b829],
27	Palmad	NNP	PERSON	Palmad	dep	137	SENT_8	[p1l1155t788r1318b834],
28	,	,	O	,	_	0	SENT_8	[p1l1155t788r1318b834],
29	Costanza	NNP	PERSON	Costanza	dep	137	SENT_8	[p1l1333t795r1518b829],
30	Lagrastae	NNP	PERSON	Lagrastae	dep	137	SENT_8	[p1l1533t795r1738b838],
31	,	,	O	,	_	0	SENT_8	[p1l1533t795r1738b838],
32	Nicoletta	NNP	PERSON	Nicoletta	dep	137	SENT_8	[p1l8t847r195b882],
33	Campaninie	NNP	PERSON	Campaninie	dep	137	SENT_8	[p1l210t847r469b891],
34	,	,	O	,	_	0	SENT_8	[p1l210t847r469b891],
35	Roberta	NNP	PERSON	Roberta	dep	137	SENT_8	[p1l484t847r645b882],
36	Camisaa	NNP	PERSON	Camisaa	dep	137	SENT_8	[p1l659t847r842b888],
37	,	,	O	,	_	0	SENT_8	[p1l659t847r842b888],
38	Luca	NNP	PERSON	Luca	dep	137	SENT_8	[p1l857t849r950b882],
39	Bonif	NNP	PERSON	Bonif	dep	137	SENT_8	[p1l965t841r1085b888],
40	,	,	O	,	_	0	SENT_8	[p1l965t841r1085b888],
41	Vittorio	NNP	PERSON	Vittorio	dep	137	SENT_8	[p1l1099t847r1259b882],
42	Franciosia	NNP	PERSON	Franciosia	dep	137	SENT_8	[p1l1274t847r1493b887],
43	,	,	O	,	_	0	SENT_8	[p1l1274t847r1493b887],
44	Guido	NNP	PERSON	Guido	dep	137	SENT_8	[p1l8t900r131b936],
45	Rindie	NNP	PERSON	Rindie	dep	137	SENT_8	[p1l146t900r288b941],
46	,	,	O	,	_	0	SENT_8	[p1l146t900r288b941],
47	Andrea	NNP	PERSON	Andrea	dep	137	SENT_8	[p1l302t900r452b936],
48	Ardizzonia	NNP	PERSON	Ardizzonia	dep	137	SENT_8	[p1l464t900r688b935],
49	3	CD	NUMBER	3	dep	137	SENT_8	[p1l6t977r15b988],
50	Division	NNP	O	Division	dep	137	SENT_8	[p1l22t976r120b998],
51	of	IN	O	of	dep	137	SENT_8	[p1l129t976r155b1003],
52	Medical	NNP	O	Medical	dep	137	SENT_8	[p1l158t976r253b998],
53	Oncology	NNP	O	Oncology	dep	137	SENT_8	[p1l262t976r376b1003],
54	,	,	O	,	_	0	SENT_8	[p1l262t976r376b1003],
55	University	NNP	ORGANIZATION	University	dep	137	SENT_8	[p1l387t976r509b1003],
56	Hospital	NNP	ORGANIZATION	Hospital	dep	137	SENT_8	[p1l516t976r617b1003],
57	of	IN	ORGANIZATION	of	dep	137	SENT_8	[p1l625t976r651b1003],
58	Panna	NNP	ORGANIZATION	Panna	dep	137	SENT_8	[p1l654t977r737b1001],
59	,	,	O	,	_	0	SENT_8	[p1l654t977r737b1001],
60	Via	NNP	PERSON	Via	dep	137	SENT_8	[p1l748t976r784b998],
61	Gramsci	NNP	PERSON	Gramsci	dep	137	SENT_8	[p1l793t976r890b998],
62	14	CD	NUMBER	14	dep	137	SENT_8	[p1l901t977r930b1001],
63	,	,	O	,	_	0	SENT_8	[p1l901t977r930b1001],
64	43100	CD	NUMBER	43100	dep	137	SENT_8	[p1l939t977r1013b998],
65	Parma	NN	ORGANIZATION	parma	dep	137	SENT_8	[p1l1020t977r1103b1001],
66	,	,	O	,	_	0	SENT_8	[p1l1020t977r1103b1001],
67	Italy	NNP	LOCATION	Italy	dep	137	SENT_8	[p1l1113t976r1166b1003],
68	b	NN	O	b	dep	137	SENT_8	[p1l6t1008r16b1023],
69	Department	NNP	ORGANIZATION	Department	dep	137	SENT_8	[p1l23t1012r170b1038],
70	of	IN	ORGANIZATION	of	dep	137	SENT_8	[p1l177t1011r203b1038],
71	Pathology	NNP	ORGANIZATION	Pathology	dep	137	SENT_8	[p1l206t1011r329b1038],
72	,	,	O	,	_	0	SENT_8	[p1l206t1011r329b1038],
73	University	NNP	ORGANIZATION	University	dep	137	SENT_8	[p1l340t1012r462b1038],
74	Hospital	NNP	ORGANIZATION	Hospital	dep	137	SENT_8	[p1l469t1011r570b1038],
75	of	IN	ORGANIZATION	of	dep	137	SENT_8	[p1l578t1011r604b1038],
76	Modena	NNP	ORGANIZATION	Modena	dep	137	SENT_8	[p1l607t1011r710b1036],
77	,	,	O	,	_	0	SENT_8	[p1l607t1011r710b1036],
78	Italy	NNP	LOCATION	Italy	dep	137	SENT_8	[p1l719t1011r773b1038],
79	S	NNP	O	S	dep	137	SENT_8	[p1l6t1048r14b1059],
80	Division	NNP	O	Division	dep	137	SENT_8	[p1l22t1047r119b1069],
81	of	IN	O	of	dep	137	SENT_8	[p1l128t1047r154b1074],
82	Pneumology	NNP	O	Pneumology	dep	137	SENT_8	[p1l158t1047r310b1074],
83	,	,	O	,	_	0	SENT_8	[p1l158t1047r310b1074],
84	AUSL	NNP	O	AUSL	dep	137	SENT_8	[p1l317t1048r380b1069],
85	Miranclola	NNP	O	Miranclola	dep	137	SENT_8	[p1l387t1047r517b1072],
86	,	,	O	,	_	0	SENT_8	[p1l387t1047r517b1072],
87	Modena	NNP	LOCATION	Modena	dep	137	SENT_8	[p1l527t1047r629b1072],
88	,	,	O	,	_	0	SENT_8	[p1l527t1047r629b1072],
89	Italy	NNP	LOCATION	Italy	dep	137	SENT_8	[p1l638t1047r692b1074],
90	'	POS	O	'	_	0	SENT_8	[p1l6t1080r16b1095],
91	1	CD	NUMBER	1	dep	137	SENT_8	[p1l6t1080r16b1095],
92	Department	NNP	O	Department	dep	137	SENT_8	[p1l24t1084r170b1110],
93	of	IN	O	of	dep	137	SENT_8	[p1l177t1083r204b1110],
94	Experimental	JJ	O	experimental	dep	137	SENT_8	[p1l207t1083r367b1110],
95	and	CC	O	and	dep	137	SENT_8	[p1l375t1083r420b1105],
96	Applied	NNP	ORGANIZATION	Applied	dep	137	SENT_8	[p1l426t1083r518b1110],
97	Medicine	NNP	ORGANIZATION	Medicine	dep	137	SENT_8	[p1l526t1083r641b1108],
98	,	,	O	,	_	0	SENT_8	[p1l526t1083r641b1108],
99	Laboratory	NNP	ORGANIZATION	Laboratory	dep	137	SENT_8	[p1l650t1083r781b1110],
100	of	IN	ORGANIZATION	of	dep	137	SENT_8	[p1l790t1083r816b1110],
101	Industrial	NNP	ORGANIZATION	Industrial	dep	137	SENT_8	[p1l819t1083r936b1105],
102	Toxicology	NNP	ORGANIZATION	Toxicology	dep	137	SENT_8	[p1l944t1083r1073b1110],
103	,	,	O	,	_	0	SENT_8	[p1l944t1083r1073b1110],
104	University	NNP	ORGANIZATION	University	dep	137	SENT_8	[p1l1084t1083r1205b1110],
105	Hospital	NNP	ORGANIZATION	Hospital	dep	137	SENT_8	[p1l1213t1083r1313b1110],
106	of	IN	ORGANIZATION	of	dep	137	SENT_8	[p1l1322t1083r1348b1110],
107	Brescia	NNP	ORGANIZATION	Brescia	dep	137	SENT_8	[p1l1351t1083r1441b1108],
108	,	,	O	,	_	0	SENT_8	[p1l1351t1083r1441b1108],
109	Italy	NNP	LOCATION	Italy	dep	137	SENT_8	[p1l1450t1083r1504b1110],
110	9	CD	NUMBER	9	dep	137	SENT_8	[p1l6t1119r15b1130],
111	Department	NNP	ORGANIZATION	Department	dep	137	SENT_8	[p1l23t1120r169b1145],
112	of	IN	ORGANIZATION	of	dep	137	SENT_8	[p1l176t1118r202b1145],
113	Pathology	NNP	ORGANIZATION	Pathology	dep	137	SENT_8	[p1l205t1118r328b1145],
114	,	,	O	,	_	0	SENT_8	[p1l205t1118r328b1145],
115	University	NNP	ORGANIZATION	University	dep	137	SENT_8	[p1l339t1119r461b1145],
116	Hospital	NNP	ORGANIZATION	Hospital	dep	137	SENT_8	[p1l468t1118r569b1145],
117	of	IN	ORGANIZATION	of	dep	137	SENT_8	[p1l577t1118r603b1145],
118	Parma	NNP	ORGANIZATION	Parma	dep	137	SENT_8	[p1l606t1120r689b1143],
119	,	,	O	,	_	0	SENT_8	[p1l606t1120r689b1143],
120	Italy	NNP	LOCATION	Italy	dep	137	SENT_8	[p1l698t1118r752b1145],
121	‘	NNP	O	‘	dep	137	SENT_8	[p1l6t1150r14b1165],
122	Clinical	JJ	O	clinical	dep	137	SENT_8	[p1l22t1153r110b1175],
123	Trials	NNS	O	trial	dep	137	SENT_8	[p1l119t1153r183b1175],
124	Coordinating	VBG	O	coordinate	dep	137	SENT_8	[p1l192t1153r349b1180],
125	Center	NNP	O	Center	dep	137	SENT_8	[p1l356t1155r437b1178],
126	,	,	O	,	_	0	SENT_8	[p1l356t1155r437b1178],
127	Istituto	NNP	PERSON	Istituto	dep	137	SENT_8	[p1l446t1154r532b1175],
128	Toscano	NNP	PERSON	Toscano	dep	137	SENT_8	[p1l541t1155r635b1175],
129	Tumori	NNP	PERSON	Tumori	dep	137	SENT_8	[p1l644t1154r735b1178],
130	,	,	O	,	_	0	SENT_8	[p1l644t1154r735b1178],
131	University	NNP	ORGANIZATION	University	dep	137	SENT_8	[p1l745t1154r867b1180],
132	Hospital	NNP	ORGANIZATION	Hospital	dep	137	SENT_8	[p1l875t1153r975b1180],
133	Careggi	NNP	ORGANIZATION	Careggi	dep	137	SENT_8	[p1l984t1154r1078b1180],
134	,	,	O	,	_	0	SENT_8	[p1l984t1154r1078b1180],
135	Firenze	NNP	O	Firenze	dep	137	SENT_8	[p1l1086t1154r1177b1178],
136	,	,	O	,	_	0	SENT_8	[p1l1086t1154r1177b1178],
137	Italy	NNP	LOCATION	Italy	_	0	SENT_8	[p1l1186t1153r1241b1180],

1	ARTICLE	NN	O	article	_	0	SENT_9	[p1l6t1289r232b1312],
2	INFO	NN	O	info	nn	3	SENT_9	[p1l277t1289r400b1312],
3	ABSTRACT	NN	O	abstract	dep	1	SENT_9	[p1l701t1289r972b1312],

1	Article	NNP	O	Article	nn	2	SENT_10	[p1l6t1368r86b1390],
2	history	NN	O	history	_	0	SENT_10	[p1l99t1368r188b1395],
3	-	:	O	-	_	0	SENT_10	[p1l99t1368r188b1395],
4	‘	NN	O	‘	dep	2	SENT_10	[p1l99t1368r188b1395],
5	A	DT	O	a	det	6	SENT_10	[p1l712t1371r732b1394],
6	number	NN	O	number	nsubj	14	SENT_10	[p1l746t1370r859b1394],
7	of	IN	O	of	_	0	SENT_10	[p1l873t1370r902b1394],
8	different	JJ	O	different	amod	10	SENT_10	[p1l914t1370r1036b1394],
9	clinical	JJ	O	clinical	amod	10	SENT_10	[p1l1051t1370r1150b1394],
10	characteristics	NNS	O	characteristic	prep_of	6	SENT_10	[p1l1166t1370r1369b1394],
11	and	CC	O	and	_	0	SENT_10	[p1l1384t1370r1436b1394],
12	molecular	JJ	O	molecular	amod	13	SENT_10	[p1l1451t1370r1594b1394],
13	markers	NNS	O	marker	conj_and	10	SENT_10	[p1l1608t1370r1722b1394],
14	related	VBN	O	relate	rcmod	4	SENT_10	[p1l1738t1370r1836b1394],
15	to	TO	O	to	_	0	SENT_10	[p1l1851t1373r1878b1394],
16	epidermal	JJ	O	epidermal	amod	18	SENT_10	[p1l1893t1370r2037b1400],
17	growth	NN	O	growth	nn	18	SENT_10	[p1l2052t1370r2154b1400],
18	factor	NN	O	factor	prep_to	14	SENT_10	[p1l6t1409r87b1433],
19	Received	VBN	O	receive	partmod	18	SENT_10	[p1l7t1437r117b1458],
20	17	CD	DATE	17	num	21	SENT_10	[p1l128t1438r153b1458],
21	December	NNP	DATE	December	dobj	19	SENT_10	[p1l163t1437r292b1458],
22	2008	CD	DATE	2008	num	21	SENT_10	[p1l299t1438r362b1458],
23	Received	VBN	O	receive	partmod	21	SENT_10	[p1l7t1472r117b1494],
24	in	IN	O	in	_	0	SENT_10	[p1l126t1473r150b1494],
25	revised	JJ	O	revised	amod	26	SENT_10	[p1l158t1472r248b1494],
26	form	NN	O	form	prep_in	23	SENT_10	[p1l257t1472r317b1494],
27	30	CD	DATE	30	num	26	SENT_10	[p1l325t1474r356b1494],
28	March	NNP	DATE	March	tmod	26	SENT_10	[p1l365t1472r444b1494],
29	2009	CD	DATE	2009	num	28	SENT_10	[p1l452t1474r515b1494],
30	Accepted	JJ	O	accepted	amod	31	SENT_10	[p1l6t1508r121b1535],
31	26	CD	DATE	26	tmod	23	SENT_10	[p1l130t1509r160b1530],
32	April	NNP	DATE	April	dep	31	SENT_10	[p1l168t1508r229b1535],
33	2009	CD	DATE	2009	num	32	SENT_10	[p1l238t1509r301b1530],

1	receptor	NN	O	receptor	nsubj	20	SENT_11	[p1l6t1624r124b1651],
2	(	CD	NUMBER	(	num	5	SENT_11	[p1l133t1621r228b1651],
3	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_11	[p1l133t1621r228b1651],
4	)	NN	O	)	nn	5	SENT_11	[p1l133t1621r228b1651],
5	activation	NN	O	activation	nsubjpass	8	SENT_11	[p1l238t1621r377b1645],
6	have	VBP	O	have	aux	8	SENT_11	[p1l387t1621r451b1645],
7	been	VBN	O	be	auxpass	8	SENT_11	[p1l461t1621r529b1645],
8	reported	VBN	O	report	rcmod	1	SENT_11	[p1l539t1621r660b1651],
9	to	TO	O	to	aux	11	SENT_11	[p1l670t1624r697b1645],
10	singly	RB	O	singly	advmod	11	SENT_11	[p1l707t1621r790b1651],
11	correlate	VB	O	correlate	xcomp	8	SENT_11	[p1l799t1621r923b1645],
12	with	IN	O	with	_	0	SENT_11	[p1l933t1621r998b1645],
13	therapeutic	JJ	O	therapeutic	amod	14	SENT_11	[p1l1007t1621r1170b1651],
14	activity	NN	O	activity	prep_with	11	SENT_11	[p1l1179t1621r1284b1651],
15	of	IN	O	of	_	0	SENT_11	[p1l1293t1621r1322b1645],
16	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_11	[p1l1329t1622r1402b1645],
17	tyrosine	NN	O	tyrosine	nn	19	SENT_11	[p1l1410t1624r1480b1651, p1l6t1661r62b1685],
18	kinase	NN	O	kinase	nn	19	SENT_11	[p1l72t1661r161b1685],
19	inhibitors	NNS	O	inhibitor	prep_of	14	SENT_11	[p1l171t1661r307b1685],
20	(	VBP	O	(	_	0	SENT_11	[p1l317t1661r399b1691],
21	TKIs	NNS	O	tki	dobj	20	SENT_11	[p1l317t1661r399b1691],
22	)	CD	NUMBER	)	num	21	SENT_11	[p1l317t1661r399b1691],
23	in	IN	O	in	_	0	SENT_11	[p1l409t1661r435b1685],
24	advanced	JJ	O	advanced	amod	26	SENT_11	[p1l444t1661r578b1685],
25	non	JJ	O	non	amod	26	SENT_11	[p1l588t1661r731b1685],
26	—	NN	O	—	prep_in	21	SENT_11	[p1l588t1661r731b1685],
27	small	JJ	O	small	amod	33	SENT_11	[p1l588t1661r731b1685],
28	cell	NN	O	cell	nn	33	SENT_11	[p1l740t1661r788b1685],
29	lung	NN	O	lung	nn	33	SENT_11	[p1l798t1661r860b1691],
30	cancer	NN	O	cancer	nn	33	SENT_11	[p1l869t1668r961b1685],
31	(	CD	NUMBER	(	num	33	SENT_11	[p1l970t1661r1090b1691],
32	NSCLC	NN	O	nsclc	nn	33	SENT_11	[p1l970t1661r1090b1691],
33	)	NN	O	)	dep	26	SENT_11	[p1l970t1661r1090b1691],
34	.	.	O	.	_	0	SENT_11	[p1l970t1661r1090b1691],

1	This	DT	O	this	det	2	SENT_12	[p1l1099t1661r1157b1685],
2	study	NN	O	study	_	0	SENT_12	[p1l1167t1661r1245b1691],
3	was	VBD	O	be	auxpass	4	SENT_12	[p1l1253t1668r1307b1685],
4	designed	VBN	O	design	partmod	2	SENT_12	[p1l1317t1661r1444b1691],
5	to	TO	O	to	aux	6	SENT_12	[p1l1453t1664r1480b1685],
6	evaluate	VB	O	evaluate	xcomp	4	SENT_12	[p1l6t1701r124b1725],
7	the	DT	O	the	det	9	SENT_12	[p1l132t1701r177b1725],
8	predictive	JJ	O	predictive	amod	9	SENT_12	[p1l186t1701r327b1731],
9	value	NN	O	value	dobj	6	SENT_12	[p1l335t1701r410b1725],
10	on	IN	O	on	_	0	SENT_12	[p1l419t1708r453b1725],
11	geﬁtinib	NN	O	geﬁtinib	nn	12	SENT_12	[p1l461t1701r579b1731],
12	outcomes	NNS	O	outcome	prep_on	6	SENT_12	[p1l587t1705r724b1725],
13	of	IN	O	of	_	0	SENT_12	[p1l733t1701r763b1725],
14	a	DT	O	a	det	16	SENT_12	[p1l768t1708r782b1725],
15	comprehensive	JJ	O	comprehensive	amod	16	SENT_12	[p1l791t1701r1006b1731],
16	panel	NN	O	panel	prep_of	12	SENT_12	[p1l1015t1701r1092b1731],
17	of	IN	O	of	_	0	SENT_12	[p1l1101t1701r1130b1725],
18	molecular	JJ	O	molecular	amod	19	SENT_12	[p1l1135t1701r1278b1725],
19	parameters	NNS	O	parameter	prep_of	16	SENT_12	[p1l1285t1705r1445b1731],
20	in	IN	O	in	_	0	SENT_12	[p1l1454t1701r1480b1725],
21	Keywords	NNS	O	keyword	prep_in	19	SENT_12	[p1l6t1757r131b1784],
22	:	:	O	:	_	0	SENT_12	[p1l6t1757r131b1784],
23	NSCLC	NNP	O	NSCLC	nn	24	SENT_12	[p1l7t1794r88b1814],
24	Geﬁtinib	NNP	O	Geﬁtinib	dep	2	SENT_12	[p1l7t1828r116b1850],
25	EGFR	NN	ORGANIZATION	egfr	nn	29	SENT_12	[p1l6t1865r68b1885],
26	gene	NN	O	gene	nn	29	SENT_12	[p1l74t1870r132b1891],
27	mutation	NN	O	mutation	nn	29	SENT_12	[p1l140t1864r256b1885],
28	EGFR	NN	ORGANIZATION	egfr	nn	29	SENT_12	[p1l6t1901r68b1921],
29	FISH	NN	O	fish	dep	24	SENT_12	[p1l77t1901r132b1921],

1	advanced	JJ	O	advanced	amod	2	SENT_13	[p1l6t1996r140b2020],
2	NSCLC	NN	O	nsclc	_	0	SENT_13	[p1l151t1997r241b2020],
3	patients	NNS	O	patient	dep	2	SENT_13	[p1l251t1996r372b2026],
4	.	.	O	.	_	0	SENT_13	[p1l251t1996r372b2026],

1	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_14	[p1l382t1997r452b2020],
2	and	CC	O	and	_	0	SENT_14	[p1l462t1996r514b2020],
3	K-ras	NN	O	k-ra	nn	4	SENT_14	[p1l523t1997r594b2020],
4	mutations	NNS	O	mutation	nsubjpass	6	SENT_14	[p1l605t1996r748b2020],
5	were	VBD	O	be	auxpass	6	SENT_14	[p1l759t2003r828b2020],
6	detected	VBN	O	detect	_	0	SENT_14	[p1l839t1996r960b2020],
7	by	IN	O	by	_	0	SENT_14	[p1l971t1996r1004b2026],
8	direct	JJ	O	direct	amod	9	SENT_14	[p1l1014t1996r1096b2020],
9	sequencing	NN	O	sequencing	agent	6	SENT_14	[p1l1106t1996r1266b2026],
10	on	IN	O	on	_	0	SENT_14	[p1l1276t2003r1310b2020],
11	tumor	NN	O	tumor	nn	12	SENT_14	[p1l1320t2000r1409b2020],
12	DNA	NN	O	dna	prep_on	9	SENT_14	[p1l1419t1997r1482b2020],
13	from	IN	O	from	_	0	SENT_14	[p1l6t2036r73b2060],
14	parafﬁn	NN	O	parafﬁn	nn	16	SENT_14	[p1l83t2036r193b2066],
15	embedded	JJ	O	embedded	amod	16	SENT_14	[p1l202t2036r352b2060],
16	samples	NNS	O	sample	prep_from	6	SENT_14	[p1l362t2036r484b2066],
17	.	.	O	.	_	0	SENT_14	[p1l362t2036r484b2066],

1	EGFR	NN	ORGANIZATION	egfr	nsubjpass	8	SENT_15	[p1l493t2037r562b2060],
2	and	CC	O	and	_	0	SENT_15	[p1l571t2036r623b2060],
3	HER2	NN	O	her2	nn	6	SENT_15	[p1l631t2037r705b2060],
4	gene	NN	O	gene	nn	6	SENT_15	[p1l712t2043r776b2066],
5	copy	NN	O	copy	nn	6	SENT_15	[p1l786t2043r852b2066],
6	number	NN	O	number	conj_and	1	SENT_15	[p1l861t2036r973b2060],
7	was	VBD	O	be	auxpass	8	SENT_15	[p1l981t2043r1035b2060],
8	assessed	VBN	O	assess	_	0	SENT_15	[p1l1045t2036r1166b2060],
9	by	IN	O	by	_	0	SENT_15	[p1l1175t2036r1209b2066],
10	FISH	NN	O	fish	agent	8	SENT_15	[p1l1218t2037r1287b2060],
11	.	.	O	.	_	0	SENT_15	[p1l1218t2037r1287b2060],

1	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_16	[p1l1298t2037r1371b2060],
2	protein	NN	O	protein	nn	3	SENT_16	[p1l1379t2036r1481b2066],
3	expression	NN	O	expression	nsubjpass	5	SENT_16	[p1l6t2076r158b2106],
4	was	VBD	O	be	auxpass	5	SENT_16	[p1l170t2083r224b2100],
5	quantiﬁed	VBN	O	quantiﬁed	_	0	SENT_16	[p1l237t2076r381b2106],
6	by	IN	O	by	_	0	SENT_16	[p1l393t2076r427b2106],
7	immunohistochemistry	NN	O	immunohistochemistry	agent	5	SENT_16	[p1l439t2076r778b2106],
8	.	.	O	.	_	0	SENT_16	[p1l439t2076r778b2106],

1	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_17	[p1l790t2077r860b2100],
2	gene	NN	O	gene	nn	3	SENT_17	[p1l869t2083r934b2106],
3	intron	NN	O	intron	nsubjpass	7	SENT_17	[p1l946t2076r1032b2100],
4	1	CD	NUMBER	1	num	5	SENT_17	[p1l1046t2077r1057b2100],
5	polymorphism	NN	O	polymorphism	dep	3	SENT_17	[p1l1073t2076r1282b2106],
6	was	VBD	O	be	auxpass	7	SENT_17	[p1l1293t2083r1347b2100],
7	assessed	VBN	O	assess	_	0	SENT_17	[p1l1360t2076r1481b2100],
8	on	IN	O	on	_	0	SENT_17	[p1l6t2123r41b2140],
9	genomic	JJ	O	genomic	amod	10	SENT_17	[p1l54t2116r175b2146],
10	DNA	NN	O	dna	prep_on	7	SENT_17	[p1l188t2117r251b2140],
11	isolated	VBN	O	isolate	partmod	10	SENT_17	[p1l264t2116r374b2140],
12	from	IN	O	from	_	0	SENT_17	[p1l388t2116r455b2140],
13	venous	JJ	O	venous	amod	16	SENT_17	[p1l467t2123r567b2140],
14	whole	JJ	O	whole	amod	16	SENT_17	[p1l581t2116r668b2140],
15	blood	NN	O	blood	nn	16	SENT_17	[p1l681t2116r760b2140],
16	samples	NNS	O	sample	prep_from	11	SENT_17	[p1l774t2116r896b2146],
17	.	.	O	.	_	0	SENT_17	[p1l774t2116r896b2146],

1	Ninety-one	CD	NUMBER	ninety-one	num	2	SENT_18	[p1l910t2116r1068b2146],
2	patients	NNS	O	patient	nsubjpass	5	SENT_18	[p1l1082t2116r1195b2146],
3	were	VBD	O	be	auxpass	5	SENT_18	[p1l1208t2123r1278b2140],
4	prospectively	RB	O	prospectively	advmod	5	SENT_18	[p1l1292t2116r1482b2146],
5	enrolled	VBN	O	enrol	_	0	SENT_18	[p1l6t2156r123b2180],
6	and	CC	O	and	_	0	SENT_18	[p1l136t2156r188b2180],
7	the	DT	O	the	det	11	SENT_18	[p1l201t2156r246b2180],
8	overall	JJ	O	overall	amod	11	SENT_18	[p1l259t2156r354b2180],
9	geﬁtinib	NN	O	geﬁtinib	nn	11	SENT_18	[p1l367t2156r485b2186],
10	response	NN	O	response	nn	11	SENT_18	[p1l499t2163r624b2186],
11	rate	NN	O	rate	nsubj	14	SENT_18	[p1l638t2159r691b2180],
12	was	VBD	O	be	cop	14	SENT_18	[p1l704t2163r758b2180],
13	18.7	CD	PERCENT	18.7	num	14	SENT_18	[p1l774t2157r848b2180],
14	%	NN	PERCENT	%	conj_and	5	SENT_18	[p1l774t2157r848b2180],
15	(	CD	NUMBER	(	number	16	SENT_18	[p1l862t2156r888b2186],
16	2	CD	NUMBER	2	num	14	SENT_18	[p1l862t2156r888b2186],
17	complete	JJ	O	complete	amod	14	SENT_18	[p1l903t2156r1033b2186],
18	and	CC	O	and	_	0	SENT_18	[p1l1047t2156r1098b2180],
19	15	CD	NUMBER	15	num	21	SENT_18	[p1l1113t2157r1142b2180],
20	partial	JJ	O	partial	amod	21	SENT_18	[p1l1157t2156r1248b2186],
21	responses	NNS	O	response	conj_and	5	SENT_18	[p1l1262t2156r1420b2186],
22	)	NN	O	)	dep	21	SENT_18	[p1l1262t2156r1420b2186],
23	.	.	O	.	_	0	SENT_18	[p1l1262t2156r1420b2186],

1	Sex	NN	O	sex	nn	6	SENT_19	[p1l1434t2157r1482b2180],
2	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_19	[p1l6t2201r68b2222],
3	gene	NN	O	gene	nn	6	SENT_19	[p1l76t2207r133b2227],
4	powmorphism	NN	O	powmorphism	nn	6	SENT_19	[p1l144t2200r329b2227],
5	(	NN	O	(	nn	6	SENT_19	[p1l707t2193r733b2223],
6	p	NN	O	p	_	0	SENT_19	[p1l707t2193r733b2223],
7	=	JJ	O	=	amod	9	SENT_19	[p1l743t2203r757b2210],
8	0.005	CD	NUMBER	0.005	tmod	7	SENT_19	[p1l767t2193r863b2223],
9	)	NN	O	)	dep	6	SENT_19	[p1l767t2193r863b2223],
10	,	,	O	,	_	0	SENT_19	[p1l767t2193r863b2223],
11	non-smoking	JJ	O	non-smoking	amod	13	SENT_19	[p1l876t2193r1065b2223],
12	status	NN	O	status	nn	13	SENT_19	[p1l1077t2196r1160b2217],
13	(	NN	O	(	appos	9	SENT_19	[p1l1173t2193r1199b2223],
14	1	CD	NUMBER	1	dep	6	SENT_19	[p1l1173t2193r1199b2223],
15	:	:	O	:	_	0	SENT_19	[p1l1173t2193r1199b2223],
16	=	JJ	O	=	amod	18	SENT_19	[p1l1208t2203r1223b2210],
17	0.010	CD	NUMBER	0.010	tmod	16	SENT_19	[p1l1232t2193r1324b2223],
18	)	NN	O	)	dep	14	SENT_19	[p1l1232t2193r1324b2223],
19	.	.	O	.	_	0	SENT_19	[p1l1232t2193r1324b2223],

1	skin	NN	O	skin	nn	3	SENT_20	[p1l1338t2193r1395b2217],
2	toxicity	NN	O	toxicity	nn	3	SENT_20	[p1l1406t2193r1513b2223],
3	(	NN	O	(	_	0	SENT_20	[p1l1525t2193r1551b2223],
4	1	CD	NUMBER	1	dep	3	SENT_20	[p1l1525t2193r1551b2223],
5	:	:	O	:	_	0	SENT_20	[p1l1525t2193r1551b2223],
6	=	JJ	O	=	dep	3	SENT_20	[p1l1560t2203r1575b2210],
7	0.020	CD	NUMBER	0.020	num	8	SENT_20	[p1l1584t2193r1679b2223],
8	)	NN	O	)	dep	6	SENT_20	[p1l1584t2193r1679b2223],
9	.	.	O	.	_	0	SENT_20	[p1l1584t2193r1679b2223],

1	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_21	[p1l1692t2194r1761b2217],
2	gene	NN	O	gene	nn	3	SENT_21	[p1l1770t2200r1835b2223],
3	mutations	NNS	O	mutation	nsubj	4	SENT_21	[p1l1848t2193r1991b2217],
4	(	VBP	O	(	_	0	SENT_21	[p1l2004t2193r2031b2223],
5	p	NN	O	p	nsubjpass	22	SENT_21	[p1l2004t2193r2031b2223],
6	<	JJR	O	<	dep	22	SENT_21	[p1l2040t2198r2054b2213],
7	0.001	CD	NUMBER	0.001	num	8	SENT_21	[p1l2063t2193r2154b2223],
8	)	NN	O	)	dep	15	SENT_21	[p1l2063t2193r2154b2223],
9	and	CC	O	and	_	0	SENT_21	[p1l6t2232r57b2257],
10	Biological	JJ	O	biological	amod	12	SENT_21	[p1l74t2236r195b2263],
11	predictive	JJ	O	predictive	amod	12	SENT_21	[p1l211t2236r337b2263],
12	factors	NNS	O	factor	conj_and	8	SENT_21	[p1l352t2235r436b2257],
13	EGFR	NN	ORGANIZATION	egfr	dep	15	SENT_21	[p1l788t2233r858b2257],
14	FISH	NN	O	fish	nn	15	SENT_21	[p1l875t2233r937b2257],
15	positivity	NN	O	positivity	dep	22	SENT_21	[p1l955t2232r1088b2263],
16	(	CD	NUMBER	(	num	17	SENT_21	[p1l1104t2232r1130b2263],
17	p	NN	O	p	dep	15	SENT_21	[p1l1104t2232r1130b2263],
18	=	JJ	O	=	amod	20	SENT_21	[p1l1145t2242r1159b2250],
19	0.016	CD	NUMBER	0.016	num	20	SENT_21	[p1l1174t2232r1259b2263],
20	)	NN	O	)	nsubjpass	22	SENT_21	[p1l1174t2232r1259b2263],
21	were	VBD	O	be	auxpass	22	SENT_21	[p1l1275t2239r1345b2257],
22	found	VBN	O	find	xcomp	4	SENT_21	[p1l1363t2232r1444b2257],
23	to	TO	O	to	aux	25	SENT_21	[p1l1461t2236r1488b2257],
24	be	VB	O	be	auxpass	25	SENT_21	[p1l1505t2232r1538b2257],
25	associated	VBN	O	associate	xcomp	22	SENT_21	[p1l1554t2232r1700b2257],
26	with	IN	O	with	_	0	SENT_21	[p1l1717t2232r1782b2257],
27	geﬁtinib	NN	O	geﬁtinib	nn	28	SENT_21	[p1l1799t2232r1916b2263],
28	response	NN	O	response	prep_with	25	SENT_21	[p1l1934t2239r2066b2263],
29	.	.	O	.	_	0	SENT_21	[p1l1934t2239r2066b2263],

1	K-ras	NN	O	k-ra	nn	2	SENT_22	[p1l2083t2234r2154b2257],
2	mutation	NN	O	mutation	nsubjpass	4	SENT_22	[p1l6t2273r137b2297],
3	was	VBD	O	be	auxpass	4	SENT_22	[p1l146t2280r200b2297],
4	detected	VBN	O	detect	_	0	SENT_22	[p1l6t2313r127b2337],
5	in	IN	O	in	_	0	SENT_22	[p1l148t2313r174b2337],
6	only	RB	O	only	quantmod	7	SENT_22	[p1l194t2313r255b2343],
7	seven	CD	NUMBER	seven	num	9	SENT_22	[p1l275t2320r354b2337],
8	non-responder	JJ	O	non-responder	amod	9	SENT_22	[p1l375t2313r587b2343],
9	patients	NNS	O	patient	prep_in	4	SENT_22	[p1l607t2313r728b2343],
10	.	.	O	.	_	0	SENT_22	[p1l607t2313r728b2343],

1	The	DT	O	the	det	4	SENT_23	[p1l747t2313r799b2337],
2	median	JJ	O	median	amod	4	SENT_23	[p1l819t2313r926b2337],
3	overall	JJ	O	overall	amod	4	SENT_23	[p1l946t2313r1040b2337],
4	survival	NN	O	survival	nsubj	5	SENT_23	[p1l1061t2313r1171b2337],
5	was	VBD	O	be	_	0	SENT_23	[p1l1191t2320r1246b2337],
6	of	IN	O	of	_	0	SENT_23	[p1l1266t2313r1296b2337],
7	10	CD	DURATION	10	num	8	SENT_23	[p1l1314t2314r1344b2337],
8	months	NNS	NUMBER	month	prep_of	5	SENT_23	[p1l1365t2313r1479b2337],
9	.	.	O	.	_	0	SENT_23	[p1l1365t2313r1479b2337],

1	Only	RB	O	only	advmod	3	SENT_24	[p1l1500t2313r1566b2343],
2	non-smoking	JJ	O	non-smoking	amod	3	SENT_24	[p1l1583t2313r1772b2343],
3	status	NN	O	status	nsubj	9	SENT_24	[p1l1787t2316r1870b2337],
4	and	CC	O	and	_	0	SENT_24	[p1l1886t2313r1938b2337],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_24	[p1l1953t2314r2023b2337],
6	intron	NN	O	intron	conj_and	3	SENT_24	[p1l2039t2313r2125b2337],
7	1	CD	NUMBER	1	num	8	SENT_24	[p1l2143t2314r2154b2337],
8	polymorphism	NN	O	polymorphism	dep	6	SENT_24	[p1l6t2352r214b2383],
9	showed	VBD	O	show	_	0	SENT_24	[p1l226t2352r334b2377],
10	a	DT	O	a	det	13	SENT_24	[p1l346t2359r360b2377],
11	statistically	RB	O	statistically	advmod	12	SENT_24	[p1l371t2352r533b2383],
12	signiﬁcant	JJ	O	signiﬁcant	amod	13	SENT_24	[p1l543t2352r691b2383],
13	correlation	NN	O	correlation	dobj	9	SENT_24	[p1l701t2352r856b2377],
14	with	IN	O	with	_	0	SENT_24	[p1l866t2352r931b2377],
15	survival	NN	O	survival	nn	17	SENT_24	[p1l943t2352r1052b2377],
16	(	CD	NUMBER	(	num	17	SENT_24	[p1l1062t2352r1089b2383],
17	p	NN	O	p	prep_with	9	SENT_24	[p1l1062t2352r1089b2383],
18	=	JJ	O	=	amod	17	SENT_24	[p1l1097t2362r1112b2370],
19	0.031	CD	NUMBER	0.031	tmod	18	SENT_24	[p1l1121t2353r1193b2377],
20	and	CC	O	and	_	0	SENT_24	[p1l1206t2352r1257b2377],
21	0.044	CD	NUMBER	0.044	conj_and	19	SENT_24	[p1l1267t2353r1352b2380],
22	,	,	O	,	_	0	SENT_24	[p1l1267t2353r1352b2380],
23	respectively	RB	O	respectively	advmod	17	SENT_24	[p1l1363t2352r1550b2383],
24	)	CD	NUMBER	)	dep	17	SENT_24	[p1l1363t2352r1550b2383],
25	.	.	O	.	_	0	SENT_24	[p1l1363t2352r1550b2383],

1	In	IN	O	in	_	0	SENT_25	[p1l1560t2354r1587b2376],
2	conclusion	NN	O	conclusion	pobj	1	SENT_25	[p1l1597t2352r1755b2380],
3	.	.	O	.	_	0	SENT_25	[p1l1597t2352r1755b2380],

1	we	PRP	O	we	nsubj	3	SENT_26	[p1l1765t2359r1806b2377],
2	have	VBP	O	have	aux	3	SENT_26	[p1l1816t2352r1881b2377],
3	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_26	[p1l1891t2352r2036b2377],
4	the	DT	O	the	det	5	SENT_26	[p1l2046t2352r2090b2377],
5	role	NN	O	role	dobj	3	SENT_26	[p1l2101t2352r2154b2377],
6	of	IN	O	of	_	0	SENT_26	[p1l6t2392r35b2417],
7	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_26	[p1l40t2393r110b2417],
8	gene	NN	O	gene	nn	9	SENT_26	[p1l115t2399r180b2423],
9	muta	NN	O	muta	prep_of	5	SENT_26	[p1l191t2396r276b2417],
10	—	CD	NUMBER	—	num	11	SENT_26	[p1l191t2396r276b2417],
11	tion	NN	O	tion	dep	20	SENT_26	[p1l289t2392r344b2417],
12	as	IN	O	as	dep	20	SENT_26	[p1l356t2399r384b2417],
13	predictor	NN	O	predictor	nsubj	20	SENT_26	[p1l397t2392r527b2423],
14	of	IN	O	of	_	0	SENT_26	[p1l539t2392r568b2417],
15	response	NN	O	response	prep_of	13	SENT_26	[p1l577t2399r703b2423],
16	to	TO	O	to	_	0	SENT_26	[p1l715t2396r741b2417],
17	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_26	[p1l754t2393r828b2417],
18	TI	NNP	O	TI	nn	19	SENT_26	[p1l838t2393r905b2417],
19	(	NNP	O	(	prep_to	15	SENT_26	[p1l838t2393r905b2417],
20	Is	VBZ	O	be	dep	3	SENT_26	[p1l838t2393r905b2417],
21	.	.	O	.	_	0	SENT_26	[p1l838t2393r905b2417],

1	Moreover	RB	O	moreover	_	0	SENT_27	[p1l918t2393r1058b2420],
2	.	.	O	.	_	0	SENT_27	[p1l918t2393r1058b2420],

1	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_28	[p1l1070t2393r1140b2417],
2	gene	NN	O	gene	nn	4	SENT_28	[p1l1149t2399r1214b2423],
3	copy	NN	O	copy	nn	4	SENT_28	[p1l1226t2399r1292b2423],
4	number	NN	O	number	nsubj	15	SENT_28	[p1l1304t2392r1417b2417],
5	and	CC	O	and	_	0	SENT_28	[p1l1428t2392r1486b2420],
6	,	,	O	,	_	0	SENT_28	[p1l1428t2392r1486b2420],
7	potentially	RB	O	potentially	dep	4	SENT_28	[p1l1499t2392r1656b2423],
8	,	,	O	,	_	0	SENT_28	[p1l1499t2392r1656b2423],
9	also	RB	O	also	advmod	10	SENT_28	[p1l1669t2392r1724b2417],
10	EGFR	NN	ORGANIZATION	egfr	conj_and	4	SENT_28	[p1l1736t2393r1806b2417],
11	intron	NN	O	intron	nn	13	SENT_28	[p1l1818t2393r1904b2417],
12	1	CD	NUMBER	1	num	13	SENT_28	[p1l1918t2394r1929b2417],
13	polymorphism	NN	O	polymorphism	dep	4	SENT_28	[p1l1945t2392r2154b2423],
14	could	MD	O	could	aux	15	SENT_28	[p1l1057t2432r1134b2456],
15	aid	VB	O	aid	_	0	SENT_28	[p1l1144t2432r1185b2456],
16	in	IN	O	in	_	0	SENT_28	[p1l1196t2432r1222b2456],
17	better	JJR	O	better	amod	18	SENT_28	[p1l1231t2432r1317b2456],
18	prediction	NN	O	prediction	prep_in	15	SENT_28	[p1l1326t2432r1471b2462],
19	of	IN	O	of	_	0	SENT_28	[p1l1481t2432r1510b2456],
20	EGFR	NN	O	egfr	nn	22	SENT_28	[p1l1517t2433r1590b2456],
21	TKI	NN	O	tkus	nn	22	SENT_28	[p1l1598t2433r1644b2456],
22	responsiveness	NN	O	responsiveness	prep_of	18	SENT_28	[p1l1654t2432r1867b2462],
23	in	IN	O	in	_	0	SENT_28	[p1l1878t2432r1904b2456],
24	advanced	JJ	O	advanced	amod	25	SENT_28	[p1l1913t2432r2047b2456],
25	NSCLC	NNP	O	NSCLC	prep_in	22	SENT_28	[p1l2057t2433r2154b2456],
26	.	.	O	.	_	0	SENT_28	[p1l2057t2433r2154b2456],

1	1	LS	NUMBER	1	_	0	SENT_29	[p1l10t2740r57b2789],
2	.	.	O	.	_	0	SENT_29	[p1l10t2740r57b2789],

1	Introduction	NN	O	introduction	_	0	SENT_30	[p1l101t2737r515b2789],

1	Epidermal	JJ	O	epidermal	amod	4	SENT_31	[p1l106t2906r420b2971],
2	growth	NN	O	growth	nn	4	SENT_31	[p1l456t2906r676b2971],
3	factor	NN	O	factor	nn	4	SENT_31	[p1l713t2906r889b2958],
4	receptor	NN	O	receptor	nsubjpass	25	SENT_31	[p1l924t2914r1180b2971],
5	(	CD	NUMBER	(	num	7	SENT_31	[p1l1215t2906r1421b2971],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_31	[p1l1215t2906r1421b2971],
7	)	NN	O	)	nsubjpass	10	SENT_31	[p1l1215t2906r1421b2971],
8	is	VBZ	O	be	auxpass	10	SENT_31	[p1l1459t2907r1503b2958],
9	frequently	RB	O	frequently	advmod	10	SENT_31	[p1l1541t2906r1858b2971],
10	overexpressed	VBN	O	overexpress	rcmod	4	SENT_31	[p1l1893t2921r2047b2958, p1l9t2989r313b3054],
11	in	IN	O	in	_	0	SENT_31	[p1l330t2990r386b3041],
12	non	JJ	O	non	amod	20	SENT_31	[p1l403t2989r712b3041],
13	—	JJ	O	—	amod	20	SENT_31	[p1l403t2989r712b3041],
14	small	JJ	O	small	amod	20	SENT_31	[p1l403t2989r712b3041],
15	cell	NN	O	cell	nn	20	SENT_31	[p1l728t2989r831b3041],
16	lung	NN	O	lung	nn	20	SENT_31	[p1l848t2989r982b3054],
17	cancer	NN	O	cancer	nn	20	SENT_31	[p1l997t3004r1197b3041],
18	(	CD	NUMBER	(	num	20	SENT_31	[p1l1211t2989r1456b3054],
19	NSCLC	NN	O	nsclc	nn	20	SENT_31	[p1l1211t2989r1456b3054],
20	)	NN	O	)	prep_in	10	SENT_31	[p1l1211t2989r1456b3054],
21	and	CC	O	and	_	0	SENT_31	[p1l1472t2989r1583b3041],
22	its	PRP$	O	its	poss	23	SENT_31	[p1l1600t2990r1669b3041],
23	activation	NN	O	activation	prep_in	10	SENT_31	[p1l1686t2990r1987b3041],
24	is	VBZ	O	be	auxpass	25	SENT_31	[p1l2003t2990r2047b3041],
25	involved	VBN	O	involve	_	0	SENT_31	[p1l9t3073r268b3124],
26	in	IN	O	in	_	0	SENT_31	[p1l292t3073r348b3124],
27	tumor	NN	O	tumor	nn	28	SENT_31	[p1l370t3080r562b3124],
28	development	NN	O	development	prep_in	25	SENT_31	[p1l583t3073r989b3137],
29	and	CC	O	and	_	0	SENT_31	[p1l1010t3073r1121b3124],
30	progression	NN	O	progression	nn	31	SENT_31	[p1l1145t3073r1504b3137],
31	[	NN	O	[	prep_in	25	SENT_31	[p1l1529t3072r1624b3137],
32	1	CD	NUMBER	1	num	33	SENT_31	[p1l1529t3072r1624b3137],
33	]	NN	O	]	dep	28	SENT_31	[p1l1529t3072r1624b3137],
34	.	.	O	.	_	0	SENT_31	[p1l1529t3072r1624b3137],

1	Geﬁtinib	NNP	O	Geﬁtinib	nn	6	SENT_32	[p1l1648t3072r1913b3124],
2	and	CC	O	and	_	0	SENT_32	[p1l1936t3073r2047b3124],
3	erlotinib	NN	O	erlotinib	nn	6	SENT_32	[p1l9t3156r284b3215],
4	,	,	O	,	_	0	SENT_32	[p1l9t3156r284b3215],
5	small	JJ	O	small	amod	6	SENT_32	[p1l307t3156r468b3208],
6	molecules	NNS	O	molecule	nsubj	8	SENT_32	[p1l491t3156r799b3208],
7	reversibly	RB	O	reversibly	advmod	8	SENT_32	[p1l822t3156r1124b3220],
8	binding	VBG	O	bind	dep	20	SENT_32	[p1l1143t3156r1378b3220],
9	the	DT	O	the	det	11	SENT_32	[p1l1397t3156r1494b3208],
10	ATP	NN	O	atp	nn	11	SENT_32	[p1l1513t3158r1630b3207],
11	pocket	NN	O	pocket	dobj	8	SENT_32	[p1l1651t3156r1854b3220],
12	in	IN	O	in	_	0	SENT_32	[p1l1874t3157r1930b3207],
13	the	DT	O	the	det	14	SENT_32	[p1l1951t3156r2047b3208],
14	EGFR	NN	ORGANIZATION	egfr	prep_in	8	SENT_32	[p1l9t3241r168b3290],
15	intracellular	JJ	O	intracellular	amod	18	SENT_32	[p1l187t3238r563b3290],
16	tyrosine	NN	O	tyrosine	nn	18	SENT_32	[p1l581t3239r830b3303],
17	kinase	NN	O	kinase	nn	18	SENT_32	[p1l852t3238r1046b3290],
18	domain	NN	O	domain	dep	14	SENT_32	[p1l1068t3238r1314b3298],
19	,	,	O	,	_	0	SENT_32	[p1l1068t3238r1314b3298],
20	represent	VBP	O	represent	_	0	SENT_32	[p1l1337t3246r1629b3303],
21	a	DT	O	a	det	23	SENT_32	[p1l1649t3253r1680b3290],
22	new	JJ	O	new	amod	23	SENT_32	[p1l1701t3253r1831b3290],
23	option	NN	O	option	dobj	20	SENT_32	[p1l1851t3239r2048b3303],
24	in	IN	O	in	_	0	SENT_32	[p1l9t3322r65b3372],
25	the	DT	O	the	det	26	SENT_32	[p1l86t3321r183b3373],
26	treatment	NN	O	treatment	prep_in	20	SENT_32	[p1l204t3329r512b3373],
27	of	IN	O	of	_	0	SENT_32	[p1l532t3321r596b3373],
28	NSCLC	NNP	O	NSCLC	prep_of	26	SENT_32	[p1l610t3324r806b3373],
29	[	CD	NUMBER	[	num	28	SENT_32	[p1l830t3321r925b3386],
30	2	CD	NUMBER	2	num	31	SENT_32	[p1l830t3321r925b3386],
31	]	NN	O	]	nsubj	20	SENT_32	[p1l830t3321r925b3386],
32	.	.	O	.	_	0	SENT_32	[p1l830t3321r925b3386],

1	These	DT	O	these	det	2	SENT_33	[p1l103t3404r280b3456],
2	drugs	NNS	O	drug	nsubj	3	SENT_33	[p1l312t3404r481b3469],
3	produce	VBP	O	produce	_	0	SENT_33	[p1l515t3404r763b3469],
4	tumor	NN	O	tumor	nn	5	SENT_33	[p1l795t3412r987b3456],
5	regression	NN	O	regression	dobj	3	SENT_33	[p1l1017t3405r1332b3469],
6	in	IN	O	in	_	0	SENT_33	[p1l1365t3405r1421b3455],
7	10-20	CD	PERCENT	10-20	num	8	SENT_33	[p1l1456t3407r1680b3456],
8	%	NN	PERCENT	%	prep_in	5	SENT_33	[p1l1456t3407r1680b3456],
9	of	IN	O	of	_	0	SENT_33	[p1l1713t3404r1776b3456],
10	patients	NNS	O	patient	prep_of	8	SENT_33	[p1l1801t3405r2047b3469],
11	with	IN	O	with	_	0	SENT_33	[p1l7t3487r148b3539],
12	heavily	RB	O	heavily	advmod	13	SENT_33	[p1l184t3487r403b3552],
13	pretreated	JJ	O	pretreated	amod	14	SENT_33	[p1l437t3487r755b3552],
14	NSCLC	NN	LOCATION	nsclc	prep_with	10	SENT_33	[p1l792t3490r1002b3547],
15	,	,	O	,	_	0	SENT_33	[p1l792t3490r1002b3547],
16	with	IN	O	with	_	0	SENT_33	[p1l1036t3487r1177b3539],
17	mild	JJ	O	mild	amod	19	SENT_33	[p1l1213t3487r1350b3539],
18	to	TO	O	to	dep	19	SENT_33	[p1l1385t3495r1443b3539],
19	moderate	JJ	O	moderate	amod	20	SENT_33	[p1l1480t3487r1772b3539],
20	toxicity	NN	O	toxicity	prep_with	8	SENT_33	[p1l1807t3488r2047b3552],
21	,	,	O	,	_	0	SENT_33	[p1l1807t3488r2047b3552],
22	consisting	VBG	O	consist	partmod	8	SENT_33	[p1l9t3571r319b3635],
23	mainly	RB	O	mainly	advmod	22	SENT_33	[p1l351t3571r562b3635],
24	of	IN	O	of	_	0	SENT_33	[p1l592t3570r656b3622],
25	skin	NN	O	skin	nn	26	SENT_33	[p1l681t3571r805b3622],
26	rash	NN	O	rash	prep_of	8	SENT_33	[p1l837t3571r965b3622],
27	and	CC	O	and	_	0	SENT_33	[p1l996t3571r1107b3622],
28	diarrhea	NN	O	diarrhea	prep_of	8	SENT_33	[p1l1140t3571r1396b3622],
29	[	CD	NUMBER	[	number	30	SENT_33	[p1l1431t3570r1604b3635],
30	3	CD	NUMBER	3	num	31	SENT_33	[p1l1431t3570r1604b3635],
31	—	NN	O	—	dep	5	SENT_33	[p1l1431t3570r1604b3635],
32	5	CD	NUMBER	5	num	33	SENT_33	[p1l1431t3570r1604b3635],
33	]	NN	O	]	dep	31	SENT_33	[p1l1431t3570r1604b3635],
34	.	.	O	.	_	0	SENT_33	[p1l1431t3570r1604b3635],

1	Nevertheless	RB	O	nevertheless	advmod	4	SENT_34	[p1l1637t3571r2047b3630],
2	,	,	O	,	_	0	SENT_34	[p1l1637t3571r2047b3630],
3	it	PRP	O	it	nsubj	4	SENT_34	[p1l9t3655r51b3706],
4	appears	VBZ	O	appear	_	0	SENT_34	[p1l77t3669r315b3718],
5	that	IN	O	that	complm	11	SENT_34	[p1l343t3654r467b3706],
6	a	DT	O	a	det	8	SENT_34	[p1l493t3669r524b3706],
7	higher	JJR	O	higher	amod	8	SENT_34	[p1l552t3654r750b3718],
8	beneﬁt	NN	O	beneﬁt	nsubjpass	11	SENT_34	[p1l776t3654r992b3706],
9	can	MD	O	can	aux	11	SENT_34	[p1l1018t3669r1122b3706],
10	be	VB	O	be	auxpass	11	SENT_34	[p1l1149t3654r1220b3706],
11	obtained	VBN	O	obtain	ccomp	4	SENT_34	[p1l1248t3654r1517b3706],
12	with	IN	O	with	_	0	SENT_34	[p1l1544t3654r1685b3706],
13	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_34	[p1l1714t3657r1873b3706],
14	tyro	NN	O	tyro	nn	15	SENT_34	[p1l1897t3662r2047b3718, p2l55t144r76b169],
15	*	NN	O	*	prep_with	11	SENT_34	[p1l1897t3662r2047b3718, p2l55t144r76b169],

1	Corresponding	VBG	O	correspond	_	0	SENT_35	[p2l105t144r467b196],
2	author	NN	O	author	dobj	1	SENT_35	[p2l483t144r654b186],
3	.	.	O	.	_	0	SENT_35	[p2l483t144r654b186],

1	Tel.	NNP	O	Tel.	_	0	SENT_36	[p2l670t144r767b186],
2	:	:	O	:	_	0	SENT_36	[p2l670t144r767b186],
3	+39 0521 702316	CD	NUMBER	+39 0521 702316	dep	1	SENT_36	[p2l1030t146r1220b192],[p2l788t146r876b186],
4	;	:	O	;	_	0	SENT_36	[p2l1030t146r1220b192],
5	fax	NN	O	fax	dep	1	SENT_36	[p2l1242t144r1328b186],
6	:	:	O	:	_	0	SENT_36	[p2l1242t144r1328b186],
7	+39 0521 995448	CD	NUMBER	+39 0521 995448	dep	5	SENT_36	[p2l1590t146r1788b186],[p2l1349t146r1437b186],
8	.	.	O	.	_	0	SENT_36	[p2l1590t146r1788b186],

1	E-mail	NN	O	e-mail	nn	2	SENT_37	[p2l106t220r261b262],
2	address	NN	O	address	_	0	SENT_37	[p2l277t220r468b262],
3	:	:	O	:	_	0	SENT_37	[p2l277t220r468b262],
4	mtiseo@ao.pr.it	NN	O	mtiseo@ao.pr.it	dep	2	SENT_37	[p2l487t221r867b273],
5	(	CD	NUMBER	(	num	8	SENT_37	[p2l883t220r962b272],
6	M.	NNP	NUMBER	M.	nn	8	SENT_37	[p2l883t220r962b272],
7	Tiseo	NNP	PERSON	Tiseo	nn	8	SENT_37	[p2l978t220r1137b272],
8	)	NN	O	)	dep	4	SENT_37	[p2l978t220r1137b272],
9	.	.	O	.	_	0	SENT_37	[p2l978t220r1137b272],

1	0169-5002	CD	DURATION	0169-5002	_	0	SENT_38	[p2l8t366r319b419],
2	/	:	O	/	punct	1	SENT_38	[p2l8t366r319b419],
3	$	$	MONEY	$	nsubj	5	SENT_38	[p2l8t366r319b419],
4	~	CD	MONEY	~	num	3	SENT_38	[p2l337t392r363b396],
5	see	VBP	O	see	dep	1	SENT_38	[p2l382t379r458b408],
6	front	JJ	O	front	amod	7	SENT_38	[p2l476t367r595b408],
7	matter	NN	O	matter	nsubj	9	SENT_38	[p2l612t373r777b408],
8	©	CD	NUMBER	©	num	9	SENT_38	[p2l792t370r832b408],
9	2009	CD	DATE	2009	xcomp	5	SENT_38	[p2l848t369r969b408],
10	Published	VBN	O	publish	partmod	9	SENT_38	[p2l987t367r1226b408],
11	by	IN	O	by	_	0	SENT_38	[p2l1243t367r1302b419],
12	Elsevier	NNP	ORGANIZATION	Elsevier	nn	14	SENT_38	[p2l1318t367r1510b408],
13	Ireland	NNP	ORGANIZATION	Ireland	nn	14	SENT_38	[p2l1526t367r1698b408],
14	Ltd.	NNP	ORGANIZATION	Ltd.	agent	10	SENT_38	[p2l1715t367r1802b409],
15	doi	FW	O	doi	dep	14	SENT_38	[p2l8t436r842b488],
16	:10.1016	CD	NUMBER	:10.1016	dep	15	SENT_38	[p2l8t436r842b488],
17	/	:	O	/	punct	19	SENT_38	[p2l8t436r842b488],
18	j.	NN	O	j.	nn	19	SENT_38	[p2l8t436r842b488],
19	lungcan	NN	O	lungcan	dep	16	SENT_38	[p2l8t436r842b488],
20	.2009.04.021	CD	NUMBER	.2009.04.021	dep	19	SENT_38	[p2l8t436r842b488],

1	©	RB	O	©	dep	2	SENT_39	[p2l981t521r1026b565],
2	2009	CD	DATE	2009	_	0	SENT_39	[p2l1046t520r1184b566],
3	Published	VBN	O	publish	partmod	2	SENT_39	[p2l1206t518r1482b566],
4	by	IN	O	by	_	0	SENT_39	[p2l1502t518r1570b578],
5	Elsevier	NNP	ORGANIZATION	Elsevier	nn	7	SENT_39	[p2l1588t518r1811b566],
6	Ireland	NNP	ORGANIZATION	Ireland	nn	7	SENT_39	[p2l1829t518r2027b566],
7	Ltd.	NNP	ORGANIZATION	Ltd.	agent	3	SENT_39	[p2l2048t518r2148b566],
8	.	.	O	.	_	0	SENT_39	[p2l2048t518r2148b566],

1	sine	NN	O	sine	nn	3	SENT_40	[p2l54t782r178b834],
2	kinase	NN	O	kinase	nn	3	SENT_40	[p2l207t781r406b834],
3	inhibitors	NNS	O	inhibitor	nsubj	4	SENT_40	[p2l435t781r738b834],
4	(	VBP	O	(	_	0	SENT_40	[p2l767t781r948b847],
5	TKIs	NNS	O	tki	dobj	4	SENT_40	[p2l767t781r948b847],
6	)	CD	NUMBER	)	num	5	SENT_40	[p2l767t781r948b847],
7	in	IN	O	in	_	0	SENT_40	[p2l978t782r1035b833],
8	some	DT	O	some	det	10	SENT_40	[p2l1064t796r1228b834],
9	patient	NN	O	patient	nn	10	SENT_40	[p2l1257t782r1481b847],
10	subgroups	NNS	O	subgroup	prep_in	5	SENT_40	[p2l1509t781r1849b847],
11	.	.	O	.	_	0	SENT_40	[p2l1509t781r1849b847],

1	A	DT	O	a	det	3	SENT_41	[p2l1875t783r1921b833],
2	higher	JJR	O	higher	amod	3	SENT_41	[p2l1947t781r2151b847],
3	probability	NN	O	probability	nsubj	6	SENT_41	[p2l54t866r400b933],
4	of	IN	O	of	_	0	SENT_41	[p2l429t866r494b919],
5	response	NN	O	response	prep_of	3	SENT_41	[p2l517t882r796b933],
6	appear	VBP	O	appear	_	0	SENT_41	[p2l826t882r1043b933],
7	to	TO	O	to	aux	9	SENT_41	[p2l1071t874r1130b919],
8	be	VB	O	be	auxpass	9	SENT_41	[p2l1160t866r1233b919],
9	associated	VBN	O	associate	xcomp	6	SENT_41	[p2l1263t866r1588b919],
10	with	IN	O	with	_	0	SENT_41	[p2l1617t866r1762b919],
11	some	DT	O	some	det	13	SENT_41	[p2l1793t882r1958b919],
12	clinical	JJ	O	clinical	amod	13	SENT_41	[p2l1988t866r2148b919, p2l54t952r138b1005],
13	characteristics	NNS	O	characteristic	prep_with	9	SENT_41	[p2l160t952r628b1014],
14	,	,	O	,	_	0	SENT_41	[p2l160t952r628b1014],
15	such	JJ	O	such	mwe	16	SENT_41	[p2l652t952r794b1005],
16	as	IN	O	as	prep_with	9	SENT_41	[p2l815t968r876b1005],
17	female	JJ	O	female	amod	18	SENT_41	[p2l899t952r1110b1005],
18	sex	NN	O	sex	pobj	16	SENT_41	[p2l1133t968r1247b1014],
19	,	,	O	,	_	0	SENT_41	[p2l1133t968r1247b1014],
20	never	RB	O	never	neg	21	SENT_41	[p2l1270t968r1446b1005],
21	smoking	VBG	O	smoke	prep_with	9	SENT_41	[p2l1466t952r1735b1019],
22	status	NN	O	status	dobj	21	SENT_41	[p2l1756t960r1956b1014],
23	,	,	O	,	_	0	SENT_41	[p2l1756t960r1956b1014],
24	Asian	JJ	MISC	asian	amod	26	SENT_41	[p2l1976t953r2149b1005],
25	ethnic	JJ	O	ethnic	amod	26	SENT_41	[p2l54t1038r249b1092],
26	origin	NN	O	origin	conj_and	13	SENT_41	[p2l270t1039r469b1105],
27	,	,	O	,	_	0	SENT_41	[p2l270t1039r469b1105],
28	adenocarcinoma	NN	O	adenocarcinoma	nn	29	SENT_41	[p2l492t1038r1014b1092],
29	histotype	NN	O	histotype	conj_and	13	SENT_41	[p2l1036t1038r1328b1105],
30	and	CC	O	and	_	0	SENT_41	[p2l1350t1038r1464b1092],
31	skin	NN	O	skin	nn	32	SENT_41	[p2l1488t1038r1614b1092],
32	toxicity	NN	O	toxicity	conj_and	13	SENT_41	[p2l1636t1039r1872b1105],
33	[	CD	NUMBER	[	number	34	SENT_41	[p2l1895t1038r1993b1105],
34	6	CD	NUMBER	6	num	35	SENT_41	[p2l1895t1038r1993b1105],
35	]	NN	O	]	dep	32	SENT_41	[p2l1895t1038r1993b1105],
36	.	.	O	.	_	0	SENT_41	[p2l1895t1038r1993b1105],

1	Although	IN	O	although	mark	5	SENT_42	[p2l150t1125r443b1191],
2	clinical	JJ	O	clinical	amod	3	SENT_42	[p2l482t1125r703b1178],
3	characteristics	NNS	O	characteristic	nsubj	5	SENT_42	[p2l742t1125r1194b1178],
4	may	MD	O	may	aux	5	SENT_42	[p2l1235t1140r1368b1191],
5	identify	VB	O	identify	csubj	24	SENT_42	[p2l1405t1124r1650b1191],
6	candidates	NNS	O	candidate	dobj	5	SENT_42	[p2l1687t1125r2023b1178],
7	for	IN	O	for	_	0	SENT_42	[p2l2064t1124r2151b1178],
8	EGFR	NN	ORGANIZATION	egfr	prep_for	6	SENT_42	[p2l54t1214r218b1264],
9	TI	NNP	O	TI	nsubj	11	SENT_42	[p2l241t1214r390b1272],
10	<	JJR	O	<	amod	9	SENT_42	[p2l241t1214r390b1272],
11	Is	VBZ	O	be	rcmod	6	SENT_42	[p2l241t1214r390b1272],
12	,	,	O	,	_	0	SENT_42	[p2l241t1214r390b1272],
13	the	DT	O	the	det	16	SENT_42	[p2l420t1211r519b1264],
14	ideal	JJ	O	ideal	amod	16	SENT_42	[p2l550t1211r699b1264],
15	patient	NN	O	patient	nn	16	SENT_42	[p2l729t1212r953b1277],
16	selection	NN	O	selection	nsubj	19	SENT_42	[p2l982t1211r1262b1264],
17	should	MD	O	should	aux	19	SENT_42	[p2l1292t1211r1501b1264],
18	mostly	RB	O	mostly	advmod	19	SENT_42	[p2l1532t1211r1745b1277],
19	rely	VB	O	rely	ccomp	11	SENT_42	[p2l1773t1211r1892b1277],
20	on	IN	O	on	_	0	SENT_42	[p2l1919t1226r1996b1264],
21	biological	JJ	O	biological	amod	23	SENT_42	[p2l2025t1211r2148b1264, p2l54t1296r256b1363],
22	tumor	NN	O	tumor	nn	23	SENT_42	[p2l275t1304r472b1349],
23	features	NNS	O	feature	prep_on	19	SENT_42	[p2l490t1296r740b1349],
24	[	VBP	O	[	_	0	SENT_42	[p2l763t1296r861b1363],
25	7	CD	NUMBER	7	number	26	SENT_42	[p2l763t1296r861b1363],
26	]	CD	NUMBER	]	dobj	24	SENT_42	[p2l763t1296r861b1363],
27	.	.	O	.	_	0	SENT_42	[p2l763t1296r861b1363],

1	Speciﬁc	JJ	MISC	speciﬁc	amod	2	SENT_43	[p2l881t1296r1121b1363],
2	mutations	NNS	O	mutation	dep	11	SENT_43	[p2l1140t1297r1460b1349],
3	in	IN	O	in	_	0	SENT_43	[p2l1480t1297r1538b1349],
4	the	DT	O	the	det	7	SENT_43	[p2l1556t1296r1655b1349],
5	tyrosine	NN	O	tyrosine	nn	7	SENT_43	[p2l1674t1297r1930b1363],
6	kinase	NN	O	kinase	nn	7	SENT_43	[p2l1950t1296r2148b1349],
7	domain	NN	O	domain	prep_in	2	SENT_43	[p2l54t1382r292b1435],
8	(	CD	NUMBER	(	num	9	SENT_43	[p2l312t1382r515b1448],
9	exons	NNS	O	exon	dep	11	SENT_43	[p2l312t1382r515b1448],
10	18-21	CD	NUMBER	18-21	num	11	SENT_43	[p2l540t1382r738b1448],
11	)	NN	O	)	dep	18	SENT_43	[p2l540t1382r738b1448],
12	of	IN	O	of	_	0	SENT_43	[p2l758t1382r823b1435],
13	the	DT	O	the	det	15	SENT_43	[p2l835t1382r935b1435],
14	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_43	[p2l953t1385r1108b1435],
15	gene	NN	O	gene	prep_of	11	SENT_43	[p2l1123t1398r1266b1449],
16	have	VBP	O	have	aux	18	SENT_43	[p2l1286t1382r1430b1435],
17	been	VBN	O	be	auxpass	18	SENT_43	[p2l1449t1382r1601b1435],
18	found	VBN	O	find	_	0	SENT_43	[p2l1622t1382r1803b1435],
19	to	TO	O	to	aux	20	SENT_43	[p2l1823t1390r1882b1435],
20	account	VB	O	account	xcomp	18	SENT_43	[p2l1903t1390r2150b1435],
21	for	IN	O	for	_	0	SENT_43	[p2l54t1468r141b1521],
22	the	DT	O	the	det	24	SENT_43	[p2l158t1468r258b1521],
23	increased	VBN	O	increase	amod	24	SENT_43	[p2l277t1468r576b1521],
24	sensitivity	NN	O	sensitivity	prep_for	20	SENT_43	[p2l597t1469r921b1535],
25	to	TO	O	to	_	0	SENT_43	[p2l938t1476r997b1521],
26	geﬁtinib	NN	O	geﬁtinib	prep_to	24	SENT_43	[p2l1016t1468r1278b1535],
27	or	CC	O	or	_	0	SENT_43	[p2l1297t1484r1362b1521],
28	erlotinib	NN	O	erlotinib	nn	29	SENT_43	[p2l1379t1468r1646b1521],
29	[	NN	O	[	prep_for	20	SENT_43	[p2l1669t1468r1766b1535],
30	8	CD	NUMBER	8	num	31	SENT_43	[p2l1669t1468r1766b1535],
31	]	NN	O	]	dep	29	SENT_43	[p2l1669t1468r1766b1535],
32	.	.	O	.	_	0	SENT_43	[p2l1669t1468r1766b1535],

1	On	IN	O	on	_	0	SENT_44	[p2l1786t1471r1874b1521],
2	the	DT	O	the	det	3	SENT_44	[p2l1892t1468r1991b1521],
3	contrary	NN	O	contrary	prep_on	10	SENT_44	[p2l2011t1484r2148b1521, p2l53t1562r216b1621],
4	,	,	O	,	_	0	SENT_44	[p2l2011t1484r2148b1521, p2l53t1562r216b1621],
5	mutations	NNS	O	mutation	nsubjpass	10	SENT_44	[p2l239t1555r558b1608],
6	of	IN	O	of	_	0	SENT_44	[p2l581t1554r646b1608],
7	K-ms	NNS	MISC	k-m	prep_of	5	SENT_44	[p2l657t1558r815b1608],
8	have	VBP	O	have	aux	10	SENT_44	[p2l835t1554r979b1608],
9	been	VBN	O	be	auxpass	10	SENT_44	[p2l1000t1554r1151b1608],
10	demonstrated	VBN	O	demonstrate	_	0	SENT_44	[p2l1172t1554r1612b1608],
11	to	TO	O	to	aux	14	SENT_44	[p2l1634t1562r1693b1608],
12	be	VB	O	be	cop	14	SENT_44	[p2l1714t1554r1787b1608],
13	a	DT	O	a	det	14	SENT_44	[p2l1808t1570r1840b1608],
14	predictor	NN	O	predictor	ccomp	10	SENT_44	[p2l1860t1554r2151b1621],
15	of	IN	O	of	_	0	SENT_44	[p2l54t1640r118b1694],
16	resistance	NN	O	resistance	prep_of	14	SENT_44	[p2l135t1641r449b1694],
17	to	TO	O	to	_	0	SENT_44	[p2l472t1649r532b1694],
18	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_44	[p2l557t1643r720b1694],
19	TKIs	NNS	O	tki	prep_to	14	SENT_44	[p2l738t1644r871b1694],
20	and	CC	O	and	_	0	SENT_44	[p2l896t1641r1010b1694],
21	to	TO	O	to	aux	24	SENT_44	[p2l1034t1649r1093b1694],
22	be	VB	O	be	cop	24	SENT_44	[p2l1117t1641r1189b1694],
23	mutually	RB	O	mutually	advmod	24	SENT_44	[p2l1214t1641r1498b1707],
24	exclusive	JJ	O	exclusive	conj_and	14	SENT_44	[p2l1521t1641r1805b1694],
25	with	IN	O	with	_	0	SENT_44	[p2l1828t1641r1973b1694],
26	EGFR	NN	ORGANIZATION	egfr	nn	27	SENT_44	[p2l1994t1643r2149b1694],
27	mutations	NNS	O	mutation	prep_with	24	SENT_44	[p2l54t1728r373b1780],
28	[	CD	NUMBER	[	number	29	SENT_44	[p2l393t1727r490b1793],
29	9	CD	NUMBER	9	num	30	SENT_44	[p2l393t1727r490b1793],
30	]	NN	O	]	dep	24	SENT_44	[p2l393t1727r490b1793],
31	.	.	O	.	_	0	SENT_44	[p2l393t1727r490b1793],

1	Other	JJ	O	other	amod	2	SENT_45	[p2l506t1727r685b1780],
2	trials	NNS	O	trial	nsubj	4	SENT_45	[p2l698t1727r855b1780],
3	have	VBP	O	have	aux	4	SENT_45	[p2l871t1727r1015b1780],
4	suggested	VBN	O	suggest	dep	49	SENT_45	[p2l1032t1727r1342b1793],
5	that	IN	O	that	complm	34	SENT_45	[p2l1357t1727r1484b1780],
6	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_45	[p2l1495t1730r1650b1780],
7	gene	NN	O	gene	nn	9	SENT_45	[p2l1659t1742r1803b1793],
8	copy	NN	O	copy	nn	9	SENT_45	[p2l1817t1742r1964b1793],
9	number	NN	O	number	nsubj	34	SENT_45	[p2l1978t1742r2148b1780, p2l53t1812r165b1873],
10	,	,	O	,	_	0	SENT_45	[p2l1978t1742r2148b1780, p2l53t1812r165b1873],
11	assessed	VBN	O	assess	partmod	9	SENT_45	[p2l186t1812r455b1865],
12	by	IN	O	by	_	0	SENT_45	[p2l475t1812r550b1879],
13	ﬂuorescence	NN	O	ﬂuorescence	agent	11	SENT_45	[p2l568t1812r962b1865],
14	in	FW	O	in	prep	13	SENT_45	[p2l982t1813r1036b1865],
15	situ	FW	O	situ	pobj	14	SENT_45	[p2l1054t1813r1164b1865],
16	hybridization	NN	O	hybridization	nn	19	SENT_45	[p2l1185t1812r1607b1879],
17	(	CD	NUMBER	(	num	19	SENT_45	[p2l1627t1812r1833b1878],
18	FISH	NN	O	fish	nn	19	SENT_45	[p2l1627t1812r1833b1878],
19	)	NN	O	)	tmod	11	SENT_45	[p2l1627t1812r1833b1878],
20	,	,	O	,	_	0	SENT_45	[p2l1627t1812r1833b1878],
21	and	CC	O	and	_	0	SENT_45	[p2l1854t1812r1968b1865],
22	EGFR	NN	ORGANIZATION	egfr	nn	24	SENT_45	[p2l1988t1815r2152b1865],
23	protein	NN	O	protein	nn	24	SENT_45	[p2l54t1899r280b1965],
24	expression	NN	O	expression	tmod	11	SENT_45	[p2l300t1899r653b1965],
25	,	,	O	,	_	0	SENT_45	[p2l300t1899r653b1965],
26	assessed	VBN	O	assess	partmod	19	SENT_45	[p2l674t1898r943b1951],
27	by	IN	O	by	_	0	SENT_45	[p2l963t1898r1038b1965],
28	immunohistochemistry	NN	O	immunohistochemistry	agent	26	SENT_45	[p2l1057t1898r1801b1965],
29	(	CD	NUMBER	(	num	28	SENT_45	[p2l1819t1898r1996b1964],
30	IHC	NNP	ORGANIZATION	IHC	dep	19	SENT_45	[p2l1819t1898r1996b1964],
31	)	CD	NUMBER	)	num	30	SENT_45	[p2l1819t1898r1996b1964],
32	,	,	O	,	_	0	SENT_45	[p2l1819t1898r1996b1964],
33	may	MD	O	may	aux	34	SENT_45	[p2l2017t1914r2151b1965],
34	predict	VB	O	predict	ccomp	4	SENT_45	[p2l54t1984r277b2051],
35	which	WDT	O	which	dobj	39	SENT_45	[p2l292t1984r486b2038],
36	patients	NNS	O	patient	nsubj	39	SENT_45	[p2l504t1985r757b2051],
37	are	VBP	O	be	cop	39	SENT_45	[p2l776t2000r870b2038],
38	more	RBR	O	more	advmod	39	SENT_45	[p2l889t2000r1051b2038],
39	likely	JJ	O	likely	ccomp	34	SENT_45	[p2l1070t1984r1240b2051],
40	to	TO	O	to	aux	41	SENT_45	[p2l1256t1992r1315b2038],
41	respond	VB	O	respond	xcomp	39	SENT_45	[p2l1334t1984r1587b2051],
42	to	TO	O	to	_	0	SENT_45	[p2l1606t1992r1665b2038],
43	EGFR	NN	ORGANIZATION	egfr	prep_to	41	SENT_45	[p2l1684t1987r1848b2038],
44	TI	NNP	O	TI	nn	45	SENT_45	[p2l1860t1988r1993b2038],
45	(	NNP	O	(	nsubj	49	SENT_45	[p2l1860t1988r1993b2038],
46	Is	VBZ	O	be	cop	49	SENT_45	[p2l1860t1988r1993b2038],
47	[	CD	NUMBER	[	number	48	SENT_45	[p2l2015t1984r2148b2051],
48	10	CD	NUMBER	10	num	49	SENT_45	[p2l2015t1984r2148b2051],
49	]	NN	O	]	_	0	SENT_45	[p2l2015t1984r2148b2051],
50	.	.	O	.	_	0	SENT_45	[p2l2015t1984r2148b2051],

1	The	DT	O	the	det	2	SENT_46	[p2l51t2070r165b2124],
2	role	NN	O	role	nsubj	15	SENT_46	[p2l194t2070r313b2124],
3	of	IN	O	of	_	0	SENT_46	[p2l341t2070r406b2124],
4	HER2	NN	O	her2	nn	7	SENT_46	[p2l425t2073r588b2123],
5	gene	NN	O	gene	nn	7	SENT_46	[p2l611t2086r754b2137],
6	copy	NN	O	copy	nn	7	SENT_46	[p2l782t2086r929b2137],
7	number	NN	O	number	prep_of	2	SENT_46	[p2l956t2070r1206b2124],
8	in	IN	O	in	_	0	SENT_46	[p2l1233t2071r1291b2123],
9	the	DT	O	the	det	10	SENT_46	[p2l1318t2070r1418b2124],
10	sensitivity	NN	O	sensitivity	prep_in	7	SENT_46	[p2l1447t2071r1772b2137],
11	to	TO	O	to	_	0	SENT_46	[p2l1797t2078r1857b2124],
12	TI	NNP	O	TI	nn	13	SENT_46	[p2l1883t2074r2016b2124],
13	(	NNP	O	(	prep_to	10	SENT_46	[p2l1883t2074r2016b2124],
14	Is	VBZ	O	be	aux	15	SENT_46	[p2l1883t2074r2016b2124],
15	has	VBZ	O	have	_	0	SENT_46	[p2l2046t2070r2148b2124],

1	356	CD	NUMBER	356	num	3	SENT_47	[p2l393t2213r440b2234],
2	M.	NN	NUMBER	m.	nn	3	SENT_47	[p2l1191t2213r1220b2234],
3	Tiseo	NNP	PERSON	Tiseo	_	0	SENT_47	[p2l1230t2212r1289b2234],
4	et	FW	O	et	nn	5	SENT_47	[p2l1298t2215r1321b2234],
5	al.	FW	O	al.	dep	3	SENT_47	[p2l1328t2212r1353b2234],
6	/	:	O	/	punct	3	SENT_47	[p2l1360t2212r1372b2239],
7	Lung	NN	O	lung	nn	8	SENT_47	[p2l1378t2213r1438b2239],
8	Cancer	NN	O	cancer	dep	3	SENT_47	[p2l1445t2213r1528b2234],
9	67	CD	NUMBER	67	number	10	SENT_47	[p2l1535t2213r1565b2234],
10	(	CD	NUMBER	(	num	11	SENT_47	[p2l1572t2212r1653b2239],
11	2010	CD	DATE	2010	dep	8	SENT_47	[p2l1572t2212r1653b2239],
12	)	CD	NUMBER	)	number	13	SENT_47	[p2l1572t2212r1653b2239],
13	355-360	CD	NUMBER	355-360	num	11	SENT_47	[p2l1660t2213r1767b2234],

1	been	VBN	O	be	cop	2	SENT_48	[p2l11t2352r165b2406],
2	less	JJR	O	less	_	0	SENT_48	[p2l196t2352r311b2406],
3	evaluated	VBD	O	evaluate	dep	2	SENT_48	[p2l343t2352r653b2406],
4	[	CD	NUMBER	[	nsubj	2	SENT_48	[p2l687t2351r819b2419],
5	11	CD	NUMBER	11	num	6	SENT_48	[p2l687t2351r819b2419],
6	]	NN	O	]	dep	4	SENT_48	[p2l687t2351r819b2419],
7	.	.	O	.	_	0	SENT_48	[p2l687t2351r819b2419],

1	Moreover	RB	O	moreover	advmod	19	SENT_49	[p2l852t2355r1171b2414],
2	,	,	O	,	_	0	SENT_49	[p2l852t2355r1171b2414],
3	a	DT	O	a	det	6	SENT_49	[p2l1203t2367r1235b2406],
4	potential	JJ	O	potential	amod	6	SENT_49	[p2l1266t2352r1551b2419],
5	predictive	JJ	O	predictive	amod	6	SENT_49	[p2l1584t2352r1903b2419],
6	role	NN	O	role	nsubjpass	19	SENT_49	[p2l1935t2352r2055b2406],
7	of	IN	O	of	_	0	SENT_49	[p2l2086t2351r2153b2406],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_49	[p2l9t2442r167b2493],
9	intron	NN	O	intron	prep_of	6	SENT_49	[p2l200t2440r395b2493],
10	1	CD	NUMBER	1	num	11	SENT_49	[p2l430t2442r455b2492],
11	polymorphism	NN	O	polymorphism	dep	9	SENT_49	[p2l495t2439r968b2506],
12	on	IN	O	on	_	0	SENT_49	[p2l1000t2455r1078b2493],
13	the	DT	O	the	det	15	SENT_49	[p2l1109t2439r1211b2493],
14	geﬁtinib	NN	O	geﬁtinib	nn	15	SENT_49	[p2l1242t2439r1509b2506],
15	outcome	NN	O	outcome	prep_on	11	SENT_49	[p2l1542t2447r1821b2493],
16	has	VBZ	O	have	aux	19	SENT_49	[p2l1854t2439r1958b2493],
17	been	VBN	O	be	auxpass	19	SENT_49	[p2l1991t2439r2145b2493],
18	recently	RB	DATE	recently	advmod	19	SENT_49	[p2l12t2525r272b2593],
19	proposed	VBN	O	propose	_	0	SENT_49	[p2l300t2525r598b2593],
20	in	IN	O	in	_	0	SENT_49	[p2l629t2526r688b2579],
21	advanced	JJ	O	advanced	amod	22	SENT_49	[p2l717t2525r1019b2579],
22	NSCLC	NNP	O	NSCLC	prep_in	19	SENT_49	[p2l1049t2528r1255b2579],
23	[	CD	NUMBER	[	num	22	SENT_49	[p2l1287t2525r1540b2593],
24	12	CD	NUMBER	12	num	25	SENT_49	[p2l1287t2525r1540b2593],
25	—	NN	O	—	tmod	19	SENT_49	[p2l1287t2525r1540b2593],
26	14	CD	NUMBER	14	num	27	SENT_49	[p2l1287t2525r1540b2593],
27	]	NN	O	]	dep	25	SENT_49	[p2l1287t2525r1540b2593],
28	.	.	O	.	_	0	SENT_49	[p2l1287t2525r1540b2593],

1	However	RB	O	however	advmod	7	SENT_50	[p2l1571t2528r1868b2588],
2	,	,	O	,	_	0	SENT_50	[p2l1571t2528r1868b2588],
3	most	JJS	O	most	nsubj	7	SENT_50	[p2l1900t2533r2058b2579],
4	of	IN	O	of	_	0	SENT_50	[p2l2086t2525r2152b2579],
5	these	DT	O	these	det	6	SENT_50	[p2l11t2612r181b2666],
6	ﬁndings	NNS	O	ﬁndings	prep_of	3	SENT_50	[p2l207t2612r462b2680],
7	come	VBP	O	come	_	0	SENT_50	[p2l488t2628r659b2666],
8	from	IN	O	from	_	0	SENT_50	[p2l684t2612r836b2666],
9	retrospective	JJ	O	retrospective	amod	10	SENT_50	[p2l861t2613r1279b2680],
10	studies	NNS	O	study	prep_from	7	SENT_50	[p2l1305t2612r1529b2666],
11	where	WRB	O	where	advmod	20	SENT_50	[p2l1553t2612r1755b2666],
12	only	RB	O	only	advmod	13	SENT_50	[p2l1780t2612r1918b2680],
13	one	CD	NUMBER	one	nsubjpass	20	SENT_50	[p2l1942t2628r2055b2666],
14	or	CC	O	or	_	0	SENT_50	[p2l2081t2628r2147b2666],
15	two	CD	NUMBER	two	nsubjpass	20	SENT_50	[p2l11t2707r132b2753],
16	of	IN	O	of	_	0	SENT_50	[p2l153t2699r219b2753],
17	the	DT	O	the	det	18	SENT_50	[p2l232t2699r333b2753],
18	parameters	NNS	O	parameter	prep_of	13	SENT_50	[p2l355t2707r716b2767],
19	were	VBD	O	be	auxpass	20	SENT_50	[p2l736t2715r894b2753],
20	assessed	VBN	O	assess	advcl	7	SENT_50	[p2l915t2699r1205b2754],
21	.	.	O	.	_	0	SENT_50	[p2l915t2699r1205b2754],

1	In	IN	O	in	_	0	SENT_51	[p2l1227t2703r1286b2753],
2	addition	NN	O	addition	prep_in	10	SENT_51	[p2l1307t2699r1589b2762],
3	,	,	O	,	_	0	SENT_51	[p2l1307t2699r1589b2762],
4	literature	NN	O	literature	nsubj	10	SENT_51	[p2l1611t2699r1908b2753],
5	on	IN	O	on	_	0	SENT_51	[p2l1930t2715r2008b2753],
6	this	DT	O	this	det	7	SENT_51	[p2l2027t2699r2144b2753],
7	area	NN	O	area	prep_on	4	SENT_51	[p2l12t2803r145b2842],
8	is	VBZ	O	be	cop	10	SENT_51	[p2l168t2788r214b2842],
9	often	RB	O	often	advmod	10	SENT_51	[p2l237t2787r402b2842],
10	controversial	JJ	O	controversial	_	0	SENT_51	[p2l424t2787r858b2842],
11	.	.	O	.	_	0	SENT_51	[p2l424t2787r858b2842],

1	In	IN	O	in	_	0	SENT_52	[p2l114t2878r173b2928],
2	this	DT	O	this	det	4	SENT_52	[p2l199t2875r315b2929],
3	prospective	JJ	O	prospective	amod	4	SENT_52	[p2l342t2875r712b2942],
4	study	NN	O	study	prep_in	7	SENT_52	[p2l739t2875r926b2942],
5	,	,	O	,	_	0	SENT_52	[p2l739t2875r926b2942],
6	we	PRP	O	we	nsubj	7	SENT_52	[p2l951t2890r1044b2929],
7	evaluated	VBD	O	evaluate	_	0	SENT_52	[p2l1071t2875r1380b2929],
8	the	DT	O	the	det	10	SENT_52	[p2l1406t2875r1508b2929],
9	predictive	JJ	O	predictive	amod	10	SENT_52	[p2l1535t2875r1854b2942],
10	role	NN	O	role	dobj	7	SENT_52	[p2l1881t2875r2001b2929],
11	of	IN	O	of	_	0	SENT_52	[p2l2028t2874r2095b2929],
12	a	DT	O	a	det	14	SENT_52	[p2l2113t2890r2145b2929],
13	large	JJ	O	large	amod	14	SENT_52	[p2l12t2962r166b3029],
14	panel	NN	O	panel	prep_of	10	SENT_52	[p2l183t2962r357b3029],
15	of	IN	O	of	_	0	SENT_52	[p2l374t2962r440b3016],
16	molecular	JJ	O	molecular	amod	17	SENT_52	[p2l449t2962r771b3016],
17	markers	NNS	O	marker	prep_of	14	SENT_52	[p2l786t2962r1061b3024],
18	,	,	O	,	_	0	SENT_52	[p2l786t2962r1061b3024],
19	such	JJ	O	such	_	0	SENT_52	[p2l1079t2962r1224b3016],
20	as	IN	O	as	_	0	SENT_52	[p2l1239t2977r1301b3016],
21	EGFR	NN	ORGANIZATION	egfr	nn	56	SENT_52	[p2l1316t2965r1474b3016],
22	and	CC	O	and	_	0	SENT_52	[p2l1489t2962r1604b3016],
23	K-ras	JJ	O	k-ras	nn	56	SENT_52	[p2l1619t2965r1780b3016],
24	gene	NN	O	gene	nn	25	SENT_52	[p2l1789t2978r1935b3029],
25	mutations	NNS	O	mutation	dep	23	SENT_52	[p2l1951t2970r2144b3016, p2l11t3049r184b3110],
26	,	,	O	,	_	0	SENT_52	[p2l1951t2970r2144b3016, p2l11t3049r184b3110],
27	EGFR	NN	ORGANIZATION	egfr	conj_and	25	SENT_52	[p2l208t3051r366b3102],
28	and	CC	O	and	_	0	SENT_52	[p2l391t3048r507b3102],
29	HER2	NN	O	her2	nn	32	SENT_52	[p2l532t3051r698b3102],
30	gene	NN	O	gene	nn	32	SENT_52	[p2l718t3064r864b3116],
31	copy	NN	O	copy	nn	32	SENT_52	[p2l890t3064r1039b3116],
32	number	NN	O	number	conj_and	25	SENT_52	[p2l1064t3048r1328b3110],
33	,	,	O	,	_	0	SENT_52	[p2l1064t3048r1328b3110],
34	EGFR	NN	ORGANIZATION	egfr	nn	36	SENT_52	[p2l1355t3051r1522b3102],
35	protein	NN	O	protein	nn	36	SENT_52	[p2l1545t3049r1776b3116],
36	expression	NN	O	expression	appos	25	SENT_52	[p2l1801t3049r2145b3116],
37	and	CC	O	and	_	0	SENT_52	[p2l12t3135r128b3189],
38	EGFR	NN	ORGANIZATION	egfr	nn	40	SENT_52	[p2l155t3138r313b3189],
39	gene	NN	O	gene	nn	40	SENT_52	[p2l337t3151r483b3203],
40	intron	NN	O	intron	conj_and	36	SENT_52	[p2l513t3136r708b3189],
41	1	CD	NUMBER	1	num	42	SENT_52	[p2l741t3138r765b3189],
42	polymorphism	NN	O	polymorphism	nsubj	46	SENT_52	[p2l803t3135r1276b3203],
43	in	IN	O	in	_	0	SENT_52	[p2l1306t3136r1365b3189],
44	NSCLC	NN	ORGANIZATION	nsclc	nn	45	SENT_52	[p2l1395t3138r1600b3189],
45	patients	NNS	O	patient	prep_in	42	SENT_52	[p2l1629t3136r1886b3203],
46	treated	VBN	O	treat	rcmod	36	SENT_52	[p2l1916t3135r2144b3189],
47	with	IN	O	with	_	0	SENT_52	[p2l10t3223r157b3276],
48	geﬁtinib	NN	O	geﬁtinib	prep_with	46	SENT_52	[p2l178t3222r445b3290],
49	in	IN	O	in	_	0	SENT_52	[p2l468t3223r527b3276],
50	an	DT	O	a	prep_in	46	SENT_52	[p2l549t3238r624b3276],
51	Expanded	VBN	O	expand	partmod	50	SENT_52	[p2l646t3222r962b3290],
52	Access	NN	O	access	nn	53	SENT_52	[p2l983t3225r1192b3276],
53	Program	NN	O	program	dobj	51	SENT_52	[p2l1216t3226r1486b3290],
54	(	CD	NUMBER	(	num	53	SENT_52	[p2l1509t3223r1697b3290],
55	EAP	NN	O	eap	nn	56	SENT_52	[p2l1509t3223r1697b3290],
56	)	NN	O	)	prep_such_as	7	SENT_52	[p2l1509t3223r1697b3290],
57	.	.	O	.	_	0	SENT_52	[p2l1509t3223r1697b3290],

1	2	LS	NUMBER	2	_	0	SENT_53	[p2l11t3427r66b3479],
2	.	.	O	.	_	0	SENT_53	[p2l11t3427r66b3479],

1	Patients	NNS	O	patient	_	0	SENT_54	[p2l112t3425r386b3479],
2	and	CC	O	and	_	0	SENT_54	[p2l407t3425r532b3479],
3	methods	NNS	O	method	conj_and	1	SENT_54	[p2l553t3425r849b3479],

1	2.1	CD	NUMBER	2.1	_	0	SENT_55	[p2l7t3605r103b3657],
2	.	.	O	.	_	0	SENT_55	[p2l7t3605r103b3657],

1	Patients	NNS	O	patient	_	0	SENT_56	[p2l152t3603r397b3656],

1	Patients	NNS	O	patient	nsubjpass	9	SENT_57	[p3l114t69r384b131],
2	,	,	O	,	_	0	SENT_57	[p3l114t69r384b131],
3	included	VBN	O	include	partmod	1	SENT_57	[p3l411t68r688b122],
4	in	IN	O	in	_	0	SENT_57	[p3l714t69r773b122],
5	geﬁtinib	NN	O	geﬁtinib	nn	6	SENT_57	[p3l796t68r1063b136],
6	EAP	NN	O	eap	prep_in	3	SENT_57	[p3l1089t71r1219b131],
7	,	,	O	,	_	0	SENT_57	[p3l1089t71r1219b131],
8	were	VBD	O	be	auxpass	9	SENT_57	[p3l1243t84r1401b122],
9	enrolled	VBN	O	enrol	_	0	SENT_57	[p3l1427t68r1690b122],
10	prospectively	RB	O	prospectively	advmod	9	SENT_57	[p3l1716t68r2147b136],
11	in	IN	O	in	_	0	SENT_57	[p3l12t156r71b209],
12	this	DT	O	this	det	13	SENT_57	[p3l101t155r216b209],
13	study	NN	O	study	prep_in	9	SENT_57	[p3l249t155r436b223],
14	,	,	O	,	_	0	SENT_57	[p3l249t155r436b223],
15	conducted	VBN	O	conduct	partmod	13	SENT_57	[p3l467t155r801b209],
16	at	IN	O	at	_	0	SENT_57	[p3l832t163r892b209],
17	the	DT	O	the	det	19	SENT_57	[p3l920t156r1021b209],
18	University	NNP	ORGANIZATION	University	nn	19	SENT_57	[p3l1051t156r1381b223],
19	Hospital	NNP	ORGANIZATION	Hospital	prep_at	15	SENT_57	[p3l1410t155r1675b223],
20	of	IN	ORGANIZATION	of	_	0	SENT_57	[p3l1707t155r1773b209],
21	Parma	NNP	ORGANIZATION	Parma	prep_of	19	SENT_57	[p3l1796t159r2012b218],
22	.	.	O	.	_	0	SENT_57	[p3l1796t159r2012b218],

1	the	DT	O	the	det	3	SENT_58	[p3l2043t156r2145b209],
2	National	NNP	ORGANIZATION	National	nn	3	SENT_58	[p3l12t243r281b297],
3	Institute	NNP	ORGANIZATION	Institute	_	0	SENT_58	[p3l301t244r569b297],
4	for	IN	ORGANIZATION	for	_	0	SENT_58	[p3l589t242r677b297],
5	Cancer	NNP	ORGANIZATION	Cancer	nn	6	SENT_58	[p3l694t245r912b297],
6	Research	NNP	ORGANIZATION	Research	prep_for	3	SENT_58	[p3l929t243r1212b297],
7	of	IN	ORGANIZATION	of	_	0	SENT_58	[p3l1231t242r1297b297],
8	Genova	NNP	ORGANIZATION	Genova	prep_of	6	SENT_58	[p3l1308t245r1545b297],
9	and	CC	O	and	_	0	SENT_58	[p3l1563t243r1679b297],
10	the	DT	O	the	det	12	SENT_58	[p3l1697t243r1798b297],
11	University	NNP	ORGANIZATION	University	nn	12	SENT_58	[p3l1817t243r2147b310],
12	Hospital	NNP	ORGANIZATION	Hospital	conj_and	6	SENT_58	[p3l12t330r277b397],
13	of	IN	O	of	_	0	SENT_58	[p3l306t330r372b384],
14	Modena	NNP	LOCATION	Modena	prep_of	12	SENT_58	[p3l393t330r667b384],
15	.	.	O	.	_	0	SENT_58	[p3l393t330r667b384],

1	The	DT	O	the	det	2	SENT_59	[p3l694t330r810b384],
2	study	NN	O	study	nsubjpass	17	SENT_59	[p3l840t330r1016b397],
3	was	VBD	O	be	auxpass	4	SENT_59	[p3l1041t346r1163b384],
4	approved	VBN	O	approve	rcmod	2	SENT_59	[p3l1192t330r1491b397],
5	by	IN	O	by	_	0	SENT_59	[p3l1519t330r1596b397],
6	the	DT	O	the	det	10	SENT_59	[p3l1621t330r1723b384],
7	institutional	JJ	O	institutional	amod	10	SENT_59	[p3l1752t330r2144b384],
8	ethical	JJ	O	ethical	amod	10	SENT_59	[p3l12t417r224b471],
9	review	NN	O	review	nn	10	SENT_59	[p3l246t418r463b471],
10	board	NN	O	board	agent	4	SENT_59	[p3l481t417r664b471],
11	and	CC	O	and	_	0	SENT_59	[p3l685t417r801b471],
12	a	DT	O	a	det	15	SENT_59	[p3l823t433r855b471],
13	written	VBN	O	write	amod	15	SENT_59	[p3l874t418r1113b471],
14	informed	VBN	O	inform	amod	15	SENT_59	[p3l1134t417r1429b471],
15	consent	NN	O	consent	conj_and	10	SENT_59	[p3l1450t425r1700b471],
16	was	VBD	O	be	auxpass	17	SENT_59	[p3l1718t433r1841b471],
17	obtained	VBN	O	obtain	_	0	SENT_59	[p3l1863t417r2144b471],
18	from	IN	O	from	_	0	SENT_59	[p3l12t504r163b558],
19	each	DT	O	each	det	20	SENT_59	[p3l186t504r331b558],
20	patient	NN	O	patient	prep_from	17	SENT_59	[p3l353t505r581b572],
21	before	IN	O	before	_	0	SENT_59	[p3l601t504r804b558],
22	enrollment	NN	O	enrollment	prep_before	17	SENT_59	[p3l827t504r1198b559],
23	.	.	O	.	_	0	SENT_59	[p3l827t504r1198b559],

1	Eligibility	NN	O	eligibility	nn	2	SENT_60	[p3l114t591r420b659],
2	criteria	NNS	O	criterion	nsubj	3	SENT_60	[p3l450t592r678b645],
3	included	VBD	O	include	_	0	SENT_60	[p3l710t591r986b645],
4	histologically	RB	O	histologically	dep	8	SENT_60	[p3l1019t591r1445b659],
5	or	CC	O	or	_	0	SENT_60	[p3l1475t607r1541b645],
6	cytologically	RB	O	cytologically	advmod	7	SENT_60	[p3l1570t591r1975b659],
7	conﬁrmed	JJ	O	conﬁrmed	dep	8	SENT_60	[p3l2005t607r2144b645, p3l12t678r224b732],
8	NSCLC	NN	O	nsclc	dobj	3	SENT_60	[p3l264t681r469b732],
9	with	IN	O	with	mark	13	SENT_60	[p3l506t678r654b732],
10	measurable	JJ	O	measurable	ccomp	13	SENT_60	[p3l693t678r1079b741],
11	,	,	O	,	_	0	SENT_60	[p3l693t678r1079b741],
12	locally	RB	O	locally	advmod	13	SENT_60	[p3l1120t678r1328b746],
13	advanced	VBD	O	advance	dep	3	SENT_60	[p3l1365t678r1668b732],
14	or	CC	O	or	_	0	SENT_60	[p3l1708t694r1774b732],
15	metastatic	JJ	O	metastatic	amod	16	SENT_60	[p3l1811t679r2146b732],
16	disease	NN	O	disease	dep	3	SENT_60	[p3l12t766r259b828],
17	,	,	O	,	_	0	SENT_60	[p3l12t766r259b828],
18	progressing	VBG	O	progress	xcomp	3	SENT_60	[p3l295t766r670b833],
19	or	CC	O	or	_	0	SENT_60	[p3l703t781r769b820],
20	relapsing	VBG	O	relapse	conj_or	18	SENT_60	[p3l803t766r1097b833],
21	after	IN	O	after	_	0	SENT_60	[p3l1131t765r1280b820],
22	at	IN	O	at	quantmod	24	SENT_60	[p3l1313t774r1373b820],
23	least	JJS	O	least	mwe	22	SENT_60	[p3l1407t766r1555b820],
24	one	CD	NUMBER	one	num	25	SENT_60	[p3l1589t781r1703b820],
25	line	NN	O	line	prep_after	18	SENT_60	[p3l1739t766r1855b820],
26	of	IN	O	of	_	0	SENT_60	[p3l1891t765r1957b820],
27	standard	JJ	O	standard	amod	28	SENT_60	[p3l1986t774r2144b820, p3l12t853r154b907],
28	chemotherapy	NN	O	chemotherapy	prep_of	25	SENT_60	[p3l177t853r651b920],
29	.	.	O	.	_	0	SENT_60	[p3l177t853r651b920],

1	Patients	NNS	O	patient	nsubj	2	SENT_61	[p3l673t854r927b907],
2	had	VBD	O	have	_	0	SENT_61	[p3l950t853r1066b907],
3	performance	NN	O	performance	nn	4	SENT_61	[p3l1088t853r1497b920],
4	status	NN	O	status	dobj	2	SENT_61	[p3l1520t861r1707b907],
5	ranging	VBG	O	range	partmod	4	SENT_61	[p3l1730t854r1974b920],
6	from	IN	O	from	_	0	SENT_61	[p3l1994t853r2145b907],
7	grade	NN	O	grade	nn	8	SENT_61	[p3l10t939r188b1007],
8	o	NN	O	o	prep_from	5	SENT_61	[p3l222t942r258b993],
9	to	TO	O	to	_	0	SENT_61	[p3l291t947r352b993],
10	2	CD	NUMBER	2	prep_to	5	SENT_61	[p3l386t942r438b1001],
11	,	,	O	,	_	0	SENT_61	[p3l386t942r438b1001],
12	according	VBG	O	accord	_	0	SENT_61	[p3l472t939r785b1007],
13	to	TO	O	to	prepc_according_to	2	SENT_61	[p3l817t947r877b993],
14	Eastern	NNP	ORGANIZATION	Eastern	nn	17	SENT_61	[p3l912t942r1149b993],
15	Cooperative	NNP	ORGANIZATION	Cooperative	nn	17	SENT_61	[p3l1183t940r1563b1007],
16	Oncology	NNP	ORGANIZATION	Oncology	nn	17	SENT_61	[p3l1598t939r1899b1007],
17	Group	NNP	ORGANIZATION	Group	pobj	2	SENT_61	[p3l1931t942r2144b1007],
18	.	.	O	.	_	0	SENT_61	[p3l1931t942r2144b1007],

1	The	DT	O	the	det	2	SENT_62	[p3l9t1026r125b1080],
2	availability	NN	O	availability	nsubj	15	SENT_62	[p3l165t1026r518b1094],
3	of	IN	O	of	_	0	SENT_62	[p3l556t1026r622b1080],
4	adequate	JJ	O	adequate	amod	10	SENT_62	[p3l654t1026r946b1094],
5	archive	NN	O	archive	nn	10	SENT_62	[p3l985t1026r1214b1080],
6	tumor	NN	O	tumor	nn	10	SENT_62	[p3l1254t1034r1455b1080],
7	tissue	NN	O	tissue	nn	10	SENT_62	[p3l1492t1027r1676b1080],
8	and/or	JJ	O	and/or	amod	10	SENT_62	[p3l1716t1026r1929b1094],
9	blood	NN	O	blood	nn	10	SENT_62	[p3l1965t1026r2144b1080],
10	samples	NNS	O	sample	prep_of	2	SENT_62	[p3l12t1113r270b1181],
11	for	IN	O	for	_	0	SENT_62	[p3l317t1113r406b1167],
12	molecular	JJ	O	molecular	amod	13	SENT_62	[p3l449t1113r772b1167],
13	analyses	NNS	O	analysis	prep_for	10	SENT_62	[p3l815t1114r1082b1181],
14	was	VBD	O	be	cop	15	SENT_62	[p3l1127t1129r1249b1167],
15	mandatory	JJ	O	mandatory	_	0	SENT_62	[p3l1296t1113r1648b1181],
16	for	IN	O	for	_	0	SENT_62	[p3l1692t1113r1781b1167],
17	the	DT	O	the	det	19	SENT_62	[p3l1823t1113r1924b1167],
18	study	NN	O	study	nn	19	SENT_62	[p3l1971t1113r2147b1181],
19	entry	NN	O	entry	prep_for	15	SENT_62	[p3l12t1209r193b1268],
20	.	.	O	.	_	0	SENT_62	[p3l12t1209r193b1268],

1	Patients	NNS	O	patient	nsubjpass	11	SENT_63	[p3l218t1201r472b1255],
2	received	VBD	O	receive	_	0	SENT_63	[p3l497t1201r764b1255],
3	oral	JJ	O	oral	amod	5	SENT_63	[p3l788t1201r908b1255],
4	geﬁtinib	NN	O	geﬁtinib	nn	5	SENT_63	[p3l931t1200r1198b1268],
5	(	NN	O	(	iobj	2	SENT_63	[p3l1222t1201r1365b1268],
6	250	CD	NUMBER	250	num	8	SENT_63	[p3l1222t1201r1365b1268],
7	mg/day	JJ	O	mg/day	amod	8	SENT_63	[p3l1382t1200r1646b1268],
8	)	NN	O	)	dobj	2	SENT_63	[p3l1382t1200r1646b1268],
9	and	CC	O	and	_	0	SENT_63	[p3l1670t1201r1786b1255],
10	were	VBD	O	be	auxpass	11	SENT_63	[p3l1808t1216r1966b1255],
11	evaluated	VBN	O	evaluate	conj_and	2	SENT_63	[p3l1990t1201r2144b1255, p3l12t1288r190b1342],
12	for	IN	O	for	_	0	SENT_63	[p3l226t1287r315b1342],
13	response	NN	O	response	prep_for	11	SENT_63	[p3l348t1303r632b1355],
14	according	VBG	O	accord	_	0	SENT_63	[p3l668t1288r980b1355],
15	to	TO	O	to	prepc_according_to	11	SENT_63	[p3l1013t1296r1073b1342],
16	the	DT	O	the	det	18	SENT_63	[p3l1108t1288r1210b1342],
17	RECIST	NNP	O	RECIST	nn	18	SENT_63	[p3l1245t1290r1466b1342],
18	criteria	NNS	O	criterion	pobj	11	SENT_63	[p3l1498t1288r1726b1342],
19	[	CD	NUMBER	[	number	20	SENT_63	[p3l1764t1287r1899b1355],
20	15	CD	NUMBER	15	num	21	SENT_63	[p3l1764t1287r1899b1355],
21	]	NN	O	]	dobj	2	SENT_63	[p3l1764t1287r1899b1355],
22	.	.	O	.	_	0	SENT_63	[p3l1764t1287r1899b1355],

1	Tumor	NN	O	tumor	nn	2	SENT_64	[p3l1932t1291r2147b1342],
2	response	NN	O	response	nsubjpass	4	SENT_64	[p3l12t1391r296b1442],
3	was	VBD	O	be	auxpass	4	SENT_64	[p3l337t1391r460b1429],
4	assessed	VBN	O	assess	_	0	SENT_64	[p3l504t1375r778b1429],
5	by	IN	O	by	_	0	SENT_64	[p3l821t1375r897b1442],
6	computed	JJ	O	computed	amod	7	SENT_64	[p3l938t1375r1261b1442],
7	tomography	NN	O	tomography	agent	4	SENT_64	[p3l1303t1375r1695b1442],
8	scan	VB	O	scan	ccomp	4	SENT_64	[p3l1738t1390r1876b1429],
9	after	IN	O	after	_	0	SENT_64	[p3l1919t1375r2068b1429],
10	2	CD	DURATION	2	num	11	SENT_64	[p3l2109t1378r2143b1428],
11	months	NNS	NUMBER	month	prep_after	8	SENT_64	[p3l12t1461r254b1515],
12	of	IN	O	of	_	0	SENT_64	[p3l274t1461r340b1515],
13	treatment	NN	O	treatment	prep_of	11	SENT_64	[p3l350t1469r686b1516],
14	.	.	O	.	_	0	SENT_64	[p3l350t1469r686b1516],

1	Patients	NNS	O	patient	nsubj	11	SENT_65	[p3l707t1462r961b1515],
2	obtaining	VBG	O	obtain	partmod	1	SENT_65	[p3l980t1461r1286b1529],
3	complete	JJ	O	complete	amod	4	SENT_65	[p3l1303t1461r1598b1529],
4	response	NN	O	response	dobj	2	SENT_65	[p3l1618t1477r1918b1529],
5	,	,	O	,	_	0	SENT_65	[p3l1618t1477r1918b1529],
6	partial	JJ	O	partial	amod	7	SENT_65	[p3l1938t1461r2144b1529],
7	response	NN	O	response	conj_or	4	SENT_65	[p3l12t1564r296b1616],
8	or	CC	O	or	_	0	SENT_65	[p3l332t1564r398b1602],
9	stable	JJ	O	stable	amod	10	SENT_65	[p3l432t1548r618b1602],
10	disease	NN	O	disease	conj_or	4	SENT_65	[p3l654t1548r885b1602],
11	continued	VBD	O	continue	_	0	SENT_65	[p3l921t1548r1244b1602],
12	therapy	NN	O	therapy	dobj	11	SENT_65	[p3l1279t1548r1526b1616],
13	until	IN	O	until	_	0	SENT_65	[p3l1560t1548r1708b1602],
14	disease	NN	O	disease	nn	15	SENT_65	[p3l1744t1548r1975b1602],
15	progression	NN	O	progression	prep_until	11	SENT_65	[p3l2011t1564r2144b1616, p3l11t1636r277b1703],
16	or	CC	O	or	_	0	SENT_65	[p3l295t1651r361b1689],
17	excessive	JJ	O	excessive	amod	18	SENT_65	[p3l377t1636r672b1689],
18	toxicity	NN	O	toxicity	prep_until	11	SENT_65	[p3l690t1636r930b1703],
19	with	IN	O	with	_	0	SENT_65	[p3l945t1636r1093b1689],
20	tumor	NN	O	tumor	nn	21	SENT_65	[p3l1110t1643r1311b1689],
21	re-assessment	NN	O	re-assessment	prep_with	11	SENT_65	[p3l1328t1643r1788b1689],
22	performed	VBN	O	perform	partmod	21	SENT_65	[p3l1805t1635r2144b1703],
23	every	DT	SET	every	det	25	SENT_65	[p3l12t1738r188b1790],
24	2	CD	SET	2	num	25	SENT_65	[p3l218t1725r252b1776],
25	months	NNS	NUMBER	month	tmod	22	SENT_65	[p3l286t1723r545b1777],
26	.	.	O	.	_	0	SENT_65	[p3l286t1723r545b1777],

1	Toxicity	NN	O	toxicity	nsubjpass	15	SENT_66	[p3l575t1723r838b1790],
2	,	,	O	,	_	0	SENT_66	[p3l575t1723r838b1790],
3	assessed	VBN	O	assess	partmod	1	SENT_66	[p3l871t1723r1145b1777],
4	monthly	RB	SET	monthly	advmod	3	SENT_66	[p3l1178t1723r1450b1790],
5	by	IN	O	by	_	0	SENT_66	[p3l1480t1723r1556b1790],
6	clinical	JJ	O	clinical	amod	7	SENT_66	[p3l1586t1723r1811b1777],
7	examination	NN	O	examination	agent	3	SENT_66	[p3l1844t1723r2144b1777, p3l11t1811r137b1864],
8	and	CC	O	and	_	0	SENT_66	[p3l164t1810r280b1864],
9	blood	NN	O	blood	nn	10	SENT_66	[p3l308t1810r487b1864],
10	counts	NNS	O	count	agent	3	SENT_66	[p3l515t1818r725b1864],
11	and	CC	O	and	_	0	SENT_66	[p3l754t1810r870b1864],
12	chemistry	NN	O	chemistry	agent	3	SENT_66	[p3l898t1810r1230b1877],
13	,	,	O	,	_	0	SENT_66	[p3l898t1810r1230b1877],
14	was	VBD	O	be	auxpass	15	SENT_66	[p3l1257t1826r1379b1864],
15	evaluated	VBN	O	evaluate	_	0	SENT_66	[p3l1408t1810r1718b1864],
16	according	VBG	O	accord	_	0	SENT_66	[p3l1746t1810r2058b1877],
17	to	TO	O	to	prepc_according_to	15	SENT_66	[p3l2084t1818r2144b1864],
18	NCIC-CTC	NN	O	ncic-ctc	nn	19	SENT_66	[p3l12t1901r318b1952],
19	version	NN	O	version	pobj	15	SENT_66	[p3l352t1899r588b1952],
20	2.0	CD	NUMBER	2.0	num	19	SENT_66	[p3l625t1901r733b1953],
21	.	.	O	.	_	0	SENT_66	[p3l625t1901r733b1953],

1	Survival	NN	O	survival	nsubjpass	3	SENT_67	[p3l772t1898r1027b1952],
2	was	VBD	O	be	auxpass	3	SENT_67	[p3l1063t1914r1185b1952],
3	calculated	VBN	O	calculate	_	0	SENT_67	[p3l1224t1898r1548b1952],
4	from	IN	O	from	_	0	SENT_67	[p3l1587t1898r1738b1952],
5	the	DT	O	the	det	6	SENT_67	[p3l1774t1898r1876b1952],
6	date	NN	O	date	prep_from	3	SENT_67	[p3l1913t1898r2049b1952],
7	of	IN	O	of	_	0	SENT_67	[p3l2086t1898r2153b1952],
8	therapy	NN	O	therapy	nn	9	SENT_67	[p3l11t1984r258b2052],
9	initiation	NN	O	initiation	prep_of	6	SENT_67	[p3l286t1985r581b2038],
10	to	TO	O	to	_	0	SENT_67	[p3l610t1992r670b2038],
11	the	DT	O	the	det	12	SENT_67	[p3l700t1984r801b2038],
12	date	NN	O	date	prep_to	3	SENT_67	[p3l831t1984r967b2038],
13	of	IN	O	of	_	0	SENT_67	[p3l997t1984r1064b2038],
14	death	NN	O	death	prep_of	12	SENT_67	[p3l1086t1984r1266b2038],
15	or	CC	O	or	_	0	SENT_67	[p3l1295t2000r1361b2038],
16	to	TO	O	to	_	0	SENT_67	[p3l1389t1992r1449b2038],
17	the	DT	O	the	det	18	SENT_67	[p3l1479t1984r1580b2038],
18	date	NN	O	date	conj_or	12	SENT_67	[p3l1610t1984r1746b2038],
19	of	IN	O	of	_	0	SENT_67	[p3l1776t1984r1842b2038],
20	last	JJ	O	last	amod	21	SENT_67	[p3l1865t1984r1976b2038],
21	contact	NN	O	contact	prep_of	18	SENT_67	[p3l2005t2000r2144b2038, p3l11t2080r145b2127],
22	.	.	O	.	_	0	SENT_67	[p3l2005t2000r2144b2038, p3l11t2080r145b2127],

1	2.2	CD	NUMBER	2.2	_	0	SENT_68	[p3l8t2273r113b2325],
2	.	.	O	.	_	0	SENT_68	[p3l8t2273r113b2325],

1	Methods	NNS	O	method	_	0	SENT_69	[p3l162t2270r426b2325],

1	The	DT	O	the	det	2	SENT_70	[p3l111t2448r227b2502],
2	assessment	NN	O	assessment	nsubj	12	SENT_70	[p3l264t2456r631b2502],
3	of	IN	O	of	_	0	SENT_70	[p3l666t2447r732b2502],
4	every	DT	O	every	det	6	SENT_70	[p3l761t2463r937b2515],
5	molecular	JJ	O	molecular	amod	6	SENT_70	[p3l972t2448r1294b2502],
6	parameter	NN	O	parameter	prep_of	2	SENT_70	[p3l1329t2456r1672b2515],
7	,	,	O	,	_	0	SENT_70	[p3l1329t2456r1672b2515],
8	performed	VBN	O	perform	partmod	6	SENT_70	[p3l1709t2447r2049b2515],
9	in	IN	O	in	_	0	SENT_70	[p3l2087t2448r2145b2501],
10	different	JJ	O	different	amod	11	SENT_70	[p3l12t2535r290b2589],
11	centres	NNS	O	centre	prep_in	8	SENT_70	[p3l334t2543r564b2589],
12	(	VBP	O	(	_	0	SENT_70	[p3l612t2535r855b2602],
13	Parma	NNP	ORGANIZATION	Parma	nsubjpass	21	SENT_70	[p3l612t2535r855b2602],
14	,	,	O	,	_	0	SENT_70	[p3l612t2535r855b2602],
15	Genova	NNP	PERSON	Genova	appos	13	SENT_70	[p3l902t2538r1139b2589],
16	and	CC	O	and	_	0	SENT_70	[p3l1185t2535r1301b2589],
17	Modena	NNP	LOCATION	Modena	appos	13	SENT_70	[p3l1348t2535r1648b2602],
18	)	CD	NUMBER	)	num	17	SENT_70	[p3l1348t2535r1648b2602],
19	,	,	O	,	_	0	SENT_70	[p3l1348t2535r1648b2602],
20	was	VBD	O	be	auxpass	21	SENT_70	[p3l1694t2550r1816b2589],
21	repeated	VBN	O	repeat	ccomp	12	SENT_70	[p3l1864t2535r2144b2602],
22	and	CC	O	and	_	0	SENT_70	[p3l12t2622r127b2676],
23	cross-checked	VBN	O	cross-check	conj_and	21	SENT_70	[p3l159t2622r611b2676],
24	in	IN	O	in	_	0	SENT_70	[p3l643t2623r702b2676],
25	the	DT	O	the	det	26	SENT_70	[p3l732t2622r834b2676],
26	laboratory	NN	O	laboratory	prep_in	21	SENT_70	[p3l866t2622r1199b2690],
27	of	IN	O	of	_	0	SENT_70	[p3l1228t2622r1294b2676],
28	the	DT	O	the	det	30	SENT_70	[p3l1317t2622r1419b2676],
29	coordinator	NN	O	coordinator	nn	30	SENT_70	[p3l1451t2622r1826b2676],
30	centre	NN	O	centre	prep_of	26	SENT_70	[p3l1855t2630r2054b2676],
31	of	IN	O	of	_	0	SENT_70	[p3l2086t2622r2153b2676],
32	Parma	NNP	ORGANIZATION	Parma	prep_of	30	SENT_70	[p3l12t2714r228b2765],
33	.	.	O	.	_	0	SENT_70	[p3l12t2714r228b2765],

1	2.2.1	CD	NUMBER	2.2.1	_	0	SENT_71	[p3l8t2911r158b2963],
2	.	.	O	.	_	0	SENT_71	[p3l8t2911r158b2963],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_72	[p3l206t2911r364b2962],
2	and	CC	O	and	_	0	SENT_72	[p3l386t2908r500b2962],
3	I	PRP	O	I	conj_and	1	SENT_72	[p3l519t2912r679b2962],
4	<	JJR	O	<	amod	1	SENT_72	[p3l519t2912r679b2962],
5	.	.	O	.	_	0	SENT_72	[p3l519t2912r679b2962],

1	—	NN	O	—	_	0	SENT_73	[p3l519t2912r679b2962],
2	.	.	O	.	_	0	SENT_73	[p3l519t2912r679b2962],

1	ras	NN	O	ra	nn	2	SENT_74	[p3l519t2912r679b2962],
2	gene	NN	O	gene	_	0	SENT_74	[p3l695t2924r842b2976],
3	mutational	JJ	O	mutational	amod	4	SENT_74	[p3l864t2908r1204b2962],
4	analysis	NN	O	analysis	dep	2	SENT_74	[p3l1225t2908r1470b2976],

1	Genomic	JJ	O	genomic	amod	2	SENT_75	[p3l114t2997r399b3051],
2	DNA	NN	O	dna	nsubjpass	4	SENT_75	[p3l424t2999r568b3050],
3	was	VBD	O	be	auxpass	4	SENT_75	[p3l589t3012r712b3051],
4	extracted	VBN	O	extract	_	0	SENT_75	[p3l739t2996r1038b3051],
5	from	IN	O	from	_	0	SENT_75	[p3l1065t2996r1216b3051],
6	micro	JJ	O	micro	amod	7	SENT_75	[p3l1242t2996r1755b3051],
7	—	NN	O	—	prep_from	4	SENT_75	[p3l1242t2996r1755b3051],
8	dissected	VBN	O	dissect	partmod	7	SENT_75	[p3l1242t2996r1755b3051],
9	tumor	NN	O	tumor	nn	10	SENT_75	[p3l1781t3004r1982b3051],
10	cells	NNS	O	cell	nsubj	14	SENT_75	[p3l2005t2996r2144b3051],
11	of	IN	O	of	_	0	SENT_75	[p3l12t3083r78b3138],
12	formalin	NN	O	formalin	prep_of	10	SENT_75	[p3l110t3083r572b3138],
13	—	CD	NUMBER	—	num	12	SENT_75	[p3l110t3083r572b3138],
14	ﬁxed	VBD	O	ﬁxed	ccomp	8	SENT_75	[p3l110t3083r572b3138],
15	parafﬁn-embedded	JJ	O	parafﬁn-embedded	amod	17	SENT_75	[p3l612t3083r1234b3151],
16	tissue	NN	O	tissue	nn	17	SENT_75	[p3l1273t3084r1458b3138],
17	sections	NNS	O	section	dobj	14	SENT_75	[p3l1498t3084r1771b3138],
18	.	.	O	.	_	0	SENT_75	[p3l1498t3084r1771b3138],

1	Ampliﬁcations	NNS	O	ampliﬁcations	nsubjpass	17	SENT_76	[p3l1808t3083r2144b3151, p3l11t3172r167b3225],
2	of	IN	O	of	_	0	SENT_76	[p3l204t3171r270b3225],
3	exons	NNS	O	exon	prep_of	1	SENT_76	[p3l298t3186r479b3225],
4	18	CD	NUMBER	18	num	3	SENT_76	[p3l519t3174r585b3225],
5	through	IN	O	through	_	0	SENT_76	[p3l622t3171r878b3238],
6	21	CD	NUMBER	21	prep_through	3	SENT_76	[p3l914t3174r979b3224],
7	of	IN	O	of	_	0	SENT_76	[p3l1023t3171r1089b3225],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_76	[p3l1115t3174r1273b3225],
9	gene	NN	O	gene	prep_of	3	SENT_76	[p3l1302t3186r1448b3238],
10	and	CC	O	and	_	0	SENT_76	[p3l1483t3171r1599b3225],
11	exon	NN	O	exon	conj_and	3	SENT_76	[p3l1636t3187r1786b3225],
12	2	CD	NUMBER	2	num	11	SENT_76	[p3l1821t3174r1855b3224],
13	of	IN	O	of	_	0	SENT_76	[p3l1893t3171r1959b3225],
14	K-ras	JJ	O	k-ras	amod	15	SENT_76	[p3l1985t3174r2145b3225],
15	gene	NN	O	gene	prep_of	11	SENT_76	[p3l6t3273r152b3325],
16	were	VBD	O	be	auxpass	17	SENT_76	[p3l171t3273r329b3311],
17	performed	VBN	O	perform	_	0	SENT_76	[p3l351t3257r691b3325],
18	using	VBG	O	use	xcomp	17	SENT_76	[p3l713t3258r885b3325],
19	nested	JJ	O	nested	amod	20	SENT_76	[p3l905t3257r1115b3311],
20	primers	NNS	O	primer	dobj	18	SENT_76	[p3l1138t3258r1386b3325],
21	as	IN	O	as	_	0	SENT_76	[p3l1409t3273r1471b3311],
22	published	VBN	O	publish	amod	23	SENT_76	[p3l1494t3257r1809b3325],
23	[	NN	O	[	prep_as	20	SENT_76	[p3l1835t3257r2144b3325],
24	16	CD	NUMBER	16	number	25	SENT_76	[p3l1835t3257r2144b3325],
25	—	CD	NUMBER	—	dep	20	SENT_76	[p3l1835t3257r2144b3325],
26	18,9	CD	NUMBER	18,9	num	27	SENT_76	[p3l1835t3257r2144b3325],
27	]	NN	O	]	dep	25	SENT_76	[p3l1835t3257r2144b3325],
28	.	.	O	.	_	0	SENT_76	[p3l1835t3257r2144b3325],

1	PCR	NN	O	pcr	nn	2	SENT_77	[p3l12t3347r136b3398],
2	fragments	NNS	O	fragment	nsubj	11	SENT_77	[p3l158t3344r480b3412],
3	were	VBD	O	be	auxpass	4	SENT_77	[p3l504t3360r661b3398],
4	sequenced	VBN	O	sequence	_	0	SENT_77	[p3l687t3344r1024b3412],
5	and	CC	O	and	_	0	SENT_77	[p3l1050t3344r1166b3398],
6	analyzed	VBN	O	analyze	conj_and	4	SENT_77	[p3l1190t3344r1474b3412],
7	in	IN	O	in	prep	4	SENT_77	[p3l1500t3345r1559b3398],
8	both	CC	O	both	dep	9	SENT_77	[p3l1583t3344r1727b3398],
9	forward	RB	O	forward	dep	7	SENT_77	[p3l1752t3344r2004b3398],
10	and	CC	O	and	_	0	SENT_77	[p3l2029t3344r2144b3398],
11	reverse	VB	O	reverse	conj_and	4	SENT_77	[p3l12t3447r242b3485],
12	directions	NNS	O	direction	dobj	11	SENT_77	[p3l269t3431r607b3494],
13	;	:	O	;	_	0	SENT_77	[p3l269t3431r607b3494],
14	mutations	NNS	O	mutation	nsubjpass	16	SENT_77	[p3l639t3432r965b3485],
15	were	VBD	O	be	auxpass	16	SENT_77	[p3l991t3447r1148b3485],
16	veriﬁed	VBN	O	veriﬁed	parataxis	4	SENT_77	[p3l1174t3431r1418b3485],
17	by	IN	O	by	_	0	SENT_77	[p3l1444t3431r1520b3499],
18	three	CD	NUMBER	three	num	20	SENT_77	[p3l1544t3431r1711b3485],
19	independent	JJ	O	independent	amod	20	SENT_77	[p3l1738t3431r2146b3499],
20	ampliﬁcations	NNS	O	ampliﬁcations	agent	16	SENT_77	[p3l12t3518r484b3586],
21	.	.	O	.	_	0	SENT_77	[p3l12t3518r484b3586],

1	The	DT	O	the	det	2	SENT_78	[p3l507t3519r623b3573],
2	mutations	NNS	O	mutation	nsubjpass	5	SENT_78	[p3l648t3520r974b3573],
3	were	VBD	O	be	auxpass	5	SENT_78	[p3l998t3534r1156b3573],
4	furthermore	RB	O	furthermore	advmod	5	SENT_78	[p3l1182t3518r1575b3573],
5	investigated	VBN	O	investigate	_	0	SENT_78	[p3l1601t3519r1990b3586],
6	by	IN	O	by	_	0	SENT_78	[p3l2014t3519r2090b3586],
7	a	DT	O	a	det	9	SENT_78	[p3l2113t3534r2145b3573],
8	Surveyor	NNP	MISC	Surveyor	nn	9	SENT_78	[p3l12t3608r297b3673],
9	assay	NN	O	assay	agent	5	SENT_78	[p3l315t3621r486b3673],
10	on	IN	O	on	_	0	SENT_78	[p3l505t3621r583b3660],
11	denaturing	VBG	O	denature	prepc_on	5	SENT_78	[p3l603t3606r957b3673],
12	high	JJ	O	high	amod	18	SENT_78	[p3l977t3606r1117b3673],
13	performance	NN	O	performance	nn	18	SENT_78	[p3l1138t3605r1547b3673],
14	liquid	NN	O	liquid	nn	18	SENT_78	[p3l1569t3606r1751b3673],
15	chromatography	NN	O	chromatography	nn	18	SENT_78	[p3l1772t3606r2144b3673, p3l12t3693r194b3760],
16	(	CD	NUMBER	(	num	18	SENT_78	[p3l215t3693r498b3760],
17	DHPLC	NN	O	dhplc	nn	18	SENT_78	[p3l215t3693r498b3760],
18	)	NN	O	)	dobj	11	SENT_78	[p3l215t3693r498b3760],
19	,	,	O	,	_	0	SENT_78	[p3l215t3693r498b3760],
20	as	IN	O	as	mark	22	SENT_78	[p3l522t3709r584b3747],
21	already	RB	O	already	advmod	22	SENT_78	[p3l607t3693r844b3760],
22	described	VBN	O	describe	dep	18	SENT_78	[p3l865t3693r1174b3747],
23	[	NN	O	[	nn	25	SENT_78	[p3l1200t3693r1335b3760],
24	19	CD	NUMBER	19	num	25	SENT_78	[p3l1200t3693r1335b3760],
25	]	NN	O	]	dobj	22	SENT_78	[p3l1200t3693r1335b3760],
26	.	.	O	.	_	0	SENT_78	[p3l1200t3693r1335b3760],

1	2.2.2	CD	NUMBER	2.2.2	_	0	SENT_79	[p4l8t104r168b156],
2	.	.	O	.	_	0	SENT_79	[p4l8t104r168b156],

1	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_80	[p4l217t104r375b155],
2	and	CC	O	and	_	0	SENT_80	[p4l396t101r510b155],
3	HER2	NN	O	her2	nn	4	SENT_80	[p4l529t104r695b155],
4	gene	NN	O	gene	_	0	SENT_80	[p4l712t117r858b169],
5	copy	NN	O	copy	nn	6	SENT_80	[p4l880t117r1021b169],
6	number	NN	O	number	dep	4	SENT_80	[p4l1043t101r1284b155],
7	by	IN	O	by	_	0	SENT_80	[p4l1303t101r1374b169],
8	ﬂuorescence	NN	O	ﬂuorescence	prep_by	6	SENT_80	[p4l1384t101r1771b169],
9	in	FW	O	in	prep	8	SENT_80	[p4l1793t102r1847b155],
10	situ	FW	O	situ	pobj	9	SENT_80	[p4l1868t102r1979b155],
11	hybridization	NN	O	hybridization	nn	14	SENT_80	[p4l12t188r420b256],
12	(	CD	NUMBER	(	num	14	SENT_80	[p4l442t188r632b256],
13	FISH	NN	O	fish	nn	14	SENT_80	[p4l442t188r632b256],
14	)	NN	O	)	dep	4	SENT_80	[p4l442t188r632b256],

1	EGFR	NN	ORGANIZATION	egfr	nsubjpass	10	SENT_81	[p4l111t278r269b329],
2	and	CC	O	and	_	0	SENT_81	[p4l301t275r417b329],
3	HER2	NN	O	her2	nn	6	SENT_81	[p4l449t278r615b329],
4	gene	NN	O	gene	nn	6	SENT_81	[p4l642t291r788b343],
5	copy	NN	O	copy	nn	6	SENT_81	[p4l821t291r970b343],
6	number	NN	O	number	conj_and	1	SENT_81	[p4l1003t275r1257b329],
7	per	IN	O	per	_	0	SENT_81	[p4l1289t291r1393b343],
8	cell	NN	O	cell	prep_per	6	SENT_81	[p4l1425t275r1532b329],
9	were	VBD	O	be	auxpass	10	SENT_81	[p4l1564t291r1722b329],
10	investigated	VBN	O	investigate	_	0	SENT_81	[p4l1756t275r2144b343],
11	on	IN	O	on	_	0	SENT_81	[p4l12t378r90b416],
12	formalin-ﬁxed	JJ	O	formalin-ﬁxed	amod	14	SENT_81	[p4l124t362r587b416],
13	parafﬁn-embedded	JJ	O	parafﬁn-embedded	amod	14	SENT_81	[p4l622t362r1244b430],
14	specimens	NNS	O	specimen	prep_on	10	SENT_81	[p4l1280t363r1615b430],
15	using	VBG	O	use	xcomp	10	SENT_81	[p4l1651t363r1823b430],
16	LSI	NNP	ORGANIZATION	LSI	nn	17	SENT_81	[p4l1856t365r1946b416],
17	EGFR	NN	O	egfr	dobj	15	SENT_81	[p4l1981t365r2148b416],
18	Spectrum	NN	O	spectrum	nn	20	SENT_81	[p4l12t452r320b517],
19	orange/CEP7	NN	O	orange/cep7	nn	20	SENT_81	[p4l355t449r757b517],
20	Spectrum	NN	O	spectrum	dep	36	SENT_81	[p4l795t452r1103b517],
21	green	JJ	O	green	amod	20	SENT_81	[p4l1137t465r1316b517],
22	and	CC	O	and	_	0	SENT_81	[p4l1351t450r1467b504],
23	LS1	NN	O	ls1	nn	27	SENT_81	[p4l1504t452r1593b504],
24	HER2	NN	MISC	her2	nn	27	SENT_81	[p4l1630t452r1799b503],
25	Spectrum	NN	MISC	spectrum	nn	27	SENT_81	[p4l1838t452r2145b517],
26	orange/CEP17	NN	MISC	orange/cep17	nn	27	SENT_81	[p4l12t537r448b604],
27	Spectrum	NN	MISC	spectrum	conj_and	20	SENT_81	[p4l500t540r808b604],
28	green	JJ	O	green	amod	30	SENT_81	[p4l856t553r1036b604],
29	probe	NN	O	probe	nn	30	SENT_81	[p4l1085t537r1268b604],
30	sets	NNS	O	set	dep	27	SENT_81	[p4l1319t545r1455b599],
31	,	,	O	,	_	0	SENT_81	[p4l1319t545r1455b599],
32	respectively	RB	O	respectively	advmod	27	SENT_81	[p4l1506t537r1891b604],
33	(	CD	NUMBER	(	dep	36	SENT_81	[p4l1939t537r2144b604],
34	Vysis	NNP	ORGANIZATION	Vysis	nn	36	SENT_81	[p4l1939t537r2144b604],
35	,	,	O	,	_	0	SENT_81	[p4l1939t537r2144b604],
36	Tablel	NNP	O	Tablel	dep	15	SENT_81	[p4l7t619r192b662],
37	Patient	NN	O	patient	nn	38	SENT_81	[p4l10t692r191b735],
38	characteristics	NNS	O	characteristic	dep	36	SENT_81	[p4l208t691r591b735],
39	.	.	O	.	_	0	SENT_81	[p4l208t691r591b735],

1	No.	NN	O	no.	dep	7	SENT_82	[p4l1212t818r1294b859],
2	of	IN	O	of	_	0	SENT_82	[p4l1313t815r1366b858],
3	patients	NNS	O	patient	prep_of	1	SENT_82	[p4l1378t815r1584b869],
4	(	CD	NUMBER	(	num	5	SENT_82	[p4l1603t815r1652b869],
5	n	NN	O	n	dep	7	SENT_82	[p4l1603t815r1652b869],
6	=	JJ	O	=	amod	7	SENT_82	[p4l1666t833r1692b846],
7	91	CD	PERCENT	91	_	0	SENT_82	[p4l1706t815r1786b869],
8	)	CD	PERCENT	)	num	9	SENT_82	[p4l1706t815r1786b869],
9	%	NN	PERCENT	%	dep	7	SENT_82	[p4l2038t817r2070b858],

1	Gender	NN	O	gender	_	0	SENT_83	[p4l10t926r198b970],

1	Males	NNS	O	male	_	0	SENT_84	[p4l64t999r214b1042],
2	56	CD	NUMBER	56	num	4	SENT_84	[p4l1212t1001r1273b1042],
3	61.5	CD	NUMBER	61.5	num	4	SENT_84	[p4l2041t1001r2145b1043],
4	Females	NNS	MISC	female	dep	1	SENT_84	[p4l64t1071r271b1115],
5	35	CD	NUMBER	35	number	6	SENT_84	[p4l1212t1073r1272b1115],
6	38.5	CD	NUMBER	38.5	dep	4	SENT_84	[p4l2038t1073r2145b1115],

1	Age	NNP	O	Age	_	0	SENT_85	[p4l8t1188r115b1240],
2	,	,	O	,	_	0	SENT_85	[p4l8t1188r115b1240],
3	years	NNS	DURATION	year	appos	1	SENT_85	[p4l133t1199r267b1240],

1	Median	JJ	O	median	amod	3	SENT_86	[p4l64t1257r258b1301],
2	(	NN	O	(	nn	3	SENT_86	[p4l276t1257r459b1312],
3	range	NN	O	range	_	0	SENT_86	[p4l276t1257r459b1312],
4	)	CD	NUMBER	)	number	5	SENT_86	[p4l276t1257r459b1312],
5	67	CD	NUMBER	67	num	6	SENT_86	[p4l1212t1260r1271b1301],
6	(	NN	O	(	dep	3	SENT_86	[p4l1291t1258r1492b1312],
7	40-85	CD	NUMBER	40-85	num	8	SENT_86	[p4l1291t1258r1492b1312],
8	)	NN	O	)	dep	6	SENT_86	[p4l1291t1258r1492b1312],

1	Histology	NNP	O	Histology	_	0	SENT_87	[p4l10t1372r255b1427],

1	Adenocarcinoma	NN	O	adenocarcinoma	_	0	SENT_88	[p4l62t1445r498b1488],
2	70	CD	NUMBER	70	number	3	SENT_88	[p4l1214t1447r1273b1488],
3	77	CD	NUMBER	77	num	4	SENT_88	[p4l2040t1447r2099b1488],
4	NSCLC	NN	O	nsclc	dep	1	SENT_88	[p4l64t1519r229b1561],
5	other	JJ	O	other	dep	4	SENT_88	[p4l246t1517r384b1561],
6	than	IN	O	than	_	0	SENT_88	[p4l400t1517r516b1561],
7	adenocarcinoma	NN	O	adenocarcinoma	prep_than	4	SENT_88	[p4l533t1517r960b1561],
8	21	CD	NUMBER	21	num	9	SENT_88	[p4l1214t1519r1267b1560],
9	29	CD	NUMBER	29	dep	1	SENT_88	[p4l2039t1519r2100b1561],

1	Stage	NN	O	stage	_	0	SENT_89	[p4l10t1634r144b1686],

1	III	NNP	O	III	_	0	SENT_90	[p4l64t1707r112b1748],
2	10	CD	NUMBER	10	num	1	SENT_90	[p4l1218t1707r1273b1748],
3	11	CD	NUMBER	11	number	4	SENT_90	[p4l2048t1707r2094b1748],
4	IV	CD	NUMBER	iv	dep	1	SENT_90	[p4l64t1779r118b1820],
5	81	CD	NUMBER	81	num	6	SENT_90	[p4l1212t1779r1267b1821],
6	89	CD	NUMBER	89	dep	4	SENT_90	[p4l2039t1779r2100b1820],

1	Performance	NNP	O	Performance	_	0	SENT_91	[p4l10t1891r337b1935],
2	status	NN	O	status	nn	5	SENT_91	[p4l356t1898r506b1935],
3	(	CD	NUMBER	(	num	5	SENT_91	[p4l524t1892r707b1946],
4	ECOG	NN	O	ecog	nn	5	SENT_91	[p4l524t1892r707b1946],
5	)	NN	O	)	dep	1	SENT_91	[p4l524t1892r707b1946],

1	O	NN	O	o	_	0	SENT_92	[p4l64t1966r93b2008],
2	31	CD	NUMBER	31	num	3	SENT_92	[p4l1214t1966r1267b2008],
3	34	CD	NUMBER	34	dep	1	SENT_92	[p4l2038t1966r2101b2008],
4	1	CD	DATE	1	number	5	SENT_92	[p4l67t2039r87b2080],
5	49	CD	DATE	49	num	7	SENT_92	[p4l1209t2039r1273b2080],
6	54	CD	DATE	54	number	7	SENT_92	[p4l2039t2039r2101b2080],
7	2	CD	DATE	2	dep	3	SENT_92	[p4l64t2111r91b2152],
8	11	CD	DATE	11	num	9	SENT_92	[p4l1221t2111r1267b2152],
9	12	CD	DATE	12	dep	1	SENT_92	[p4l2044t2111r2099b2152],

1	Smoking	NN	O	smoking	nn	2	SENT_93	[p4l10t2224r235b2278],
2	statusa	NN	O	statusa	_	0	SENT_93	[p4l252t2226r424b2267],

1	Current	JJ	DATE	current	amod	4	SENT_94	[p4l64t2298r260b2340],
2	or	CC	O	or	_	0	SENT_94	[p4l277t2309r330b2340],
3	former	JJ	O	former	amod	4	SENT_94	[p4l347t2296r524b2340],
4	smokers	NNS	O	smoker	_	0	SENT_94	[p4l540t2296r754b2340],
5	71	CD	NUMBER	71	number	6	SENT_94	[p4l1215t2299r1267b2339],
6	78	CD	NUMBER	78	num	8	SENT_94	[p4l2040t2298r2099b2340],
7	No	DT	O	no	det	8	SENT_94	[p4l64t2371r133b2412],
8	smokers	NNS	O	smoker	dep	4	SENT_94	[p4l152t2369r365b2412],
9	20	CD	NUMBER	20	number	10	SENT_94	[p4l1212t2371r1273b2412],
10	22	CD	NUMBER	22	amod	8	SENT_94	[p4l2039t2371r2099b2412],

1	a	DT	O	a	det	3	SENT_95	[p4l61t2484r79b2506],
2	Current	JJ	DATE	current	amod	3	SENT_95	[p4l112t2484r308b2526],
3	smokers	NNS	O	smoker	nsubj	4	SENT_95	[p4l335t2482r549b2526],
4	(	VBP	O	(	ccomp	20	SENT_95	[p4l577t2482r699b2536],
5	quit	VBN	O	quit	dep	4	SENT_95	[p4l577t2482r699b2536],
6	smoking	NN	O	smoking	nsubj	7	SENT_95	[p4l726t2482r946b2536],
7	<	JJR	O	<	xcomp	5	SENT_95	[p4l973t2484r1033b2526],
8	6	CD	DURATION	6	num	9	SENT_95	[p4l973t2484r1033b2526],
9	months	NNS	NUMBER	month	npadvmod	5	SENT_95	[p4l1061t2482r1255b2526],
10	before	IN	O	before	_	0	SENT_95	[p4l1283t2482r1446b2526],
11	starting	VBG	O	start	prepc_before	5	SENT_95	[p4l1474t2483r1672b2536],
12	therapy	NN	O	therapy	nn	15	SENT_95	[p4l1698t2482r1897b2536],
13	or	CC	O	or	_	0	SENT_95	[p4l1923t2495r1976b2526],
14	active	JJ	O	active	nn	15	SENT_95	[p4l2002t2483r2151b2526],
15	smokers	NNS	O	smoker	dobj	11	SENT_95	[p4l10t2553r258b2607],
16	)	RB	O	)	advmod	11	SENT_95	[p4l10t2553r258b2607],
17	,	,	O	,	_	0	SENT_95	[p4l10t2553r258b2607],
18	former	JJ	O	former	amod	19	SENT_95	[p4l272t2553r449b2597],
19	smokers	NNS	O	smoker	nsubj	20	SENT_95	[p4l460t2553r674b2597],
20	(	VBP	O	(	_	0	SENT_95	[p4l687t2554r810b2608],
21	quit	VBN	O	quit	dep	20	SENT_95	[p4l687t2554r810b2608],
22	smoking	NN	O	smoking	dobj	21	SENT_95	[p4l822t2553r1042b2608],
23	6	CD	DURATION	6	num	24	SENT_95	[p4l1054t2556r1082b2597],
24	months	NNS	NUMBER	month	npadvmod	21	SENT_95	[p4l1096t2553r1290b2597],
25	before	IN	O	before	_	0	SENT_95	[p4l1303t2553r1465b2597],
26	starting	VBG	O	start	prepc_before	21	SENT_95	[p4l1479t2554r1677b2608],
27	therapy	NN	O	therapy	dobj	26	SENT_95	[p4l1688t2554r1905b2608],
28	)	CD	NUMBER	)	num	27	SENT_95	[p4l1688t2554r1905b2608],
29	no	DT	O	no	det	30	SENT_95	[p4l1919t2566r1980b2597],
30	smokers	NNS	O	smoker	nsubj	31	SENT_95	[p4l1994t2553r2151b2597, p4l10t2637r83b2668],
31	(	VBP	O	(	rcmod	27	SENT_95	[p4l102t2625r246b2679],
32	<	JJR	O	<	acomp	31	SENT_95	[p4l102t2625r246b2679],
33	100	CD	NUMBER	100	num	34	SENT_95	[p4l102t2625r246b2679],
34	cigarettes	NNS	O	cigarette	dep	32	SENT_95	[p4l265t2626r512b2679],
35	per	IN	O	per	_	0	SENT_95	[p4l531t2637r615b2679],
36	lifetime	NN	O	lifetime	nn	37	SENT_95	[p4l631t2625r863b2679],
37	)	NN	O	)	prep_per	34	SENT_95	[p4l631t2625r863b2679],
38	.	.	O	.	_	0	SENT_95	[p4l631t2625r863b2679],

1	Downers	NNP	PERSON	Downers	nn	2	SENT_96	[p4l11t2837r295b2889],
2	Grove	NNP	PERSON	Grove	_	0	SENT_96	[p4l316t2836r517b2897],
3	,	,	O	,	_	0	SENT_96	[p4l316t2836r517b2897],
4	IL	NN	O	il	appos	2	SENT_96	[p4l538t2837r605b2897],
5	,	,	O	,	_	0	SENT_96	[p4l538t2837r605b2897],
6	US	NNP	LOCATION	US	appos	4	SENT_96	[p4l625t2834r750b2902],
7	)	CD	NUMBER	)	num	6	SENT_96	[p4l625t2834r750b2902],
8	.	.	O	.	_	0	SENT_96	[p4l625t2834r750b2902],

1	The	DT	O	the	det	3	SENT_97	[p4l768t2834r884b2889],
2	FISH	NN	O	fish	nn	3	SENT_97	[p4l905t2836r1046b2889],
3	protocol	NN	O	protocol	nsubjpass	8	SENT_97	[p4l1066t2834r1330b2902],
4	and	CC	O	and	_	0	SENT_97	[p4l1350t2834r1467b2889],
5	sample	NN	O	sample	nn	6	SENT_97	[p4l1487t2834r1715b2902],
6	classiﬁcation	NN	O	classiﬁcation	conj_and	3	SENT_97	[p4l1735t2833r2151b2889],
7	are	VBP	O	be	auxpass	8	SENT_97	[p4l10t2938r107b2978],
8	described	VBN	O	describe	_	0	SENT_97	[p4l130t2923r441b2978],
9	in	IN	O	in	_	0	SENT_97	[p4l464t2923r523b2977],
10	details	NNS	O	detail	prep_in	8	SENT_97	[p4l546t2923r755b2978],
11	elsewhere	RB	O	elsewhere	advmod	8	SENT_97	[p4l779t2923r1105b2978],
12	[	RB	O	[	dep	13	SENT_97	[p4l1131t2922r1357b2991],
13	20,11	CD	NUMBER	20,11	num	14	SENT_97	[p4l1131t2922r1357b2991],
14	]	NN	O	]	pobj	11	SENT_97	[p4l1131t2922r1357b2991],
15	.	.	O	.	_	0	SENT_97	[p4l1131t2922r1357b2991],

1	2.2.3	CD	NUMBER	2.2.3	_	0	SENT_98	[p4l6t3148r168b3200],
2	.	.	O	.	_	0	SENT_98	[p4l6t3148r168b3200],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_99	[p4l217t3148r375b3200],
2	immunohistochemistry	NN	O	immunohistochemistry	_	0	SENT_99	[p4l397t3145r1110b3214],

1	Parafﬁn	NNP	O	Parafﬁn	dep	3	SENT_100	[p4l113t3234r734b3289],
2	—	CD	NUMBER	—	num	1	SENT_100	[p4l113t3234r734b3289],
3	embedded	JJ	O	embedded	amod	5	SENT_100	[p4l113t3234r734b3289],
4	tissue	NN	O	tissue	nn	5	SENT_100	[p4l790t3235r975b3289],
5	sections	NNS	O	section	nsubjpass	14	SENT_100	[p4l1033t3235r1291b3289],
6	from	IN	O	from	_	0	SENT_100	[p4l1349t3234r1501b3289],
7	tumor	NN	O	tumor	nn	8	SENT_100	[p4l1557t3242r1758b3289],
8	specimens	NNS	O	specimen	prep_from	5	SENT_100	[p4l1813t3235r2150b3303],
9	obtained	VBN	O	obtain	partmod	8	SENT_100	[p4l10t3323r293b3378],
10	at	IN	O	at	_	0	SENT_100	[p4l312t3331r371b3378],
11	ﬁrst	JJ	O	ﬁrst	amod	12	SENT_100	[p4l388t3323r515b3378],
12	diagnosis	NN	O	diagnosis	prep_at	9	SENT_100	[p4l531t3323r831b3392],
13	were	VBD	O	be	auxpass	14	SENT_100	[p4l848t3339r1006b3378],
14	analyzed	VBN	O	analyze	_	0	SENT_100	[p4l1025t3323r1310b3392],
15	for	IN	O	for	_	0	SENT_100	[p4l1329t3323r1418b3378],
16	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_100	[p4l1434t3326r1601b3378],
17	expression	NN	O	expression	nsubj	23	SENT_100	[p4l1616t3324r1976b3392],
18	,	,	O	,	_	0	SENT_100	[p4l1616t3324r1976b3392],
19	evaluated	VBN	O	evaluate	partmod	17	SENT_100	[p4l1995t3323r2150b3378, p4l10t3412r189b3467],
20	by	IN	O	by	_	0	SENT_100	[p4l225t3412r301b3481],
21	IHC	NNP	ORGANIZATION	IHC	agent	19	SENT_100	[p4l335t3415r462b3476],
22	,	,	O	,	_	0	SENT_100	[p4l335t3415r462b3476],
23	using	VBG	O	use	prepc_for	14	SENT_100	[p4l499t3413r672b3481],
24	methods	NNS	O	method	dobj	23	SENT_100	[p4l706t3412r985b3467],
25	and	CC	O	and	_	0	SENT_100	[p4l1021t3412r1137b3467],
26	assessment	NN	O	assessment	nn	27	SENT_100	[p4l1173t3421r1541b3467],
27	criteria	NNS	O	criterion	dobj	23	SENT_100	[p4l1576t3413r1804b3467],
28	described	VBN	O	describe	partmod	24	SENT_100	[p4l1840t3412r2150b3467],
29	elsewhere	RB	O	elsewhere	advmod	28	SENT_100	[p4l10t3502r337b3557],
30	[	RB	O	[	amod	32	SENT_100	[p4l374t3501r512b3570],
31	21	CD	NUMBER	21	tmod	30	SENT_100	[p4l374t3501r512b3570],
32	]	NN	O	]	dobj	28	SENT_100	[p4l374t3501r512b3570],
33	.	.	O	.	_	0	SENT_100	[p4l374t3501r512b3570],

1	Preparations	NNS	O	preparation	nsubjpass	3	SENT_101	[p4l547t3502r951b3570],
2	were	VBD	O	be	auxpass	3	SENT_101	[p4l985t3517r1143b3557],
3	assessed	VBN	O	assess	_	0	SENT_101	[p4l1177t3502r1451b3557],
4	by	IN	O	by	_	0	SENT_101	[p4l1485t3502r1562b3570],
5	two	CD	NUMBER	two	num	6	SENT_101	[p4l1593t3510r1714b3557],
6	observers	NNS	O	observer	agent	3	SENT_101	[p4l1749t3502r2057b3557],
7	in	IN	O	in	_	0	SENT_101	[p4l2092t3502r2151b3556],
8	blind	JJ	O	blind	prep_in	3	SENT_101	[p4l10t3591r189b3646],
9	.	.	O	.	_	0	SENT_101	[p4l10t3591r189b3646],

1	If	IN	O	if	mark	3	SENT_102	[p4l206t3591r254b3645],
2	discrepancies	NNS	O	discrepancy	nsubj	3	SENT_102	[p4l262t3591r695b3659],
3	occurred	VBD	O	occur	advcl	9	SENT_102	[p4l711t3591r1009b3654],
4	,	,	O	,	_	0	SENT_102	[p4l711t3591r1009b3654],
5	a	DT	O	a	det	7	SENT_102	[p4l1025t3607r1057b3646],
6	consensus	NN	O	consensus	nn	7	SENT_102	[p4l1072t3607r1400b3646],
7	score	NN	NUMBER	score	nsubjpass	9	SENT_102	[p4l1417t3607r1582b3646],
8	was	VBD	O	be	auxpass	9	SENT_102	[p4l1596t3607r1718b3646],
9	reached	VBN	O	reach	_	0	SENT_102	[p4l1735t3591r1987b3646],
10	after	IN	O	after	_	0	SENT_102	[p4l2003t3591r2153b3646],
11	discussion	NN	O	discussion	prep_after	9	SENT_102	[p4l10t3679r359b3734],
12	.	.	O	.	_	0	SENT_102	[p4l10t3679r359b3734],

1	2.2.4	CD	NUMBER	2.2.4	_	0	SENT_103	[p5l6t114r168b167],
2	.	.	O	.	_	0	SENT_103	[p5l6t114r168b167],

1	Genotype	NN	O	genotype	nn	2	SENT_104	[p5l220t114r508b180],
2	characterization	NN	O	characterization	_	0	SENT_104	[p5l530t111r1028b166],

1	Genomic	JJ	O	genomic	amod	2	SENT_105	[p5l112t201r398b255],
2	DNA	NN	O	dna	nsubjpass	11	SENT_105	[p5l426t203r570b255],
3	was	VBD	O	be	auxpass	4	SENT_105	[p5l594t216r716b255],
4	isolated	VBN	O	isolate	_	0	SENT_105	[p5l746t200r996b255],
5	from	IN	O	from	_	0	SENT_105	[p5l1025t200r1177b255],
6	whole	JJ	O	whole	amod	9	SENT_105	[p5l1202t200r1401b255],
7	venous	JJ	O	venous	amod	9	SENT_105	[p5l1427t216r1654b255],
8	blood	NN	O	blood	nn	9	SENT_105	[p5l1682t200r1862b255],
9	samples	NNS	O	sample	prep_from	4	SENT_105	[p5l1891t200r2150b269],
10	and	CC	O	and	_	0	SENT_105	[p5l10t290r126b345],
11	ampliﬁed	VBN	O	ampliﬁed	conj_and	4	SENT_105	[p5l164t289r470b358],
12	as	IN	O	as	mark	14	SENT_105	[p5l508t305r570b345],
13	previously	RB	DATE	previously	advmod	14	SENT_105	[p5l609t290r945b358],
14	described	VBN	O	describe	advcl	11	SENT_105	[p5l981t290r1292b345],
15	[	NN	O	[	nn	17	SENT_105	[p5l1333t289r1474b358],
16	22	CD	NUMBER	22	num	17	SENT_105	[p5l1333t289r1474b358],
17	]	NN	O	]	dobj	14	SENT_105	[p5l1333t289r1474b358],
18	.	.	O	.	_	0	SENT_105	[p5l1333t289r1474b358],

1	Fluorescent	JJ	O	fluorescent	amod	2	SENT_106	[p5l1513t290r2150b345],
2	—	NN	O	—	_	0	SENT_106	[p5l1513t290r2150b345],
3	labeled	VBN	O	label	dep	2	SENT_106	[p5l1513t290r2150b345],
4	PCR	NN	O	pcr	nn	5	SENT_106	[p5l11t382r134b434],
5	products	NNS	O	product	dobj	3	SENT_106	[p5l153t379r434b447],
6	were	VBD	O	be	auxpass	7	SENT_106	[p5l455t395r613b434],
7	run	VBN	O	run	rcmod	5	SENT_106	[p5l636t395r745b434],
8	on	IN	O	on	_	0	SENT_106	[p5l766t395r844b434],
9	an	DT	O	a	det	13	SENT_106	[p5l866t395r941b434],
10	automated	VBN	O	automate	amod	13	SENT_106	[p5l962t379r1308b434],
11	capillary	JJ	O	capillary	amod	13	SENT_106	[p5l1330t379r1609b447],
12	electrophoresisbased	JJ	O	electrophoresisbased	amod	13	SENT_106	[p5l1628t379r2150b447, p5l10t467r194b522],
13	DNA	NN	O	dna	prep_on	7	SENT_106	[p5l229t469r373b522],
14	sequencer	NN	O	sequencer	nn	16	SENT_106	[p5l405t483r732b536],
15	ABI	NNP	O	ABI	nn	16	SENT_106	[p5l761t469r869b521],
16	PRISM	NN	O	prism	dep	13	SENT_106	[p5l904t470r1106b522],
17	310	CD	NUMBER	310	num	23	SENT_106	[p5l1140t470r1250b522],
18	Genetic	JJ	O	genetic	amod	23	SENT_106	[p5l1285t468r1528b522],
19	Analyzer	NNP	O	Analyzer	nn	23	SENT_106	[p5l1558t467r1844b536],
20	(	NNP	O	(	nn	23	SENT_106	[p5l1876t467r2150b536],
21	Applied	NNP	O	Applied	nn	23	SENT_106	[p5l1876t467r2150b536],
22	Biosystems	NNP	O	Biosystems	nn	23	SENT_106	[p5l11t556r395b625],
23	)	NN	O	)	nsubjpass	7	SENT_106	[p5l11t556r395b625],
24	and	CC	O	and	_	0	SENT_106	[p5l423t556r540b611],
25	were	VBD	O	be	auxpass	26	SENT_106	[p5l567t572r725b611],
26	analyzed	VBN	O	analyze	dep	2	SENT_106	[p5l753t556r1038b625],
27	using	VBG	O	use	xcomp	26	SENT_106	[p5l1066t557r1239b625],
28	Genescan	NNP	MISC	Genescan	nsubj	30	SENT_106	[p5l1266t559r1573b611],
29	to	TO	O	to	aux	30	SENT_106	[p5l1600t564r1661b611],
30	determine	VB	O	determine	xcomp	27	SENT_106	[p5l1689t556r2021b611],
31	the	DT	O	the	det	32	SENT_106	[p5l2049t556r2150b611],
32	sizes	NNS	O	size	dobj	30	SENT_106	[p5l11t646r161b700],
33	of	IN	O	of	_	0	SENT_106	[p5l185t645r251b700],
34	intron	NN	O	intron	prep_of	32	SENT_106	[p5l267t646r463b700],
35	1	CD	NUMBER	1	num	37	SENT_106	[p5l489t648r513b700],
36	CA	NNP	O	CA	nn	37	SENT_106	[p5l544t648r623b700],
37	repeats	NNS	O	repeat	dobj	3	SENT_106	[p5l646t653r895b714],
38	.	.	O	.	_	0	SENT_106	[p5l646t653r895b714],

1	2.3	CD	NUMBER	2.3	_	0	SENT_107	[p5l6t870r113b923],
2	.	.	O	.	_	0	SENT_107	[p5l6t870r113b923],

1	Statistical	JJ	O	statistical	amod	2	SENT_108	[p5l160t868r464b923],
2	analysis	NN	O	analysis	_	0	SENT_108	[p5l485t868r730b936],

1	The	DT	O	the	det	2	SENT_109	[p5l109t1046r226b1101],
2	association	NN	O	association	nsubjpass	9	SENT_109	[p5l256t1047r613b1101],
3	between	IN	O	between	_	0	SENT_109	[p5l641t1046r919b1101],
4	clinical	JJ	O	clinical	amod	7	SENT_109	[p5l947t1046r1174b1101],
5	and	CC	O	and	_	0	SENT_109	[p5l1203t1046r1319b1101],
6	biological	JJ	O	biological	amod	7	SENT_109	[p5l1348t1046r1658b1114],
7	characteristics	NNS	O	characteristic	prep_between	2	SENT_109	[p5l1688t1046r2150b1101],
8	were	VBD	O	be	auxpass	9	SENT_109	[p5l9t1149r167b1188],
9	tested	VBN	O	test	_	0	SENT_109	[p5l184t1133r378b1188],
10	using	VBG	O	use	xcomp	9	SENT_109	[p5l396t1134r569b1202],
11	the	DT	O	the	det	13	SENT_109	[p5l584t1133r686b1188],
12	standard	JJ	O	standard	amod	13	SENT_109	[p5l705t1133r984b1188],
13	X2	NN	O	x2	dobj	10	SENT_109	[p5l1003t1124r1074b1203],
14	—	CD	NUMBER	—	num	15	SENT_109	[p5l1084t1141r1230b1188],
15	test	NN	O	test	dep	13	SENT_109	[p5l1084t1141r1230b1188],
16	or	CC	O	or	_	0	SENT_109	[p5l1246t1149r1312b1188],
17	the	DT	O	the	det	18	SENT_109	[p5l1326t1133r1428b1188],
18	Fisher	NNP	PERSON	Fisher	poss	21	SENT_109	[p5l1446t1133r1685b1188],
19	’s	POS	O	’s	_	0	SENT_109	[p5l1446t1133r1685b1188],
20	exact	JJ	O	exact	amod	21	SENT_109	[p5l1703t1141r1872b1188],
21	test	NN	O	test	conj_or	13	SENT_109	[p5l1887t1141r2018b1189],
22	.	.	O	.	_	0	SENT_109	[p5l1887t1141r2018b1189],

1	The	DT	O	the	det	2	SENT_110	[p5l2033t1133r2150b1188],
2	impact	NN	O	impact	nsubjpass	12	SENT_110	[p5l11t1223r232b1291],
3	of	IN	O	of	_	0	SENT_110	[p5l246t1222r312b1277],
4	clinical	JJ	O	clinical	amod	7	SENT_110	[p5l320t1222r546b1277],
5	and	CC	O	and	_	0	SENT_110	[p5l562t1222r678b1277],
6	biological	JJ	O	biological	amod	7	SENT_110	[p5l693t1222r1003b1291],
7	characteristics	NNS	O	characteristic	prep_of	2	SENT_110	[p5l1019t1222r1481b1277],
8	on	IN	O	on	_	0	SENT_110	[p5l1497t1238r1575b1277],
9	response	NN	O	response	nn	10	SENT_110	[p5l1591t1238r1876b1291],
10	rate	NN	O	rate	prep_on	7	SENT_110	[p5l1891t1230r2013b1277],
11	was	VBD	O	be	auxpass	12	SENT_110	[p5l2027t1238r2150b1277],
12	analyzed	VBN	O	analyze	_	0	SENT_110	[p5l10t1311r295b1380],
13	using	VBG	O	use	xcomp	12	SENT_110	[p5l312t1312r485b1380],
14	multivariate	JJ	O	multivariate	amod	16	SENT_110	[p5l500t1311r893b1366],
15	logistic	JJ	O	logistic	amod	16	SENT_110	[p5l910t1311r1138b1380],
16	regression	NN	O	regression	dobj	13	SENT_110	[p5l1155t1312r1500b1380],
17	.	.	O	.	_	0	SENT_110	[p5l1155t1312r1500b1380],

1	Overall	JJ	O	overall	amod	2	SENT_111	[p5l1518t1311r1745b1366],
2	survival	NN	O	survival	nsubjpass	4	SENT_111	[p5l1762t1311r2012b1366],
3	was	VBD	O	be	auxpass	4	SENT_111	[p5l2027t1327r2150b1366],
4	deﬁned	VBN	O	deﬁned	_	0	SENT_111	[p5l10t1400r251b1456],
5	as	IN	O	as	_	0	SENT_111	[p5l268t1416r330b1456],
6	the	DT	O	the	det	7	SENT_111	[p5l348t1401r449b1456],
7	time	NN	O	time	prep_as	4	SENT_111	[p5l466t1401r611b1456],
8	between	IN	O	between	_	0	SENT_111	[p5l628t1401r905b1456],
9	study	NN	O	study	nn	10	SENT_111	[p5l923t1401r1099b1469],
10	registration	NN	O	registration	prep_between	7	SENT_111	[p5l1114t1401r1487b1469],
11	and	CC	O	and	_	0	SENT_111	[p5l1503t1401r1619b1456],
12	death	NN	O	death	conj_and	10	SENT_111	[p5l1636t1401r1832b1464],
13	,	,	O	,	_	0	SENT_111	[p5l1636t1401r1832b1464],
14	whatever	WDT	O	whatever	dep	16	SENT_111	[p5l1848t1401r2153b1456],
15	the	DT	O	the	det	16	SENT_111	[p5l10t1490r111b1545],
16	cause	NN	O	cause	rcmod	7	SENT_111	[p5l139t1506r330b1545],
17	.	.	O	.	_	0	SENT_111	[p5l139t1506r330b1545],

1	Estimates	NNS	O	estimate	nsubjpass	6	SENT_112	[p5l359t1491r667b1545],
2	of	IN	O	of	_	0	SENT_112	[p5l696t1490r762b1545],
3	overall	JJ	O	overall	amod	4	SENT_112	[p5l781t1490r996b1545],
4	survival	NN	O	survival	prep_of	1	SENT_112	[p5l1024t1490r1274b1545],
5	were	VBD	O	be	auxpass	6	SENT_112	[p5l1300t1506r1458b1545],
6	calculated	VBN	O	calculate	_	0	SENT_112	[p5l1486t1490r1811b1545],
7	according	VBG	O	accord	_	0	SENT_112	[p5l1839t1490r2152b1558],
8	to	TO	O	to	prepc_according_to	6	SENT_112	[p5l10t1586r71b1633],
9	the	DT	O	the	det	12	SENT_112	[p5l101t1578r203b1633],
10	I	PRP	O	I	npadvmod	11	SENT_112	[p5l234t1578r688b1647],
11	<	JJR	O	<	amod	12	SENT_112	[p5l234t1578r688b1647],
12	aplan	NN	O	aplan	pobj	6	SENT_112	[p5l234t1578r688b1647],
13	.	.	O	.	_	0	SENT_112	[p5l234t1578r688b1647],

1	—	NN	O	—	_	0	SENT_113	[p5l234t1578r688b1647],
2	.	.	O	.	_	0	SENT_113	[p5l234t1578r688b1647],

1	Meier	JJR	PERSON	meier	_	0	SENT_114	[p5l234t1578r688b1647],
2	method	NN	O	method	dep	1	SENT_114	[p5l717t1578r980b1634],
3	.	.	O	.	_	0	SENT_114	[p5l717t1578r980b1634],

1	Comparisons	NNS	O	comparison	nsubjpass	7	SENT_115	[p5l1013t1579r1429b1647],
2	of	IN	O	of	_	0	SENT_115	[p5l1461t1578r1528b1633],
3	estimated	VBN	O	estimate	amod	5	SENT_115	[p5l1551t1578r1869b1633],
4	survival	NN	O	survival	nn	5	SENT_115	[p5l1901t1578r2150b1633],
5	curves	NNS	O	curve	prep_of	1	SENT_115	[p5l10t1683r216b1722],
6	were	VBD	O	be	auxpass	7	SENT_115	[p5l246t1683r404b1722],
7	performed	VBN	O	perform	_	0	SENT_115	[p5l435t1667r776b1736],
8	by	IN	O	by	_	0	SENT_115	[p5l806t1667r882b1736],
9	means	NNS	O	means	_	0	SENT_115	[p5l912t1683r1119b1722],
10	of	IN	O	of	_	0	SENT_115	[p5l1151t1667r1217b1722],
11	the	DT	O	the	det	12	SENT_115	[p5l1239t1667r1341b1722],
12	log	NN	O	log	prep_by_means_of	7	SENT_115	[p5l1372t1667r1644b1736],
13	—	CD	NUMBER	—	num	15	SENT_115	[p5l1372t1667r1644b1736],
14	rank	NN	O	rank	nn	15	SENT_115	[p5l1372t1667r1644b1736],
15	test	NN	O	test	dep	12	SENT_115	[p5l1672t1675r1803b1723],
16	.	.	O	.	_	0	SENT_115	[p5l1672t1675r1803b1723],

1	Finally	RB	O	finally	advmod	24	SENT_116	[p5l1836t1667r2059b1736],
2	,	,	O	,	_	0	SENT_116	[p5l1836t1667r2059b1736],
3	to	TO	O	to	aux	4	SENT_116	[p5l2089t1675r2150b1722],
4	investigate	VB	O	investigate	purpcl	24	SENT_116	[p5l11t1757r358b1825],
5	the	DT	O	the	det	7	SENT_116	[p5l377t1756r479b1811],
6	joint	JJ	O	joint	amod	7	SENT_116	[p5l491t1757r647b1825],
7	effect	NN	O	effect	dobj	4	SENT_116	[p5l665t1756r843b1811],
8	of	IN	O	of	_	0	SENT_116	[p5l861t1756r927b1811],
9	the	DT	O	the	det	13	SENT_116	[p5l939t1756r1041b1811],
10	clinical	JJ	O	clinical	amod	13	SENT_116	[p5l1060t1756r1286b1811],
11	and	CC	O	and	_	0	SENT_116	[p5l1306t1756r1422b1811],
12	biological	JJ	O	biological	conj_and	10	SENT_116	[p5l1442t1756r1751b1825],
13	characteristics	NNS	O	characteristic	prep_of	7	SENT_116	[p5l1771t1756r2150b1811, p5l10t1846r117b1900],
14	on	IN	O	on	_	0	SENT_116	[p5l139t1861r218b1900],
15	overall	JJ	O	overall	amod	16	SENT_116	[p5l238t1845r453b1900],
16	survival	NN	O	survival	prep_on	4	SENT_116	[p5l475t1845r741b1909],
17	,	,	O	,	_	0	SENT_116	[p5l475t1845r741b1909],
18	a	DT	O	a	det	19	SENT_116	[p5l762t1861r795b1900],
19	Cox	NN	ORGANIZATION	cox	nsubjpass	24	SENT_116	[p5l815t1848r932b1900],
20	proportional	JJ	O	proportional	amod	22	SENT_116	[p5l951t1845r1355b1914],
21	hazard	NN	O	hazard	nn	22	SENT_116	[p5l1378t1845r1593b1900],
22	model	NN	O	model	dep	19	SENT_116	[p5l1615t1845r1815b1900],
23	was	VBD	O	be	auxpass	24	SENT_116	[p5l1835t1861r1958b1900],
24	ﬁtted	VBN	O	ﬁtted	_	0	SENT_116	[p5l1980t1845r2150b1900],
25	to	TO	O	to	_	0	SENT_116	[p5l10t1943r71b1989],
26	the	DT	O	the	det	27	SENT_116	[p5l93t1935r194b1989],
27	data	NNS	O	datum	prep_to	24	SENT_116	[p5l218t1935r370b1989],
28	.	.	O	.	_	0	SENT_116	[p5l218t1935r370b1989],

1	To	TO	O	to	aux	2	SENT_117	[p5l109t2026r182b2078],
2	assess	VB	O	assess	_	0	SENT_117	[p5l219t2039r413b2078],
3	for	IN	O	for	_	0	SENT_117	[p5l452t2023r541b2078],
4	possible	JJ	O	possible	amod	6	SENT_117	[p5l576t2023r836b2091],
5	evolutionary	JJ	O	evolutionary	amod	6	SENT_117	[p5l873t2023r1283b2091],
6	changes	NNS	O	change	prep_for	2	SENT_117	[p5l1318t2023r1573b2091],
7	occurring	VBG	O	occur	partmod	6	SENT_117	[p5l1611t2024r1918b2091],
8	in	IN	O	in	_	0	SENT_117	[p5l1954t2024r2013b2077],
9	the	DT	O	the	det	10	SENT_117	[p5l2049t2023r2150b2078],
10	EGFRintron1	NN	O	egfrintron1	prep_in	7	SENT_117	[p5l8t2112r427b2166],
11	[	CD	NUMBER	[	number	12	SENT_117	[p5l456t2111r641b2180],
12	(	CD	NUMBER	(	num	16	SENT_117	[p5l456t2111r641b2180],
13	CA	NNP	O	CA	nn	16	SENT_117	[p5l456t2111r641b2180],
14	)	CD	NUMBER	)	num	16	SENT_117	[p5l456t2111r641b2180],
15	n	NN	O	n	nn	16	SENT_117	[p5l456t2111r641b2180],
16	repeat	NN	O	repeat	dep	10	SENT_117	[p5l664t2111r888b2180],
17	]	CD	NUMBER	]	num	18	SENT_117	[p5l664t2111r888b2180],
18	polymorphism	NN	O	polymorphism	dep	10	SENT_117	[p5l910t2111r1400b2180],
19	,	,	O	,	_	0	SENT_117	[p5l910t2111r1400b2180],
20	Hardy	NNP	PERSON	Hardy	appos	10	SENT_117	[p5l1420t2111r1973b2180],
21	.	.	O	.	_	0	SENT_117	[p5l1420t2111r1973b2180],

1	—	NN	O	—	_	0	SENT_118	[p5l1420t2111r1973b2180],
2	.	.	O	.	_	0	SENT_118	[p5l1420t2111r1973b2180],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_119	[p5l1420t2111r1973b2180],
2	analysis	NN	O	analysis	nsubjpass	4	SENT_119	[p5l1989t2111r2150b2166, p5l9t2201r127b2269],
3	was	VBD	O	be	auxpass	4	SENT_119	[p5l147t2216r270b2255],
4	performed	VBN	O	perform	_	0	SENT_119	[p5l293t2200r633b2269],
5	by	IN	O	by	_	0	SENT_119	[p5l655t2200r731b2269],
6	matching	VBG	O	match	agent	4	SENT_119	[p5l751t2200r1054b2269],
7	allele	NN	O	allele	nn	8	SENT_119	[p5l1074t2200r1243b2255],
8	frequencies	NNS	O	frequency	dobj	6	SENT_119	[p5l1266t2200r1634b2269],
9	in	IN	O	in	_	0	SENT_119	[p5l1657t2201r1716b2255],
10	the	DT	O	the	det	12	SENT_119	[p5l1736t2200r1838b2255],
11	observed	VBN	O	observe	amod	12	SENT_119	[p5l1860t2200r2150b2255],
12	individuals	NNS	O	individual	prep_in	6	SENT_119	[p5l11t2289r364b2344],
13	to	TO	O	to	_	0	SENT_119	[p5l385t2298r446b2344],
14	those	DT	O	those	prep_to	12	SENT_119	[p5l467t2289r640b2344],
15	expected	VBN	O	expect	partmod	14	SENT_119	[p5l662t2289r950b2358],
16	under	IN	O	under	_	0	SENT_119	[p5l972t2289r1163b2344],
17	Hardy	NNP	PERSON	Hardy	prep_under	15	SENT_119	[p5l1182t2289r1735b2358],
18	.	.	O	.	_	0	SENT_119	[p5l1182t2289r1735b2358],

1	—	NN	O	—	_	0	SENT_120	[p5l1182t2289r1735b2358],
2	.	.	O	.	_	0	SENT_120	[p5l1182t2289r1735b2358],

1	Weinberg	NNP	ORGANIZATION	Weinberg	nn	2	SENT_121	[p5l1182t2289r1735b2358],
2	Equilibrium	NNP	ORGANIZATION	Equilibrium	_	0	SENT_121	[p5l1755t2289r2150b2358],
3	.	.	O	.	_	0	SENT_121	[p5l1755t2289r2150b2358],

1	Genotypes	NNS	O	genotype	nsubjpass	3	SENT_122	[p5l11t2381r349b2447],
2	were	VBD	O	be	auxpass	3	SENT_122	[p5l366t2394r524b2433],
3	dichotomized	VBN	O	dichotomize	_	0	SENT_122	[p5l541t2378r981b2433],
4	as	IN	O	as	_	0	SENT_122	[p5l999t2394r1061b2433],
5	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_122	[p5l1077t2381r1235b2433],
6	(	CD	NUMBER	(	num	7	SENT_122	[p5l1251t2378r1460b2447],
7	CA	NNP	O	CA	prep_as	3	SENT_122	[p5l1251t2378r1460b2447],
8	)	CD	NUMBER	)	num	9	SENT_122	[p5l1251t2378r1460b2447],
9	15	CD	NUMBER	15	dep	7	SENT_122	[p5l1251t2378r1460b2447],
10	,	,	O	,	_	0	SENT_122	[p5l1251t2378r1460b2447],
11	including	VBG	O	include	_	0	SENT_122	[p5l1479t2378r1781b2447],
12	at	IN	O	at	quantmod	15	SENT_122	[p5l1796t2387r1856b2433],
13	least	JJS	O	least	mwe	12	SENT_122	[p5l1872t2378r2020b2433],
14	one	CD	NUMBER	one	number	15	SENT_122	[p5l2036t2394r2150b2433],
15	(	CD	NUMBER	(	num	19	SENT_122	[p5l10t2468r200b2536],
16	CA	NNP	O	CA	nn	19	SENT_122	[p5l10t2468r200b2536],
17	)	CD	NUMBER	)	num	19	SENT_122	[p5l10t2468r200b2536],
18	15	CD	NUMBER	15	amod	19	SENT_122	[p5l10t2468r200b2536],
19	allele	NN	O	allele	prep_including	9	SENT_122	[p5l230t2468r415b2531],
20	,	,	O	,	_	0	SENT_122	[p5l230t2468r415b2531],
21	and	CC	O	and	_	0	SENT_122	[p5l442t2468r558b2523],
22	EGFR	NN	ORGANIZATION	egfr	prep_including	9	SENT_122	[p5l582t2470r741b2523],
23	(	CD	NUMBER	(	num	22	SENT_122	[p5l766t2468r1004b2537],
24	CA	NNP	O	CA	dep	22	SENT_122	[p5l766t2468r1004b2537],
25	)	CD	NUMBER	)	num	24	SENT_122	[p5l766t2468r1004b2537],
26	e	LS	O	e	dep	28	SENT_122	[p5l766t2468r1004b2537],
27	,	,	O	,	_	0	SENT_122	[p5l766t2468r1004b2537],
28	se	FW	O	se	dep	9	SENT_122	[p5l766t2468r1004b2537],
29	,	,	O	,	_	0	SENT_122	[p5l766t2468r1004b2537],
30	lacking	VBG	O	lack	dep	28	SENT_122	[p5l1032t2468r1260b2536],
31	the	DT	O	the	det	32	SENT_122	[p5l1284t2468r1386b2523],
32	EGFR	NN	ORGANIZATION	egfr	dobj	30	SENT_122	[p5l1410t2470r1569b2523],
33	(	CD	NUMBER	(	num	34	SENT_122	[p5l1594t2468r1783b2536],
34	CA	NNP	O	CA	dep	32	SENT_122	[p5l1594t2468r1783b2536],
35	)	CD	NUMBER	)	num	34	SENT_122	[p5l1594t2468r1783b2536],
36	15	CD	NUMBER	15	num	37	SENT_122	[p5l1594t2468r1783b2536],
37	allele	NN	O	allele	dep	34	SENT_122	[p5l1811t2468r1980b2523],
38	[	CD	NUMBER	[	number	39	SENT_122	[p5l2010t2467r2150b2536],
39	23	CD	NUMBER	23	num	40	SENT_122	[p5l2010t2467r2150b2536],
40	]	NN	O	]	dep	37	SENT_122	[p5l2010t2467r2150b2536],
41	,	,	O	,	_	0	SENT_122	[p5l2010t2467r2150b2536],
42	and	CC	O	and	_	0	SENT_122	[p5l10t2556r127b2611],
43	compared	VBN	O	compare	conj_and	34	SENT_122	[p5l149t2556r470b2624],
44	using	VBG	O	use	xcomp	43	SENT_122	[p5l493t2557r666b2624],
45	a	DT	O	a	det	50	SENT_122	[p5l687t2572r719b2611],
46	X2	NN	O	x2	nn	50	SENT_122	[p5l743t2547r814b2625],
47	—	CD	NUMBER	—	num	50	SENT_122	[p5l825t2564r970b2611],
48	test	NN	O	test	nn	50	SENT_122	[p5l825t2564r970b2611],
49	goodness	NN	O	goodness	nn	50	SENT_122	[p5l990t2556r1483b2624],
50	—	NN	O	—	dobj	44	SENT_122	[p5l990t2556r1483b2624],
51	of	IN	O	of	_	0	SENT_122	[p5l990t2556r1483b2624],
52	—	CD	NUMBER	—	num	54	SENT_122	[p5l990t2556r1483b2624],
53	ﬁt	NN	O	ﬁt	nn	54	SENT_122	[p5l990t2556r1483b2624],
54	test	NN	O	test	prep_of	50	SENT_122	[p5l1503t2564r1634b2611],
55	.	.	O	.	_	0	SENT_122	[p5l1503t2564r1634b2611],

1	M.	NNP	PERSON	M.	nn	2	SENT_123	[p5l393t2701r422b2722],
2	Tiseo	NNP	PERSON	Tiseo	_	0	SENT_123	[p5l432t2700r491b2722],
3	et	FW	O	et	nn	4	SENT_123	[p5l500t2703r523b2722],
4	al.	FW	O	al.	dep	2	SENT_123	[p5l530t2700r555b2722],
5	/	:	O	/	punct	2	SENT_123	[p5l562t2700r574b2727],
6	Lung	NN	O	lung	nn	7	SENT_123	[p5l580t2701r640b2727],
7	Cancer	NN	O	cancer	dep	2	SENT_123	[p5l647t2701r730b2722],
8	67	CD	NUMBER	67	number	9	SENT_123	[p5l737t2701r767b2722],
9	(	CD	NUMBER	(	num	10	SENT_123	[p5l774t2700r855b2727],
10	2010	CD	DATE	2010	dep	7	SENT_123	[p5l774t2700r855b2727],
11	)	CD	NUMBER	)	number	12	SENT_123	[p5l774t2700r855b2727],
12	355-360 357	CD	NUMBER	355-360 357	num	10	SENT_123	[p5l1720t2701r1766b2722],[p5l862t2701r969b2722],

1	3	LS	NUMBER	3	_	0	SENT_124	[p5l10t2842r66b2894],
2	.	.	O	.	_	0	SENT_124	[p5l10t2842r66b2894],

1	Results	NNS	O	result	_	0	SENT_125	[p5l112t2840r353b2894],

1	3	LS	NUMBER	3	_	0	SENT_126	[p5l9t3020r103b3072],
2	.	.	O	.	_	0	SENT_126	[p5l9t3020r103b3072],
3	]	SYM	O	]	dep	1	SENT_126	[p5l9t3020r103b3072],

1	.	.	O	.	_	0	SENT_127	[p5l9t3020r103b3072],

1	Patient	NN	O	patient	nn	2	SENT_128	[p5l152t3018r373b3071],
2	characteristics	NNS	O	characteristic	_	0	SENT_128	[p5l392t3017r833b3071],

1	A	DT	O	a	det	2	SENT_129	[p5l111t3197r158b3249],
2	total	NN	O	total	nsubjpass	14	SENT_129	[p5l209t3194r352b3249],
3	of	IN	O	of	_	0	SENT_129	[p5l407t3194r474b3249],
4	91	CD	NUMBER	91	prep_of	2	SENT_129	[p5l520t3197r586b3249],
5	previously	RB	DATE	previously	advmod	6	SENT_129	[p5l648t3194r985b3263],
6	treated	VBN	O	treat	partmod	2	SENT_129	[p5l1036t3194r1265b3249],
7	Caucasian	JJ	LOCATION	caucasian	amod	8	SENT_129	[p5l1320t3195r1639b3249],
8	patients	NNS	O	patient	dobj	6	SENT_129	[p5l1693t3195r1951b3263],
9	with	IN	O	with	_	0	SENT_129	[p5l2004t3194r2153b3249],
10	advanced	JJ	O	advanced	amod	11	SENT_129	[p5l12t3283r315b3338],
11	NSCLC	NN	O	nsclc	prep_with	6	SENT_129	[p5l331t3286r537b3338],
12	were	VBD	O	be	auxpass	14	SENT_129	[p5l549t3299r708b3338],
13	prospectively	RB	O	prospectively	advmod	14	SENT_129	[p5l724t3283r1155b3352],
14	enrolled	VBN	O	enrol	_	0	SENT_129	[p5l1169t3283r1434b3338],
15	in	IN	O	in	_	0	SENT_129	[p5l1450t3284r1509b3338],
16	this	DT	O	this	det	17	SENT_129	[p5l1524t3283r1640b3338],
17	study	NN	O	study	prep_in	14	SENT_129	[p5l1658t3283r1844b3352],
18	.	.	O	.	_	0	SENT_129	[p5l1658t3283r1844b3352],

1	The	DT	O	the	det	3	SENT_130	[p5l1858t3283r1975b3338],
2	main	JJ	O	main	amod	3	SENT_130	[p5l1991t3284r2152b3338],
3	characteristics	NNS	O	characteristic	nsubjpass	8	SENT_130	[p5l12t3373r474b3428],
4	of	IN	O	of	_	0	SENT_130	[p5l497t3372r564b3428],
5	the	DT	O	the	det	6	SENT_130	[p5l578t3373r680b3428],
6	patients	NNS	O	patient	prep_of	3	SENT_130	[p5l703t3373r961b3441],
7	are	VBP	O	be	auxpass	8	SENT_130	[p5l984t3388r1081b3428],
8	shown	VBN	O	show	_	0	SENT_130	[p5l1105t3373r1316b3428],
9	in	IN	O	in	_	0	SENT_130	[p5l1339t3373r1398b3427],
10	Table	NNP	O	Table	prep_in	8	SENT_130	[p5l1417t3373r1586b3428],
11	1	CD	NUMBER	1	num	10	SENT_130	[p5l1613t3376r1661b3428],
12	.	.	O	.	_	0	SENT_130	[p5l1613t3376r1661b3428],

1	For	IN	O	for	_	0	SENT_131	[p5l114t3465r215b3517],
2	the	DT	O	the	det	4	SENT_131	[p5l241t3462r343b3517],
3	entire	JJ	O	entire	amod	4	SENT_131	[p5l372t3463r560b3517],
4	group	NN	O	group	prep_for	12	SENT_131	[p5l588t3478r791b3530],
5	,	,	O	,	_	0	SENT_131	[p5l588t3478r791b3530],
6	the	DT	O	the	det	9	SENT_131	[p5l820t3462r922b3517],
7	objective	JJ	O	objective	amod	9	SENT_131	[p5l952t3462r1241b3530],
8	response	NN	O	response	nn	9	SENT_131	[p5l1271t3478r1555b3530],
9	rate	NN	O	rate	nsubj	12	SENT_131	[p5l1585t3470r1707b3517],
10	was	VBD	O	be	cop	12	SENT_131	[p5l1734t3478r1857b3517],
11	18.7	CD	PERCENT	18.7	num	12	SENT_131	[p5l1891t3465r2061b3517],
12	%	NN	PERCENT	%	_	0	SENT_131	[p5l1891t3465r2061b3517],
13	(	CD	NUMBER	(	number	14	SENT_131	[p5l2090t3462r2150b3530],
14	2	CD	NUMBER	2	num	12	SENT_131	[p5l2090t3462r2150b3530],
15	complete	JJ	O	complete	amod	12	SENT_131	[p5l12t3550r308b3619],
16	and	CC	O	and	_	0	SENT_131	[p5l342t3550r458b3605],
17	15	CD	NUMBER	15	num	19	SENT_131	[p5l496t3553r562b3605],
18	partial	JJ	O	partial	amod	19	SENT_131	[p5l598t3550r806b3619],
19	responses	NNS	O	response	conj_and	12	SENT_131	[p5l841t3550r1183b3619],
20	)	NN	O	)	dep	19	SENT_131	[p5l841t3550r1183b3619],
21	and	CC	O	and	_	0	SENT_131	[p5l1217t3550r1333b3605],
22	the	DT	O	the	det	25	SENT_131	[p5l1367t3550r1469b3605],
23	disease	NN	O	disease	nn	25	SENT_131	[p5l1503t3550r1735b3605],
24	control	NN	O	control	nn	25	SENT_131	[p5l1769t3550r1995b3605],
25	rate	NN	O	rate	nsubj	26	SENT_131	[p5l2030t3558r2152b3605],
26	(	VBD	O	(	conj_and	12	SENT_131	[p5l12t3639r335b3708],
27	complete	JJ	O	complete	amod	28	SENT_131	[p5l12t3639r335b3708],
28	response	NN	O	response	dobj	26	SENT_131	[p5l375t3639r934b3708],
29	+	CC	O	+	_	0	SENT_131	[p5l375t3639r934b3708],
30	partial	JJ	O	partial	amod	31	SENT_131	[p5l375t3639r934b3708],
31	response	NN	O	response	nsubj	38	SENT_131	[p5l975t3639r1515b3708],
32	+	CC	O	+	_	0	SENT_131	[p5l975t3639r1515b3708],
33	stable	JJ	O	stable	amod	35	SENT_131	[p5l975t3639r1515b3708],
34	disease	NN	O	disease	nn	35	SENT_131	[p5l1555t3639r1813b3707],
35	)	NN	O	)	conj_+	31	SENT_131	[p5l1555t3639r1813b3707],
36	was	VBD	O	be	cop	38	SENT_131	[p5l1851t3655r1974b3694],
37	45	CD	PERCENT	45	num	38	SENT_131	[p5l2013t3642r2151b3695],
38	%	NN	PERCENT	%	rcmod	28	SENT_131	[p5l2013t3642r2151b3695],
39	.	.	O	.	_	0	SENT_131	[p5l2013t3642r2151b3695],

1	The	DT	O	the	det	4	SENT_132	[p5l9t3728r126b3783],
2	median	JJ	O	median	amod	4	SENT_132	[p5l149t3728r391b3783],
3	overall	JJ	O	overall	amod	4	SENT_132	[p5l413t3728r627b3783],
4	survival	NN	O	survival	nsubj	7	SENT_132	[p5l652t3728r901b3783],
5	was	VBD	O	be	cop	7	SENT_132	[p5l922t3744r1045b3783],
6	10	CD	DURATION	10	num	7	SENT_132	[p5l1072t3731r1141b3783],
7	months	NNS	NUMBER	month	_	0	SENT_132	[p5l1164t3728r1424b3783],
8	.	.	O	.	_	0	SENT_132	[p5l1164t3728r1424b3783],

1	Female	JJ	O	female	amod	2	SENT_133	[p6l114t23r341b78],
2	sex	NN	O	sex	_	0	SENT_133	[p6l374t39r477b78],
3	and	CC	O	and	_	0	SENT_133	[p6l506t23r622b78],
4	non	JJ	O	non	amod	8	SENT_133	[p6l656t23r1085b92],
5	—	NN	O	—	nn	8	SENT_133	[p6l656t23r1085b92],
6	smoking	NN	O	smoking	nn	8	SENT_133	[p6l656t23r1085b92],
7	status	NN	O	status	nn	8	SENT_133	[p6l1116t31r1304b78],
8	(	NN	O	(	conj_and	2	SENT_133	[p6l1336t23r1517b92],
9	<	JJR	O	<	amod	2	SENT_133	[p6l1336t23r1517b92],
10	100	CD	NUMBER	100	num	11	SENT_133	[p6l1336t23r1517b92],
11	cigarettes	NNS	O	cigarette	nsubjpass	16	SENT_133	[p6l1549t24r1857b92],
12	per	IN	O	per	_	0	SENT_133	[p6l1890t39r1996b92],
13	lifetime	NN	O	lifetime	nn	14	SENT_133	[p6l2026t23r2151b78, p6l11t113r183b181],
14	)	NN	O	)	prep_per	11	SENT_133	[p6l2026t23r2151b78, p6l11t113r183b181],
15	were	VBD	O	be	auxpass	16	SENT_133	[p6l219t128r377b168],
16	associated	VBN	O	associate	ccomp	9	SENT_133	[p6l415t113r747b168],
17	with	IN	O	with	_	0	SENT_133	[p6l783t113r931b168],
18	a	DT	O	a	det	20	SENT_133	[p6l969t128r1001b168],
19	higher	JJR	O	higher	amod	20	SENT_133	[p6l1038t113r1246b181],
20	probability	NN	O	probability	prep_with	16	SENT_133	[p6l1282t113r1636b181],
21	of	IN	O	of	_	0	SENT_133	[p6l1672t112r1738b168],
22	response	NN	O	response	prep_of	20	SENT_133	[p6l1769t128r2054b181],
23	to	TO	O	to	_	0	SENT_133	[p6l2091t121r2151b168],
24	geﬁtinib	NN	O	geﬁtinib	nn	25	SENT_133	[p6l11t202r278b270],
25	treatment	NN	O	treatment	prep_to	9	SENT_133	[p6l297t210r621b257],
26	(	CD	NUMBER	(	num	27	SENT_133	[p6l639t202r699b270],
27	p	NN	O	p	dep	2	SENT_133	[p6l639t202r699b270],
28	=	JJ	O	=	amod	27	SENT_133	[p6l716t225r749b241],
29	0.005	CD	NUMBER	0.005	tmod	28	SENT_133	[p6l765t205r940b257],
30	and	CC	O	and	_	0	SENT_133	[p6l962t202r1079b257],
31	0.010	CD	NUMBER	0.010	tmod	28	SENT_133	[p6l1099t205r1282b265],
32	,	,	O	,	_	0	SENT_133	[p6l1099t205r1282b265],
33	respectively	RB	O	respectively	advmod	27	SENT_133	[p6l1303t202r1706b270],
34	;	:	O	;	_	0	SENT_133	[p6l1303t202r1706b270],
35	Table	NNP	O	Table	dep	2	SENT_133	[p6l1728t202r1897b257],
36	2	CD	NUMBER	2	number	37	SENT_133	[p6l1917t202r1995b270],
37	)	CD	NUMBER	)	dep	35	SENT_133	[p6l1917t202r1995b270],
38	.	.	O	.	_	0	SENT_133	[p6l1917t202r1995b270],

1	Toxicity	NN	O	toxicity	nsubjpass	8	SENT_134	[p6l2013t205r2151b257, p6l12t291r150b359],
2	of	IN	O	of	_	0	SENT_134	[p6l168t290r234b345],
3	any	DT	O	any	det	4	SENT_134	[p6l245t306r358b359],
4	grade	NN	O	grade	prep_of	1	SENT_134	[p6l374t290r553b359],
5	and	CC	O	and	_	0	SENT_134	[p6l572t290r688b345],
6	type	NN	O	type	prep_of	1	SENT_134	[p6l708t298r847b359],
7	was	VBD	O	be	auxpass	8	SENT_134	[p6l866t306r988b345],
8	noted	VBN	O	note	_	0	SENT_134	[p6l1010t290r1191b345],
9	in	IN	O	in	_	0	SENT_134	[p6l1211t291r1270b344],
10	43	CD	NUMBER	43	num	11	SENT_134	[p6l1287t293r1363b345],
11	patients	NNS	O	patient	prep_in	8	SENT_134	[p6l1385t291r1644b359],
12	(	IN	O	(	_	0	SENT_134	[p6l1664t290r1849b358],
13	47	CD	PERCENT	47	num	14	SENT_134	[p6l1664t290r1849b358],
14	%	NN	PERCENT	%	prep_(	8	SENT_134	[p6l1664t290r1849b358],
15	)	CD	NUMBER	)	tmod	14	SENT_134	[p6l1664t290r1849b358],
16	,	,	O	,	_	0	SENT_134	[p6l1664t290r1849b358],
17	of	IN	O	of	_	0	SENT_134	[p6l1870t290r1936b345],
18	whom	WP	O	whom	rel	24	SENT_134	[p6l1946t290r2152b345],
19	30	CD	PERCENT	30	dep	18	SENT_134	[p6l10t382r88b434],
20	(	CD	PERCENT	(	num	22	SENT_134	[p6l105t379r276b448],
21	33	CD	PERCENT	33	num	22	SENT_134	[p6l105t379r276b448],
22	%	NN	PERCENT	%	nsubj	24	SENT_134	[p6l105t379r276b448],
23	)	CD	NUMBER	)	dep	22	SENT_134	[p6l105t379r276b448],
24	developed	VBD	O	develop	rcmod	15	SENT_134	[p6l293t379r624b448],
25	skin	NN	O	skin	nn	26	SENT_134	[p6l642t379r772b434],
26	rash	NN	O	rash	dobj	24	SENT_134	[p6l788t379r937b435],
27	.	.	O	.	_	0	SENT_134	[p6l788t379r937b435],

1	A	DT	O	a	det	4	SENT_135	[p6l951t382r998b434],
2	positive	JJ	O	positive	amod	4	SENT_135	[p6l1012t380r1263b448],
3	predictive	JJ	O	predictive	amod	4	SENT_135	[p6l1279t379r1600b448],
4	role	NN	O	role	nsubj	18	SENT_135	[p6l1617t379r1738b434],
5	for	IN	O	for	_	0	SENT_135	[p6l1755t379r1844b434],
6	skin	NN	O	skin	nn	7	SENT_135	[p6l1859t379r1988b434],
7	toxicity	NN	O	toxicity	prep_for	4	SENT_135	[p6l2003t380r2151b434, p6l12t469r129b537],
8	(	CD	NUMBER	(	num	9	SENT_135	[p6l142t469r202b537],
9	p	NN	O	p	npadvmod	10	SENT_135	[p6l142t469r202b537],
10	=	JJ	O	=	amod	7	SENT_135	[p6l220t492r252b508],
11	0.020	CD	NUMBER	0.020	num	12	SENT_135	[p6l269t469r470b537],
12	)	NN	O	)	nsubjpass	14	SENT_135	[p6l269t469r470b537],
13	was	VBD	O	be	auxpass	14	SENT_135	[p6l484t484r607b523],
14	observed	VBN	O	observe	rcmod	4	SENT_135	[p6l623t468r914b523],
15	(	RB	O	(	advmod	14	SENT_135	[p6l930t468r1122b537],
16	Table	NNP	O	Table	dep	18	SENT_135	[p6l930t468r1122b537],
17	2	CD	NUMBER	2	num	18	SENT_135	[p6l1138t468r1216b537],
18	)	CD	NUMBER	)	_	0	SENT_135	[p6l1138t468r1216b537],
19	.	.	O	.	_	0	SENT_135	[p6l1138t468r1216b537],

1	Patients	NNS	O	patient	nsubj	8	SENT_136	[p6l1232t469r1487b523],
2	developing	VBG	O	develop	partmod	1	SENT_136	[p6l1503t468r1859b537],
3	skin	NN	O	skin	nn	4	SENT_136	[p6l1874t468r2003b523],
4	rash	NN	O	rash	dobj	2	SENT_136	[p6l2019t468r2152b523],
5	during	IN	O	during	_	0	SENT_136	[p6l12t558r224b626],
6	geﬁtinib	NN	O	geﬁtinib	nn	7	SENT_136	[p6l246t557r514b626],
7	treatment	NN	O	treatment	prep_during	2	SENT_136	[p6l539t566r862b613],
8	had	VBD	O	have	_	0	SENT_136	[p6l886t558r1002b613],
9	a	DT	O	a	det	10	SENT_136	[p6l1027t573r1059b613],
10	trend	NN	O	trend	dobj	8	SENT_136	[p6l1084t558r1255b613],
11	toward	IN	O	toward	_	0	SENT_136	[p6l1280t558r1505b613],
12	an	DT	O	a	det	13	SENT_136	[p6l1531t573r1606b613],
13	improvement	NN	O	improvement	prep_toward	10	SENT_136	[p6l1631t558r2069b626],
14	in	IN	O	in	_	0	SENT_136	[p6l2093t558r2152b612],
15	survival	NN	O	survival	nn	17	SENT_136	[p6l13t647r262b702],
16	(	CD	NUMBER	(	num	17	SENT_136	[p6l285t647r345b715],
17	p	NN	O	p	prep_in	8	SENT_136	[p6l285t647r345b715],
18	=	JJ	O	=	dep	17	SENT_136	[p6l362t670r395b686],
19	0.058	CD	NUMBER	0.058	iobj	18	SENT_136	[p6l412t647r613b715],
20	)	CD	NUMBER	)	number	21	SENT_136	[p6l412t647r613b715],
21	(	CD	NUMBER	(	num	22	SENT_136	[p6l636t647r828b715],
22	Table	NNP	O	Table	dobj	18	SENT_136	[p6l636t647r828b715],
23	2	CD	NUMBER	2	num	22	SENT_136	[p6l851t647r929b715],
24	)	CD	NUMBER	)	tmod	8	SENT_136	[p6l851t647r929b715],
25	.	.	O	.	_	0	SENT_136	[p6l851t647r929b715],

1	3.2	CD	NUMBER	3.2	_	0	SENT_137	[p6l9t872r114b924],
2	.	.	O	.	_	0	SENT_137	[p6l9t872r114b924],

1	Molecular	JJ	O	molecular	amod	2	SENT_138	[p6l162t870r476b924],
2	markers	NNS	O	marker	_	0	SENT_138	[p6l494t870r744b924],

1	3.2.1	CD	NUMBER	3.2.1	_	0	SENT_139	[p6l9t1050r159b1102],
2	.	.	O	.	_	0	SENT_139	[p6l9t1050r159b1102],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_140	[p6l207t1050r366b1102],
2	and	CC	O	and	_	0	SENT_140	[p6l387t1047r501b1102],
3	K	NN	O	k	conj_and	1	SENT_140	[p6l521t1050r682b1102],
4	—	CD	NUMBER	—	num	7	SENT_140	[p6l521t1050r682b1102],
5	ras	NN	O	ra	nn	7	SENT_140	[p6l521t1050r682b1102],
6	gene	NN	O	gene	nn	7	SENT_140	[p6l698t1063r844b1116],
7	mutations	NNS	O	mutation	dep	1	SENT_140	[p6l866t1048r1179b1102],

1	EGFR	NN	ORGANIZATION	egfr	nsubjpass	10	SENT_141	[p6l111t1139r270b1191],
2	and	CC	O	and	_	0	SENT_141	[p6l303t1136r419b1191],
3	K	NN	O	k	nn	6	SENT_141	[p6l451t1140r612b1191],
4	—	CD	NUMBER	—	num	6	SENT_141	[p6l451t1140r612b1191],
5	ras	NN	O	ra	nn	6	SENT_141	[p6l451t1140r612b1191],
6	gene	NN	O	gene	conj_and	1	SENT_141	[p6l639t1152r785b1205],
7	mutational	JJ	O	mutational	amod	8	SENT_141	[p6l819t1136r1172b1191],
8	analyses	NNS	O	analysis	dep	6	SENT_141	[p6l1206t1136r1474b1205],
9	were	VBD	O	be	auxpass	10	SENT_141	[p6l1507t1152r1665b1191],
10	performed	VBN	O	perform	_	0	SENT_141	[p6l1699t1136r2040b1205],
11	on	IN	O	on	_	0	SENT_141	[p6l2074t1152r2152b1191],
12	63	CD	NUMBER	63	num	13	SENT_141	[p6l12t1228r86b1280],
13	patients	NNS	O	patient	prep_on	10	SENT_141	[p6l122t1226r380b1294],
14	for	IN	O	for	_	0	SENT_141	[p6l415t1225r504b1280],
15	whom	WP	O	whom	dobj	20	SENT_141	[p6l533t1225r739b1280],
16	parafﬁn	JJ	O	parafﬁn	amod	18	SENT_141	[p6l772t1225r1022b1294],
17	embedded	JJ	O	embedded	amod	18	SENT_141	[p6l1055t1225r1396b1280],
18	blocks	NNS	O	block	nsubj	20	SENT_141	[p6l1428t1225r1630b1280],
19	were	VBD	O	be	cop	20	SENT_141	[p6l1662t1241r1821b1280],
20	available	JJ	O	available	prepc_for	13	SENT_141	[p6l1854t1225r2151b1281],
21	.	.	O	.	_	0	SENT_141	[p6l1854t1225r2151b1281],

1	Eleven	CD	NUMBER	eleven	num	5	SENT_142	[p6l12t1314r222b1369],
2	heterozygous	JJ	O	heterozygous	amod	5	SENT_142	[p6l256t1314r683b1383],
3	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_142	[p6l715t1317r874b1369],
4	gene	NN	O	gene	nn	5	SENT_142	[p6l901t1330r1047b1383],
5	mutations	NNS	O	mutation	nsubjpass	7	SENT_142	[p6l1080t1315r1406b1369],
6	were	VBD	O	be	auxpass	7	SENT_142	[p6l1439t1330r1597b1369],
7	found	VBN	O	find	_	0	SENT_142	[p6l1631t1314r1837b1378],
8	;	:	O	;	_	0	SENT_142	[p6l1631t1314r1837b1378],
9	all	DT	O	all	dobj	15	SENT_142	[p6l1875t1314r1948b1369],
10	these	DT	O	these	det	11	SENT_142	[p6l1982t1314r2152b1369],
11	mutations	NNS	O	mutation	nsubjpass	15	SENT_142	[p6l12t1404r339b1459],
12	have	VBP	O	have	aux	15	SENT_142	[p6l376t1404r523b1459],
13	previously	RB	DATE	previously	advmod	15	SENT_142	[p6l559t1404r895b1472],
14	been	VBN	O	be	auxpass	15	SENT_142	[p6l929t1404r1084b1459],
15	described	VBN	O	describe	dep	45	SENT_142	[p6l1119t1403r1430b1459],
16	[	CD	NUMBER	[	number	17	SENT_142	[p6l1469t1403r1525b1472],
17	5	CD	NUMBER	5	num	18	SENT_142	[p6l1469t1403r1525b1472],
18	exon	NN	O	exon	dobj	15	SENT_142	[p6l1563t1419r1715b1459],
19	19	CD	NUMBER	19	num	20	SENT_142	[p6l1754t1406r1821b1459],
20	deletions	NNS	O	deletion	nsubj	21	SENT_142	[p6l1858t1404r2151b1459],
21	(	VBD	O	(	rcmod	18	SENT_142	[p6l12t1493r204b1561],
22	three	CD	NUMBER	three	num	23	SENT_142	[p6l12t1493r204b1561],
23	2235del15	CD	NUMBER	2235del15	dobj	21	SENT_142	[p6l222t1493r573b1556],
24	,	,	O	,	_	0	SENT_142	[p6l222t1493r573b1556],
25	one	CD	NUMBER	one	num	26	SENT_142	[p6l591t1509r706b1548],
26	2240del12	NN	O	2240del12	dep	41	SENT_142	[p6l724t1493r1058b1548],
27	and	CC	O	and	_	0	SENT_142	[p6l1077t1493r1194b1548],
28	one	CD	NUMBER	one	num	30	SENT_142	[p6l1212t1509r1326b1548],
29	2240del18	NN	O	2240del18	nn	30	SENT_142	[p6l1344t1493r1705b1561],
30	)	NN	O	)	conj_and	26	SENT_142	[p6l1344t1493r1705b1561],
31	and	CC	O	and	_	0	SENT_142	[p6l1722t1493r1839b1548],
32	6	CD	NUMBER	6	num	33	SENT_142	[p6l1857t1496r1892b1548],
33	exon	NN	O	exon	conj_and	26	SENT_142	[p6l1910t1509r2061b1548],
34	21	CD	NUMBER	21	num	36	SENT_142	[p6l2078t1496r2144b1547],
35	missense	NN	O	missense	nn	36	SENT_142	[p6l12t1582r305b1636],
36	mutation	NN	O	mutation	dep	33	SENT_142	[p6l332t1582r628b1636],
37	(	CD	NUMBER	(	num	38	SENT_142	[p6l655t1581r926b1650],
38	L858R	NN	O	l858r	dep	41	SENT_142	[p6l655t1581r926b1650],
39	)	CD	NUMBER	)	num	41	SENT_142	[p6l655t1581r926b1650],
40	]	CD	NUMBER	]	num	41	SENT_142	[p6l655t1581r926b1650],
41	[	NN	O	[	dep	45	SENT_142	[p6l959t1581r1212b1650],
42	16	CD	NUMBER	16	num	43	SENT_142	[p6l959t1581r1212b1650],
43	—	CD	NUMBER	—	dep	41	SENT_142	[p6l959t1581r1212b1650],
44	18	CD	NUMBER	18	num	45	SENT_142	[p6l959t1581r1212b1650],
45	]	NN	O	]	dep	7	SENT_142	[p6l959t1581r1212b1650],
46	.	.	O	.	_	0	SENT_142	[p6l959t1581r1212b1650],

1	Nine	CD	PERCENT	nine	num	9	SENT_143	[p6l1240t1582r1387b1636],
2	(	CD	PERCENT	(	number	3	SENT_143	[p6l1414t1581r1587b1649],
3	82	CD	PERCENT	82	dep	4	SENT_143	[p6l1414t1581r1587b1649],
4	%	NN	PERCENT	%	amod	9	SENT_143	[p6l1414t1581r1587b1649],
5	)	CD	NUMBER	)	nsubj	8	SENT_143	[p6l1414t1581r1587b1649],
6	of	IN	O	of	_	0	SENT_143	[p6l1614t1581r1680b1636],
7	EGFR	NN	ORGANIZATION	egfr	prep_of	5	SENT_143	[p6l1697t1584r1855b1636],
8	mutated	VBN	O	mutate	ccomp	4	SENT_143	[p6l1881t1581r2151b1636],
9	patients	NNS	O	patient	nsubj	10	SENT_143	[p6l12t1671r270b1739],
10	had	VBD	O	have	_	0	SENT_143	[p6l294t1670r409b1725],
11	an	DT	O	a	det	13	SENT_143	[p6l432t1686r507b1725],
12	objective	JJ	O	objective	amod	13	SENT_143	[p6l529t1670r818b1739],
13	response	NN	O	response	dobj	10	SENT_143	[p6l842t1686r1126b1739],
14	to	TO	O	to	_	0	SENT_143	[p6l1148t1678r1209b1725],
15	geﬁtinib	NN	O	geﬁtinib	prep_to	10	SENT_143	[p6l1231t1670r1514b1739],
16	,	,	O	,	_	0	SENT_143	[p6l1231t1670r1514b1739],
17	while	IN	O	while	mark	21	SENT_143	[p6l1535t1670r1714b1725],
18	two	CD	NUMBER	two	nsubj	21	SENT_143	[p6l1737t1678r1858b1725],
19	mutated	VBN	O	mutate	partmod	18	SENT_143	[p6l1881t1670r2152b1725],
20	patients	NNS	O	patient	dobj	19	SENT_143	[p6l12t1760r270b1828],
21	had	VBD	O	have	advcl	10	SENT_143	[p6l295t1759r411b1814],
22	no	DT	O	no	det	23	SENT_143	[p6l436t1775r513b1814],
23	response	NN	O	response	dep	26	SENT_143	[p6l538t1775r823b1828],
24	(	CD	NUMBER	(	number	25	SENT_143	[p6l847t1760r988b1828],
25	one	CD	NUMBER	one	npadvmod	26	SENT_143	[p6l847t1760r988b1828],
26	stable	JJ	O	stable	dep	21	SENT_143	[p6l1013t1759r1199b1814],
27	and	CC	O	and	_	0	SENT_143	[p6l1224t1759r1340b1814],
28	one	CD	NUMBER	one	num	31	SENT_143	[p6l1365t1775r1479b1814],
29	progressive	JJ	O	progressive	amod	31	SENT_143	[p6l1504t1760r1870b1828],
30	disease	NN	O	disease	nn	31	SENT_143	[p6l1894t1759r2152b1828],
31	)	NN	O	)	dep	36	SENT_143	[p6l1894t1759r2152b1828],
32	(	CD	NUMBER	(	num	33	SENT_143	[p6l12t1849r72b1917],
33	p	NN	O	p	npadvmod	34	SENT_143	[p6l12t1849r72b1917],
34	<	JJR	O	<	amod	31	SENT_143	[p6l88t1861r121b1896],
35	0.001	CD	NUMBER	0.001	num	36	SENT_143	[p6l139t1849r355b1917],
36	)	NN	O	)	dep	21	SENT_143	[p6l139t1849r355b1917],
37	.	.	O	.	_	0	SENT_143	[p6l139t1849r355b1917],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_144	[p6l373t1851r532b1904],
2	mutation	NN	O	mutation	nsubjpass	5	SENT_144	[p6l551t1849r847b1904],
3	was	VBD	O	be	auxpass	5	SENT_144	[p6l864t1864r987b1904],
4	signiﬁcantly	RB	O	signiﬁcantly	advmod	5	SENT_144	[p6l1008t1848r1402b1917],
5	associated	VBN	O	associate	_	0	SENT_144	[p6l1419t1849r1751b1904],
6	with	IN	O	with	_	0	SENT_144	[p6l1769t1849r1917b1904],
7	female	JJ	O	female	amod	9	SENT_144	[p6l1937t1848r2151b1904],
8	sex	NN	O	sex	nn	9	SENT_144	[p6l13t1954r115b1993],
9	(	NN	O	(	prep_with	5	SENT_144	[p6l131t1938r228b2006],
10	10	CD	NUMBER	10	npadvmod	11	SENT_144	[p6l131t1938r228b2006],
11	out	IN	O	out	_	0	SENT_144	[p6l246t1946r352b1993],
12	of	IN	O	of	_	0	SENT_144	[p6l368t1938r434b1993],
13	11	CD	NUMBER	11	num	14	SENT_144	[p6l447t1941r505b1992],
14	patients	NNS	O	patient	prep_out_of	9	SENT_144	[p6l531t1939r789b2006],
15	were	VBD	O	be	cop	16	SENT_144	[p6l805t1954r963b1993],
16	females	NNS	O	female	rcmod	14	SENT_144	[p6l981t1938r1248b2001],
17	;	:	O	;	_	0	SENT_144	[p6l981t1938r1248b2001],
18	p	NN	O	p	nsubj	35	SENT_144	[p6l1265t1954r1304b2006],
19	=	JJ	O	=	amod	21	SENT_144	[p6l1321t1961r1354b1977],
20	0.001	CD	NUMBER	0.001	tmod	19	SENT_144	[p6l1371t1938r1572b2006],
21	)	NN	O	)	dep	18	SENT_144	[p6l1371t1938r1572b2006],
22	and	CC	O	and	_	0	SENT_144	[p6l1589t1938r1706b1993],
23	non	JJ	O	non	amod	27	SENT_144	[p6l1724t1938r2153b2006],
24	—	NN	O	—	nn	27	SENT_144	[p6l1724t1938r2153b2006],
25	smoking	NN	O	smoking	nn	27	SENT_144	[p6l1724t1938r2153b2006],
26	status	NN	O	status	nn	27	SENT_144	[p6l13t2035r200b2082],
27	(	NN	O	(	conj_and	18	SENT_144	[p6l240t2027r301b2095],
28	7	CD	NUMBER	7	npadvmod	27	SENT_144	[p6l240t2027r301b2095],
29	out	IN	O	out	_	0	SENT_144	[p6l342t2035r447b2082],
30	of	IN	O	of	_	0	SENT_144	[p6l485t2027r552b2082],
31	11	CD	NUMBER	11	num	32	SENT_144	[p6l586t2030r644b2081],
32	patients	NNS	O	patient	prep_out_of	27	SENT_144	[p6l692t2028r950b2095],
33	were	VBD	O	be	cop	35	SENT_144	[p6l989t2043r1147b2082],
34	no	DT	O	no	det	35	SENT_144	[p6l1187t2043r1264b2082],
35	smokers	NNS	O	smoker	parataxis	5	SENT_144	[p6l1305t2027r1592b2090],
36	;	:	O	;	_	0	SENT_144	[p6l1305t2027r1592b2090],
37	p	NN	O	p	dep	35	SENT_144	[p6l1631t2027r1956b2095],
38	=	JJ	O	=	amod	40	SENT_144	[p6l1631t2027r1956b2095],
39	0.009	CD	NUMBER	0.009	tmod	38	SENT_144	[p6l1631t2027r1956b2095],
40	)	NN	O	)	dep	37	SENT_144	[p6l1631t2027r1956b2095],
41	.	.	O	.	_	0	SENT_144	[p6l1631t2027r1956b2095],

1	EGFR	NN	ORGANIZATION	egfr	nsubj	4	SENT_145	[p6l1994t2030r2153b2082],
2	mutated	VBN	O	mutate	partmod	1	SENT_145	[p6l12t2115r283b2170],
3	patients	NNS	O	patient	dobj	2	SENT_145	[p6l299t2116r557b2184],
4	showed	VBD	O	show	dep	21	SENT_145	[p6l575t2115r822b2170],
5	a	DT	O	a	det	7	SENT_145	[p6l838t2131r870b2170],
6	median	JJ	O	median	amod	7	SENT_145	[p6l886t2115r1127b2170],
7	survival	NN	O	survival	dobj	4	SENT_145	[p6l1143t2115r1392b2170],
8	of	IN	O	of	_	0	SENT_145	[p6l1409t2115r1476b2170],
9	14	CD	DURATION	14	num	10	SENT_145	[p6l1487t2118r1556b2169],
10	months	NNS	NUMBER	month	prep_of	7	SENT_145	[p6l1572t2115r1814b2170],
11	compared	VBN	O	compare	_	0	SENT_145	[p6l1831t2115r2151b2184],
12	to	TO	O	to	prepc_compared_to	4	SENT_145	[p6l11t2212r72b2259],
13	8	CD	DURATION	8	num	14	SENT_145	[p6l95t2207r129b2259],
14	months	NNS	NUMBER	month	pobj	4	SENT_145	[p6l154t2204r397b2259],
15	of	IN	O	of	_	0	SENT_145	[p6l420t2204r487b2259],
16	EGFR	NN	ORGANIZATION	egfr	prep_of	14	SENT_145	[p6l499t2207r658b2259],
17	wild	JJ	O	wild	amod	20	SENT_145	[p6l678t2204r993b2273],
18	—	NN	O	—	nn	20	SENT_145	[p6l678t2204r993b2273],
19	type	NN	O	type	nn	20	SENT_145	[p6l678t2204r993b2273],
20	ones	NNS	O	one	nsubj	21	SENT_145	[p6l1016t2220r1162b2259],
21	(	VBP	O	(	_	0	SENT_145	[p6l1185t2204r1245b2273],
22	p	NN	O	p	dobj	21	SENT_145	[p6l1185t2204r1245b2273],
23	=	JJ	O	=	amod	22	SENT_145	[p6l1262t2227r1296b2244],
24	0.147	CD	NUMBER	0.147	number	25	SENT_145	[p6l1312t2204r1500b2273],
25	)	CD	NUMBER	)	dep	23	SENT_145	[p6l1312t2204r1500b2273],
26	(	CD	NUMBER	(	num	27	SENT_145	[p6l1523t2204r1715b2273],
27	Table	NNP	O	Table	tmod	21	SENT_145	[p6l1523t2204r1715b2273],
28	2	CD	NUMBER	2	num	27	SENT_145	[p6l1738t2204r1816b2272],
29	)	CD	NUMBER	)	dep	27	SENT_145	[p6l1738t2204r1816b2272],
30	.	.	O	.	_	0	SENT_145	[p6l1738t2204r1816b2272],

1	Seven	CD	NUMBER	seven	num	3	SENT_146	[p6l114t2296r300b2348],
2	heterozygous	JJ	O	heterozygous	amod	3	SENT_146	[p6l337t2293r765b2362],
3	mutations	NNS	O	mutation	nsubjpass	5	SENT_146	[p6l804t2294r1130b2348],
4	were	VBD	O	be	auxpass	5	SENT_146	[p6l1167t2309r1325b2348],
5	observed	VBN	O	observe	_	0	SENT_146	[p6l1363t2293r1653b2348],
6	in	IN	O	in	mark	8	SENT_146	[p6l1691t2294r1750b2348],
7	I	PRP	O	I	nsubj	8	SENT_146	[p6l1787t2297r1948b2348],
8	(	VBP	O	(	advcl	5	SENT_146	[p6l1787t2297r1948b2348],
9	.	.	O	.	_	0	SENT_146	[p6l1787t2297r1948b2348],

1	—	NN	O	—	_	0	SENT_147	[p6l1787t2297r1948b2348],
2	.	.	O	.	_	0	SENT_147	[p6l1787t2297r1948b2348],

1	ras	NN	O	ra	nn	2	SENT_148	[p6l1787t2297r1948b2348],
2	gene	NN	O	gene	_	0	SENT_148	[p6l1985t2309r2151b2362],
3	,	,	O	,	_	0	SENT_148	[p6l1985t2309r2151b2362],
4	all	DT	O	all	det	6	SENT_148	[p6l12t2383r85b2438],
5	mutually	RB	O	mutually	advmod	6	SENT_148	[p6l112t2383r402b2451],
6	exclusive	JJ	O	exclusive	appos	2	SENT_148	[p6l426t2383r717b2438],
7	with	IN	O	with	_	0	SENT_148	[p6l741t2383r889b2438],
8	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_148	[p6l913t2385r1071b2438],
9	gene	NN	O	gene	nn	10	SENT_148	[p6l1090t2398r1237b2451],
10	mutations	NNS	O	mutation	prep_with	6	SENT_148	[p6l1263t2383r1606b2438],
11	.	.	O	.	_	0	SENT_148	[p6l1263t2383r1606b2438],

1	Six	CD	NUMBER	six	num	2	SENT_149	[p6l1632t2383r1726b2438],
2	patients	NNS	O	patient	nsubj	3	SENT_149	[p6l1751t2383r2009b2451],
3	had	VBD	O	have	dep	37	SENT_149	[p6l2036t2383r2151b2438],
4	a	DT	O	a	det	10	SENT_149	[p6l12t2488r44b2527],
5	single	JJ	O	single	amod	10	SENT_149	[p6l75t2472r659b2540],
6	—	CD	NUMBER	—	tmod	5	SENT_149	[p6l75t2472r659b2540],
7	amino	NN	O	amino	nn	10	SENT_149	[p6l75t2472r659b2540],
8	—	NN	O	—	nn	10	SENT_149	[p6l75t2472r659b2540],
9	acid	NN	O	acid	nn	10	SENT_149	[p6l75t2472r659b2540],
10	substitution	NN	O	substitution	dobj	3	SENT_149	[p6l692t2472r1080b2527],
11	in	IN	O	in	_	0	SENT_149	[p6l1111t2473r1170b2526],
12	codon	NN	O	codon	prep_in	10	SENT_149	[p6l1201t2472r1395b2527],
13	12	CD	NUMBER	12	number	14	SENT_149	[p6l1429t2475r1497b2526],
14	(	CD	NUMBER	(	num	15	SENT_149	[p6l1531t2472r1738b2540],
15	G12C	NN	O	g12c	dep	12	SENT_149	[p6l1531t2472r1738b2540],
16	,	,	O	,	_	0	SENT_149	[p6l1531t2472r1738b2540],
17	n	NN	O	n	appos	12	SENT_149	[p6l1770t2475r1928b2535],
18	=	JJ	O	=	amod	17	SENT_149	[p6l1770t2475r1928b2535],
19	4	CD	NUMBER	4	tmod	18	SENT_149	[p6l1770t2475r1928b2535],
20	;	:	O	;	_	0	SENT_149	[p6l1770t2475r1928b2535],
21	G12A	NN	O	g12a	dep	17	SENT_149	[p6l1965t2474r2151b2535],
22	,	,	O	,	_	0	SENT_149	[p6l1965t2474r2151b2535],
23	n	NN	O	n	appos	21	SENT_149	[p6l12t2576r47b2615],
24	=	JJ	O	=	amod	23	SENT_149	[p6l64t2583r97b2599],
25	1	CD	NUMBER	1	tmod	24	SENT_149	[p6l117t2563r170b2623],
26	;	:	O	;	_	0	SENT_149	[p6l117t2563r170b2623],
27	G12	CD	NUMBER	g12	num	28	SENT_149	[p6l193t2563r314b2615],
28	V	NN	O	v	dep	17	SENT_149	[p6l330t2563r390b2623],
29	,	,	O	,	_	0	SENT_149	[p6l330t2563r390b2623],
30	n	NN	O	n	conj_and	28	SENT_149	[p6l410t2576r445b2615],
31	=	JJ	O	=	amod	33	SENT_149	[p6l462t2583r495b2599],
32	1	CD	NUMBER	1	tmod	31	SENT_149	[p6l515t2560r573b2628],
33	)	NN	O	)	dep	30	SENT_149	[p6l515t2560r573b2628],
34	and	CC	O	and	_	0	SENT_149	[p6l592t2560r708b2615],
35	one	CD	NUMBER	one	num	36	SENT_149	[p6l727t2576r842b2615],
36	patient	NN	O	patient	conj_and	28	SENT_149	[p6l861t2561r1090b2629],
37	had	VBD	O	have	_	0	SENT_149	[p6l1107t2560r1223b2615],
38	a	DT	O	a	det	41	SENT_149	[p6l1242t2576r1274b2615],
39	codon	NN	O	codon	nn	41	SENT_149	[p6l1292t2560r1486b2615],
40	13	CD	NUMBER	13	num	41	SENT_149	[p6l1508t2563r1574b2615],
41	mutation	NN	O	mutation	dobj	37	SENT_149	[p6l1596t2561r1892b2615],
42	(	CD	NUMBER	(	num	44	SENT_149	[p6l1910t2560r2151b2628],
43	G13D	NN	O	g13d	nn	44	SENT_149	[p6l1910t2560r2151b2628],
44	)	NN	O	)	nsubj	37	SENT_149	[p6l1910t2560r2151b2628],
45	.	.	O	.	_	0	SENT_149	[p6l1910t2560r2151b2628],

1	None	NN	O	none	nsubj	5	SENT_150	[p6l12t2652r178b2704],
2	of	IN	O	of	_	0	SENT_150	[p6l204t2649r271b2704],
3	these	DT	O	these	det	4	SENT_150	[p6l289t2649r459b2704],
4	patients	NNS	O	patient	prep_of	1	SENT_150	[p6l486t2650r744b2718],
5	responded	VBD	O	respond	_	0	SENT_150	[p6l772t2649r1110b2718],
6	to	TO	O	to	_	0	SENT_150	[p6l1136t2657r1197b2704],
7	geﬁtinib	NN	O	geﬁtinib	prep_to	5	SENT_150	[p6l1222t2649r1505b2718],
8	.	.	O	.	_	0	SENT_150	[p6l1222t2649r1505b2718],

1	No	DT	O	no	det	4	SENT_151	[p6l1533t2652r1618b2704],
2	statistically	RB	O	statistically	advmod	3	SENT_151	[p6l1646t2649r2012b2718],
3	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_151	[p6l2038t2650r2151b2718, p6l12t2738r256b2793],
4	association	NN	O	association	nsubjpass	6	SENT_151	[p6l285t2739r643b2793],
5	was	VBD	O	be	auxpass	6	SENT_151	[p6l671t2754r793b2793],
6	found	VBN	O	find	_	0	SENT_151	[p6l825t2738r1010b2793],
7	between	IN	O	between	_	0	SENT_151	[p6l1040t2738r1318b2793],
8	K	NNP	O	K	nn	11	SENT_151	[p6l1345t2742r1506b2793],
9	—	NNP	O	—	nn	11	SENT_151	[p6l1345t2742r1506b2793],
10	ras	NN	O	ra	nn	11	SENT_151	[p6l1345t2742r1506b2793],
11	mutations	NNS	O	mutation	prep_between	6	SENT_151	[p6l1537t2739r1863b2793],
12	and	CC	O	and	_	0	SENT_151	[p6l1894t2738r2010b2793],
13	any	DT	O	any	det	15	SENT_151	[p6l2041t2754r2154b2807],
14	clinical	JJ	O	clinical	amod	15	SENT_151	[p6l12t2827r238b2882],
15	characteristics	NNS	O	characteristic	conj_and	11	SENT_151	[p6l271t2827r749b2883],
16	.	.	O	.	_	0	SENT_151	[p6l271t2827r749b2883],

1	K-ras	JJ	O	k-ras	amod	3	SENT_152	[p6l780t2831r941b2882],
2	mutated	VBN	O	mutate	amod	3	SENT_152	[p6l973t2827r1243b2882],
3	patients	NNS	O	patient	nsubj	4	SENT_152	[p6l1277t2828r1534b2896],
4	showed	VBD	O	show	dep	23	SENT_152	[p6l1568t2827r1814b2882],
5	a	DT	O	a	det	7	SENT_152	[p6l1847t2843r1879b2882],
6	median	JJ	O	median	amod	7	SENT_152	[p6l1911t2827r2152b2882],
7	survival	NN	O	survival	dobj	4	SENT_152	[p6l13t2917r262b2972],
8	of	IN	O	of	_	0	SENT_152	[p6l295t2916r361b2972],
9	4	CD	DURATION	4	num	10	SENT_152	[p6l383t2919r422b2971],
10	months	NNS	NUMBER	month	prep_of	7	SENT_152	[p6l454t2917r697b2972],
11	compared	VBN	O	compare	_	0	SENT_152	[p6l730t2917r1050b2985],
12	to	TO	O	to	prepc_compared_to	4	SENT_152	[p6l1082t2925r1143b2972],
13	12	CD	DURATION	12	num	14	SENT_152	[p6l1179t2919r1246b2971],
14	months	NNS	NUMBER	month	pobj	4	SENT_152	[p6l1281t2917r1524b2972],
15	of	IN	O	of	_	0	SENT_152	[p6l1557t2916r1624b2972],
16	K	NNP	O	K	nn	22	SENT_152	[p6l1646t2920r1807b2972],
17	—	NNP	O	—	nn	22	SENT_152	[p6l1646t2920r1807b2972],
18	ras	NN	O	ra	nn	22	SENT_152	[p6l1646t2920r1807b2972],
19	wild	JJ	O	wild	amod	22	SENT_152	[p6l1837t2917r2151b2985],
20	—	NN	O	—	nn	22	SENT_152	[p6l1837t2917r2151b2985],
21	type	NN	O	type	nn	22	SENT_152	[p6l1837t2917r2151b2985],
22	ones	NNS	O	one	prep_of	14	SENT_152	[p6l12t3022r158b3061],
23	(	VBP	O	(	_	0	SENT_152	[p6l181t3006r241b3074],
24	p	NN	O	p	dobj	23	SENT_152	[p6l181t3006r241b3074],
25	=	JJ	O	=	dep	24	SENT_152	[p6l258t3029r291b3045],
26	0.507	CD	NUMBER	0.507	iobj	25	SENT_152	[p6l308t3006r507b3074],
27	)	CD	NUMBER	)	number	28	SENT_152	[p6l308t3006r507b3074],
28	(	CD	NUMBER	(	num	29	SENT_152	[p6l530t3006r723b3074],
29	Table	NNP	O	Table	dobj	25	SENT_152	[p6l530t3006r723b3074],
30	2	CD	NUMBER	2	num	29	SENT_152	[p6l746t3006r823b3074],
31	)	CD	NUMBER	)	nsubj	23	SENT_152	[p6l746t3006r823b3074],
32	.	.	O	.	_	0	SENT_152	[p6l746t3006r823b3074],

1	3.2.2	CD	NUMBER	3.2.2	_	0	SENT_153	[p6l9t3231r169b3283],
2	.	.	O	.	_	0	SENT_153	[p6l9t3231r169b3283],

1	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_154	[p6l218t3231r377b3283],
2	and	CC	O	and	_	0	SENT_154	[p6l398t3228r512b3283],
3	HER2	NN	O	her2	nn	4	SENT_154	[p6l531t3231r698b3282],
4	gene	NN	O	gene	_	0	SENT_154	[p6l715t3244r861b3296],
5	copy	NN	O	copy	nn	6	SENT_154	[p6l883t3244r1025b3296],
6	number	NN	O	number	dep	4	SENT_154	[p6l1047t3228r1289b3283],

1	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_155	[p6l111t3320r270b3372],
2	FISH	NN	O	fish	nn	3	SENT_155	[p6l311t3320r452b3372],
3	analysis	NN	O	analysis	nsubjpass	5	SENT_155	[p6l495t3317r747b3385],
4	was	VBD	O	be	auxpass	5	SENT_155	[p6l788t3333r911b3372],
5	performed	VBN	O	perform	_	0	SENT_155	[p6l953t3317r1294b3385],
6	on	IN	O	on	_	0	SENT_155	[p6l1336t3333r1415b3372],
7	54	CD	NUMBER	54	num	9	SENT_155	[p6l1457t3320r1533b3372],
8	tumor	NN	O	tumor	nn	9	SENT_155	[p6l1574t3325r1775b3372],
9	specimens	NNS	O	specimen	prep_on	5	SENT_155	[p6l1815t3318r2151b3385],
10	and	CC	O	and	_	0	SENT_155	[p6l12t3405r128b3460],
11	was	VBD	O	be	cop	12	SENT_155	[p6l153t3421r275b3460],
12	positive	JJ	O	positive	conj_and	5	SENT_155	[p6l303t3406r553b3474],
13	in	IN	O	in	_	0	SENT_155	[p6l580t3406r639b3459],
14	12	CD	NUMBER	12	num	15	SENT_155	[p6l668t3408r736b3459],
15	patients	NNS	O	patient	prep_in	12	SENT_155	[p6l764t3406r1022b3474],
16	(	IN	O	(	_	0	SENT_155	[p6l1050t3405r1238b3473],
17	22	CD	PERCENT	22	num	18	SENT_155	[p6l1050t3405r1238b3473],
18	%	NN	PERCENT	%	prep_(	12	SENT_155	[p6l1050t3405r1238b3473],
19	)	CD	NUMBER	)	dobj	5	SENT_155	[p6l1050t3405r1238b3473],
20	.	.	O	.	_	0	SENT_155	[p6l1050t3405r1238b3473],

1	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_156	[p6l1263t3408r1422b3460],
2	FISH	NN	O	fish	nn	4	SENT_156	[p6l1447t3408r1589b3460],
3	positive	JJ	O	positive	amod	4	SENT_156	[p6l1616t3406r1866b3474],
4	patients	NNS	O	patient	nsubj	6	SENT_156	[p6l1893t3406r2151b3474],
5	were	VBD	O	be	cop	6	SENT_156	[p6l10t3510r168b3549],
6	responders	NNS	O	responder	_	0	SENT_156	[p6l195t3494r550b3563],
7	to	TO	O	to	aux	8	SENT_156	[p6l577t3502r638b3549],
8	geﬁtinib	VB	O	geﬁtinib	infmod	6	SENT_156	[p6l663t3494r930b3563],
9	in	IN	O	in	_	0	SENT_156	[p6l957t3495r1016b3549],
10	the	DT	O	the	det	12	SENT_156	[p6l1041t3494r1143b3549],
11	50	CD	PERCENT	50	num	12	SENT_156	[p6l1170t3497r1290b3549],
12	%	NN	PERCENT	%	prep_in	8	SENT_156	[p6l1170t3497r1290b3549],
13	of	IN	O	of	_	0	SENT_156	[p6l1317t3494r1383b3549],
14	the	DT	O	the	det	15	SENT_156	[p6l1401t3494r1502b3549],
15	cases	NNS	O	case	prep_of	12	SENT_156	[p6l1529t3510r1693b3549],
16	versus	CC	O	versus	prep	15	SENT_156	[p6l1719t3510r1924b3549],
17	14	CD	PERCENT	14	num	18	SENT_156	[p6l1954t3497r2067b3549],
18	%	NN	PERCENT	%	dep	16	SENT_156	[p6l1954t3497r2067b3549],
19	in	IN	O	in	_	0	SENT_156	[p6l2093t3495r2152b3549],
20	EGFR	NN	ORGANIZATION	egfr	nn	23	SENT_156	[p6l10t3586r168b3638],
21	FISH	NN	O	fish	nn	23	SENT_156	[p6l195t3586r337b3638],
22	negative	JJ	O	negative	amod	23	SENT_156	[p6l366t3584r636b3652],
23	ones	NNS	O	one	prep_in	18	SENT_156	[p6l664t3599r826b3639],
24	.	.	O	.	_	0	SENT_156	[p6l664t3599r826b3639],

1	The	DT	O	the	det	2	SENT_157	[p6l852t3583r969b3638],
2	difference	NN	O	difference	nsubj	15	SENT_157	[p6l997t3583r1318b3638],
3	between	IN	O	between	_	0	SENT_157	[p6l1346t3583r1623b3638],
4	responders	NNS	O	responder	prep_between	2	SENT_157	[p6l1651t3583r2006b3652],
5	and	CC	O	and	_	0	SENT_157	[p6l2035t3583r2151b3638],
6	non	JJ	O	non	amod	8	SENT_157	[p6l12t3673r522b3741],
7	—	NN	O	—	nn	8	SENT_157	[p6l12t3673r522b3741],
8	responders	NNS	O	responder	prep_between	2	SENT_157	[p6l12t3673r522b3741],
9	according	VBG	O	accord	_	0	SENT_157	[p6l553t3673r867b3741],
10	to	TO	O	to	prepc_according_to	8	SENT_157	[p6l895t3681r956b3728],
11	FISH	NN	O	fish	nn	12	SENT_157	[p6l988t3675r1129b3728],
12	status	NN	O	status	pobj	8	SENT_157	[p6l1161t3681r1348b3728],
13	was	VBD	O	be	cop	15	SENT_157	[p6l1378t3688r1501b3728],
14	statistically	RB	O	statistically	advmod	15	SENT_157	[p6l1534t3673r1900b3741],
15	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_157	[p6l1930t3672r2151b3741, p7l12t25r148b72],

1	(	NN	O	(	nn	2	SENT_158	[p7l169t17r228b85],
2	p	NN	O	p	nsubjpass	11	SENT_158	[p7l169t17r228b85],
3	=	JJ	O	=	amod	2	SENT_158	[p7l245t40r278b56],
4	0.016	CD	NUMBER	0.016	num	5	SENT_158	[p7l295t17r505b85],
5	)	NN	O	)	tmod	3	SENT_158	[p7l295t17r505b85],
6	,	,	O	,	_	0	SENT_158	[p7l295t17r505b85],
7	but	CC	O	but	prep	5	SENT_158	[p7l528t17r635b72],
8	no	DT	O	no	det	9	SENT_158	[p7l656t33r733b72],
9	difference	NN	O	difference	dep	7	SENT_158	[p7l755t17r1077b72],
10	was	VBD	O	be	auxpass	11	SENT_158	[p7l1098t33r1220b72],
11	observed	VBN	O	observe	_	0	SENT_158	[p7l1243t17r1534b72],
12	in	IN	O	in	_	0	SENT_158	[p7l1557t18r1616b71],
13	median	JJ	O	median	amod	14	SENT_158	[p7l1638t17r1880b72],
14	survival	NN	O	survival	prep_in	11	SENT_158	[p7l1902t17r2151b72],
15	(	CD	NUMBER	(	num	16	SENT_158	[p7l12t105r204b173],
16	Table	NNP	O	Table	tmod	11	SENT_158	[p7l12t105r204b173],
17	2	CD	NUMBER	2	num	16	SENT_158	[p7l227t105r305b173],
18	)	CD	NUMBER	)	dep	16	SENT_158	[p7l227t105r305b173],
19	.	.	O	.	_	0	SENT_158	[p7l227t105r305b173],

1	HER2	NN	O	her2	nn	3	SENT_159	[p7l111t197r278b248],
2	FISH	NN	O	fish	nn	3	SENT_159	[p7l319t197r460b249],
3	analysis	NN	O	analysis	nsubjpass	5	SENT_159	[p7l501t194r754b263],
4	was	VBD	O	be	auxpass	5	SENT_159	[p7l794t210r916b249],
5	performed	VBN	O	perform	_	0	SENT_159	[p7l958t194r1299b263],
6	on	IN	O	on	_	0	SENT_159	[p7l1340t210r1418b249],
7	58	CD	NUMBER	58	num	9	SENT_159	[p7l1459t197r1533b249],
8	tumor	NN	O	tumor	nn	9	SENT_159	[p7l1575t202r1776b249],
9	specimens	NNS	O	specimen	prep_on	5	SENT_159	[p7l1815t195r2151b263],
10	and	CC	O	and	_	0	SENT_159	[p7l12t283r128b338],
11	was	VBD	O	be	cop	12	SENT_159	[p7l157t299r279b338],
12	positive	JJ	O	positive	conj_and	5	SENT_159	[p7l311t284r562b352],
13	in	IN	O	in	_	0	SENT_159	[p7l592t284r652b338],
14	11	CD	NUMBER	11	num	15	SENT_159	[p7l684t286r742b338],
15	patients	NNS	O	patient	prep_in	12	SENT_159	[p7l781t284r1039b352],
16	(	CD	PERCENT	(	number	17	SENT_159	[p7l1070t283r1255b352],
17	19	CD	PERCENT	19	dep	18	SENT_159	[p7l1070t283r1255b352],
18	%	NN	PERCENT	%	dep	15	SENT_159	[p7l1070t283r1255b352],
19	)	CD	NUMBER	)	tmod	12	SENT_159	[p7l1070t283r1255b352],
20	.	.	O	.	_	0	SENT_159	[p7l1070t283r1255b352],

1	The	DT	O	the	det	3	SENT_160	[p7l1283t283r1400b338],
2	response	NN	O	response	nn	3	SENT_160	[p7l1431t299r1715b352],
3	rate	NN	O	rate	nsubj	11	SENT_160	[p7l1747t291r1868b338],
4	in	IN	O	in	_	0	SENT_160	[p7l1899t284r1958b338],
5	HER2	NN	O	her2	nn	8	SENT_160	[p7l1985t286r2152b338],
6	gene	NN	O	gene	nn	8	SENT_160	[p7l6t388r152b441],
7	positive	JJ	O	positive	amod	8	SENT_160	[p7l181t373r432b441],
8	patients	NNS	O	patient	prep_in	3	SENT_160	[p7l461t373r719b441],
9	was	VBD	O	be	cop	11	SENT_160	[p7l748t388r871b427],
10	18	CD	PERCENT	18	num	11	SENT_160	[p7l904t375r1017b427],
11	%	NN	PERCENT	%	_	0	SENT_160	[p7l904t375r1017b427],
12	versus	CC	O	versus	prep	11	SENT_160	[p7l1043t388r1248b427],
13	23	CD	PERCENT	23	num	14	SENT_160	[p7l1278t375r1400b427],
14	%	NN	PERCENT	%	dep	12	SENT_160	[p7l1278t375r1400b427],
15	in	IN	O	in	_	0	SENT_160	[p7l1429t373r1488b427],
16	HER2	NN	O	her2	nn	19	SENT_160	[p7l1514t375r1681b427],
17	FISH	NN	O	fish	nn	19	SENT_160	[p7l1710t375r1852b427],
18	negative	JJ	O	negative	amod	19	SENT_160	[p7l1882t373r2151b441],
19	patients	NNS	O	patient	prep_in	14	SENT_160	[p7l12t462r287b530],
20	.	.	O	.	_	0	SENT_160	[p7l12t462r287b530],

1	No	DT	O	no	det	4	SENT_161	[p7l306t465r391b517],
2	statistically	RB	O	statistically	advmod	3	SENT_161	[p7l410t462r776b530],
3	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_161	[p7l793t461r1127b530],
4	differences	NNS	O	difference	nsubjpass	6	SENT_161	[p7l1143t461r1495b517],
5	were	VBD	O	be	auxpass	6	SENT_161	[p7l1512t477r1670b517],
6	found	VBN	O	find	_	0	SENT_161	[p7l1689t461r1874b517],
7	in	IN	O	in	_	0	SENT_161	[p7l1892t462r1951b516],
8	terms	NNS	O	term	prep_in	6	SENT_161	[p7l1968t470r2151b517],
9	of	IN	O	of	_	0	SENT_161	[p7l12t551r78b606],
10	response	NN	O	response	prep_of	8	SENT_161	[p7l94t567r378b619],
11	and	CC	O	and	_	0	SENT_161	[p7l401t551r518b606],
12	survival	NN	O	survival	nn	14	SENT_161	[p7l541t551r791b606],
13	(	CD	NUMBER	(	num	14	SENT_161	[p7l814t551r1006b619],
14	Table	NNP	O	Table	conj_and	8	SENT_161	[p7l814t551r1006b619],
15	2	CD	NUMBER	2	number	16	SENT_161	[p7l1029t551r1107b619],
16	)	CD	NUMBER	)	dep	14	SENT_161	[p7l1029t551r1107b619],
17	.	.	O	.	_	0	SENT_161	[p7l1029t551r1107b619],

1	A	DT	O	a	det	3	SENT_162	[p7l111t641r158b693],
2	signiﬁcant	JJ	O	signiﬁcant	amod	3	SENT_162	[p7l191t639r525b708],
3	correlation	NN	O	correlation	nsubj	12	SENT_162	[p7l558t639r910b694],
4	between	IN	O	between	_	0	SENT_162	[p7l943t639r1221b694],
5	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_162	[p7l1253t642r1411b694],
6	FISH	NN	O	fish	nn	7	SENT_162	[p7l1445t642r1587b694],
7	status	NN	O	status	prep_between	3	SENT_162	[p7l1623t647r1810b694],
8	and	CC	O	and	_	0	SENT_162	[p7l1846t639r1962b694],
9	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_162	[p7l1994t642r2153b694],
10	gene	NN	O	gene	nn	11	SENT_162	[p7l6t744r152b797],
11	mutations	NNS	O	mutation	conj_and	7	SENT_162	[p7l179t729r505b783],
12	(	VBP	O	(	_	0	SENT_162	[p7l534t728r593b797],
13	p	NN	O	p	dobj	12	SENT_162	[p7l534t728r593b797],
14	=	JJ	O	=	amod	16	SENT_162	[p7l610t751r643b768],
15	0.005	CD	NUMBER	0.005	num	16	SENT_162	[p7l660t728r863b797],
16	)	NN	O	)	nsubjpass	18	SENT_162	[p7l660t728r863b797],
17	was	VBD	O	be	auxpass	18	SENT_162	[p7l889t744r1012b783],
18	observed	VBN	O	observe	rcmod	13	SENT_162	[p7l1040t728r1346b784],
19	.	.	O	.	_	0	SENT_162	[p7l1040t728r1346b784],

1	Moreover	RB	O	moreover	advmod	4	SENT_163	[p7l1374t732r1695b792],
2	,	,	O	,	_	0	SENT_163	[p7l1374t732r1695b792],
3	we	PRP	O	we	nsubj	54	SENT_163	[p7l1721t744r1814b783],
4	evaluated	VBD	O	evaluate	_	0	SENT_163	[p7l1841t728r2151b783],
5	patients	NNS	O	patient	dobj	4	SENT_163	[p7l12t818r270b886],
6	with	IN	O	with	_	0	SENT_163	[p7l289t817r437b872],
7	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_163	[p7l454t820r613b872],
8	and	CC	O	and	_	0	SENT_163	[p7l631t817r747b872],
9	HER2	NN	O	her2	nn	10	SENT_163	[p7l765t820r932b872],
10	FISH	NN	O	fish	prep_with	5	SENT_163	[p7l952t820r1094b872],
11	both	CC	O	both	dep	5	SENT_163	[p7l1113t817r1259b872],
12	positive	JJ	O	positive	amod	14	SENT_163	[p7l1278t818r1529b886],
13	(	NN	O	(	nn	14	SENT_163	[p7l1549t818r1610b886],
14	n	NN	O	n	conj	5	SENT_163	[p7l1549t818r1610b886],
15	=	JJ	O	=	amod	17	SENT_163	[p7l1627t841r1660b857],
16	8	CD	NUMBER	8	number	17	SENT_163	[p7l1677t817r1739b886],
17	)	CD	NUMBER	)	nsubj	21	SENT_163	[p7l1677t817r1739b886],
18	versus	CC	O	versus	prep	17	SENT_163	[p7l1757t833r1962b872],
19	other	JJ	O	other	amod	20	SENT_163	[p7l1983t817r2154b872],
20	ones	NNS	O	one	dep	18	SENT_163	[p7l12t922r158b961],
21	(	VBP	O	(	rcmod	14	SENT_163	[p7l196t907r421b975],
22	n	NN	O	n	dobj	21	SENT_163	[p7l196t907r421b975],
23	=	JJ	O	=	amod	22	SENT_163	[p7l196t907r421b975],
24	46	CD	NUMBER	46	tmod	23	SENT_163	[p7l196t907r421b975],
25	;	:	O	;	_	0	SENT_163	[p7l196t907r421b975],
26	EGFR	NN	ORGANIZATION	egfr	nn	27	SENT_163	[p7l461t909r620b961],
27	FISH	NN	O	fish	dep	14	SENT_163	[p7l657t906r1046b975],
28	—	CD	NUMBER	—	dep	27	SENT_163	[p7l657t906r1046b975],
29	/	:	O	/	punct	32	SENT_163	[p7l657t906r1046b975],
30	HER2	CD	NUMBER	her2	num	32	SENT_163	[p7l657t906r1046b975],
31	FISH	NN	O	fish	nn	32	SENT_163	[p7l1084t909r1295b970],
32	—	NN	O	—	dep	28	SENT_163	[p7l1084t909r1295b970],
33	,	,	O	,	_	0	SENT_163	[p7l1084t909r1295b970],
34	EGFR	NN	ORGANIZATION	egfr	nn	35	SENT_163	[p7l1331t909r1490b961],
35	FISH	NN	O	fish	appos	32	SENT_163	[p7l1527t906r1902b975],
36	+	CC	O	+	_	0	SENT_163	[p7l1527t906r1902b975],
37	/	:	O	/	punct	39	SENT_163	[p7l1527t906r1902b975],
38	HER2	NN	O	her2	nn	39	SENT_163	[p7l1527t906r1902b975],
39	FISH	NN	O	fish	dep	4	SENT_163	[p7l1940t909r2151b970],
40	—	CD	NUMBER	—	dep	39	SENT_163	[p7l1940t909r2151b970],
41	,	,	O	,	_	0	SENT_163	[p7l1940t909r2151b970],
42	EGFR	NN	ORGANIZATION	egfr	nn	43	SENT_163	[p7l10t998r168b1051],
43	FISH	NN	O	fish	conj_and	39	SENT_163	[p7l184t995r573b1064],
44	—	CD	NUMBER	—	dep	43	SENT_163	[p7l184t995r573b1064],
45	/	:	O	/	punct	47	SENT_163	[p7l184t995r573b1064],
46	HER2	CD	NUMBER	her2	num	47	SENT_163	[p7l184t995r573b1064],
47	FISH	NN	O	fish	dep	44	SENT_163	[p7l589t996r796b1064],
48	+	CC	O	+	_	0	SENT_163	[p7l589t996r796b1064],
49	)	NN	O	)	conj_+	47	SENT_163	[p7l589t996r796b1064],
50	and	CC	O	and	_	0	SENT_163	[p7l812t996r928b1051],
51	we	PRP	O	we	dep	4	SENT_163	[p7l943t1011r1037b1051],
52	did	VBD	O	do	aux	54	SENT_163	[p7l1053t996r1153b1051],
53	not	RB	O	not	neg	54	SENT_163	[p7l1170t1004r1274b1051],
54	ﬁnd	VB	O	ﬁnd	conj_+	4	SENT_163	[p7l1289t995r1412b1051],
55	any	DT	O	any	det	56	SENT_163	[p7l1428t1011r1541b1064],
56	difference	NN	O	difference	dobj	54	SENT_163	[p7l1555t995r1877b1051],
57	in	IN	O	in	_	0	SENT_163	[p7l1894t996r1953b1050],
58	terms	NNS	O	term	prep_in	54	SENT_163	[p7l1968t1004r2151b1051],
59	of	IN	O	of	_	0	SENT_163	[p7l12t1085r78b1140],
60	tumor	NN	O	tumor	nn	61	SENT_163	[p7l92t1093r294b1140],
61	response	NN	O	response	prep_of	58	SENT_163	[p7l315t1101r615b1153],
62	.	.	O	.	_	0	SENT_163	[p7l315t1101r615b1153],

1	1	CD	NUMBER	1	num	2	SENT_164	[p7l150t1306r171b1349],
2	DD	NN	O	dd	_	0	SENT_164	[p7l180t1306r245b1349],

1	80	CD	NUMBER	80	_	0	SENT_165	[p7l180t1566r245b1609],
2	"	``	O	"	punct	1	SENT_165	[p7l397t1557r422b1593],
3	-	:	O	-	_	0	SENT_165	[p7l397t1557r422b1593],
4	I	PRP	O	I	dep	1	SENT_165	[p7l397t1557r422b1593],
5	-	:	O	-	_	0	SENT_165	[p7l437t1584r444b1597],
6	_	CD	NUMBER	_	num	7	SENT_165	[p7l1025t1602r1054b1609],
7	Y	NN	O	y	dep	4	SENT_165	[p7l1066t1602r1078b1609],
8	+	CC	O	+	_	0	SENT_165	[p7l1066t1602r1078b1609],
9	_	NN	O	_	conj_+	7	SENT_165	[p7l1090t1602r1139b1609],
10	.	.	O	.	_	0	SENT_165	[p7l1090t1602r1139b1609],

1	_	NN	O	_	_	0	SENT_166	[p7l1154t1602r1182b1609],
2	.	.	O	.	_	0	SENT_166	[p7l1154t1602r1182b1609],

1	.	.	O	.	_	0	SENT_167	[p7l1197t1602r1204b1609],

1	(	RB	O	(	advmod	2	SENT_168	[p7l1243t1566r1399b1624],
2	CAL	NNP	O	CAL	_	0	SENT_168	[p7l1243t1566r1399b1624],
3	,	,	O	,	_	0	SENT_168	[p7l1243t1566r1399b1624],
4	genotype	NN	O	genotype	appos	2	SENT_168	[p7l1414t1569r1650b1618],
5	{	CD	NUMBER	{	num	13	SENT_168	[p7l1243t1633r1430b1689],
6	CA	NNP	O	CA	nn	13	SENT_168	[p7l1243t1633r1430b1689],
7	)	NNP	O	)	nn	13	SENT_168	[p7l1243t1633r1430b1689],
8	m	NN	O	m	nn	13	SENT_168	[p7l1243t1633r1430b1689],
9	,	,	O	,	_	0	SENT_168	[p7l1243t1633r1430b1689],
10	genotype	NN	O	genotype	dep	13	SENT_168	[p7l1445t1634r1681b1683],
11	proportion	NN	O	proportion	nn	13	SENT_168	[p7l58t1890r122b2225],
12	alive	JJ	O	alive	amod	13	SENT_168	[p7l58t1716r110b1866],
13	months	NNS	DURATION	month	dep	2	SENT_168	[p7l1066t2779r1308b2831],

1	Fig	NN	O	fig	_	0	SENT_169	[p7l10t2941r103b2996],
2	.	.	O	.	_	0	SENT_169	[p7l10t2941r103b2996],

1	1	LS	NUMBER	1	_	0	SENT_170	[p7l118t2944r158b2985],
2	.	.	O	.	_	0	SENT_170	[p7l118t2944r158b2985],

1	Kaplan	NNP	PERSON	Kaplan	_	0	SENT_171	[p7l190t2941r552b2996],
2	.	.	O	.	_	0	SENT_171	[p7l190t2941r552b2996],

1	—	NN	O	—	_	0	SENT_172	[p7l190t2941r552b2996],
2	.	.	O	.	_	0	SENT_172	[p7l190t2941r552b2996],

1	Meier	NNP	PERSON	Meier	nn	2	SENT_173	[p7l190t2941r552b2996],
2	plot	NN	O	plot	_	0	SENT_173	[p7l566t2941r665b2996],
3	of	IN	O	of	_	0	SENT_173	[p7l679t2941r732b2985],
4	survival	NN	O	survival	prep_of	2	SENT_173	[p7l741t2941r940b2985],
5	time	NN	O	time	nsubj	12	SENT_173	[p7l955t2942r1071b2985],
6	according	VBG	O	accord	_	0	SENT_173	[p7l1086t2941r1336b2996],
7	to	TO	O	to	prepc_according_to	5	SENT_173	[p7l1349t2948r1398b2985],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_173	[p7l1411t2943r1538b2985],
9	intron	NN	O	intron	pobj	5	SENT_173	[p7l1552t2942r1709b2985],
10	1	CD	NUMBER	1	num	12	SENT_173	[p7l1726t2944r1745b2984],
11	polymorphism	NN	O	polymorphism	nn	12	SENT_173	[p7l1767t2941r2145b2996],
12	[	NN	O	[	rcmod	2	SENT_173	[p7l14t3012r179b3067],
13	(	CD	NUMBER	(	num	17	SENT_173	[p7l14t3012r179b3067],
14	CA	NNP	O	CA	nn	17	SENT_173	[p7l14t3012r179b3067],
15	)	NNP	O	)	nn	17	SENT_173	[p7l14t3012r179b3067],
16	ze	NN	O	ze	nn	17	SENT_173	[p7l14t3012r179b3067],
17	genotype	NN	O	genotype	dep	12	SENT_173	[p7l199t3019r435b3067],
18	VS	SYM	O	vs	dep	12	SENT_173	[p7l452t3025r517b3057],
19	-	:	O	-	_	0	SENT_173	[p7l452t3025r517b3057],
20	(	NN	O	(	nn	22	SENT_173	[p7l536t3013r707b3067],
21	CA	NNP	O	CA	nn	22	SENT_173	[p7l536t3013r707b3067],
22	)	NNP	O	)	dep	2	SENT_173	[p7l536t3013r707b3067],
23	else	RB	O	else	advmod	24	SENT_173	[p7l536t3013r707b3067],
24	genotype	NN	O	genotype	dep	22	SENT_173	[p7l727t3012r997b3067, p7l8t3220r168b3272],
25	]	CD	NUMBER	]	number	26	SENT_173	[p7l727t3012r997b3067, p7l8t3220r168b3272],
26	3.2.3	CD	NUMBER	3.2.3	dep	24	SENT_173	[p7l727t3012r997b3067, p7l8t3220r168b3272],
27	.	.	O	.	_	0	SENT_173	[p7l727t3012r997b3067, p7l8t3220r168b3272],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_174	[p7l217t3220r375b3271],
2	immunohistochemistry	NN	O	immunohistochemistry	_	0	SENT_174	[p7l397t3217r1107b3285],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_175	[p7l114t3307r280b3359],
2	IHC	NN	ORGANIZATION	ihc	nsubj	13	SENT_175	[p7l319t3307r431b3359],
3	was	VBD	O	be	auxpass	4	SENT_175	[p7l470t3320r592b3359],
4	assessed	VBN	O	assess	_	0	SENT_175	[p7l635t3304r908b3359],
5	in	IN	O	in	_	0	SENT_175	[p7l951t3305r1010b3358],
6	tumor	NN	O	tumor	nn	7	SENT_175	[p7l1050t3312r1251b3359],
7	specimens	NNS	O	specimen	prep_in	4	SENT_175	[p7l1291t3305r1626b3372],
8	of	IN	O	of	_	0	SENT_175	[p7l1668t3304r1734b3359],
9	59	CD	NUMBER	59	num	10	SENT_175	[p7l1769t3307r1844b3359],
10	patients	NNS	O	patient	prep_of	7	SENT_175	[p7l1887t3305r2144b3372],
11	and	CC	O	and	_	0	SENT_175	[p7l11t3392r127b3446],
12	was	VBD	O	be	cop	13	SENT_175	[p7l156t3407r278b3446],
13	positive	JJ	O	positive	conj_and	4	SENT_175	[p7l310t3392r559b3459],
14	in	IN	O	in	_	0	SENT_175	[p7l590t3392r649b3445],
15	45	CD	PERCENT	45	number	16	SENT_175	[p7l676t3394r752b3446],
16	(	CD	PERCENT	(	prep_in	13	SENT_175	[p7l784t3392r969b3459],
17	76	CD	PERCENT	76	num	18	SENT_175	[p7l784t3392r969b3459],
18	%	NN	PERCENT	%	dep	16	SENT_175	[p7l784t3392r969b3459],
19	)	CD	NUMBER	)	tmod	13	SENT_175	[p7l784t3392r969b3459],
20	.	.	O	.	_	0	SENT_175	[p7l784t3392r969b3459],

1	No	DT	O	no	det	3	SENT_176	[p7l1001t3395r1086b3446],
2	signiﬁcant	NN	O	signiﬁcant	nn	3	SENT_176	[p7l1117t3391r1451b3459],
3	difference	NN	O	difference	nsubjpass	17	SENT_176	[p7l1479t3391r1799b3446],
4	in	IN	O	in	_	0	SENT_176	[p7l1830t3392r1889b3445],
5	clinical	JJ	O	clinical	amod	6	SENT_176	[p7l1918t3392r2144b3446],
6	response	NN	O	response	prep_in	3	SENT_176	[p7l12t3494r296b3546],
7	to	TO	O	to	_	0	SENT_176	[p7l313t3487r373b3533],
8	geﬁtinib	NN	O	geﬁtinib	prep_to	6	SENT_176	[p7l389t3479r656b3546],
9	and	CC	O	and	_	0	SENT_176	[p7l673t3479r789b3533],
10	survival	NN	O	survival	prep_to	6	SENT_176	[p7l807t3479r1056b3533],
11	according	VBG	O	accord	_	0	SENT_176	[p7l1073t3479r1386b3546],
12	to	TO	O	to	prepc_according_to	17	SENT_176	[p7l1401t3487r1461b3533],
13	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_176	[p7l1480t3482r1646b3533],
14	protein	NN	O	protein	nn	15	SENT_176	[p7l1660t3480r1891b3546],
15	expression	NN	O	expression	pobj	17	SENT_176	[p7l1907t3494r2144b3546, p7l12t3566r142b3619],
16	was	VBD	O	be	auxpass	17	SENT_176	[p7l163t3581r285b3619],
17	observed	VBN	O	observe	_	0	SENT_176	[p7l309t3565r598b3619],
18	(	RB	O	(	advmod	17	SENT_176	[p7l621t3565r813b3632],
19	Table	NNP	O	Table	prep	17	SENT_176	[p7l621t3565r813b3632],
20	2	CD	NUMBER	2	num	21	SENT_176	[p7l836t3565r913b3632],
21	)	CD	NUMBER	)	dep	19	SENT_176	[p7l836t3565r913b3632],
22	.	.	O	.	_	0	SENT_176	[p7l836t3565r913b3632],

1	3.2.4	CD	NUMBER	3.2.4	_	0	SENT_177	[p8l8t74r168b125],
2	.	.	O	.	_	0	SENT_177	[p8l8t74r168b125],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_178	[p8l217t74r375b125],
2	intron	NN	O	intron	_	0	SENT_178	[p8l396t72r582b125],
3	1	CD	NUMBER	1	num	4	SENT_178	[p8l612t74r632b124],
4	polymorphism	NN	O	polymorphism	dep	2	SENT_178	[p8l657t71r1104b138],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_179	[p8l111t160r269b211],
2	intron	NN	O	intron	nsubjpass	6	SENT_179	[p8l295t158r491b211],
3	1	CD	NUMBER	1	num	4	SENT_179	[p8l520t160r544b211],
4	polymorphism	NN	O	polymorphism	dep	2	SENT_179	[p8l579t157r1052b225],
5	was	VBD	O	be	auxpass	6	SENT_179	[p8l1076t173r1198b211],
6	characterized	VBN	O	characterize	_	0	SENT_179	[p8l1226t157r1658b211],
7	in	IN	O	in	_	0	SENT_179	[p8l1685t158r1744b211],
8	76	CD	NUMBER	76	num	9	SENT_179	[p8l1771t160r1843b211],
9	patients	NNS	O	patient	prep_in	6	SENT_179	[p8l1870t158r2144b225],
10	.	.	O	.	_	0	SENT_179	[p8l1870t158r2144b225],

1	Alleles	NNS	MISC	allele	nsubj	2	SENT_180	[p8l9t244r220b298],
2	ranged	VBD	O	range	_	0	SENT_180	[p8l249t244r467b312],
3	between	IN	O	between	quantmod	4	SENT_180	[p8l493t244r769b298],
4	14	CD	NUMBER	14	num	7	SENT_180	[p8l798t247r868b298],
5	and	CC	NUMBER	and	_	0	SENT_180	[p8l893t244r1009b298],
6	21	CD	NUMBER	21	num	7	SENT_180	[p8l1036t247r1102b298],
7	dinucleotides	NNS	O	dinucleotide	nsubjpass	9	SENT_180	[p8l1136t244r1567b298],
8	were	VBD	O	be	auxpass	9	SENT_180	[p8l1593t260r1750b298],
9	found	VBN	O	find	ccomp	2	SENT_180	[p8l1777t244r1978b299],
10	.	.	O	.	_	0	SENT_180	[p8l1777t244r1978b299],

1	Heterozygosity	NN	PERSON	heterozygosity	nsubjpass	3	SENT_181	[p8l2006t248r2144b298, p8l12t332r380b399],
2	was	VBD	O	be	auxpass	3	SENT_181	[p8l406t347r528b386],
3	observed	VBN	O	observe	dep	18	SENT_181	[p8l559t331r848b386],
4	in	IN	O	in	_	0	SENT_181	[p8l879t332r937b385],
5	54	CD	NUMBER	54	prep_in	3	SENT_181	[p8l967t334r1043b386],
6	of	IN	O	of	_	0	SENT_181	[p8l1072t331r1138b385],
7	76	CD	NUMBER	76	num	8	SENT_181	[p8l1161t334r1233b385],
8	patients	NNS	O	patient	prep_of	5	SENT_181	[p8l1263t332r1520b399],
9	(	IN	O	(	_	0	SENT_181	[p8l1550t332r1720b399],
10	71	CD	PERCENT	71	num	11	SENT_181	[p8l1550t332r1720b399],
11	%	NN	PERCENT	%	prep_(	3	SENT_181	[p8l1550t332r1720b399],
12	)	CD	NUMBER	)	dep	11	SENT_181	[p8l1550t332r1720b399],
13	and	CC	O	and	_	0	SENT_181	[p8l1749t331r1865b385],
14	in	IN	O	in	_	0	SENT_181	[p8l1896t332r1954b385],
15	37	CD	NUMBER	37	prep_in	3	SENT_181	[p8l1982t334r2055b386],
16	of	IN	O	of	_	0	SENT_181	[p8l2086t331r2153b386],
17	them	PRP	O	they	prep_of	15	SENT_181	[p8l11t419r178b473],
18	(	VBP	O	(	_	0	SENT_181	[p8l194t419r425b486],
19	68.5	CD	PERCENT	68.5	num	20	SENT_181	[p8l194t419r425b486],
20	%	NN	PERCENT	%	dobj	18	SENT_181	[p8l194t419r425b486],
21	)	CD	NUMBER	)	nsubj	18	SENT_181	[p8l194t419r425b486],
22	the	DT	O	the	det	24	SENT_181	[p8l441t419r542b473],
23	shorter	JJR	O	shorter	amod	24	SENT_181	[p8l560t419r791b473],
24	allele	NN	O	allele	nsubj	25	SENT_181	[p8l805t418r973b473],
25	consisted	VBD	O	consist	rcmod	21	SENT_181	[p8l990t419r1290b473],
26	of	IN	O	of	_	0	SENT_181	[p8l1307t418r1373b473],
27	(	CD	NUMBER	(	num	31	SENT_181	[p8l1382t419r1571b486],
28	CA	NNP	O	CA	nn	31	SENT_181	[p8l1382t419r1571b486],
29	)	CD	NUMBER	)	num	31	SENT_181	[p8l1382t419r1571b486],
30	15	CD	NUMBER	15	num	31	SENT_181	[p8l1382t419r1571b486],
31	repeats	NNS	O	repeat	prep_of	25	SENT_181	[p8l1591t427r1839b486],
32	.	.	O	.	_	0	SENT_181	[p8l1591t427r1839b486],

1	The	DT	O	the	det	4	SENT_182	[p8l1854t419r1971b473],
2	most	RBS	O	most	advmod	4	SENT_182	[p8l1988t427r2146b473],
3	common	JJ	O	common	amod	4	SENT_182	[p8l12t521r294b560],
4	genotypes	NNS	O	genotype	nsubj	7	SENT_182	[p8l312t514r639b573],
5	were	VBD	O	be	cop	7	SENT_182	[p8l659t522r816b560],
6	16-16	CD	PERCENT	16-16	num	7	SENT_182	[p8l840t509r1026b560],
7	(	CD	PERCENT	(	_	0	SENT_182	[p8l1046t506r1218b573],
8	25	CD	PERCENT	25	number	9	SENT_182	[p8l1046t506r1218b573],
9	%	NN	PERCENT	%	amod	7	SENT_182	[p8l1046t506r1218b573],
10	)	CD	NUMBER	)	number	14	SENT_182	[p8l1046t506r1218b573],
11	and	CC	O	and	_	0	SENT_182	[p8l1239t506r1355b560],
12	16-20	CD	PERCENT	16-20	num	15	SENT_182	[p8l1379t509r1569b560],
13	(	CD	PERCENT	(	number	14	SENT_182	[p8l1590t506r1775b573],
14	21	CD	PERCENT	21	num	15	SENT_182	[p8l1590t506r1775b573],
15	%	NN	PERCENT	%	dep	7	SENT_182	[p8l1590t506r1775b573],
16	)	CD	NUMBER	)	dep	15	SENT_182	[p8l1590t506r1775b573],
17	.	.	O	.	_	0	SENT_182	[p8l1590t506r1775b573],

1	Among	IN	O	among	_	0	SENT_183	[p8l1793t508r2025b573],
2	the	DT	O	the	det	4	SENT_183	[p8l2043t506r2144b560],
3	20	CD	NUMBER	20	num	4	SENT_183	[p8l11t595r88b646],
4	patients	NNS	O	patient	nsubj	8	SENT_183	[p8l107t593r364b660],
5	with	IN	O	with	_	0	SENT_183	[p8l383t592r530b646],
6	a	DT	O	a	det	7	SENT_183	[p8l549t608r581b646],
7	genotype	NN	O	genotype	prep_with	4	SENT_183	[p8l598t600r894b660],
8	lacking	VBG	O	lack	prepc_among	17	SENT_183	[p8l914t592r1141b660],
9	the	DT	O	the	det	11	SENT_183	[p8l1158t592r1260b646],
10	(	CD	NUMBER	(	num	11	SENT_183	[p8l1279t592r1468b659],
11	CA	NNP	O	CA	dobj	8	SENT_183	[p8l1279t592r1468b659],
12	)	CD	NUMBER	)	number	13	SENT_183	[p8l1279t592r1468b659],
13	15	CD	NUMBER	15	num	14	SENT_183	[p8l1279t592r1468b659],
14	allele	NN	O	allele	dep	11	SENT_183	[p8l1491t592r1675b654],
15	,	,	O	,	_	0	SENT_183	[p8l1491t592r1675b654],
16	19	CD	NUMBER	19	nsubj	17	SENT_183	[p8l1698t595r1766b646],
17	had	VBD	O	have	_	0	SENT_183	[p8l1786t592r1901b646],
18	at	IN	O	at	quantmod	20	SENT_183	[p8l1921t600r1980b646],
19	least	JJS	O	least	mwe	18	SENT_183	[p8l1998t592r2146b646],
20	one	CD	NUMBER	one	num	23	SENT_183	[p8l12t695r126b733],
21	long	JJ	O	long	amod	23	SENT_183	[p8l149t679r287b747],
22	allele	NN	O	allele	nn	23	SENT_183	[p8l308t679r477b733],
23	(	NN	O	(	dobj	17	SENT_183	[p8l500t679r646b746],
24	317	CD	NUMBER	317	num	25	SENT_183	[p8l500t679r646b746],
25	dinucleotides	NNS	O	dinucleotide	dep	23	SENT_183	[p8l670t679r1143b746],
26	)	CD	NUMBER	)	dep	25	SENT_183	[p8l670t679r1143b746],
27	.	.	O	.	_	0	SENT_183	[p8l670t679r1143b746],

1	To	TO	O	to	aux	2	SENT_184	[p8l110t770r183b820],
2	evaluate	VB	O	evaluate	purpcl	14	SENT_184	[p8l224t766r491b820],
3	the	DT	O	the	det	5	SENT_184	[p8l531t766r632b820],
4	predictive	JJ	O	predictive	amod	5	SENT_184	[p8l673t766r992b834],
5	value	NN	O	value	dobj	2	SENT_184	[p8l1032t766r1202b820],
6	of	IN	O	of	_	0	SENT_184	[p8l1243t766r1309b820],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_184	[p8l1339t769r1497b820],
8	intron	NN	O	intron	prep_of	5	SENT_184	[p8l1538t767r1733b820],
9	1	CD	NUMBER	1	number	10	SENT_184	[p8l1777t769r1801b820],
10	polymorphism	NN	O	polymorphism	amod	8	SENT_184	[p8l1850t766r2144b834, p8l12t853r224b921],
11	,	,	O	,	_	0	SENT_184	[p8l1850t766r2144b834, p8l12t853r224b921],
12	patients	NNS	O	patient	nsubjpass	14	SENT_184	[p8l257t854r514b921],
13	were	VBD	O	be	auxpass	14	SENT_184	[p8l544t869r702b908],
14	clustered	VBN	O	cluster	_	0	SENT_184	[p8l733t853r1026b908],
15	into	IN	O	into	_	0	SENT_184	[p8l1058t854r1181b908],
16	two	CD	NUMBER	two	num	17	SENT_184	[p8l1211t861r1332b907],
17	subgroups	NNS	O	subgroup	prep_into	14	SENT_184	[p8l1364t853r1711b921],
18	,	,	O	,	_	0	SENT_184	[p8l1364t853r1711b921],
19	according	VBG	O	accord	_	0	SENT_184	[p8l1743t853r2055b921],
20	to	TO	O	to	prepc_according_to	14	SENT_184	[p8l2084t861r2144b908],
21	our	PRP$	O	we	poss	23	SENT_184	[p8l12t956r120b995],
22	previous	JJ	O	previous	amod	23	SENT_184	[p8l157t941r430b1008],
23	results	NNS	O	result	pobj	14	SENT_184	[p8l471t941r682b995],
24	[	VBP	O	[	rcmod	23	SENT_184	[p8l725t940r869b1008],
25	23	CD	NUMBER	23	number	26	SENT_184	[p8l725t940r869b1008],
26	]	CD	NUMBER	]	dobj	24	SENT_184	[p8l725t940r869b1008],
27	:	:	O	:	_	0	SENT_184	[p8l725t940r869b1008],
28	56	CD	PERCENT	56	number	29	SENT_184	[p8l914t943r989b995],
29	(	CD	PERCENT	(	dep	26	SENT_184	[p8l1029t941r1196b1008],
30	74	CD	PERCENT	74	num	31	SENT_184	[p8l1029t941r1196b1008],
31	%	NN	PERCENT	%	dep	29	SENT_184	[p8l1029t941r1196b1008],
32	)	CD	NUMBER	)	num	33	SENT_184	[p8l1029t941r1196b1008],
33	bearing	NN	O	bearing	dep	29	SENT_184	[p8l1235t941r1478b1008],
34	at	IN	O	at	quantmod	37	SENT_184	[p8l1515t949r1575b995],
35	least	JJS	O	least	mwe	34	SENT_184	[p8l1612t941r1760b995],
36	one	CD	NUMBER	one	number	37	SENT_184	[p8l1798t956r1912b995],
37	(	CD	NUMBER	(	num	41	SENT_184	[p8l1952t941r2141b1008],
38	CA	NNP	O	CA	nn	41	SENT_184	[p8l1952t941r2141b1008],
39	)	CD	NUMBER	)	number	40	SENT_184	[p8l1952t941r2141b1008],
40	15	CD	NUMBER	15	amod	41	SENT_184	[p8l1952t941r2141b1008],
41	allele	NN	O	allele	dep	23	SENT_184	[p8l11t1028r180b1082],
42	[	CD	NUMBER	[	number	43	SENT_184	[p8l225t1028r436b1095],
43	(	CD	NUMBER	(	num	48	SENT_184	[p8l225t1028r436b1095],
44	CA	NNP	O	CA	nn	48	SENT_184	[p8l225t1028r436b1095],
45	)	CD	NUMBER	)	num	48	SENT_184	[p8l225t1028r436b1095],
46	15	CD	NUMBER	15	number	47	SENT_184	[p8l225t1028r436b1095],
47	genotype	NN	O	genotype	amod	48	SENT_184	[p8l480t1028r798b1095],
48	]	NN	O	]	dep	23	SENT_184	[p8l480t1028r798b1095],
49	and	CC	O	and	_	0	SENT_184	[p8l843t1028r959b1082],
50	20	CD	PERCENT	20	number	51	SENT_184	[p8l1000t1031r1076b1082],
51	(	CD	PERCENT	(	amod	70	SENT_184	[p8l1118t1028r1290b1095],
52	26	CD	PERCENT	26	num	53	SENT_184	[p8l1118t1028r1290b1095],
53	%	NN	PERCENT	%	dep	51	SENT_184	[p8l1118t1028r1290b1095],
54	)	NN	O	)	dep	55	SENT_184	[p8l1118t1028r1290b1095],
55	lacking	VBG	O	lack	dep	70	SENT_184	[p8l1332t1028r1560b1095],
56	the	DT	O	the	det	57	SENT_184	[p8l1599t1028r1700b1082],
57	(	CD	NUMBER	(	nsubj	58	SENT_184	[p8l1742t1028r1931b1095],
58	CA	NNP	O	CA	ccomp	55	SENT_184	[p8l1742t1028r1931b1095],
59	)	CD	NUMBER	)	number	60	SENT_184	[p8l1742t1028r1931b1095],
60	15	CD	NUMBER	15	nsubj	61	SENT_184	[p8l1742t1028r1931b1095],
61	allele	NN	O	allele	ccomp	58	SENT_184	[p8l1975t1028r2144b1082],
62	[	CD	NUMBER	[	number	63	SENT_184	[p8l15t1114r256b1183],
63	(	CD	NUMBER	(	dobj	61	SENT_184	[p8l15t1114r256b1183],
64	CA	NNP	O	CA	dep	63	SENT_184	[p8l15t1114r256b1183],
65	)	CD	NUMBER	)	num	64	SENT_184	[p8l15t1114r256b1183],
66	e	SYM	O	e	dep	67	SENT_184	[p8l15t1114r256b1183],
67	,5	CD	NUMBER	,5	dep	63	SENT_184	[p8l15t1114r256b1183],
68	e	LS	O	e	dep	70	SENT_184	[p8l15t1114r256b1183],
69	genotype	NN	O	genotype	nn	70	SENT_184	[p8l299t1114r636b1182],
70	]	NN	O	]	conj_and	23	SENT_184	[p8l299t1114r636b1182],
71	.	.	O	.	_	0	SENT_184	[p8l299t1114r636b1182],

1	According	VBG	O	accord	_	0	SENT_185	[p8l676t1114r1001b1182],
2	to	TO	O	to	prepc_according_to	11	SENT_185	[p8l1040t1122r1101b1168],
3	this	DT	O	this	det	4	SENT_185	[p8l1142t1114r1258b1168],
4	dichotomy	NN	O	dichotomy	pobj	11	SENT_185	[p8l1301t1114r1653b1182],
5	,	,	O	,	_	0	SENT_185	[p8l1301t1114r1653b1182],
6	genotype	NN	O	genotype	nn	7	SENT_185	[p8l1694t1122r1990b1182],
7	frequencies	NNS	O	frequency	nsubj	11	SENT_185	[p8l2033t1114r2144b1168, p8l12t1202r291b1269],
8	were	VBD	O	be	cop	11	SENT_185	[p8l335t1217r493b1255],
9	not	RB	O	not	neg	11	SENT_185	[p8l538t1209r642b1255],
10	signiﬁcantly	RB	O	signiﬁcantly	advmod	11	SENT_185	[p8l686t1201r1079b1269],
11	different	JJ	O	different	_	0	SENT_185	[p8l1122t1201r1400b1255],
12	from	IN	O	from	_	0	SENT_185	[p8l1443t1201r1595b1255],
13	those	DT	O	those	prep_from	11	SENT_185	[p8l1639t1201r1812b1255],
14	expected	VBN	O	expect	partmod	13	SENT_185	[p8l1857t1201r2144b1269],
15	on	IN	O	on	_	0	SENT_185	[p8l12t1304r90b1343],
16	the	DT	O	the	det	17	SENT_185	[p8l138t1288r240b1343],
17	basis	NN	O	basis	prep_on	14	SENT_185	[p8l289t1288r445b1343],
18	of	IN	O	of	_	0	SENT_185	[p8l496t1288r562b1343],
19	the	DT	O	the	det	20	SENT_185	[p8l604t1288r705b1343],
20	Hardy	NNP	PERSON	Hardy	prep_of	17	SENT_185	[p8l756t1288r1307b1357],
21	.	.	O	.	_	0	SENT_185	[p8l756t1288r1307b1357],

1	—	NN	O	—	_	0	SENT_186	[p8l756t1288r1307b1357],
2	.	.	O	.	_	0	SENT_186	[p8l756t1288r1307b1357],

1	Weinberg	NNP	ORGANIZATION	Weinberg	nn	2	SENT_187	[p8l756t1288r1307b1357],
2	Equilibrium	NNP	ORGANIZATION	Equilibrium	_	0	SENT_187	[p8l1356t1288r1734b1357],
3	(	CD	NUMBER	(	num	4	SENT_187	[p8l1784t1279r1882b1358],
4	X2	NN	O	x2	dep	2	SENT_187	[p8l1784t1279r1882b1358],
5	=	JJ	O	=	amod	11	SENT_187	[p8l1904t1291r2144b1352],
6	0.052	CD	NUMBER	0.052	tmod	5	SENT_187	[p8l1904t1291r2144b1352],
7	,	,	O	,	_	0	SENT_187	[p8l1904t1291r2144b1352],
8	p	NN	O	p	appos	6	SENT_187	[p8l7t1377r321b1444],
9	=	JJ	O	=	amod	11	SENT_187	[p8l7t1377r321b1444],
10	0.974	CD	NUMBER	0.974	tmod	9	SENT_187	[p8l7t1377r321b1444],
11	)	NN	O	)	dep	4	SENT_187	[p8l7t1377r321b1444],
12	.	.	O	.	_	0	SENT_187	[p8l7t1377r321b1444],

1	No	DT	O	no	det	2	SENT_188	[p8l114t1467r199b1518],
2	correlation	NN	O	correlation	nsubjpass	4	SENT_188	[p8l251t1464r602b1518],
3	was	VBD	O	be	auxpass	4	SENT_188	[p8l651t1479r773b1518],
4	found	VBN	O	find	_	0	SENT_188	[p8l827t1463r1011b1518],
5	between	IN	O	between	_	0	SENT_188	[p8l1062t1464r1339b1518],
6	clinical	JJ	O	clinical	amod	9	SENT_188	[p8l1390t1464r1616b1518],
7	and	CC	O	and	_	0	SENT_188	[p8l1668t1464r1784b1518],
8	biological	JJ	O	biological	amod	9	SENT_188	[p8l1835t1463r2144b1531],
9	characteristics	NNS	O	characteristic	prep_between	4	SENT_188	[p8l12t1551r472b1605],
10	and	CC	O	and	_	0	SENT_188	[p8l491t1551r608b1605],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_188	[p8l624t1554r783b1605],
12	intron	NN	O	intron	prep_between	4	SENT_188	[p8l801t1552r997b1605],
13	1	CD	NUMBER	1	num	14	SENT_188	[p8l1019t1554r1043b1604],
14	polymorphism	NN	O	polymorphism	dep	12	SENT_188	[p8l1070t1551r1558b1618],
15	.	.	O	.	_	0	SENT_188	[p8l1070t1551r1558b1618],

1	The	DT	O	the	det	4	SENT_189	[p8l1576t1551r1692b1605],
2	intron	NN	O	intron	nn	4	SENT_189	[p8l1712t1552r1907b1605],
3	1	CD	NUMBER	1	num	4	SENT_189	[p8l1929t1554r1953b1604],
4	polymorphism	NN	O	polymorphism	nsubj	7	SENT_189	[p8l1981t1551r2144b1618, p8l12t1637r344b1705],
5	did	VBD	O	do	aux	7	SENT_189	[p8l369t1637r468b1691],
6	not	RB	O	not	neg	7	SENT_189	[p8l495t1645r599b1691],
7	show	VB	O	show	_	0	SENT_189	[p8l624t1637r794b1691],
8	a	DT	O	a	det	11	SENT_189	[p8l817t1653r849b1691],
9	statistically	RB	O	statistically	advmod	10	SENT_189	[p8l875t1637r1241b1705],
10	signiﬁcant	JJ	O	signiﬁcant	amod	11	SENT_189	[p8l1265t1637r1599b1705],
11	correlation	NN	O	correlation	dobj	7	SENT_189	[p8l1623t1637r1974b1691],
12	with	IN	O	with	_	0	SENT_189	[p8l1997t1637r2145b1691],
13	geﬁtinib	NN	O	geﬁtinib	nn	14	SENT_189	[p8l10t1724r277b1792],
14	activity	NN	O	activity	prep_with	11	SENT_189	[p8l305t1725r553b1792],
15	.	.	O	.	_	0	SENT_189	[p8l305t1725r553b1792],

1	Fourteen	CD	NUMBER	fourteen	nsubj	15	SENT_190	[p8l582t1728r865b1778],
2	of	IN	O	of	_	0	SENT_190	[p8l892t1724r959b1778],
3	56	CD	NUMBER	56	num	4	SENT_190	[p8l980t1727r1055b1778],
4	patients	NNS	O	patient	prep_of	1	SENT_190	[p8l1083t1725r1341b1792],
5	(	IN	O	(	_	0	SENT_190	[p8l1369t1724r1541b1792],
6	25	CD	PERCENT	25	num	7	SENT_190	[p8l1369t1724r1541b1792],
7	%	NN	PERCENT	%	prep_(	15	SENT_190	[p8l1369t1724r1541b1792],
8	)	CD	NUMBER	)	nsubj	15	SENT_190	[p8l1369t1724r1541b1792],
9	with	IN	O	with	_	0	SENT_190	[p8l1568t1724r1716b1778],
10	(	CD	NUMBER	(	num	11	SENT_190	[p8l1743t1724r1932b1792],
11	CA	NNP	O	CA	prep_with	8	SENT_190	[p8l1743t1724r1932b1792],
12	)	CD	NUMBER	)	num	11	SENT_190	[p8l1743t1724r1932b1792],
13	15	CD	NUMBER	15	number	14	SENT_190	[p8l1743t1724r1932b1792],
14	genotype	NN	O	genotype	amod	11	SENT_190	[p8l1962t1740r2144b1792, p8l11t1819r150b1879],
15	had	VBD	O	have	_	0	SENT_190	[p8l177t1811r292b1865],
16	an	DT	O	a	det	18	SENT_190	[p8l318t1827r393b1866],
17	objective	JJ	O	objective	amod	18	SENT_190	[p8l419t1811r707b1879],
18	response	NN	O	response	dobj	15	SENT_190	[p8l733t1827r1017b1879],
19	versus	CC	O	versus	prep	18	SENT_190	[p8l1041t1827r1246b1866],
20	2	CD	TIME	2	dep	19	SENT_190	[p8l1273t1814r1307b1865],
21	of	IN	TIME	of	_	0	SENT_190	[p8l1335t1811r1400b1865],
22	20	CD	TIME	20	num	23	SENT_190	[p8l1418t1814r1495b1865],
23	patients	NNS	O	patient	prep_of	20	SENT_190	[p8l1521t1812r1778b1879],
24	(	IN	O	(	_	0	SENT_190	[p8l1805t1812r1973b1879],
25	10	CD	PERCENT	10	num	26	SENT_190	[p8l1805t1812r1973b1879],
26	%	NN	PERCENT	%	prep_(	15	SENT_190	[p8l1805t1812r1973b1879],
27	)	CD	NUMBER	)	npadvmod	15	SENT_190	[p8l1805t1812r1973b1879],
28	with	IN	O	with	_	0	SENT_190	[p8l1998t1811r2145b1865],
29	(	CD	NUMBER	(	num	30	SENT_190	[p8l12t1899r230b1967],
30	CA	NNP	O	CA	prep_with	15	SENT_190	[p8l12t1899r230b1967],
31	)	CD	NUMBER	)	num	30	SENT_190	[p8l12t1899r230b1967],
32	e	LS	O	e	dep	34	SENT_190	[p8l12t1899r230b1967],
33	,	,	O	,	_	0	SENT_190	[p8l12t1899r230b1967],
34	se	FW	O	se	dep	30	SENT_190	[p8l12t1899r230b1967],
35	genotype	NN	O	genotype	advmod	34	SENT_190	[p8l266t1906r562b1966],
36	(	NN	O	(	prep	34	SENT_190	[p8l595t1898r928b1966],
37	p	NN	O	p	dep	36	SENT_190	[p8l595t1898r928b1966],
38	=	JJ	O	=	prep	34	SENT_190	[p8l595t1898r928b1966],
39	O.	NNP	O	O.	nn	41	SENT_190	[p8l595t1898r928b1966],
40	211	CD	NUMBER	211	num	41	SENT_190	[p8l595t1898r928b1966],
41	)	NN	O	)	dep	38	SENT_190	[p8l595t1898r928b1966],
42	.	.	O	.	_	0	SENT_190	[p8l595t1898r928b1966],

1	These	DT	O	these	det	4	SENT_191	[p8l959t1898r1144b1953],
2	two	CD	NUMBER	two	num	4	SENT_191	[p8l1177t1906r1298b1952],
3	responsive	JJ	O	responsive	amod	4	SENT_191	[p8l1333t1899r1673b1966],
4	patients	NNS	O	patient	_	0	SENT_191	[p8l1707t1899r1964b1966],
5	with	IN	O	with	_	0	SENT_191	[p8l1997t1898r2145b1953],
6	(	NN	O	(	nn	8	SENT_191	[p8l12t1986r230b2054],
7	CA	NNP	O	CA	nn	8	SENT_191	[p8l12t1986r230b2054],
8	)	NNP	O	)	prep_with	4	SENT_191	[p8l12t1986r230b2054],
9	e	LS	O	e	dep	12	SENT_191	[p8l12t1986r230b2054],
10	,	,	O	,	_	0	SENT_191	[p8l12t1986r230b2054],
11	Se	NNP	O	Se	nn	12	SENT_191	[p8l12t1986r230b2054],
12	genotype	NN	O	genotype	dep	4	SENT_191	[p8l267t1994r563b2053],
13	were	VBD	O	be	auxpass	14	SENT_191	[p8l596t2001r754b2040],
14	mutated	VBN	O	mutate	rcmod	12	SENT_191	[p8l789t1986r1059b2040],
15	in	IN	O	in	_	0	SENT_191	[p8l1095t1986r1154b2039],
16	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_191	[p8l1186t1988r1344b2040],
17	gene	NN	O	gene	prep_in	14	SENT_191	[p8l1372t2001r1533b2053],
18	.	.	O	.	_	0	SENT_191	[p8l1372t2001r1533b2053],

1	Although	IN	O	although	mark	9	SENT_192	[p8l1566t1986r1864b2053],
2	the	DT	O	the	det	3	SENT_192	[p8l1898t1986r1999b2040],
3	difference	NN	O	difference	nsubj	9	SENT_192	[p8l2034t1985r2144b2040, p8l12t2073r245b2127],
4	in	IN	O	in	_	0	SENT_192	[p8l282t2074r341b2126],
5	response	NN	O	response	nn	6	SENT_192	[p8l377t2088r661b2140],
6	rate	NN	O	rate	prep_in	3	SENT_192	[p8l698t2081r819b2127],
7	did	VBD	O	do	aux	9	SENT_192	[p8l856t2073r956b2127],
8	not	RB	O	not	neg	9	SENT_192	[p8l993t2081r1097b2127],
9	reach	VB	O	reach	advcl	16	SENT_192	[p8l1133t2073r1305b2127],
10	a	DT	O	a	det	12	SENT_192	[p8l1341t2088r1373b2127],
11	statistical	JJ	O	statistical	amod	12	SENT_192	[p8l1410t2073r1714b2127],
12	signiﬁcance	NN	O	signiﬁcance	dobj	9	SENT_192	[p8l1752t2073r2144b2140],
13	,	,	O	,	_	0	SENT_192	[p8l1752t2073r2144b2140],
14	it	PRP	O	it	nsubj	16	SENT_192	[p8l12t2160r55b2213],
15	is	VBZ	O	be	cop	16	SENT_192	[p8l86t2160r132b2213],
16	worth	JJ	O	worth	_	0	SENT_192	[p8l163t2159r358b2213],
17	noting	VBG	O	note	xcomp	16	SENT_192	[p8l389t2160r595b2227],
18	that	IN	O	that	complm	26	SENT_192	[p8l625t2159r754b2213],
19	patients	NNS	O	patient	nsubj	26	SENT_192	[p8l784t2160r1041b2227],
20	bearing	VBG	O	bear	partmod	19	SENT_192	[p8l1073t2159r1316b2227],
21	(	IN	O	(	_	0	SENT_192	[p8l1346t2159r1536b2226],
22	CA	NNP	O	CA	nn	23	SENT_192	[p8l1346t2159r1536b2226],
23	)	NNP	O	)	prep_(	20	SENT_192	[p8l1346t2159r1536b2226],
24	15	CD	NUMBER	15	number	25	SENT_192	[p8l1346t2159r1536b2226],
25	genotype	NN	O	genotype	amod	23	SENT_192	[p8l1570t2167r1866b2227],
26	showed	VBD	O	show	ccomp	17	SENT_192	[p8l1899t2159r2144b2213],
27	a	DT	O	a	det	30	SENT_192	[p8l11t2262r44b2300],
28	signiﬁcantly	RB	O	signiﬁcantly	advmod	29	SENT_192	[p8l86t2246r479b2314],
29	longer	JJR	O	longer	amod	30	SENT_192	[p8l520t2246r723b2314],
30	survival	NN	O	survival	dobj	26	SENT_192	[p8l764t2246r1013b2300],
31	compared	VBN	O	compare	_	0	SENT_192	[p8l1055t2246r1375b2314],
32	to	TO	O	to	prepc_compared_to	26	SENT_192	[p8l1417t2254r1477b2300],
33	those	DT	O	those	pobj	26	SENT_192	[p8l1519t2246r1692b2300],
34	with	IN	O	with	_	0	SENT_192	[p8l1733t2246r1881b2300],
35	(	CD	NUMBER	(	num	36	SENT_192	[p8l1922t2246r2142b2315],
36	CA	NNP	O	CA	prep_with	33	SENT_192	[p8l1922t2246r2142b2315],
37	)	CD	NUMBER	)	num	36	SENT_192	[p8l1922t2246r2142b2315],
38	e	SYM	O	e	dep	39	SENT_192	[p8l1922t2246r2142b2315],
39	,3	CD	NUMBER	,3	dep	36	SENT_192	[p8l1922t2246r2142b2315],
40	e	LS	O	e	dep	41	SENT_192	[p8l1922t2246r2142b2315],
41	genotype	NN	O	genotype	dep	39	SENT_192	[p8l10t2341r306b2401],
42	(	CD	NUMBER	(	prep	41	SENT_192	[p8l352t2333r449b2401],
43	12	CD	NUMBER	12	dep	42	SENT_192	[p8l352t2333r449b2401],
44	versus	CC	O	versus	cc	46	SENT_192	[p8l494t2349r699b2388],
45	4	CD	DURATION	4	num	46	SENT_192	[p8l743t2336r781b2387],
46	months	NNS	NUMBER	month	dep	33	SENT_192	[p8l827t2333r1085b2396],
47	,	,	O	,	_	0	SENT_192	[p8l827t2333r1085b2396],
48	respectively	RB	O	respectively	advmod	46	SENT_192	[p8l1132t2333r1533b2401],
49	;	:	O	;	_	0	SENT_192	[p8l1132t2333r1533b2401],
50	p	NN	O	p	dep	46	SENT_192	[p8l1579t2336r1881b2401],
51	=	JJ	O	=	amod	50	SENT_192	[p8l1579t2336r1881b2401],
52	0.044	CD	NUMBER	0.044	tmod	51	SENT_192	[p8l1579t2336r1881b2401],
53	;	:	O	;	_	0	SENT_192	[p8l1579t2336r1881b2401],
54	Fig	NN	O	fig	dep	46	SENT_192	[p8l1932t2334r2036b2401],
55	.	.	O	.	_	0	SENT_192	[p8l1932t2334r2036b2401],

1	1	CD	NUMBER	1	number	2	SENT_193	[p8l2086t2334r2144b2401],
2	)	CD	NUMBER	)	num	3	SENT_193	[p8l2086t2334r2144b2401],
3	(	CD	NUMBER	(	_	0	SENT_193	[p8l12t2421r203b2488],
4	Table	NNP	O	Table	dep	3	SENT_193	[p8l12t2421r203b2488],
5	2	CD	NUMBER	2	number	6	SENT_193	[p8l226t2421r303b2488],
6	)	CD	NUMBER	)	dep	4	SENT_193	[p8l226t2421r303b2488],
7	.	.	O	.	_	0	SENT_193	[p8l226t2421r303b2488],

1	3.2.5	CD	NUMBER	3.2.5	_	0	SENT_194	[p8l8t2619r168b2671],
2	.	.	O	.	_	0	SENT_194	[p8l8t2619r168b2671],

1	Multivariate	JJ	O	multivariate	amod	2	SENT_195	[p8l217t2616r599b2670],
2	analysis	NN	O	analysis	_	0	SENT_195	[p8l620t2616r865b2684],

1	In	IN	O	in	_	0	SENT_196	[p8l114t2707r173b2757],
2	a	DT	O	a	det	5	SENT_196	[p8l200t2719r232b2758],
3	logistic	JJ	O	logistic	amod	5	SENT_196	[p8l259t2704r487b2771],
4	regression	NN	O	regression	nn	5	SENT_196	[p8l513t2704r843b2771],
5	analysis	NN	O	analysis	prep_in	29	SENT_196	[p8l870t2704r1121b2771],
6	performed	VBN	O	perform	partmod	5	SENT_196	[p8l1150t2703r1489b2771],
7	on	IN	O	on	_	0	SENT_196	[p8l1517t2719r1595b2758],
8	54	CD	NUMBER	54	num	9	SENT_196	[p8l1622t2706r1699b2758],
9	cases	NNS	O	case	prep_on	6	SENT_196	[p8l1726t2719r1890b2758],
10	including	VBG	O	include	_	0	SENT_196	[p8l1918t2704r2144b2758, p8l12t2792r110b2858],
11	gender	NN	O	gender	prep_including	9	SENT_196	[p8l131t2791r364b2858],
12	,	,	O	,	_	0	SENT_196	[p8l131t2791r364b2858],
13	smoking	NN	O	smoking	nn	14	SENT_196	[p8l389t2791r663b2858],
14	status	NN	O	status	conj_and	11	SENT_196	[p8l686t2799r889b2853],
15	,	,	O	,	_	0	SENT_196	[p8l686t2799r889b2853],
16	skin	NN	O	skin	nn	17	SENT_196	[p8l915t2791r1043b2845],
17	toxicity	NN	O	toxicity	conj_and	11	SENT_196	[p8l1066t2792r1317b2858],
18	,	,	O	,	_	0	SENT_196	[p8l1066t2792r1317b2858],
19	EGFR	NN	ORGANIZATION	egfr	nn	20	SENT_196	[p8l1340t2794r1498b2845],
20	FISH	NN	O	fish	conj_and	11	SENT_196	[p8l1521t2794r1662b2845],
21	and	CC	O	and	_	0	SENT_196	[p8l1686t2791r1802b2845],
22	EGFR	NN	ORGANIZATION	egfr	nn	24	SENT_196	[p8l1824t2794r1982b2845],
23	gene	NN	O	gene	nn	24	SENT_196	[p8l1999t2806r2145b2858],
24	mutation	NN	O	mutation	conj_and	11	SENT_196	[p8l12t2878r322b2940],
25	,	,	O	,	_	0	SENT_196	[p8l12t2878r322b2940],
26	the	DT	O	the	det	27	SENT_196	[p8l351t2877r453b2931],
27	latter	NN	O	latter	nsubjpass	29	SENT_196	[p8l481t2877r654b2931],
28	was	VBD	O	be	auxpass	29	SENT_196	[p8l678t2893r801b2931],
29	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_196	[p8l830t2877r1158b2931],
30	to	TO	O	to	aux	35	SENT_196	[p8l1187t2885r1247b2931],
31	be	VB	O	be	cop	35	SENT_196	[p8l1275t2877r1349b2931],
32	an	DT	O	a	det	35	SENT_196	[p8l1378t2893r1452b2931],
33	independent	JJ	O	independent	amod	35	SENT_196	[p8l1481t2877r1890b2945],
34	predictive	JJ	O	predictive	amod	35	SENT_196	[p8l1916t2877r2144b2945, p8l11t2965r126b3018],
35	signiﬁcance	NN	O	signiﬁcance	xcomp	29	SENT_196	[p8l157t2964r533b3032],
36	of	IN	O	of	_	0	SENT_196	[p8l562t2964r628b3018],
37	geﬁtinib	NN	O	geﬁtinib	nn	38	SENT_196	[p8l648t2964r915b3032],
38	response	NN	O	response	prep_of	35	SENT_196	[p8l944t2980r1228b3032],
39	(	CD	NUMBER	(	num	40	SENT_196	[p8l1257t2964r1433b3032],
40	odds	NNS	O	odds	dep	38	SENT_196	[p8l1257t2964r1433b3032],
41	ratio	NN	O	ratio	nn	44	SENT_196	[p8l1463t2965r1609b3018],
42	[	CD	NUMBER	[	num	44	SENT_196	[p8l1642t2964r1775b3032],
43	OR	NN	O	or	nn	44	SENT_196	[p8l1642t2964r1775b3032],
44	]	NN	O	]	dep	38	SENT_196	[p8l1642t2964r1775b3032],
45	=	JJ	O	=	amod	44	SENT_196	[p8l1795t2967r1994b3027],
46	38.5	CD	NUMBER	38.5	tmod	45	SENT_196	[p8l1795t2967r1994b3027],
47	,	,	O	,	_	0	SENT_196	[p8l1795t2967r1994b3027],
48	95	CD	PERCENT	95	num	51	SENT_196	[p8l2024t2967r2145b3018],
49	%	NN	PERCENT	%	nn	51	SENT_196	[p8l2024t2967r2145b3018],
50	conﬁdence	NN	O	conﬁdence	nn	51	SENT_196	[p8l12t3051r359b3106],
51	interval	NN	O	interval	appos	38	SENT_196	[p8l382t3051r626b3106],
52	3.1	CD	NUMBER	3.1	number	53	SENT_196	[p8l648t3054r728b3106],
53	—	CD	NUMBER	—	num	54	SENT_196	[p8l742t3054r972b3114],
54	481.7	CD	NUMBER	481.7	dep	51	SENT_196	[p8l742t3054r972b3114],
55	;	:	O	;	_	0	SENT_196	[p8l742t3054r972b3114],
56	p	NN	O	p	dep	51	SENT_196	[p8l995t3067r1033b3119],
57	=	JJ	O	=	amod	56	SENT_196	[p8l1050t3074r1083b3091],
58	0.005	CD	NUMBER	0.005	tmod	57	SENT_196	[p8l1100t3051r1302b3119],
59	)	CD	NUMBER	)	number	60	SENT_196	[p8l1100t3051r1302b3119],
60	(	CD	NUMBER	(	num	63	SENT_196	[p8l1326t3051r1517b3119],
61	Table	NNP	O	Table	nn	63	SENT_196	[p8l1326t3051r1517b3119],
62	3	CD	NUMBER	3	num	63	SENT_196	[p8l1539t3051r1618b3119],
63	)	NN	O	)	dep	56	SENT_196	[p8l1539t3051r1618b3119],
64	.	.	O	.	_	0	SENT_196	[p8l1539t3051r1618b3119],

1	A	DT	O	a	det	5	SENT_197	[p8l110t3141r157b3192],
2	Cox	NN	ORGANIZATION	cox	nn	5	SENT_197	[p8l174t3141r290b3193],
3	proportional	JJ	O	proportional	amod	5	SENT_197	[p8l308t3138r710b3206],
4	hazard	NN	O	hazard	nn	5	SENT_197	[p8l730t3138r945b3193],
5	model	NN	O	model	nsubjpass	24	SENT_197	[p8l966t3138r1165b3193],
6	performed	VBN	O	perform	partmod	5	SENT_197	[p8l1185t3138r1524b3206],
7	on	IN	O	on	_	0	SENT_197	[p8l1544t3154r1622b3192],
8	76	CD	NUMBER	76	num	9	SENT_197	[p8l1642t3141r1714b3192],
9	cases	NNS	O	case	prep_on	6	SENT_197	[p8l1734t3154r1897b3193],
10	including	VBG	O	include	_	0	SENT_197	[p8l1918t3138r2144b3193, p8l12t3226r110b3293],
11	smoking	NN	O	smoking	nn	12	SENT_197	[p8l152t3226r425b3293],
12	status	NN	O	status	prep_including	9	SENT_197	[p8l467t3234r670b3288],
13	,	,	O	,	_	0	SENT_197	[p8l467t3234r670b3288],
14	histology	NN	O	histology	conj_and	12	SENT_197	[p8l714t3225r1019b3293],
15	,	,	O	,	_	0	SENT_197	[p8l714t3225r1019b3293],
16	skin	NN	O	skin	nn	17	SENT_197	[p8l1063t3226r1192b3280],
17	toxicity	NN	O	toxicity	prep_including	9	SENT_197	[p8l1234t3226r1474b3293],
18	and	CC	O	and	_	0	SENT_197	[p8l1514t3226r1630b3280],
19	EGFR	NN	ORGANIZATION	egfr	nn	20	SENT_197	[p8l1671t3228r1829b3280],
20	intron	NN	O	intron	prep_including	9	SENT_197	[p8l1871t3226r2067b3280],
21	1	CD	NUMBER	1	num	22	SENT_197	[p8l2112t3229r2137b3279],
22	polymorphism	NN	O	polymorphism	dep	20	SENT_197	[p8l12t3313r485b3380],
23	was	VBD	O	be	auxpass	24	SENT_197	[p8l499t3328r621b3367],
24	ﬁtted	VBN	O	ﬁtted	_	0	SENT_197	[p8l639t3313r809b3367],
25	to	TO	O	to	_	0	SENT_197	[p8l825t3321r885b3367],
26	the	DT	O	the	det	27	SENT_197	[p8l902t3313r1003b3367],
27	data	NNS	O	datum	prep_to	24	SENT_197	[p8l1020t3313r1172b3367],
28	.	.	O	.	_	0	SENT_197	[p8l1020t3313r1172b3367],

1	In	IN	O	in	_	0	SENT_198	[p8l1189t3316r1249b3366],
2	this	DT	O	this	det	5	SENT_198	[p8l1264t3313r1380b3367],
3	analysis	NN	O	analysis	nn	5	SENT_198	[p8l1398t3313r1649b3380],
4	smoking	NN	O	smoking	nn	5	SENT_198	[p8l1668t3313r1941b3380],
5	status	NN	O	status	pobj	1	SENT_198	[p8l1957t3321r2144b3367],

1	358	CD	NUMBER	358	num	3	SENT_199	[p8l6t3456r52b3477],
2	M.	NN	NUMBER	m.	nn	3	SENT_199	[p8l804t3456r833b3477],
3	Tiseo	NNP	PERSON	Tiseo	_	0	SENT_199	[p8l843t3455r902b3477],
4	et	FW	O	et	nn	5	SENT_199	[p8l911t3458r934b3477],
5	al.	FW	O	al.	dep	3	SENT_199	[p8l941t3455r966b3477],
6	/	:	O	/	punct	3	SENT_199	[p8l973t3455r985b3482],
7	Lung	NN	O	lung	nn	8	SENT_199	[p8l991t3456r1051b3482],
8	Cancer	NN	O	cancer	dep	3	SENT_199	[p8l1058t3456r1141b3477],
9	67	CD	NUMBER	67	number	10	SENT_199	[p8l1148t3456r1178b3477],
10	(	CD	NUMBER	(	num	11	SENT_199	[p8l1185t3455r1266b3482],
11	2010	CD	DATE	2010	dep	8	SENT_199	[p8l1185t3455r1266b3482],
12	)	CD	NUMBER	)	number	13	SENT_199	[p8l1185t3455r1266b3482],
13	355-360	CD	NUMBER	355-360	num	11	SENT_199	[p8l1273t3456r1380b3477],

1	Table	NNP	O	Table	_	0	SENT_200	[p8l6t3535r76b3556],
2	2	CD	NUMBER	2	num	4	SENT_200	[p8l84t3536r99b3556],
3	General	NNP	O	General	nn	4	SENT_200	[p8l6t3570r102b3592],
4	characteristics	NNS	O	characteristic	dep	1	SENT_200	[p8l112t3570r299b3595],
5	,	,	O	,	_	0	SENT_200	[p8l112t3570r299b3595],
6	EGFR	NN	ORGANIZATION	egfr	dep	1	SENT_200	[p8l308t3571r370b3592],
7	and	CC	O	and	_	0	SENT_200	[p8l379t3570r424b3592],
8	I	PRP	O	I	conj_and	4	SENT_200	[p8l433t3571r496b3592],
9	(	RB	O	(	advmod	8	SENT_200	[p8l433t3571r496b3592],
10	.	.	O	.	_	0	SENT_200	[p8l433t3571r496b3592],

1	—	NN	O	—	_	0	SENT_201	[p8l433t3571r496b3592],
2	.	.	O	.	_	0	SENT_201	[p8l433t3571r496b3592],

1	ras	NN	O	ra	nn	3	SENT_202	[p8l433t3571r496b3592],
2	gene	NN	O	gene	nn	3	SENT_202	[p8l503t3576r560b3597],
3	mutations	NNS	O	mutation	_	0	SENT_202	[p8l569t3570r703b3595],
4	,	,	O	,	_	0	SENT_202	[p8l569t3570r703b3595],
5	EGFR	NN	ORGANIZATION	egfr	appos	3	SENT_202	[p8l712t3571r774b3592],
6	and	CC	O	and	_	0	SENT_202	[p8l783t3570r828b3592],
7	HER2	NN	O	her2	nn	10	SENT_202	[p8l837t3571r902b3592],
8	gene	NN	O	gene	nn	10	SENT_202	[p8l909t3576r966b3597],
9	copy	NN	O	copy	nn	10	SENT_202	[p8l975t3576r1034b3597],
10	number	NN	O	number	conj_and	5	SENT_202	[p8l1043t3570r1147b3595],
11	,	,	O	,	_	0	SENT_202	[p8l1043t3570r1147b3595],
12	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_202	[p8l1156t3571r1222b3592],
13	protein	NN	O	protein	nn	14	SENT_202	[p8l1230t3570r1320b3597],
14	expression	NN	O	expression	appos	3	SENT_202	[p8l1329t3570r1464b3597],
15	and	CC	O	and	_	0	SENT_202	[p8l1473t3570r1519b3592],
16	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_202	[p8l1528t3571r1590b3592],
17	intron	NN	O	intron	appos	3	SENT_202	[p8l1599t3570r1675b3592],
18	1	CD	NUMBER	1	num	19	SENT_202	[p8l1686t3571r1695b3592],
19	polymorphism	NN	O	polymorphism	dep	3	SENT_202	[p8l1708t3570r1893b3597],
20	in	IN	O	in	_	0	SENT_202	[p8l1903t3570r1926b3592],
21	geﬁtinib	NN	O	geﬁtinib	nn	22	SENT_202	[p8l1934t3570r2039b3597],
22	responder	NN	O	responder	prep_in	19	SENT_202	[p8l6t3605r134b3632],
23	and	CC	O	and	_	0	SENT_202	[p8l143t3605r188b3627],
24	non	JJ	O	non	amod	27	SENT_202	[p8l198t3605r386b3632],
25	—	NN	O	—	nn	27	SENT_202	[p8l198t3605r386b3632],
26	responder	NN	O	responder	nn	27	SENT_202	[p8l198t3605r386b3632],
27	patients	NNS	O	patient	conj_and	22	SENT_202	[p8l394t3605r501b3632],
28	.	.	O	.	_	0	SENT_202	[p8l394t3605r501b3632],

1	Characteristics	NNS	O	characteristic	_	0	SENT_203	[p8l6t3676r190b3698],
2	(	VBP	O	(	rcmod	1	SENT_203	[p8l199t3676r223b3703],
3	n	NN	O	n	nsubj	4	SENT_203	[p8l199t3676r223b3703],
4	=	JJ	O	=	ccomp	2	SENT_203	[p8l230t3685r243b3692],
5	91	CD	NUMBER	91	num	6	SENT_203	[p8l250t3676r289b3703],
6	)	CD	NUMBER	)	iobj	4	SENT_203	[p8l250t3676r289b3703],
7	CR	NN	O	cr	dobj	4	SENT_203	[p8l524t3677r576b3698],
8	+	CC	O	+	_	0	SENT_203	[p8l524t3677r576b3698],
9	PR	NN	O	pr	rcmod	1	SENT_203	[p8l582t3677r614b3697],
10	n	NN	O	n	dobj	9	SENT_203	[p8l622t3682r636b3698],
11	(	CD	PERCENT	(	num	12	SENT_203	[p8l645t3676r680b3703],
12	%	NN	PERCENT	%	dep	21	SENT_203	[p8l645t3676r680b3703],
13	)	CD	NUMBER	)	num	14	SENT_203	[p8l645t3676r680b3703],
14	SD	NN	O	sd	dep	12	SENT_203	[p8l835t3677r867b3698],
15	+	CC	O	+	_	0	SENT_203	[p8l874t3681r887b3694],
16	PD	NN	O	pd	nn	17	SENT_203	[p8l894t3677r927b3697],
17	n	NN	O	n	dep	12	SENT_203	[p8l936t3682r949b3698],
18	(	CD	PERCENT	(	num	19	SENT_203	[p8l959t3676r994b3703],
19	%	NN	PERCENT	%	dep	21	SENT_203	[p8l959t3676r994b3703],
20	)	CD	NUMBER	)	num	21	SENT_203	[p8l959t3676r994b3703],
21	p	NN	O	p	dep	25	SENT_203	[p8l1147t3682r1162b3703],
22	Median	JJ	MISC	median	amod	23	SENT_203	[p8l1390t3676r1485b3698],
23	survival	NN	O	survival	dep	21	SENT_203	[p8l1494t3676r1591b3698],
24	(	CD	NUMBER	(	num	25	SENT_203	[p8l1600t3676r1716b3703],
25	months	NNS	NUMBER	month	dep	1	SENT_203	[p8l1600t3676r1716b3703],
26	)	VBP	O	)	rcmod	25	SENT_203	[p8l1600t3676r1716b3703],
27	95	CD	PERCENT	95	number	28	SENT_203	[p8l1871t3677r1918b3698],
28	%	NN	PERCENT	%	amod	30	SENT_203	[p8l1871t3677r1918b3698],
29	CI	NN	O	ci	nn	30	SENT_203	[p8l1927t3677r1950b3698],
30	p	NN	O	p	dobj	26	SENT_203	[p8l2103t3682r2118b3703],

1	Overall	JJ	O	overall	amod	2	SENT_204	[p8l9t3750r211b3798],
2	17	CD	NUMBER	17	_	0	SENT_204	[p8l1202t3752r1261b3798],
3	(	CD	NUMBER	(	number	4	SENT_204	[p8l1282t3750r1444b3810],
4	18.7	CD	NUMBER	18.7	num	5	SENT_204	[p8l1282t3750r1444b3810],
5	)	NN	O	)	dep	2	SENT_204	[p8l1282t3750r1444b3810],
6	74	CD	NUMBER	74	number	7	SENT_204	[p8l1908t3752r1972b3798],
7	(	CD	NUMBER	(	dep	2	SENT_204	[p8l1992t3750r2152b3810],
8	81.3	CD	NUMBER	81.3	num	9	SENT_204	[p8l1992t3750r2152b3810],
9	)	NN	O	)	dep	7	SENT_204	[p8l1992t3750r2152b3810],

1	Sex	NN	O	sex	_	0	SENT_205	[p9l9t65r107b111],

1	Female	JJ	O	female	amod	2	SENT_206	[p9l70t143r273b192],
2	Male	NN	O	male	_	0	SENT_206	[p9l70t223r209b273],

1	Histology	NNP	O	Histology	_	0	SENT_207	[p9l9t352r282b414],

1	Adenocarcinoma	NN	O	adenocarcinoma	nn	2	SENT_208	[p9l67t434r554b482],
2	Non	NN	O	non	_	0	SENT_208	[p9l70t513r691b562],
3	—	CD	NUMBER	—	num	4	SENT_208	[p9l70t513r691b562],
4	adenocarcinoma	NN	O	adenocarcinoma	dep	2	SENT_208	[p9l70t513r691b562],

1	Performance	NNP	O	Performance	_	0	SENT_209	[p9l9t641r374b690],
2	status	NN	O	status	dep	1	SENT_209	[p9l395t648r562b690],

1	ECOG	NN	ORGANIZATION	ecog	_	0	SENT_210	[p9l70t725r228b772],
2	0-1	CD	NUMBER	0-1	num	3	SENT_210	[p9l248t725r346b772],
3	ECOG	NN	O	ecog	dep	1	SENT_210	[p9l70t805r228b851],
4	2	CD	NUMBER	2	dep	3	SENT_210	[p9l248t805r278b851],

1	Smoking	NN	O	smoking	nn	2	SENT_211	[p9l9t931r260b991],
2	status	NN	O	status	_	0	SENT_211	[p9l280t938r447b979],
3	No	DT	O	no	det	4	SENT_211	[p9l70t1013r147b1059],
4	smokers	NNS	O	smoker	dep	2	SENT_211	[p9l168t1010r406b1059],
5	Current	JJ	DATE	current	amod	8	SENT_211	[p9l70t1093r289b1140],
6	or	CC	O	or	_	0	SENT_211	[p9l307t1105r367b1140],
7	former	JJ	O	former	conj_or	5	SENT_211	[p9l385t1090r582b1140],
8	smokers	NNS	O	smoker	dep	2	SENT_211	[p9l601t1090r839b1140],

1	Toxicity	NN	O	toxicity	_	0	SENT_212	[p9l7t1220r233b1280],

1	Yes	UH	O	yes	_	0	SENT_213	[p9l67t1302r160b1347],
2	No	DT	O	no	dep	1	SENT_213	[p9l70t1381r147b1427],

1	Skin	NN	O	skin	nn	2	SENT_214	[p9l9t1506r131b1555],
2	toxicity	NN	O	toxicity	_	0	SENT_214	[p9l150t1507r366b1568],

1	Yes	UH	O	yes	_	0	SENT_215	[p9l67t1590r160b1636],
2	No	DT	O	no	dep	1	SENT_215	[p9l70t1670r147b1716],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_216	[p9l7t1797r149b1843],
2	gene	NN	O	gene	nn	3	SENT_216	[p9l163t1809r294b1855],
3	mutations	NNS	O	mutation	dep	1	SENT_216	[p9l314t1795r620b1851],
4	,	,	O	,	_	0	SENT_216	[p9l314t1795r620b1851],
5	n	NN	O	n	appos	3	SENT_216	[p9l641t1809r673b1843],
6	=	JJ	O	=	amod	5	SENT_216	[p9l687t1815r717b1830],
7	63	CD	NUMBER	63	tmod	6	SENT_216	[p9l732t1797r798b1843],

1	Mutated	VBN	O	mutate	_	0	SENT_217	[p9l70t1874r312b1923],
2	Wi1d	NN	O	wi1d	nn	4	SENT_217	[p9l67t1955r361b2015],
3	—	CD	NUMBER	—	num	4	SENT_217	[p9l67t1955r361b2015],
4	type	NN	O	type	dobj	1	SENT_217	[p9l67t1955r361b2015],

1	K-ras	JJ	O	k-ras	amod	3	SENT_218	[p9l7t2085r151b2131],
2	gene	NN	O	gene	nn	3	SENT_218	[p9l165t2096r296b2143],
3	mutations	NNS	O	mutation	dep	6	SENT_218	[p9l316t2083r622b2139],
4	,	,	O	,	_	0	SENT_218	[p9l316t2083r622b2139],
5	n	NN	O	n	appos	3	SENT_218	[p9l644t2096r675b2131],
6	=	JJ	O	=	_	0	SENT_218	[p9l690t2103r720b2117],
7	63	CD	NUMBER	63	tmod	6	SENT_218	[p9l735t2085r800b2131],

1	Mutated	VBN	O	mutate	_	0	SENT_219	[p9l70t2162r312b2211],
2	Wild	NNP	O	Wild	nsubj	4	SENT_219	[p9l67t2242r361b2304],
3	—	CD	NUMBER	—	num	2	SENT_219	[p9l67t2242r361b2304],
4	type	NN	O	type	xcomp	1	SENT_219	[p9l67t2242r361b2304],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_220	[p9l7t2373r149b2420],
2	FISH	NN	O	fish	dep	5	SENT_220	[p9l169t2373r310b2427],
3	,	,	O	,	_	0	SENT_220	[p9l169t2373r310b2427],
4	n	NN	O	n	appos	2	SENT_220	[p9l331t2385r362b2420],
5	=	JJ	O	=	_	0	SENT_220	[p9l378t2391r407b2406],
6	54	CD	NUMBER	54	tmod	5	SENT_220	[p9l422t2373r491b2420],

1	Positive	JJ	O	positive	_	0	SENT_221	[p9l71t2453r291b2501],
2	Negative	JJ	O	negative	dep	1	SENT_221	[p9l70t2533r318b2592],

1	HER2	NN	O	her2	nn	2	SENT_222	[p9l7t2662r156b2708],
2	FISH	NN	O	fish	dep	5	SENT_222	[p9l176t2662r318b2716],
3	,	,	O	,	_	0	SENT_222	[p9l176t2662r318b2716],
4	n	NN	O	n	appos	2	SENT_222	[p9l339t2674r370b2709],
5	=	JJ	O	=	_	0	SENT_222	[p9l385t2680r415b2695],
6	58	CD	NUMBER	58	tmod	5	SENT_222	[p9l430t2662r497b2709],

1	Positive	JJ	O	positive	_	0	SENT_223	[p9l70t2742r291b2791],
2	Negative	JJ	O	negative	dep	1	SENT_223	[p9l70t2822r318b2882],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_224	[p9l10t2952r159b2998],
2	IHC	NN	ORGANIZATION	ihc	dep	5	SENT_224	[p9l177t2952r290b3006],
3	,	,	O	,	_	0	SENT_224	[p9l177t2952r290b3006],
4	n	NN	O	n	appos	2	SENT_224	[p9l312t2963r343b2998],
5	=	JJ	O	=	_	0	SENT_224	[p9l358t2970r387b2985],
6	59	CD	NUMBER	59	tmod	5	SENT_224	[p9l403t2952r471b2998],

1	Positive	JJ	O	positive	_	0	SENT_225	[p9l70t3031r291b3079],
2	Negative	JJ	O	negative	dep	1	SENT_225	[p9l70t3111r318b3172],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_226	[p9l7t3242r149b3289],
2	intron	NN	O	intron	_	0	SENT_226	[p9l169t3240r344b3289],
3	1	CD	NUMBER	1	num	4	SENT_226	[p9l367t3242r388b3288],
4	polymorphism	NN	O	polymorphism	dep	2	SENT_226	[p9l416t3239r853b3301],
5	,	,	O	,	_	0	SENT_226	[p9l416t3239r853b3301],
6	n	NN	O	n	appos	4	SENT_226	[p9l874t3254r906b3289],
7	=	JJ	O	=	amod	6	SENT_226	[p9l921t3260r950b3275],
8	76	CD	NUMBER	76	tmod	7	SENT_226	[p9l966t3242r1031b3289],

1	(	NN	O	(	nn	3	SENT_227	[p9l70t3320r236b3380],
2	CA	NNP	O	CA	nn	3	SENT_227	[p9l70t3320r236b3380],
3	)	NNP	O	)	_	0	SENT_227	[p9l70t3320r236b3380],
4	15	CD	NUMBER	15	num	3	SENT_227	[p9l70t3320r236b3380],
5	genotype	NN	O	genotype	nn	8	SENT_227	[p9l259t3327r524b3380],
6	(	CD	NUMBER	(	num	8	SENT_227	[p9l70t3400r261b3461],
7	C/Delse	NN	O	c/delse	nn	8	SENT_227	[p9l70t3400r261b3461],
8	genotype	NN	O	genotype	dep	3	SENT_227	[p9l283t3408r548b3462],
9	10	CD	NUMBER	10	dep	3	SENT_227	[p9l517t3495r573b3537],

1	12	CD	NUMBER	12	num	2	SENT_228	[p9l1246t1299r1444b1359],
2	(	CD	NUMBER	(	_	0	SENT_228	[p9l1246t1299r1444b1359],
3	28	CD	NUMBER	28	num	4	SENT_228	[p9l1246t1299r1444b1359],
4	)	NN	O	)	dep	2	SENT_228	[p9l1246t1299r1444b1359],
5	5	CD	NUMBER	5	number	6	SENT_228	[p9l1281t1378r1444b1438],
6	(	CD	NUMBER	(	num	8	SENT_228	[p9l1281t1378r1444b1438],
7	1o	NN	O	1o	nn	8	SENT_228	[p9l1281t1378r1444b1438],
8	)	NN	O	)	dep	4	SENT_228	[p9l1281t1378r1444b1438],

1	1o	NN	O	1o	_	0	SENT_229	[p9l1248t1588r1444b1648],
2	(	CD	NUMBER	(	number	3	SENT_229	[p9l1248t1588r1444b1648],
3	33	CD	NUMBER	33	num	4	SENT_229	[p9l1248t1588r1444b1648],
4	)	NN	O	)	dep	1	SENT_229	[p9l1248t1588r1444b1648],
5	7	CD	NUMBER	7	num	6	SENT_229	[p9l1284t1667r1444b1727],
6	(	NN	O	(	dep	4	SENT_229	[p9l1284t1667r1444b1727],
7	11	CD	NUMBER	11	num	8	SENT_229	[p9l1284t1667r1444b1727],
8	)	NN	O	)	dep	1	SENT_229	[p9l1284t1667r1444b1727],

1	9	CD	NUMBER	9	num	2	SENT_230	[p9l1276t1874r1444b1934],
2	(	NN	O	(	_	0	SENT_230	[p9l1276t1874r1444b1934],
3	82	CD	NUMBER	82	num	4	SENT_230	[p9l1276t1874r1444b1934],
4	)	NN	O	)	dep	2	SENT_230	[p9l1276t1874r1444b1934],
5	5	CD	NUMBER	5	number	6	SENT_230	[p9l1282t1955r1444b2015],
6	(	CD	NUMBER	(	num	8	SENT_230	[p9l1282t1955r1444b2015],
7	1o	NN	O	1o	nn	8	SENT_230	[p9l1282t1955r1444b2015],
8	)	NN	O	)	dep	4	SENT_230	[p9l1282t1955r1444b2015],

1	14	CD	NUMBER	14	num	2	SENT_231	[p9l1248t3320r1444b3380],
2	(	CD	NUMBER	(	_	0	SENT_231	[p9l1248t3320r1444b3380],
3	25	CD	NUMBER	25	num	4	SENT_231	[p9l1248t3320r1444b3380],
4	)	NN	O	)	dep	2	SENT_231	[p9l1248t3320r1444b3380],
5	2	CD	NUMBER	2	number	6	SENT_231	[p9l1281t3400r1444b3461],
6	(	CD	NUMBER	(	num	8	SENT_231	[p9l1281t3400r1444b3461],
7	1o	NN	O	1o	nn	8	SENT_231	[p9l1281t3400r1444b3461],
8	)	NN	O	)	dep	4	SENT_231	[p9l1281t3400r1444b3461],

1	LITIOO	NNP	O	LITIOO	nn	2	SENT_232	[p9l1517t3687r1578b3804],
2	LDr	NNP	O	LDr	nsubj	3	SENT_232	[p9l1583t3687r1612b3804],
3	—	VBD	O	—	_	0	SENT_232	[p9l1583t3687r1612b3804],
4	|	CD	NUMBER	|	dobj	3	SENT_232	[p9l1583t3687r1612b3804],

1	63	CD	NUMBER	63	number	2	SENT_233	[p9l1949t723r2152b784],
2	(	CD	NUMBER	(	_	0	SENT_233	[p9l1949t723r2152b784],
3	79	CD	NUMBER	79	num	4	SENT_233	[p9l1949t723r2152b784],
4	)	NN	O	)	dep	2	SENT_233	[p9l1949t723r2152b784],
5	11	CD	NUMBER	11	number	6	SENT_233	[p9l1924t803r2152b863],
6	(	CD	NUMBER	(	dep	2	SENT_233	[p9l1924t803r2152b863],
7	1oo	JJ	O	1oo	amod	8	SENT_233	[p9l1924t803r2152b863],
8	)	NN	O	)	dep	6	SENT_233	[p9l1924t803r2152b863],

1	31	CD	NUMBER	31	num	2	SENT_234	[p9l1952t1299r2152b1359],
2	(	CD	NUMBER	(	_	0	SENT_234	[p9l1952t1299r2152b1359],
3	72	CD	NUMBER	72	num	4	SENT_234	[p9l1952t1299r2152b1359],
4	)	NN	O	)	dep	2	SENT_234	[p9l1952t1299r2152b1359],
5	43	CD	NUMBER	43	number	6	SENT_234	[p9l1947t1378r2152b1438],
6	(	CD	NUMBER	(	num	8	SENT_234	[p9l1947t1378r2152b1438],
7	9o	NN	O	9o	nn	8	SENT_234	[p9l1947t1378r2152b1438],
8	)	NN	O	)	dep	4	SENT_234	[p9l1947t1378r2152b1438],

1	2	CD	NUMBER	2	num	2	SENT_235	[p9l1990t1874r2152b1934],
2	(	CD	NUMBER	(	_	0	SENT_235	[p9l1990t1874r2152b1934],
3	18	CD	NUMBER	18	num	4	SENT_235	[p9l1990t1874r2152b1934],
4	)	NN	O	)	dep	2	SENT_235	[p9l1990t1874r2152b1934],
5	47	CD	NUMBER	47	number	6	SENT_235	[p9l1950t1955r2152b2015],
6	(	CD	NUMBER	(	num	8	SENT_235	[p9l1950t1955r2152b2015],
7	9o	NN	O	9o	nn	8	SENT_235	[p9l1950t1955r2152b2015],
8	)	NN	O	)	dep	4	SENT_235	[p9l1950t1955r2152b2015],

1	7	CD	NUMBER	7	num	3	SENT_236	[p9l1952t2162r2152b2222],
2	(	CD	NUMBER	(	num	3	SENT_236	[p9l1952t2162r2152b2222],
3	1o0	NN	O	1o0	_	0	SENT_236	[p9l1952t2162r2152b2222],
4	)	CD	NUMBER	)	number	5	SENT_236	[p9l1952t2162r2152b2222],
5	42	CD	NUMBER	42	num	6	SENT_236	[p9l1947t2243r2152b2304],
6	(	NN	O	(	dep	3	SENT_236	[p9l1947t2243r2152b2304],
7	75	CD	NUMBER	75	num	8	SENT_236	[p9l1947t2243r2152b2304],
8	)	NN	O	)	dep	6	SENT_236	[p9l1947t2243r2152b2304],

1	Egrientagelafmg	NNP	O	Egrientagelafmg	_	0	SENT_237	[p10l6t2951r220b3005],
2	each	DT	O	each	det	3	SENT_237	[p10l229t2951r285b2973],
3	rm-N	NN	O	rm-n	dep	1	SENT_237	[p10l294t2957r400b3005],
4	'	''	O	'	_	0	SENT_237	[p10l294t2957r400b3005],
5	PR	NN	O	pr	dep	3	SENT_237	[p10l294t2957r400b3005],
6	=	JJ	O	=	amod	8	SENT_237	[p10l294t2957r400b3005],
7	t	NN	O	t	nn	8	SENT_237	[p10l456t2983r471b3005],
8	’	NN	O	’	dobj	5	SENT_237	[p10l456t2983r471b3005],
9	1	CD	NUMBER	1	rcmod	8	SENT_237	[p10l489t2983r495b3005],
10	-	:	O	-	_	0	SENT_237	[p10l631t2989r636b2993],
11	so	RB	O	so	advmod	9	SENT_237	[p10l658t2984r691b3005],
12	=	JJ	O	=	dep	9	SENT_237	[p10l704t2992r717b2999],
13	t	NN	O	t	rcmod	12	SENT_237	[p10l743t2986r752b3005],
14	bl	NN	O	bl	dep	13	SENT_237	[p10l768t2983r790b3005],
15	d’	SYM	O	d’	dep	13	SENT_237	[p10l825t2983r847b3005],
16	-	:	O	-	_	0	SENT_237	[p10l920t2989r924b2993],
17	PD	NN	O	pd	dep	12	SENT_237	[p10l947t2984r980b3005],
18	=	JJ	O	=	amod	17	SENT_237	[p10l994t2992r1007b2999],
19	'	''	O	'	_	0	SENT_237	[p10l1131t2983r1134b2987],
20	d’	SYM	O	d’	dep	8	SENT_237	[p10l1185t2983r1206b3005],
21	-	:	O	-	_	0	SENT_237	[p10l1279t2989r1283b2993],
22	95	CD	PERCENT	95	number	23	SENT_237	[p10l1306t2984r1354b3005],
23	%	NN	PERCENT	%	amod	24	SENT_237	[p10l1306t2984r1354b3005],
24	CI	NN	O	ci	dep	3	SENT_237	[p10l1374t2984r1397b3005],
25	=	JJ	O	=	amod	24	SENT_237	[p10l1411t2992r1424b2999],
26	957	CD	NUMBER	957	tmod	25	SENT_237	[p10l1438t2984r1485b3005],
27	ﬁd	NN	O	ﬁd	nn	29	SENT_237	[p10l1552t2983r1583b3005],
28	'	''	O	'	_	0	SENT_237	[p10l1665t2983r1668b2987],
29	t	NN	O	t	dep	1	SENT_237	[p10l1688t2986r1697b3005],
30	1	CD	NUMBER	1	rcmod	29	SENT_237	[p10l1753t2983r1767b3005],
31	-	:	O	-	_	0	SENT_237	[p10l1753t2983r1767b3005],
32	FISH	NN	O	fish	dep	30	SENT_237	[p10l1790t2984r1845b3005],
33	=	JJ	O	=	amod	34	SENT_237	[p10l1859t2992r1872b2999],
34	r1	NN	O	r1	dep	32	SENT_237	[p10l1886t2983r1901b3005],
35	'	''	O	'	_	0	SENT_237	[p10l2066t2983r2069b2987],
36	'	''	O	'	_	0	SENT_237	[p10l2122t2983r2138b3005],
37	t	NN	O	t	nn	38	SENT_237	[p10l2122t2983r2138b3005],
38	hybridizaltion	NN	O	hybridizaltion	dep	30	SENT_237	[p10l6t2989r366b3064],
39	;	:	O	;	_	0	SENT_237	[p10l6t2989r366b3064],
40	D	NN	O	d	dep	30	SENT_237	[p10l414t2989r428b3010],
41	D	NN	O	d	dep	40	SENT_237	[p10l554t2989r568b3010],
42	'	''	O	'	_	0	SENT_237	[p10l632t3001r636b3008],
43	'	''	O	'	_	0	SENT_237	[p10l920t3001r924b3008],
44	P	NN	O	p	dep	30	SENT_237	[p10l1021t2989r1035b3010],
45	g	NN	O	g	dep	44	SENT_237	[p10l1063t2989r1078b3010],
46	'	''	O	'	_	0	SENT_237	[p10l1279t3001r1283b3008],
47	o	NN	O	o	nn	49	SENT_237	[p10l1476t2996r1485b3005],
48	'	''	O	'	_	0	SENT_237	[p10l1763t3001r1767b3008],
49	IHC	NN	O	ihc	dep	30	SENT_237	[p10l10t3085r99b3126],
50	=	JJ	O	=	amod	51	SENT_237	[p10l112t3101r138b3114],
51	immunohistochemistry	NN	O	immunohistochemistry	dep	49	SENT_237	[p10l152t3082r769b3137],
52	.	.	O	.	_	0	SENT_237	[p10l152t3082r769b3137],

1	(	NN	O	(	nn	6	SENT_238	[p10l10t3291r252b3359],
2	hazard	NN	O	hazard	nn	6	SENT_238	[p10l10t3291r252b3359],
3	ratio	NN	O	ratio	nn	6	SENT_238	[p10l283t3292r429b3346],
4	[	CD	NUMBER	[	num	6	SENT_238	[p10l462t3291r599b3360],
5	HR	NN	DURATION	hr	nn	6	SENT_238	[p10l462t3291r599b3360],
6	]	NN	O	]	_	0	SENT_238	[p10l462t3291r599b3360],
7	=	JJ	O	=	amod	13	SENT_238	[p10l619t3294r777b3354],
8	2.0	CD	NUMBER	2.0	tmod	7	SENT_238	[p10l619t3294r777b3354],
9	,	,	O	,	_	0	SENT_238	[p10l619t3294r777b3354],
10	95	CD	PERCENT	95	number	11	SENT_238	[p10l808t3294r929b3346],
11	%	NN	PERCENT	%	amod	8	SENT_238	[p10l808t3294r929b3346],
12	conﬁdence	NN	O	conﬁdence	nn	13	SENT_238	[p10l959t3291r1307b3346],
13	interval	NN	O	interval	dep	6	SENT_238	[p10l1338t3291r1582b3346],
14	1.1	CD	NUMBER	1.1	number	15	SENT_238	[p10l1616t3294r1687b3347],
15	-3.4	CD	NUMBER	-3.4	num	13	SENT_238	[p10l1701t3294r1854b3355],
16	;	:	O	;	_	0	SENT_238	[p10l1701t3294r1854b3355],
17	p	NN	O	p	dep	6	SENT_238	[p10l1884t3291r2149b3360],
18	=	JJ	O	=	rcmod	17	SENT_238	[p10l1884t3291r2149b3360],
19	0.03	CD	NUMBER	0.03	iobj	18	SENT_238	[p10l1884t3291r2149b3360],
20	)	NN	O	)	nn	27	SENT_238	[p10l1884t3291r2149b3360],
21	and	CC	O	and	_	0	SENT_238	[p10l10t3380r126b3435],
22	EGFR	NN	ORGANIZATION	egfr	nn	27	SENT_238	[p10l147t3383r306b3435],
23	intron	NN	O	intron	nn	27	SENT_238	[p10l329t3381r525b3435],
24	1	CD	NUMBER	1	num	27	SENT_238	[p10l551t3383r576b3435],
25	polymorphism	NN	O	polymorphism	nn	27	SENT_238	[p10l608t3380r1082b3449],
26	(	CD	NUMBER	(	num	27	SENT_238	[p10l1105t3380r1272b3448],
27	HR	NN	DURATION	hr	dobj	18	SENT_238	[p10l1105t3380r1272b3448],
28	=	JJ	O	=	amod	17	SENT_238	[p10l1105t3380r1272b3448],
29	1.95	CD	NUMBER	1.95	tmod	28	SENT_238	[p10l1293t3383r1433b3444],
30	,	,	O	,	_	0	SENT_238	[p10l1293t3383r1433b3444],
31	95	CD	PERCENT	95	num	34	SENT_238	[p10l1457t3383r1579b3435],
32	%	NN	PERCENT	%	nn	34	SENT_238	[p10l1457t3383r1579b3435],
33	conﬁdence	NN	O	conﬁdence	nn	34	SENT_238	[p10l1602t3380r1951b3435],
34	interval	NN	O	interval	appos	17	SENT_238	[p10l1975t3381r2149b3435, p10l8t3469r98b3524],
35	1.12	CD	NUMBER	1.12	amod	34	SENT_238	[p10l123t3472r399b3533],
36	—	CD	NUMBER	—	number	37	SENT_238	[p10l123t3472r399b3533],
37	3.7	CD	NUMBER	3.7	dep	35	SENT_238	[p10l123t3472r399b3533],
38	;	:	O	;	_	0	SENT_238	[p10l123t3472r399b3533],
39	p	NN	O	p	dep	37	SENT_238	[p10l419t3485r458b3538],
40	=	JJ	O	=	amod	42	SENT_238	[p10l475t3493r509b3509],
41	0.02	CD	NUMBER	0.02	num	42	SENT_238	[p10l525t3470r685b3538],
42	)	NN	O	)	nsubjpass	44	SENT_238	[p10l525t3470r685b3538],
43	were	VBD	O	be	auxpass	44	SENT_238	[p10l704t3485r863b3524],
44	retained	VBN	O	retain	rcmod	39	SENT_238	[p10l884t3469r1149b3524],
45	as	IN	O	as	_	0	SENT_238	[p10l1171t3485r1233b3524],
46	strong	JJ	O	strong	amod	48	SENT_238	[p10l1255t3478r1458b3538],
47	prognostic	JJ	O	prognostic	amod	48	SENT_238	[p10l1477t3470r1817b3538],
48	factors	NNS	O	factor	prep_as	44	SENT_238	[p10l1837t3469r2050b3524],
49	on	IN	O	on	_	0	SENT_238	[p10l2072t3485r2150b3524],
50	duration	NN	O	duration	prep_on	44	SENT_238	[p10l10t3559r285b3614],
51	of	IN	O	of	_	0	SENT_238	[p10l307t3558r374b3614],
52	survival	NN	O	survival	nn	54	SENT_238	[p10l389t3559r638b3614],
53	(	CD	NUMBER	(	num	54	SENT_238	[p10l662t3559r854b3627],
54	Table	NNP	O	Table	prep_of	50	SENT_238	[p10l662t3559r854b3627],
55	3	CD	NUMBER	3	num	56	SENT_238	[p10l876t3559r955b3627],
56	)	NN	O	)	dep	54	SENT_238	[p10l876t3559r955b3627],
57	.	.	O	.	_	0	SENT_238	[p10l876t3559r955b3627],

1	Table	NNP	O	Table	_	0	SENT_239	[p10l6t3732r149b3776],
2	3	CD	NUMBER	3	dep	1	SENT_239	[p10l165t3735r195b3776],

1	Multivariate	JJ	O	multivariate	amod	2	SENT_240	[p11l10t21r324b64],
2	analyses	NNS	O	analysis	_	0	SENT_240	[p11l342t21r570b75],
3	.	.	O	.	_	0	SENT_240	[p11l342t21r570b75],

1	Characteristics	NNS	O	characteristic	nn	2	SENT_241	[p11l9t159r386b202],
2	OR	NN	O	or	_	0	SENT_241	[p11l911t161r985b202],
3	95	CD	PERCENT	95	number	4	SENT_241	[p11l1369t161r1466b202],
4	%	NN	PERCENT	%	amod	6	SENT_241	[p11l1369t161r1466b202],
5	CI	NN	O	ci	nn	6	SENT_241	[p11l1484t161r1531b202],
6	p	NN	O	p	dep	2	SENT_241	[p11l2001t171r2032b213],
7	Logistic	JJ	O	logistic	amod	10	SENT_241	[p11l9t271r204b324],
8	regression	NN	O	regression	nn	10	SENT_241	[p11l221t271r486b324],
9	(	NN	O	(	nn	10	SENT_241	[p11l504t270r553b324],
10	n	NN	O	n	dep	2	SENT_241	[p11l504t270r553b324],
11	=	JJ	O	=	amod	13	SENT_241	[p11l567t288r594b302],
12	54	CD	NUMBER	54	tmod	11	SENT_241	[p11l607t270r689b324],
13	)	NN	O	)	dep	10	SENT_241	[p11l607t270r689b324],

1	Gender	NN	O	gender	dep	11	SENT_242	[p11l63t342r252b386],
2	7.1	CD	NUMBER	7.1	num	1	SENT_242	[p11l945t345r1012b387],
3	0.8	CD	NUMBER	0.8	num	4	SENT_242	[p11l1421t345r1639b387],
4	—	NN	O	—	dep	1	SENT_242	[p11l1421t345r1639b387],
5	62.8	CD	NUMBER	62.8	number	6	SENT_242	[p11l1421t345r1639b387],
6	0.08	CD	NUMBER	0.08	num	7	SENT_242	[p11l2005t345r2111b387],
7	Smoking	NN	O	smoking	dep	4	SENT_242	[p11l63t414r288b468],
8	status	NN	O	status	dep	11	SENT_242	[p11l306t420r455b457],
9	0.11	CD	NUMBER	0.11	num	8	SENT_242	[p11l944t416r1039b458],
10	0.007	CD	NUMBER	0.007	num	11	SENT_242	[p11l1355t416r1607b458],
11	—	NN	O	—	dep	18	SENT_242	[p11l1355t416r1607b458],
12	2.0	CD	NUMBER	2.0	number	13	SENT_242	[p11l1355t416r1607b458],
13	0.14	CD	NUMBER	0.14	num	15	SENT_242	[p11l2005t416r2109b458],
14	Skin	NN	O	skin	nn	15	SENT_242	[p11l63t485r172b529],
15	toxicity	NN	O	toxicity	dep	11	SENT_242	[p11l189t486r383b540],
16	6.9	CD	NUMBER	6.9	number	17	SENT_242	[p11l944t487r1018b529],
17	0.8	CD	NUMBER	0.8	amod	15	SENT_242	[p11l1421t487r1633b529],
18	—	NN	O	—	dep	23	SENT_242	[p11l1421t487r1633b529],
19	61.0	CD	NUMBER	61.0	num	18	SENT_242	[p11l1421t487r1633b529],
20	0.08	CD	NUMBER	0.08	num	23	SENT_242	[p11l2005t487r2111b529],
21	EGFR	NN	ORGANIZATION	egfr	nn	23	SENT_242	[p11l61t559r188b600],
22	gene	NN	O	gene	nn	23	SENT_242	[p11l201t569r318b611],
23	mutations	NNS	O	mutation	dep	35	SENT_242	[p11l336t557r598b600],
24	38.5	CD	NUMBER	38.5	number	25	SENT_242	[p11l910t559r1017b601],
25	3.1	CD	NUMBER	3.1	num	26	SENT_242	[p11l1424t559r1490b601],
26	—	NN	O	—	dep	23	SENT_242	[p11l1501t559r1668b601],
27	481.7	CD	NUMBER	481.7	number	28	SENT_242	[p11l1501t559r1668b601],
28	0.005	CD	NUMBER	0.005	num	33	SENT_242	[p11l2006t559r2146b601],
29	EGFR	NN	ORGANIZATION	egfr	nn	33	SENT_242	[p11l61t631r188b673],
30	FISH	NN	O	fish	nn	33	SENT_242	[p11l206t631r320b673],
31	3.2	CD	NUMBER	3.2	num	33	SENT_242	[p11l943t631r1017b673],
32	0.3	CD	NUMBER	0.3	amod	33	SENT_242	[p11l1421t631r1638b673],
33	—	NN	O	—	dep	26	SENT_242	[p11l1421t631r1638b673],
34	34.5	CD	NUMBER	34.5	num	35	SENT_242	[p11l1421t631r1638b673],
35	0.33	CD	NUMBER	0.33	_	0	SENT_242	[p11l2006t631r2110b673],

1	Characteristics	NNS	O	characteristic	nn	2	SENT_243	[p11l9t786r386b830],
2	HR	NN	DURATION	hr	_	0	SENT_243	[p11l1126t789r1202b830],
3	95	CD	PERCENT	95	num	6	SENT_243	[p11l1557t789r1654b830],
4	%	NN	PERCENT	%	nn	6	SENT_243	[p11l1557t789r1654b830],
5	CI	NN	O	ci	nn	6	SENT_243	[p11l1672t789r1719b830],
6	p	NN	O	p	dep	2	SENT_243	[p11l2034t799r2065b841],
7	Cox	NN	ORGANIZATION	cox	dep	6	SENT_243	[p11l9t900r102b941],
8	proportional	JJ	O	proportional	amod	15	SENT_243	[p11l119t898r443b952],
9	hazard	NN	O	hazard	nn	15	SENT_243	[p11l461t898r634b941],
10	model	NN	O	model	nn	15	SENT_243	[p11l653t898r813b941],
11	(	CD	NUMBER	(	num	15	SENT_243	[p11l832t898r881b952],
12	n	NN	O	n	nn	15	SENT_243	[p11l832t898r881b952],
13	=	JJ	O	=	amod	15	SENT_243	[p11l894t916r921b929],
14	76	CD	NUMBER	76	num	15	SENT_243	[p11l935t898r1014b952],
15	)	NN	O	)	dobj	7	SENT_243	[p11l935t898r1014b952],

1	Histology	NNP	O	Histology	dep	7	SENT_244	[p11l64t969r308b1024],
2	1.4	CD	NUMBER	1.4	num	1	SENT_244	[p11l1129t971r1201b1013],
3	0.7-2	CD	NUMBER	0.7-2	num	4	SENT_244	[p11l1511t971r1696b1013],
4	.5	CD	NUMBER	.5	dep	1	SENT_244	[p11l1511t971r1696b1013],
5	0.3	CD	NUMBER	0.3	num	6	SENT_244	[p11l2038t971r2110b1013],
6	Smoking	NN	O	smoking	dep	7	SENT_244	[p11l63t1040r288b1094],
7	status	NN	O	status	dep	16	SENT_244	[p11l306t1046r455b1083],
8	2.0	CD	NUMBER	2.0	number	9	SENT_244	[p11l1126t1042r1200b1084],
9	1.1-3	CD	NUMBER	1.1-3	dep	7	SENT_244	[p11l1522t1042r1698b1084],
10	.4	NN	NUMBER	.4	nn	13	SENT_244	[p11l1522t1042r1698b1084],
11	0.03	CD	NUMBER	0.03	num	13	SENT_244	[p11l2038t1042r2143b1084],
12	Skin	NN	O	skin	nn	13	SENT_244	[p11l63t1111r172b1155],
13	toxicity	NN	O	toxicity	dep	9	SENT_244	[p11l189t1112r383b1165],
14	1.4	CD	NUMBER	1.4	num	16	SENT_244	[p11l1129t1113r1201b1155],
15	0.8-2	CD	NUMBER	0.8-2	num	16	SENT_244	[p11l1511t1113r1698b1155],
16	.4	NN	NUMBER	.4	dep	19	SENT_244	[p11l1511t1113r1698b1155],
17	0.2	CD	NUMBER	0.2	num	18	SENT_244	[p11l2038t1113r2111b1155],
18	EGFR	NN	ORGANIZATION	egfr	dep	16	SENT_244	[p11l61t1184r188b1225],
19	intron	NN	O	intron	dep	21	SENT_244	[p11l206t1182r363b1225],
20	1	CD	NUMBER	1	num	19	SENT_244	[p11l384t1184r403b1225],
21	polymorphism	NN	O	polymorphism	dep	24	SENT_244	[p11l428t1181r808b1236],
22	1.95	CD	NUMBER	1.95	num	21	SENT_244	[p11l1129t1184r1232b1225],
23	1.12	CD	NUMBER	1.12	num	24	SENT_244	[p11l1493t1184r1696b1225],
24	—	NN	O	—	dep	26	SENT_244	[p11l1493t1184r1696b1225],
25	3.7	CD	NUMBER	3.7	num	26	SENT_244	[p11l1493t1184r1696b1225],
26	0.02	CD	NUMBER	0.02	_	0	SENT_244	[p11l2038t1184r2144b1225],

1	OR	NN	O	or	_	0	SENT_245	[p11l9t1294r83b1336],
2	=	JJ	O	=	amod	4	SENT_245	[p11l94t1310r120b1324],
3	odds	NNS	O	odds	nn	4	SENT_245	[p11l134t1292r254b1336],
4	ratio	NN	O	ratio	dep	1	SENT_245	[p11l273t1293r406b1342],
5	;	:	O	;	_	0	SENT_245	[p11l273t1293r406b1342],
6	HR	NN	DURATION	hr	dep	1	SENT_245	[p11l428t1295r504b1335],
7	=	JJ	O	=	amod	9	SENT_245	[p11l515t1310r541b1324],
8	hazard	NN	O	hazard	nn	9	SENT_245	[p11l555t1292r728b1336],
9	ratio	NN	O	ratio	dep	6	SENT_245	[p11l746t1293r880b1342],
10	;	:	O	;	_	0	SENT_245	[p11l746t1293r880b1342],
11	95	CD	PERCENT	95	number	12	SENT_245	[p11l902t1294r999b1336],
12	%	NN	PERCENT	%	amod	13	SENT_245	[p11l902t1294r999b1336],
13	CI	NN	O	ci	dep	1	SENT_245	[p11l1017t1294r1064b1336],
14	=	JJ	O	=	dep	16	SENT_245	[p11l1077t1310r1104b1324],
15	95	CD	PERCENT	95	number	16	SENT_245	[p11l1117t1294r1215b1336],
16	%	NN	PERCENT	%	amod	18	SENT_245	[p11l1117t1294r1215b1336],
17	conﬁdence	NN	O	conﬁdence	nn	18	SENT_245	[p11l1232t1292r1511b1336],
18	interval	NN	O	interval	dep	13	SENT_245	[p11l1530t1292r1739b1336],
19	.	.	O	.	_	0	SENT_245	[p11l1530t1292r1739b1336],

1	4	LS	NUMBER	4	_	0	SENT_246	[p11l9t1498r66b1550],
2	.	.	O	.	_	0	SENT_246	[p11l9t1498r66b1550],

1	Discussion	NN	O	discussion	_	0	SENT_247	[p11l112t1495r474b1549],

1	The	DT	O	the	det	2	SENT_248	[p11l110t1672r227b1727],
2	purpose	NN	O	purpose	nsubj	6	SENT_248	[p11l252t1688r512b1741],
3	of	IN	O	of	_	0	SENT_248	[p11l536t1672r603b1727],
4	this	DT	O	this	det	5	SENT_248	[p11l618t1672r735b1727],
5	study	NN	O	study	prep_of	2	SENT_248	[p11l761t1672r937b1741],
6	was	VBD	O	be	_	0	SENT_248	[p11l958t1688r1081b1727],
7	to	TO	O	to	aux	8	SENT_248	[p11l1105t1681r1166b1727],
8	assess	VB	O	assess	xcomp	6	SENT_248	[p11l1190t1688r1385b1727],
9	the	DT	O	the	det	11	SENT_248	[p11l1409t1672r1511b1727],
10	predictive	JJ	O	predictive	amod	11	SENT_248	[p11l1536t1672r1856b1741],
11	value	NN	O	value	dobj	8	SENT_248	[p11l1879t1672r2049b1727],
12	on	IN	O	on	_	0	SENT_248	[p11l2074t1688r2152b1727],
13	geﬁtinib	NN	O	geﬁtinib	nn	14	SENT_248	[p11l10t1761r277b1830],
14	outcomes	NNS	O	outcome	prep_on	8	SENT_248	[p11l310t1770r621b1817],
15	of	IN	O	of	_	0	SENT_248	[p11l654t1761r720b1817],
16	a	DT	O	a	det	19	SENT_248	[p11l745t1777r777b1817],
17	molecular	JJ	O	molecular	amod	19	SENT_248	[p11l809t1762r1133b1817],
18	marker	NN	O	marker	nn	19	SENT_248	[p11l1163t1762r1395b1817],
19	panel	NN	O	panel	prep_of	14	SENT_248	[p11l1424t1762r1599b1830],
20	(	CD	NUMBER	(	num	21	SENT_248	[p11l1631t1762r1814b1830],
21	EGFR	NN	ORGANIZATION	egfr	dep	19	SENT_248	[p11l1631t1762r1814b1830],
22	and	CC	O	and	_	0	SENT_248	[p11l1845t1762r1961b1817],
23	K-ras	JJ	O	k-ras	amod	25	SENT_248	[p11l1991t1765r2152b1817],
24	gene	NN	O	gene	nn	25	SENT_248	[p11l6t1867r152b1919],
25	mutations	NNS	O	mutation	conj_and	21	SENT_248	[p11l182t1852r525b1914],
26	,	,	O	,	_	0	SENT_248	[p11l182t1852r525b1914],
27	EGFR	NN	ORGANIZATION	egfr	prep_of	14	SENT_248	[p11l553t1854r712b1906],
28	and	CC	O	and	_	0	SENT_248	[p11l741t1851r857b1906],
29	HER2	NN	O	her2	nn	36	SENT_248	[p11l885t1854r1051b1905],
30	gene	NN	O	gene	nn	36	SENT_248	[p11l1076t1867r1222b1919],
31	copy	NN	O	copy	nn	36	SENT_248	[p11l1252t1867r1402b1919],
32	number	NN	O	number	nn	36	SENT_248	[p11l1430t1851r1695b1914],
33	,	,	O	,	_	0	SENT_248	[p11l1430t1851r1695b1914],
34	EGFR	NN	ORGANIZATION	egfr	dep	36	SENT_248	[p11l1727t1854r1893b1906],
35	protein	NN	O	protein	nn	36	SENT_248	[p11l1921t1852r2152b1919],
36	expression	NN	O	expression	conj_and	27	SENT_248	[p11l11t1941r356b2008],
37	and	CC	O	and	_	0	SENT_248	[p11l392t1940r508b1995],
38	EGFR	NN	ORGANIZATION	egfr	nn	43	SENT_248	[p11l542t1943r701b1995],
39	gene	NN	O	gene	nn	43	SENT_248	[p11l730t1956r877b2008],
40	intron	NN	O	intron	nn	43	SENT_248	[p11l913t1941r1109b1995],
41	1	CD	NUMBER	1	num	43	SENT_248	[p11l1148t1943r1172b1994],
42	polymorphism	NN	O	polymorphism	nn	43	SENT_248	[p11l1216t1940r1716b2008],
43	)	NN	O	)	prep_of	14	SENT_248	[p11l1216t1940r1716b2008],
44	in	IN	O	in	_	0	SENT_248	[p11l1754t1941r1812b1994],
45	advanced	JJ	O	advanced	amod	47	SENT_248	[p11l1848t1940r2151b1995],
46	NSCLC	NN	O	nsclc	nn	47	SENT_248	[p11l12t2031r218b2083],
47	patients	NNS	O	patient	prep_in	43	SENT_248	[p11l233t2029r508b2097],
48	.	.	O	.	_	0	SENT_248	[p11l233t2029r508b2097],

1	The	DT	O	the	det	2	SENT_249	[p11l522t2028r639b2083],
2	correlation	NN	O	correlation	nsubjpass	14	SENT_249	[p11l655t2028r1007b2083],
3	between	IN	O	between	_	0	SENT_249	[p11l1022t2028r1299b2083],
4	all	DT	O	all	dep	6	SENT_249	[p11l1314t2028r1388b2083],
5	these	DT	O	these	det	6	SENT_249	[p11l1404t2028r1574b2083],
6	factors	NNS	O	factor	prep_between	2	SENT_249	[p11l1591t2028r1804b2083],
7	and	CC	O	and	_	0	SENT_249	[p11l1820t2028r1937b2083],
8	tumor	NN	O	tumor	nn	9	SENT_249	[p11l1952t2036r2154b2083],
9	response	NN	O	response	prep_between	2	SENT_249	[p11l12t2133r297b2186],
10	or	CC	O	or	_	0	SENT_249	[p11l320t2133r386b2172],
11	overall	JJ	O	overall	amod	12	SENT_249	[p11l406t2117r621b2172],
12	survival	NN	O	survival	conj_or	6	SENT_249	[p11l645t2117r894b2172],
13	was	VBD	O	be	auxpass	14	SENT_249	[p11l916t2133r1039b2172],
14	performed	VBN	O	perform	_	0	SENT_249	[p11l1063t2117r1419b2186],
15	.	.	O	.	_	0	SENT_249	[p11l1063t2117r1419b2186],

1	Several	JJ	O	several	amod	2	SENT_250	[p11l113t2206r342b2261],
2	trials	NNS	O	trial	nsubj	3	SENT_250	[p11l373t2206r533b2261],
3	documented	VBD	O	document	dep	27	SENT_250	[p11l565t2206r969b2261],
4	a	DT	O	a	det	5	SENT_250	[p11l1000t2222r1032b2261],
5	relationship	NN	O	relationship	dobj	3	SENT_250	[p11l1063t2206r1449b2275],
6	between	IN	O	between	_	0	SENT_250	[p11l1479t2206r1756b2261],
7	female	JJ	O	female	amod	8	SENT_250	[p11l1787t2206r2003b2261],
8	sex	NN	O	sex	prep_between	5	SENT_250	[p11l2034t2222r2151b2270],
9	,	,	O	,	_	0	SENT_250	[p11l2034t2222r2151b2270],
10	adenocarcinoma	NN	O	adenocarcinoma	nn	11	SENT_250	[p11l11t2296r544b2351],
11	histology	NN	O	histology	appos	8	SENT_250	[p11l560t2296r866b2364],
12	,	,	O	,	_	0	SENT_250	[p11l560t2296r866b2364],
13	never	RB	O	never	neg	14	SENT_250	[p11l884t2311r1064b2351],
14	smoking	VBG	O	smoke	partmod	3	SENT_250	[p11l1078t2296r1353b2364],
15	status	NN	O	status	dobj	14	SENT_250	[p11l1369t2304r1556b2351],
16	and	CC	O	and	_	0	SENT_250	[p11l1573t2296r1689b2351],
17	a	DT	O	a	det	19	SENT_250	[p11l1706t2311r1738b2351],
18	higher	JJR	O	higher	amod	19	SENT_250	[p11l1754t2296r1962b2364],
19	probability	NN	O	probability	dobj	14	SENT_250	[p11l1977t2296r2151b2364, p11l11t2385r215b2453],
20	of	IN	O	of	_	0	SENT_250	[p11l247t2385r314b2440],
21	responding	VBG	O	respond	prepc_of	19	SENT_250	[p11l341t2385r703b2453],
22	to	TO	O	to	_	0	SENT_250	[p11l736t2393r797b2440],
23	EGFR	NN	ORGANIZATION	egfr	nn	25	SENT_250	[p11l832t2388r999b2440],
24	TI	NNP	O	TI	nn	25	SENT_250	[p11l1028t2388r1164b2440],
25	(	NNP	O	(	prep_to	21	SENT_250	[p11l1028t2388r1164b2440],
26	Is	VBZ	O	be	cop	27	SENT_250	[p11l1028t2388r1164b2440],
27	[	CD	NUMBER	[	_	0	SENT_250	[p11l1202t2385r1383b2453],
28	3	CD	NUMBER	3	num	31	SENT_250	[p11l1202t2385r1383b2453],
29	—	NN	O	—	nn	31	SENT_250	[p11l1202t2385r1383b2453],
30	6	CD	NUMBER	6	num	31	SENT_250	[p11l1202t2385r1383b2453],
31	]	NN	O	]	nsubj	27	SENT_250	[p11l1202t2385r1383b2453],
32	.	.	O	.	_	0	SENT_250	[p11l1202t2385r1383b2453],

1	In	IN	O	in	_	0	SENT_251	[p11l1419t2388r1479b2439],
2	our	PRP$	O	we	poss	3	SENT_251	[p11l1513t2401r1622b2440],
3	study	NN	O	study	prep_in	7	SENT_251	[p11l1655t2385r1842b2453],
4	,	,	O	,	_	0	SENT_251	[p11l1655t2385r1842b2453],
5	we	PRP	O	we	nsubj	7	SENT_251	[p11l1876t2401r1969b2440],
6	have	VBP	O	have	aux	7	SENT_251	[p11l2004t2385r2151b2440],
7	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_251	[p11l11t2473r341b2528],
8	the	DT	O	the	det	11	SENT_251	[p11l382t2473r484b2528],
9	positive	JJ	O	positive	amod	11	SENT_251	[p11l526t2474r777b2542],
10	predictive	JJ	O	predictive	amod	11	SENT_251	[p11l818t2473r1139b2542],
11	role	NN	O	role	xcomp	7	SENT_251	[p11l1182t2473r1302b2528],
12	of	IN	O	of	prep	11	SENT_251	[p11l1344t2473r1410b2528],
13	female	JJ	O	female	amod	14	SENT_251	[p11l1444t2473r1659b2528],
14	sex	NN	O	sex	pobj	12	SENT_251	[p11l1702t2489r1804b2528],
15	and	CC	O	and	_	0	SENT_251	[p11l1844t2473r1960b2528],
16	nonsmoking	JJ	O	nonsmoking	amod	17	SENT_251	[p11l2002t2489r2151b2528, p11l12t2562r287b2631],
17	status	NN	O	status	conj_and	14	SENT_251	[p11l304t2570r508b2626],
18	,	,	O	,	_	0	SENT_251	[p11l304t2570r508b2626],
19	but	CC	O	but	_	0	SENT_251	[p11l525t2562r632b2617],
20	not	RB	O	not	prep	11	SENT_251	[p11l649t2570r753b2617],
21	of	IN	O	of	dep	12	SENT_251	[p11l769t2562r836b2617],
22	histology	NN	O	histology	pobj	21	SENT_251	[p11l846t2562r1151b2631],
23	,	,	O	,	_	0	SENT_251	[p11l846t2562r1151b2631],
24	likely	RB	O	likely	advmod	7	SENT_251	[p11l1170t2562r1344b2631],
25	due	JJ	O	due	_	0	SENT_251	[p11l1360t2562r1476b2617],
26	to	TO	O	to	_	0	SENT_251	[p11l1494t2570r1554b2617],
27	the	DT	O	the	det	30	SENT_251	[p11l1572t2562r1673b2617],
28	limited	JJ	O	limited	amod	30	SENT_251	[p11l1691t2562r1920b2617],
29	simple	JJ	O	simple	amod	30	SENT_251	[p11l1939t2562r2151b2631],
30	size	NN	O	size	prep_due_to	7	SENT_251	[p11l12t2652r147b2715],
31	,	,	O	,	_	0	SENT_251	[p11l12t2652r147b2715],
32	since	IN	O	since	mark	42	SENT_251	[p11l176t2652r336b2706],
33	95	CD	PERCENT	95	num	34	SENT_251	[p11l362t2654r483b2706],
34	%	NN	PERCENT	%	nsubj	42	SENT_251	[p11l362t2654r483b2706],
35	of	IN	O	of	_	0	SENT_251	[p11l509t2651r576b2706],
36	non	JJ	O	non	amod	39	SENT_251	[p11l595t2651r1281b2706],
37	—	NN	O	—	nn	39	SENT_251	[p11l595t2651r1281b2706],
38	adenocarcinoma	NN	O	adenocarcinoma	nn	39	SENT_251	[p11l595t2651r1281b2706],
39	patients	NNS	O	patient	prep_of	34	SENT_251	[p11l1308t2652r1566b2720],
40	were	VBD	O	be	cop	42	SENT_251	[p11l1592t2667r1750b2706],
41	not	RB	O	not	neg	42	SENT_251	[p11l1777t2659r1881b2706],
42	responders	NNS	O	responder	advcl	7	SENT_251	[p11l1906t2667r2151b2720, p11l11t2740r162b2795],
43	.	.	O	.	_	0	SENT_251	[p11l1906t2667r2151b2720, p11l11t2740r162b2795],

1	Geﬁtinib	NNP	O	Geﬁtinib	nsubj	4	SENT_252	[p11l113t2828r392b2884],
2	is	VBZ	O	be	cop	4	SENT_252	[p11l421t2829r468b2884],
3	generally	RB	O	generally	advmod	4	SENT_252	[p11l497t2829r794b2897],
4	well	RB	O	well	_	0	SENT_252	[p11l819t2829r955b2884],
5	tolerated	VBD	O	tolerate	dep	4	SENT_252	[p11l984t2829r1289b2892],
6	,	,	O	,	_	0	SENT_252	[p11l984t2829r1289b2892],
7	with	IN	O	with	_	0	SENT_252	[p11l1317t2829r1465b2884],
8	mild	JJ	O	mild	amod	10	SENT_252	[p11l1495t2829r1638b2884],
9	adverse	JJ	O	adverse	amod	10	SENT_252	[p11l1668t2829r1914b2884],
10	effects	NNS	O	effect	prep_with	5	SENT_252	[p11l1943t2828r2151b2884],
11	mostly	RB	O	mostly	advmod	12	SENT_252	[p11l12t2918r230b2986],
12	related	JJ	O	related	amod	10	SENT_252	[p11l259t2918r481b2973],
13	to	TO	O	to	_	0	SENT_252	[p11l510t2926r571b2973],
14	skin	NN	O	skin	nn	15	SENT_252	[p11l602t2918r731b2973],
15	disorders	NNS	O	disorder	prep_to	5	SENT_252	[p11l760t2918r1057b2973],
16	and	CC	O	and	_	0	SENT_252	[p11l1088t2918r1204b2973],
17	diarrhea	NN	O	diarrhea	conj_and	15	SENT_252	[p11l1234t2918r1518b2973],
18	.	.	O	.	_	0	SENT_252	[p11l1234t2918r1518b2973],

1	Skin	NN	O	skin	nn	2	SENT_253	[p11l1549t2918r1684b2973],
2	rash	NN	O	rash	nsubj	4	SENT_253	[p11l1714t2918r1848b2973],
3	typically	RB	O	typically	advmod	4	SENT_253	[p11l1877t2918r2153b2986],
4	resolves	VBZ	O	resolve	conj_or	4	SENT_253	[p11l12t3006r268b3061],
5	during	IN	O	during	_	0	SENT_253	[p11l299t3006r511b3075],
6	treatment	NN	O	treatment	prep_during	4	SENT_253	[p11l538t3014r862b3061],
7	or	CC	O	or	_	0	SENT_253	[p11l890t3022r956b3061],
8	after	IN	O	after	_	0	SENT_253	[p11l983t3006r1133b3061],
9	temporary	JJ	O	temporary	amod	13	SENT_253	[p11l1159t3014r1500b3075],
10	or	CC	O	or	_	0	SENT_253	[p11l1527t3022r1593b3061],
11	permanent	JJ	O	permanent	amod	13	SENT_253	[p11l1621t3014r1977b3075],
12	drug	NN	O	drug	nn	13	SENT_253	[p11l2005t3006r2153b3075],
13	withdrawal	NN	O	withdrawal	prep_after	4	SENT_253	[p11l10t3095r378b3150],
14	and	CC	O	and	_	0	SENT_253	[p11l410t3095r527b3150],
15	it	PRP	O	it	nsubj	16	SENT_253	[p11l559t3096r603b3150],
16	appears	VBZ	O	appear	conj_and	4	SENT_253	[p11l633t3111r883b3164],
17	to	TO	O	to	aux	22	SENT_253	[p11l915t3103r976b3150],
18	be	VB	O	be	cop	22	SENT_253	[p11l1008t3095r1082b3150],
19	a	DT	O	a	det	22	SENT_253	[p11l1114t3111r1146b3150],
20	potential	JJ	O	potential	amod	22	SENT_253	[p11l1178t3095r1464b3164],
21	predictive	JJ	O	predictive	amod	22	SENT_253	[p11l1497t3095r1817b3164],
22	factor	NN	O	factor	xcomp	16	SENT_253	[p11l1850t3095r2034b3150],
23	for	IN	O	for	_	0	SENT_253	[p11l2065t3095r2154b3150],
24	activity	NN	O	activity	prep_for	22	SENT_253	[p11l11t3185r250b3253],
25	of	IN	O	of	_	0	SENT_253	[p11l276t3184r342b3239],
26	TKIs	NNS	O	tki	prep_of	24	SENT_253	[p11l360t3188r495b3239],
27	[	CD	NUMBER	[	num	29	SENT_253	[p11l528t3184r666b3253],
28	24	CD	NUMBER	24	num	29	SENT_253	[p11l528t3184r666b3253],
29	]	NN	O	]	dep	26	SENT_253	[p11l528t3184r666b3253],
30	,	,	O	,	_	0	SENT_253	[p11l528t3184r666b3253],
31	as	IN	O	as	_	0	SENT_253	[p11l696t3200r758b3239],
32	conﬁrmed	NN	O	conﬁrmed	prep_as	26	SENT_253	[p11l787t3184r1116b3239],
33	also	RB	O	also	advmod	26	SENT_253	[p11l1145t3184r1269b3239],
34	in	IN	O	in	_	0	SENT_253	[p11l1298t3185r1357b3239],
35	our	PRP$	O	we	poss	36	SENT_253	[p11l1384t3200r1493b3239],
36	study	NN	O	study	prep_in	26	SENT_253	[p11l1520t3184r1707b3253],
37	.	.	O	.	_	0	SENT_253	[p11l1520t3184r1707b3253],

1	It	PRP	O	it	nsubj	3	SENT_254	[p11l1736t3188r1781b3239],
2	is	VBZ	O	be	cop	3	SENT_254	[p11l1808t3185r1854b3239],
3	conceivable	JJ	O	conceivable	_	0	SENT_254	[p11l1883t3185r2151b3239, p11l11t3273r142b3328],
4	that	IN	O	that	complm	6	SENT_254	[p11l176t3273r305b3328],
5	the	DT	O	the	det	6	SENT_254	[p11l336t3274r438b3328],
6	effects	NNS	O	effect	dep	3	SENT_254	[p11l472t3273r679b3328],
7	in	IN	O	in	dep	6	SENT_254	[p11l715t3274r774b3327],
8	skin	NN	O	skin	nn	9	SENT_254	[p11l808t3273r937b3328],
9	reﬂect	NN	O	reﬂect	pobj	7	SENT_254	[p11l971t3273r1174b3328],
10	the	DT	O	the	det	11	SENT_254	[p11l1205t3273r1307b3328],
11	extent	NN	O	extent	attr	3	SENT_254	[p11l1341t3281r1544b3328],
12	of	IN	O	of	_	0	SENT_254	[p11l1577t3273r1643b3328],
13	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_254	[p11l1669t3276r1836b3328],
14	blockade	NN	O	blockade	prep_of	11	SENT_254	[p11l1866t3273r2151b3328],

1	M.	NNP	PERSON	M.	nn	2	SENT_255	[p11l393t3404r422b3425],
2	Tiseo	NNP	PERSON	Tiseo	_	0	SENT_255	[p11l432t3403r491b3425],
3	et	FW	O	et	nn	4	SENT_255	[p11l500t3406r523b3425],
4	al.	FW	O	al.	dep	2	SENT_255	[p11l530t3403r556b3425],
5	/	:	O	/	punct	2	SENT_255	[p11l562t3403r574b3430],
6	Lung	NN	O	lung	nn	7	SENT_255	[p11l580t3404r640b3430],
7	Cancer	NN	O	cancer	dep	2	SENT_255	[p11l647t3404r730b3425],
8	67	CD	NUMBER	67	number	9	SENT_255	[p11l737t3404r767b3425],
9	(	CD	NUMBER	(	num	10	SENT_255	[p11l774t3403r855b3430],
10	2010	CD	DATE	2010	dep	7	SENT_255	[p11l774t3403r855b3430],
11	)	CD	NUMBER	)	number	12	SENT_255	[p11l774t3403r855b3430],
12	355-360 359	CD	NUMBER	355-360 359	num	10	SENT_255	[p11l1721t3404r1767b3425],[p11l862t3404r969b3425],

1	achieved	VBN	O	achieve	_	0	SENT_256	[p11l12t3543r293b3597],
2	in	IN	O	in	_	0	SENT_256	[p11l315t3543r374b3596],
3	the	DT	O	the	det	4	SENT_256	[p11l394t3543r495b3597],
4	tumor	NN	O	tumor	prep_in	1	SENT_256	[p11l516t3551r726b3605],
5	,	,	O	,	_	0	SENT_256	[p11l516t3551r726b3605],
6	in	IN	O	in	_	0	SENT_256	[p11l748t3543r807b3596],
7	which	WDT	O	which	det	8	SENT_256	[p11l826t3543r1023b3597],
8	case	NN	O	case	rel	12	SENT_256	[p11l1044t3558r1177b3597],
9	the	DT	O	the	det	10	SENT_256	[p11l1198t3542r1299b3597],
10	rash	NN	O	rash	nsubj	12	SENT_256	[p11l1321t3543r1455b3597],
11	would	MD	O	would	aux	12	SENT_256	[p11l1473t3543r1674b3597],
12	correlate	VB	O	correlate	rcmod	4	SENT_256	[p11l1696t3543r1978b3597],
13	with	IN	O	with	prep	12	SENT_256	[p11l1997t3543r2145b3597],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_257	[p12l12t22r179b73],
2	saturation	NN	O	saturation	nsubj	4	SENT_257	[p12l203t20r529b73],
3	or	CC	O	or	dep	4	SENT_257	[p12l555t34r621b73],
4	with	IN	O	with	_	0	SENT_257	[p12l643t19r792b73],
5	a	DT	O	a	det	8	SENT_257	[p12l818t34r850b73],
6	relevant	JJ	O	relevant	amod	8	SENT_257	[p12l877t19r1137b73],
7	drug	NN	O	drug	nn	8	SENT_257	[p12l1162t19r1310b86],
8	concentration	NN	O	concentration	pobj	4	SENT_257	[p12l1336t20r1782b73],
9	within	IN	O	within	_	0	SENT_257	[p12l1806t19r2018b73],
10	the	DT	O	the	det	11	SENT_257	[p12l2043t19r2145b73],
11	tumor	NN	O	tumor	prep_within	4	SENT_257	[p12l11t113r221b160],
12	.	.	O	.	_	0	SENT_257	[p12l11t113r221b160],

1	Nevertheless	RB	O	nevertheless	advmod	6	SENT_258	[p12l245t105r673b168],
2	,	,	O	,	_	0	SENT_258	[p12l245t105r673b168],
3	this	DT	O	this	det	4	SENT_258	[p12l696t105r812b159],
4	correlation	NN	O	correlation	nsubj	6	SENT_258	[p12l836t105r1186b159],
5	could	MD	O	could	aux	6	SENT_258	[p12l1209t105r1382b159],
6	support	VB	O	support	_	0	SENT_258	[p12l1406t113r1655b173],
7	the	DT	O	the	det	8	SENT_258	[p12l1675t105r1777b159],
8	hypothesis	NN	O	hypothesis	dobj	6	SENT_258	[p12l1800t105r2144b173],
9	that	IN	O	that	complm	16	SENT_258	[p12l11t192r140b246],
10	sensitivity	NN	O	sensitivity	nsubjpass	16	SENT_258	[p12l161t193r491b260],
11	to	TO	O	to	_	0	SENT_258	[p12l510t200r570b246],
12	anti-EGFR	JJ	O	anti-egfr	amod	13	SENT_258	[p12l592t193r914b246],
13	treatment	NN	O	treatment	prep_to	10	SENT_258	[p12l932t200r1255b246],
14	may	MD	O	may	aux	16	SENT_258	[p12l1275t208r1411b260],
15	be	VB	O	be	auxpass	16	SENT_258	[p12l1429t192r1503b246],
16	inﬂuenced	VBN	O	inﬂuenced	ccomp	6	SENT_258	[p12l1525t192r1862b246],
17	not	RB	O	not	neg	18	SENT_258	[p12l1885t200r1989b246],
18	only	RB	O	only	preconj	16	SENT_258	[p12l2008t192r2147b260],
19	by	IN	O	by	_	0	SENT_258	[p12l11t279r87b347],
20	different	JJ	O	different	amod	21	SENT_258	[p12l116t279r394b333],
21	levels	NNS	O	level	agent	16	SENT_258	[p12l424t279r602b333],
22	of	IN	O	of	_	0	SENT_258	[p12l635t279r701b333],
23	target	NN	O	target	nn	24	SENT_258	[p12l724t287r912b347],
24	expression	NN	O	expression	prep_of	21	SENT_258	[p12l942t280r1286b347],
25	in	IN	O	in	_	0	SENT_258	[p12l1317t280r1376b333],
26	the	DT	O	the	det	27	SENT_258	[p12l1406t279r1507b333],
27	tumor	NN	O	tumor	prep_in	24	SENT_258	[p12l1539t287r1748b342],
28	,	,	O	,	_	0	SENT_258	[p12l1539t287r1748b342],
29	but	CC	O	but	_	0	SENT_258	[p12l1780t279r1887b333],
30	also	RB	O	also	_	0	SENT_258	[p12l1916t279r2040b333],
31	by	IN	O	by	_	0	SENT_258	[p12l2071t279r2147b347],
32	some	DT	O	some	det	35	SENT_258	[p12l13t382r180b421],
33	inherited	VBN	O	inherit	amod	35	SENT_258	[p12l208t366r501b421],
34	genetic	JJ	O	genetic	amod	35	SENT_258	[p12l527t367r759b434],
35	factor	NN	O	factor	conj_and	21	SENT_258	[p12l786t366r970b421],
36	in	IN	O	in	_	0	SENT_258	[p12l995t367r1054b420],
37	the	DT	O	the	det	38	SENT_258	[p12l1081t366r1182b421],
38	host	NN	O	host	prep_in	35	SENT_258	[p12l1210t366r1360b429],
39	,	,	O	,	_	0	SENT_258	[p12l1210t366r1360b429],
40	such	JJ	O	such	_	0	SENT_258	[p12l1389t366r1533b421],
41	as	IN	O	as	_	0	SENT_258	[p12l1559t382r1622b421],
42	speciﬁc	JJ	O	speciﬁc	amod	44	SENT_258	[p12l1651t366r1889b434],
43	genetic	JJ	O	genetic	amod	44	SENT_258	[p12l1914t367r2146b434],
44	polymorphisms	NNS	O	polymorphism	prep_such_as	35	SENT_258	[p12l12t454r531b521],
45	.	.	O	.	_	0	SENT_258	[p12l12t454r531b521],

1	About	IN	O	about	_	0	SENT_259	[p12l111t541r306b595],
2	this	DT	O	this	prep_about	52	SENT_259	[p12l325t541r458b603],
3	,	,	O	,	_	0	SENT_259	[p12l325t541r458b603],
4	in	IN	O	in	_	0	SENT_259	[p12l480t542r539b594],
5	consideration	NN	O	consideration	nsubj	14	SENT_259	[p12l560t541r998b595],
6	of	IN	O	of	_	0	SENT_259	[p12l1019t541r1085b595],
7	recent	JJ	O	recent	amod	13	SENT_259	[p12l1098t549r1299b595],
8	in	FW	O	in	nn	9	SENT_259	[p12l1319t542r1374b595],
9	vitro	FW	O	vitro	dep	13	SENT_259	[p12l1395t542r1536b595],
10	and	CC	O	and	_	0	SENT_259	[p12l1558t541r1674b595],
11	in	FW	O	in	conj_and	9	SENT_259	[p12l1696t542r1751b595],
12	vivo	FW	O	vivo	pobj	11	SENT_259	[p12l1772t542r1897b595],
13	studies	NNS	O	study	prep_of	5	SENT_259	[p12l1919t541r2144b595],
14	indicating	VBG	O	indicate	prepc_in	52	SENT_259	[p12l12t627r334b695],
15	that	IN	O	that	complm	23	SENT_259	[p12l359t627r488b681],
16	the	DT	O	the	det	18	SENT_259	[p12l513t627r614b681],
17	transcriptional	JJ	O	transcriptional	amod	18	SENT_259	[p12l641t627r1113b695],
18	activity	NN	O	activity	nsubjpass	23	SENT_259	[p12l1141t628r1378b695],
19	of	IN	O	of	_	0	SENT_259	[p12l1404t627r1470b681],
20	EGFR	NN	ORGANIZATION	egfr	nn	21	SENT_259	[p12l1487t630r1645b681],
21	gene	NN	O	gene	prep_of	18	SENT_259	[p12l1670t643r1820b695],
22	is	VBZ	O	be	auxpass	23	SENT_259	[p12l1848t628r1894b681],
23	related	VBN	O	relate	ccomp	14	SENT_259	[p12l1922t627r2144b681],
24	to	TO	O	to	_	0	SENT_259	[p12l11t722r71b768],
25	the	DT	O	the	det	26	SENT_259	[p12l97t714r199b768],
26	number	NN	O	number	prep_to	23	SENT_259	[p12l225t714r479b768],
27	of	IN	O	of	_	0	SENT_259	[p12l503t714r569b768],
28	CA	NNP	O	CA	nn	29	SENT_259	[p12l588t717r666b768],
29	repeats	NNS	O	repeat	prep_of	26	SENT_259	[p12l692t722r924b782],
30	in	IN	O	in	_	0	SENT_259	[p12l951t715r1010b768],
31	intron	NN	O	intron	prep_in	23	SENT_259	[p12l1036t715r1231b768],
32	1	CD	NUMBER	1	num	31	SENT_259	[p12l1260t717r1284b768],
33	[	CD	NUMBER	[	number	34	SENT_259	[p12l1322t714r1559b782],
34	25,26	CD	NUMBER	25,26	num	35	SENT_259	[p12l1322t714r1559b782],
35	]	NN	O	]	dep	23	SENT_259	[p12l1322t714r1559b782],
36	,	,	O	,	_	0	SENT_259	[p12l1322t714r1559b782],
37	the	DT	O	the	det	39	SENT_259	[p12l1585t714r1686b768],
38	possible	JJ	O	possible	amod	39	SENT_259	[p12l1713t714r1972b782],
39	relationship	NN	O	relationship	nsubjpass	52	SENT_259	[p12l1999t714r2144b768, p12l11t801r274b869],
40	between	IN	O	between	_	0	SENT_259	[p12l290t801r567b856],
41	EGFR	NN	ORGANIZATION	egfr	nn	42	SENT_259	[p12l580t804r739b856],
42	intron	NN	O	intron	prep_between	39	SENT_259	[p12l755t802r950b856],
43	1	CD	NUMBER	1	num	44	SENT_259	[p12l970t804r994b855],
44	polymorphism	NN	O	polymorphism	dep	42	SENT_259	[p12l1019t801r1492b869],
45	and	CC	O	and	_	0	SENT_259	[p12l1508t801r1624b855],
46	the	DT	O	the	det	47	SENT_259	[p12l1641t801r1742b855],
47	outcomes	NNS	O	outcome	prep_between	39	SENT_259	[p12l1759t809r2069b856],
48	of	IN	O	of	_	0	SENT_259	[p12l2086t801r2153b855],
49	geﬁtinib	NN	O	geﬁtinib	nn	50	SENT_259	[p12l10t888r277b956],
50	treatment	NN	O	treatment	prep_of	47	SENT_259	[p12l298t896r621b943],
51	was	VBD	O	be	auxpass	52	SENT_259	[p12l639t904r762b943],
52	analyzed	VBN	O	analyze	_	0	SENT_259	[p12l785t888r1069b956],
53	in	IN	O	in	_	0	SENT_259	[p12l1091t889r1150b942],
54	our	PRP$	O	we	poss	55	SENT_259	[p12l1172t904r1280b942],
55	study	NN	O	study	prep_in	52	SENT_259	[p12l1300t888r1487b956],
56	.	.	O	.	_	0	SENT_259	[p12l1300t888r1487b956],

1	To	TO	O	to	aux	2	SENT_260	[p12l1507t892r1579b943],
2	evaluate	VB	O	evaluate	purpcl	8	SENT_260	[p12l1602t888r1869b943],
3	the	DT	O	the	det	5	SENT_260	[p12l1890t888r1992b943],
4	predictive	JJ	O	predictive	amod	5	SENT_260	[p12l2014t904r2144b956, p12l12t976r223b1030],
5	value	NN	O	value	dobj	2	SENT_260	[p12l244t976r430b1038],
6	,	,	O	,	_	0	SENT_260	[p12l244t976r430b1038],
7	we	PRP	O	we	nsubj	8	SENT_260	[p12l452t991r545b1030],
8	divided	VBD	O	divide	_	0	SENT_260	[p12l568t976r805b1030],
9	patients	NNS	O	patient	dobj	8	SENT_260	[p12l828t976r1085b1043],
10	into	IN	O	into	_	0	SENT_260	[p12l1109t976r1232b1030],
11	two	CD	NUMBER	two	num	12	SENT_260	[p12l1254t984r1375b1030],
12	subgroups	NNS	O	subgroup	prep_into	8	SENT_260	[p12l1398t976r1728b1043],
13	according	VBG	O	accord	_	0	SENT_260	[p12l1751t976r2064b1043],
14	to	TO	O	to	prepc_according_to	8	SENT_260	[p12l2084t984r2144b1030],
15	the	DT	O	the	det	16	SENT_260	[p12l11t1063r112b1117],
16	presence	NN	O	presence	pobj	8	SENT_260	[p12l129t1078r412b1130],
17	of	IN	O	of	_	0	SENT_260	[p12l429t1063r495b1117],
18	the	DT	O	the	det	19	SENT_260	[p12l502t1063r603b1117],
19	allele	NN	O	allele	prep_of	16	SENT_260	[p12l619t1063r788b1117],
20	16	CD	NUMBER	16	dep	25	SENT_260	[p12l807t1066r876b1117],
21	[	CD	NUMBER	[	num	22	SENT_260	[p12l895t1063r1106b1130],
22	(	NN	O	(	dep	20	SENT_260	[p12l895t1063r1106b1130],
23	CA	NNP	O	CA	nn	24	SENT_260	[p12l895t1063r1106b1130],
24	)	NNP	O	)	dep	25	SENT_260	[p12l895t1063r1106b1130],
25	15	CD	NUMBER	15	dep	16	SENT_260	[p12l895t1063r1106b1130],
26	and	CC	O	and	_	0	SENT_260	[p12l1126t1063r1241b1117],
27	(	CD	NUMBER	(	num	28	SENT_260	[p12l1258t1063r1477b1132],
28	CA	NNP	O	CA	conj_and	25	SENT_260	[p12l1258t1063r1477b1132],
29	)	CD	NUMBER	)	num	28	SENT_260	[p12l1258t1063r1477b1132],
30	e	LS	O	e	dep	32	SENT_260	[p12l1258t1063r1477b1132],
31	,	,	O	,	_	0	SENT_260	[p12l1258t1063r1477b1132],
32	se	FW	O	se	dep	16	SENT_260	[p12l1258t1063r1477b1132],
33	genotype	NN	O	genotype	nn	34	SENT_260	[p12l1494t1063r1832b1130],
34	]	NN	O	]	nsubj	43	SENT_260	[p12l1494t1063r1832b1130],
35	,	,	O	,	_	0	SENT_260	[p12l1494t1063r1832b1130],
36	considering	VBG	O	consider	_	0	SENT_260	[p12l1848t1063r2144b1117, p12l12t1150r110b1217],
37	our	PRP$	O	we	poss	39	SENT_260	[p12l126t1165r235b1203],
38	previous	JJ	O	previous	amod	39	SENT_260	[p12l250t1150r524b1217],
39	clinical	JJ	O	clinical	prep_considering	34	SENT_260	[p12l542t1149r768b1203],
40	and	CC	O	and	_	0	SENT_260	[p12l786t1149r902b1203],
41	pre-clinical	JJ	O	pre-clinical	amod	42	SENT_260	[p12l920t1149r1281b1217],
42	results	NNS	O	result	prep_considering	34	SENT_260	[p12l1300t1149r1511b1203],
43	[	VBP	O	[	rcmod	32	SENT_260	[p12l1533t1149r1672b1217],
44	23	CD	NUMBER	23	num	45	SENT_260	[p12l1533t1149r1672b1217],
45	]	CD	NUMBER	]	dobj	43	SENT_260	[p12l1533t1149r1672b1217],
46	.	.	O	.	_	0	SENT_260	[p12l1533t1149r1672b1217],

1	No	DT	O	no	det	2	SENT_261	[p12l1691t1152r1776b1203],
2	correlation	NN	O	correlation	nsubjpass	4	SENT_261	[p12l1794t1149r2145b1203],
3	was	VBD	O	be	auxpass	4	SENT_261	[p12l10t1252r133b1290],
4	observed	VBN	O	observe	_	0	SENT_261	[p12l152t1236r442b1290],
5	between	IN	O	between	_	0	SENT_261	[p12l460t1236r736b1290],
6	(	CD	NUMBER	(	num	7	SENT_261	[p12l754t1236r916b1304],
7	CA	NNP	O	CA	prep_between	4	SENT_261	[p12l754t1236r916b1304],
8	)	CD	NUMBER	)	num	7	SENT_261	[p12l754t1236r916b1304],
9	n	NN	O	n	nn	11	SENT_261	[p12l754t1236r916b1304],
10	repeat	NN	O	repeat	nn	11	SENT_261	[p12l939t1244r1142b1304],
11	polymorphism	NN	O	polymorphism	dep	7	SENT_261	[p12l1159t1236r1632b1304],
12	and	CC	O	and	_	0	SENT_261	[p12l1649t1236r1766b1290],
13	clinical	JJ	O	clinical	amod	16	SENT_261	[p12l1784t1236r2010b1290],
14	and	CC	O	and	_	0	SENT_261	[p12l2028t1236r2144b1290],
15	biological	JJ	O	biological	amod	16	SENT_261	[p12l11t1323r319b1391],
16	characteristics	NNS	O	characteristic	conj_and	7	SENT_261	[p12l340t1323r816b1378],
17	.	.	O	.	_	0	SENT_261	[p12l340t1323r816b1378],

1	We	PRP	O	we	nsubj	2	SENT_262	[p12l834t1327r939b1378],
2	found	VBD	O	find	_	0	SENT_262	[p12l959t1323r1144b1377],
3	that	IN	O	that	complm	44	SENT_262	[p12l1163t1323r1292b1378],
4	patients	NNS	O	patient	nsubj	44	SENT_262	[p12l1310t1324r1568b1391],
5	lacking	VBG	O	lack	dep	4	SENT_262	[p12l1589t1323r1816b1391],
6	the	DT	O	the	det	8	SENT_262	[p12l1834t1323r1935b1378],
7	(	CD	NUMBER	(	num	8	SENT_262	[p12l1955t1324r2143b1391],
8	CA	NNP	O	CA	dobj	5	SENT_262	[p12l1955t1324r2143b1391],
9	)	CD	NUMBER	)	number	10	SENT_262	[p12l1955t1324r2143b1391],
10	15	CD	NUMBER	15	num	11	SENT_262	[p12l1955t1324r2143b1391],
11	allele	NN	O	allele	npadvmod	12	SENT_262	[p12l12t1411r180b1465],
12	almost	RB	O	almost	advmod	5	SENT_262	[p12l203t1411r420b1465],
13	universally	RB	O	universally	advmod	5	SENT_262	[p12l441t1410r804b1478],
14	,	,	O	,	_	0	SENT_262	[p12l441t1410r804b1478],
15	except	IN	O	except	_	0	SENT_262	[p12l828t1419r1035b1478],
16	two	CD	NUMBER	two	num	17	SENT_262	[p12l1055t1419r1176b1465],
17	EGFR	NN	ORGANIZATION	egfr	prep_except	5	SENT_262	[p12l1197t1413r1355b1465],
18	mutated	VBN	O	mutate	partmod	17	SENT_262	[p12l1377t1411r1647b1465],
19	patients	NNS	O	patient	dobj	18	SENT_262	[p12l1670t1411r1944b1478],
20	,	,	O	,	_	0	SENT_262	[p12l1670t1411r1944b1478],
21	experience	NN	O	experience	conj_and	19	SENT_262	[p12l1967t1426r2144b1478, p12l12t1499r207b1552],
22	rapid	JJ	O	rapid	amod	24	SENT_262	[p12l225t1498r389b1565],
23	disease	NN	O	disease	nn	24	SENT_262	[p12l407t1498r638b1552],
24	progression	NN	O	progression	dep	21	SENT_262	[p12l656t1499r1031b1565],
25	and	CC	O	and	_	0	SENT_262	[p12l1048t1498r1164b1552],
26	short	JJ	O	short	amod	27	SENT_262	[p12l1183t1498r1348b1552],
27	survival	NN	O	survival	dobj	18	SENT_262	[p12l1364t1498r1613b1552],
28	despite	IN	O	despite	_	0	SENT_262	[p12l1631t1498r1862b1565],
29	geﬁtinib	NN	O	geﬁtinib	nn	30	SENT_262	[p12l1878t1498r2145b1565],
30	treatment	NN	O	treatment	prep_despite	18	SENT_262	[p12l11t1593r348b1647],
31	,	,	O	,	_	0	SENT_262	[p12l11t1593r348b1647],
32	suggesting	VBG	O	suggest	partmod	18	SENT_262	[p12l369t1586r710b1652],
33	a	DT	O	a	det	37	SENT_262	[p12l728t1600r760b1639],
34	possible	JJ	O	possible	amod	37	SENT_262	[p12l779t1585r1038b1652],
35	negative	JJ	O	negative	amod	37	SENT_262	[p12l1059t1586r1327b1652],
36	predictive	JJ	O	predictive	amod	37	SENT_262	[p12l1347t1585r1666b1652],
37	value	NN	O	value	dobj	32	SENT_262	[p12l1684t1585r1854b1639],
38	of	IN	O	of	_	0	SENT_262	[p12l1874t1585r1941b1639],
39	(	CD	NUMBER	(	prep_of	37	SENT_262	[p12l1952t1585r2141b1652],
40	CA	NNP	O	CA	dep	44	SENT_262	[p12l1952t1585r2141b1652],
41	)	CD	NUMBER	)	number	42	SENT_262	[p12l1952t1585r2141b1652],
42	15	CD	NUMBER	15	num	44	SENT_262	[p12l1952t1585r2141b1652],
43	allele	NN	O	allele	nn	44	SENT_262	[p12l12t1671r180b1725],
44	absence	NN	O	absence	ccomp	2	SENT_262	[p12l209t1671r463b1725],
45	in	IN	O	in	_	0	SENT_262	[p12l491t1672r550b1725],
46	the	DT	O	the	det	47	SENT_262	[p12l577t1671r678b1725],
47	response	NN	O	response	prep_in	44	SENT_262	[p12l707t1687r991b1739],
48	to	TO	O	to	_	0	SENT_262	[p12l1019t1679r1079b1725],
49	EGFR	NN	ORGANIZATION	egfr	nn	51	SENT_262	[p12l1108t1674r1275b1725],
50	TKI	NN	O	tkus	nn	51	SENT_262	[p12l1297t1674r1401b1725],
51	therapy	NN	O	therapy	prep_to	44	SENT_262	[p12l1429t1671r1686b1739],
52	.	.	O	.	_	0	SENT_262	[p12l1429t1671r1686b1739],

1	Nevertheless	RB	O	nevertheless	advmod	27	SENT_263	[p12l1716t1671r2144b1733],
2	,	,	O	,	_	0	SENT_263	[p12l1716t1671r2144b1733],
3	without	IN	O	without	_	0	SENT_263	[p12l10t1758r267b1812],
4	a	DT	O	a	det	6	SENT_263	[p12l291t1774r323b1812],
5	control	NN	O	control	nn	6	SENT_263	[p12l348t1758r574b1812],
6	group	NN	O	group	prep_without	27	SENT_263	[p12l598t1774r801b1826],
7	,	,	O	,	_	0	SENT_263	[p12l598t1774r801b1826],
8	the	DT	O	the	det	11	SENT_263	[p12l826t1758r927b1812],
9	truly	RB	O	truly	advmod	11	SENT_263	[p12l952t1758r1106b1826],
10	predictive	JJ	O	predictive	amod	11	SENT_263	[p12l1130t1758r1449b1826],
11	role	NN	O	role	appos	6	SENT_263	[p12l1475t1758r1595b1812],
12	for	IN	O	for	_	0	SENT_263	[p12l1621t1758r1710b1812],
13	this	DT	O	this	det	14	SENT_263	[p12l1733t1758r1849b1812],
14	variable	JJ	O	variable	prep_for	11	SENT_263	[p12l1873t1758r2144b1821],
15	,	,	O	,	_	0	SENT_263	[p12l1873t1758r2144b1821],
16	and	CC	O	and	_	0	SENT_263	[p12l12t1845r128b1900],
17	also	RB	O	also	advmod	27	SENT_263	[p12l148t1845r271b1900],
18	for	IN	O	for	_	0	SENT_263	[p12l292t1845r381b1899],
19	the	DT	O	the	det	22	SENT_263	[p12l398t1845r499b1900],
20	other	JJ	O	other	amod	22	SENT_263	[p12l520t1845r691b1900],
21	biological	JJ	O	biological	amod	22	SENT_263	[p12l707t1845r1016b1913],
22	factors	NNS	O	factor	prep_for	27	SENT_263	[p12l1037t1845r1266b1908],
23	,	,	O	,	_	0	SENT_263	[p12l1037t1845r1266b1908],
24	can	MD	O	can	aux	27	SENT_263	[p12l1287t1853r1504b1900],
25	not	RB	O	not	neg	27	SENT_263	[p12l1287t1853r1504b1900],
26	be	VB	O	be	cop	27	SENT_263	[p12l1521t1845r1595b1900],
27	distinctly	RB	O	distinctly	conj_and	27	SENT_263	[p12l1616t1845r1915b1913],
28	clarify	VB	O	clarify	ccomp	27	SENT_263	[p12l1934t1845r2144b1913],
29	.	.	O	.	_	0	SENT_263	[p12l1934t1845r2144b1913],

1	Concerning	VBG	O	concern	_	0	SENT_264	[p12l114t1933r479b2000],
2	tissue	NN	O	tissue	nn	3	SENT_264	[p12l493t1933r678b1987],
3	biomarkers	NNS	O	biomarker	dobj	1	SENT_264	[p12l694t1933r1073b1995],
4	,	,	O	,	_	0	SENT_264	[p12l694t1933r1073b1995],
5	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_264	[p12l1088t1935r1246b1987],
6	gene	NN	O	gene	nn	7	SENT_264	[p12l1255t1948r1401b2000],
7	mutations	NNS	O	mutation	dobj	1	SENT_264	[p12l1417t1933r1742b1987],
8	or	CC	O	or	_	0	SENT_264	[p12l1760t1948r1826b1987],
9	increased	VBN	O	increase	amod	13	SENT_264	[p12l1840t1933r2144b1987],
10	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_264	[p12l9t2023r167b2074],
11	gene	NN	O	gene	nn	13	SENT_264	[p12l187t2035r333b2087],
12	copy	NN	O	copy	nn	13	SENT_264	[p12l359t2035r509b2087],
13	number	NN	O	number	dobj	1	SENT_264	[p12l534t2020r789b2074],
14	assessed	VBN	O	assess	partmod	13	SENT_264	[p12l813t2020r1086b2074],
15	by	IN	O	by	_	0	SENT_264	[p12l1113t2020r1188b2087],
16	FISH	NN	O	fish	agent	14	SENT_264	[p12l1214t2023r1355b2074],
17	identify	VBP	O	identify	dep	1	SENT_264	[p12l1383t2020r1631b2087],
18	NSCLC	NN	O	nsclc	nn	19	SENT_264	[p12l1656t2023r1861b2074],
19	patients	NNS	O	patient	dobj	17	SENT_264	[p12l1887t2021r2144b2087],
20	with	IN	O	with	_	0	SENT_264	[p12l10t2106r158b2160],
21	the	DT	O	the	det	23	SENT_264	[p12l208t2106r310b2160],
22	highest	JJS	O	highest	amod	23	SENT_264	[p12l362t2106r597b2174],
23	probability	NN	O	probability	prep_with	19	SENT_264	[p12l647t2106r1000b2174],
24	to	TO	O	to	aux	25	SENT_264	[p12l1049t2114r1110b2160],
25	respond	VB	O	respond	xcomp	17	SENT_264	[p12l1162t2106r1420b2174],
26	to	TO	O	to	_	0	SENT_264	[p12l1471t2114r1531b2160],
27	geﬁtinib	NN	O	geﬁtinib	nn	28	SENT_264	[p12l1582t2106r1849b2174],
28	therapy	NN	O	therapy	prep_to	25	SENT_264	[p12l1900t2106r2147b2174],
29	[	CD	NUMBER	[	num	28	SENT_264	[p12l15t2193r373b2261],
30	20,27	CD	NUMBER	20,27	num	33	SENT_264	[p12l15t2193r373b2261],
31	—	NN	O	—	nn	33	SENT_264	[p12l15t2193r373b2261],
32	29	CD	NUMBER	29	num	33	SENT_264	[p12l15t2193r373b2261],
33	]	NN	O	]	nsubj	1	SENT_264	[p12l15t2193r373b2261],
34	.	.	O	.	_	0	SENT_264	[p12l15t2193r373b2261],

1	The	DT	O	the	det	2	SENT_265	[p12l407t2193r523b2247],
2	association	NN	O	association	nsubj	8	SENT_265	[p12l560t2194r916b2247],
3	between	IN	O	between	_	0	SENT_265	[p12l951t2193r1227b2247],
4	response	NN	O	response	prep_between	2	SENT_265	[p12l1263t2209r1547b2261],
5	to	TO	O	to	_	0	SENT_265	[p12l1583t2201r1643b2247],
6	TI	NNP	O	TI	nn	7	SENT_265	[p12l1677t2196r1812b2247],
7	(	NNP	O	(	prep_to	4	SENT_265	[p12l1677t2196r1812b2247],
8	Is	VBZ	O	be	_	0	SENT_265	[p12l1677t2196r1812b2247],
9	and	CC	O	and	_	0	SENT_265	[p12l1849t2193r1965b2247],
10	both	DT	O	both	preconj	13	SENT_265	[p12l2000t2193r2145b2247],
11	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_265	[p12l9t2283r167b2334],
12	gene	NN	O	gene	nn	13	SENT_265	[p12l191t2296r337b2348],
13	mutations	NNS	O	mutation	nsubjpass	19	SENT_265	[p12l368t2281r693b2334],
14	and	CC	O	and	_	0	SENT_265	[p12l724t2280r840b2334],
15	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_265	[p12l869t2283r1026b2334],
16	FISH	NN	O	fish	conj_and	13	SENT_265	[p12l1056t2283r1198b2334],
17	have	VBP	O	have	aux	19	SENT_265	[p12l1229t2280r1375b2334],
18	been	VBN	O	be	auxpass	19	SENT_265	[p12l1405t2280r1560b2334],
19	conﬁrmed	VBN	O	conﬁrmed	conj_and	8	SENT_265	[p12l1590t2280r1919b2334],
20	in	IN	O	in	_	0	SENT_265	[p12l1950t2281r2008b2334],
21	our	PRP$	O	we	poss	22	SENT_265	[p12l2039t2296r2147b2334],
22	trial	NN	O	trial	prep_in	19	SENT_265	[p12l11t2367r156b2422],
23	.	.	O	.	_	0	SENT_265	[p12l11t2367r156b2422],

1	In	IN	O	in	_	0	SENT_266	[p12l194t2371r254b2421],
2	fact	NN	O	fact	prep_in	17	SENT_266	[p12l291t2367r420b2430],
3	,	,	O	,	_	0	SENT_266	[p12l291t2367r420b2430],
4	82	CD	PERCENT	82	num	5	SENT_266	[p12l459t2370r579b2422],
5	%	NN	PERCENT	%	nsubj	17	SENT_266	[p12l459t2370r579b2422],
6	of	IN	O	of	_	0	SENT_266	[p12l616t2367r682b2421],
7	EGFR	NN	ORGANIZATION	egfr	prep_of	5	SENT_266	[p12l709t2370r867b2422],
8	mutated	VBN	O	mutate	partmod	7	SENT_266	[p12l903t2367r1173b2422],
9	and	CC	O	and	_	0	SENT_266	[p12l1210t2367r1326b2422],
10	50	CD	PERCENT	50	num	11	SENT_266	[p12l1364t2370r1484b2422],
11	%	NN	PERCENT	%	prep_of	5	SENT_266	[p12l1364t2370r1484b2422],
12	of	IN	O	of	_	0	SENT_266	[p12l1520t2367r1586b2421],
13	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_266	[p12l1613t2370r1771b2422],
14	FISH	NN	O	fish	nn	16	SENT_266	[p12l1807t2370r1948b2422],
15	positive	JJ	O	positive	amod	16	SENT_266	[p12l1987t2368r2144b2435, p12l11t2455r127b2509],
16	patients	NNS	O	patient	prep_of	11	SENT_266	[p12l157t2455r414b2522],
17	had	VBD	O	have	_	0	SENT_266	[p12l444t2455r560b2509],
18	an	DT	O	a	det	20	SENT_266	[p12l589t2470r664b2509],
19	objective	JJ	O	objective	amod	20	SENT_266	[p12l693t2455r981b2522],
20	response	NN	O	response	dobj	17	SENT_266	[p12l1011t2470r1295b2522],
21	to	TO	O	to	_	0	SENT_266	[p12l1324t2463r1384b2509],
22	geﬁtinib	JJ	O	geﬁtinib	prep_to	17	SENT_266	[p12l1413t2454r1679b2522],
23	versus	CC	O	versus	prep	22	SENT_266	[p12l1707t2470r1911b2509],
24	10	CD	PERCENT	10	num	25	SENT_266	[p12l1945t2457r2058b2509],
25	%	NN	PERCENT	%	dep	23	SENT_266	[p12l1945t2457r2058b2509],
26	of	IN	O	of	_	0	SENT_266	[p12l2087t2454r2153b2509],
27	wild	JJ	O	wild	amod	29	SENT_266	[p12l10t2542r324b2609],
28	—	NN	O	—	nn	29	SENT_266	[p12l10t2542r324b2609],
29	type	NN	O	type	prep_of	25	SENT_266	[p12l10t2542r324b2609],
30	and	CC	O	and	_	0	SENT_266	[p12l352t2542r468b2596],
31	14	CD	PERCENT	14	num	32	SENT_266	[p12l500t2545r612b2596],
32	%	NN	PERCENT	%	conj_and	25	SENT_266	[p12l500t2545r612b2596],
33	of	IN	O	of	_	0	SENT_266	[p12l640t2542r706b2596],
34	EGFR	NN	ORGANIZATION	egfr	nn	37	SENT_266	[p12l724t2545r882b2596],
35	FISH	NN	O	fish	nn	37	SENT_266	[p12l909t2545r1050b2596],
36	negative	JJ	O	negative	amod	37	SENT_266	[p12l1080t2543r1348b2609],
37	patients	NNS	O	patient	prep_of	32	SENT_266	[p12l1376t2543r1650b2609],
38	,	,	O	,	_	0	SENT_266	[p12l1376t2543r1650b2609],
39	respectively	RB	O	respectively	advmod	17	SENT_266	[p12l1680t2542r2075b2609],
40	.	.	O	.	_	0	SENT_266	[p12l1680t2542r2075b2609],

1	A	DT	O	a	det	2	SENT_267	[p12l2101t2544r2148b2595],
2	trend	NN	O	trend	nsubjpass	8	SENT_267	[p12l11t2628r182b2682],
3	in	IN	O	in	_	0	SENT_267	[p12l207t2629r266b2682],
4	survival	NN	O	survival	nn	5	SENT_267	[p12l290t2628r539b2682],
5	difference	NN	O	difference	prep_in	2	SENT_267	[p12l564t2628r884b2682],
6	have	VBP	O	have	aux	8	SENT_267	[p12l909t2628r1055b2682],
7	been	VBN	O	be	auxpass	8	SENT_267	[p12l1079t2628r1233b2682],
8	observed	VBN	O	observe	_	0	SENT_267	[p12l1256t2628r1546b2682],
9	according	VBG	O	accord	_	0	SENT_267	[p12l1570t2628r1883b2696],
10	to	TO	O	to	prepc_according_to	8	SENT_267	[p12l1905t2636r1965b2682],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_267	[p12l1988t2631r2146b2682],
12	mutations	NNS	O	mutation	pobj	8	SENT_267	[p12l12t2716r338b2769],
13	and	CC	O	and	_	0	SENT_267	[p12l364t2715r479b2769],
14	copy	NN	O	copy	nn	15	SENT_267	[p12l505t2731r655b2783],
15	number	NN	O	number	conj_and	12	SENT_267	[p12l678t2715r942b2778],
16	,	,	O	,	_	0	SENT_267	[p12l678t2715r942b2778],
17	although	IN	O	although	mark	18	SENT_267	[p12l968t2715r1254b2783],
18	not	RB	O	not	dep	15	SENT_267	[p12l1279t2723r1383b2769],
19	statistically	RB	O	statistically	advmod	20	SENT_267	[p12l1407t2715r1773b2783],
20	signiﬁcant	JJ	O	signiﬁcant	dep	18	SENT_267	[p12l1797t2715r2144b2783],
21	,	,	O	,	_	0	SENT_267	[p12l1797t2715r2144b2783],
22	probably	RB	O	probably	advmod	15	SENT_267	[p12l12t2802r296b2870],
23	due	JJ	O	due	_	0	SENT_267	[p12l316t2802r432b2857],
24	to	TO	O	to	_	0	SENT_267	[p12l455t2810r515b2857],
25	the	DT	O	the	det	28	SENT_267	[p12l537t2802r639b2857],
26	relatively	RB	O	relatively	advmod	27	SENT_267	[p12l662t2802r960b2870],
27	small	JJ	O	small	amod	28	SENT_267	[p12l982t2802r1151b2857],
28	number	NN	O	number	prep_due_to	15	SENT_267	[p12l1175t2802r1429b2857],
29	of	IN	O	of	_	0	SENT_267	[p12l1449t2802r1516b2856],
30	cases	NNS	O	case	prep_of	28	SENT_267	[p12l1531t2818r1711b2857],
31	.	.	O	.	_	0	SENT_267	[p12l1531t2818r1711b2857],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_268	[p12l114t2892r280b2944],
2	expression	NN	O	expression	nsubj	21	SENT_268	[p12l296t2890r640b2957],
3	as	IN	O	as	mark	10	SENT_268	[p12l659t2905r721b2944],
4	assessed	VBN	O	assess	csubj	10	SENT_268	[p12l741t2889r1015b2944],
5	by	IN	O	by	_	0	SENT_268	[p12l1034t2889r1110b2957],
6	immunohistochemistry	NN	O	immunohistochemistry	prep_by	4	SENT_268	[p12l1128t2889r1886b2957],
7	was	VBD	O	be	cop	10	SENT_268	[p12l1901t2905r2024b2944],
8	the	DT	O	the	det	10	SENT_268	[p12l2043t2889r2145b2944],
9	ﬁrst	JJ	O	ﬁrst	amod	10	SENT_268	[p12l12t2976r138b3031],
10	biomarker	NN	O	biomarker	dep	2	SENT_268	[p12l170t2977r504b3031],
11	investigated	VBN	O	investigate	partmod	10	SENT_268	[p12l536t2977r924b3044],
12	as	IN	O	as	_	0	SENT_268	[p12l958t2992r1020b3031],
13	a	DT	O	a	det	15	SENT_268	[p12l1055t2992r1087b3031],
14	potential	JJ	O	potential	amod	15	SENT_268	[p12l1121t2977r1406b3044],
15	predictor	NN	O	predictor	prep_as	11	SENT_268	[p12l1441t2977r1736b3044],
16	of	IN	O	of	_	0	SENT_268	[p12l1768t2976r1834b3031],
17	response	NN	O	response	prep_of	15	SENT_268	[p12l1860t2992r2145b3044],
18	to	TO	O	to	_	0	SENT_268	[p12l11t3072r71b3118],
19	TI	NNP	O	TI	nn	20	SENT_268	[p12l99t3067r250b3118],
20	(	NNP	O	(	prep_to	11	SENT_268	[p12l99t3067r250b3118],
21	Is	VBZ	O	be	_	0	SENT_268	[p12l99t3067r250b3118],
22	.	.	O	.	_	0	SENT_268	[p12l99t3067r250b3118],

1	Several	JJ	O	several	amod	2	SENT_269	[p12l281t3064r508b3118],
2	studies	NNS	O	study	nsubj	3	SENT_269	[p12l539t3064r763b3118],
3	failed	VBD	O	fail	dep	21	SENT_269	[p12l794t3064r985b3126],
4	,	,	O	,	_	0	SENT_269	[p12l794t3064r985b3126],
5	however	RB	O	however	advmod	3	SENT_269	[p12l1016t3064r1303b3126],
6	,	,	O	,	_	0	SENT_269	[p12l1016t3064r1303b3126],
7	to	TO	O	to	aux	8	SENT_269	[p12l1332t3072r1392b3118],
8	show	VB	O	show	xcomp	3	SENT_269	[p12l1423t3064r1592b3118],
9	any	DT	O	any	det	10	SENT_269	[p12l1620t3079r1732b3131],
10	relationship	NN	O	relationship	dobj	8	SENT_269	[p12l1760t3064r2144b3131],
11	between	IN	O	between	_	0	SENT_269	[p12l11t3150r288b3204],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_269	[p12l317t3153r483b3204],
13	expression	NN	O	expression	prep_between	10	SENT_269	[p12l510t3151r854b3218],
14	and	CC	O	and	_	0	SENT_269	[p12l883t3150r999b3204],
15	the	DT	O	the	det	17	SENT_269	[p12l1028t3150r1129b3204],
16	clinical	JJ	O	clinical	amod	17	SENT_269	[p12l1159t3150r1385b3204],
17	activity	NN	O	activity	conj_and	10	SENT_269	[p12l1415t3151r1652b3218],
18	of	IN	O	of	_	0	SENT_269	[p12l1680t3150r1746b3204],
19	these	DT	O	these	det	20	SENT_269	[p12l1767t3150r1937b3204],
20	drugs	NNS	O	drug	prep_of	17	SENT_269	[p12l1967t3150r2144b3218],
21	[	VBP	O	[	_	0	SENT_269	[p12l15t3237r293b3305],
22	l0	NN	O	l0	dobj	21	SENT_269	[p12l15t3237r293b3305],
23	,30,3	CD	NUMBER	,30,3	num	25	SENT_269	[p12l15t3237r293b3305],
24	l	NN	O	l	nn	25	SENT_269	[p12l15t3237r293b3305],
25	]	NN	O	]	nsubj	21	SENT_269	[p12l311t3237r342b3305],
26	.	.	O	.	_	0	SENT_269	[p12l311t3237r342b3305],

1	Our	PRP$	O	we	poss	2	SENT_270	[p12l364t3240r483b3291],
2	study	NN	O	study	nsubj	4	SENT_270	[p12l502t3237r678b3305],
3	has	VBZ	O	have	aux	4	SENT_270	[p12l697t3237r802b3291],
4	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_270	[p12l823t3237r1152b3291],
5	these	DT	O	these	det	6	SENT_270	[p12l1172t3237r1342b3291],
6	ﬁndings	NNS	O	ﬁndings	dobj	4	SENT_270	[p12l1363t3237r1635b3305],
7	,	,	O	,	_	0	SENT_270	[p12l1363t3237r1635b3305],
8	suggesting	VBG	O	suggest	dep	4	SENT_270	[p12l1658t3238r1999b3305],
9	that	IN	O	that	complm	16	SENT_270	[p12l2017t3237r2146b3291],
10	immunohistochemical	JJ	O	immunohistochemical	amod	11	SENT_270	[p12l12t3324r733b3379],
11	test	NN	O	test	nsubj	16	SENT_270	[p12l751t3332r868b3379],
12	is	VBZ	O	be	cop	16	SENT_270	[p12l884t3325r930b3379],
13	not	RB	O	not	neg	16	SENT_270	[p12l949t3332r1054b3379],
14	an	DT	O	a	det	16	SENT_270	[p12l1070t3340r1144b3379],
15	optimal	JJ	O	optimal	amod	16	SENT_270	[p12l1161t3324r1408b3392],
16	method	NN	O	method	ccomp	8	SENT_270	[p12l1426t3324r1673b3379],
17	for	IN	O	for	_	0	SENT_270	[p12l1691t3324r1780b3379],
18	identifying	VBG	O	identify	prepc_for	16	SENT_270	[p12l1796t3324r2147b3392],
19	patients	NNS	O	patient	nsubj	27	SENT_270	[p12l12t3412r269b3479],
20	responsive	JJ	O	responsive	dep	27	SENT_270	[p12l294t3412r634b3479],
21	to	TO	O	to	_	0	SENT_270	[p12l658t3420r718b3466],
22	treatment	NN	O	treatment	prep_to	20	SENT_270	[p12l741t3420r1064b3466],
23	with	IN	O	with	_	0	SENT_270	[p12l1083t3412r1231b3466],
24	EGFR	NN	ORGANIZATION	egfr	prep_with	22	SENT_270	[p12l1254t3414r1421b3466],
25	TI	NNP	O	TI	nn	26	SENT_270	[p12l1438t3415r1589b3474],
26	(	NNP	O	(	nsubj	27	SENT_270	[p12l1438t3415r1589b3474],
27	Is	VBZ	O	be	xcomp	18	SENT_270	[p12l1438t3415r1589b3474],
28	,	,	O	,	_	0	SENT_270	[p12l1438t3415r1589b3474],
29	being	VBG	O	be	auxpass	30	SENT_270	[p12l1612t3412r1790b3479],
30	difﬁcult	VBN	O	difﬁcult	conj_and	8	SENT_270	[p12l1812t3411r2063b3466],
31	to	TO	O	to	aux	32	SENT_270	[p12l2084t3420r2144b3466],
32	standardize	VB	O	standardize	xcomp	30	SENT_270	[p12l13t3499r384b3553],
33	and	CC	O	and	_	0	SENT_270	[p12l407t3499r523b3553],
34	suffering	VBG	O	suffer	conj_and	8	SENT_270	[p12l546t3498r831b3566],
35	from	IN	O	from	_	0	SENT_270	[p12l853t3498r1004b3553],
36	intrinsic	JJ	O	intrinsic	amod	37	SENT_270	[p12l1027t3499r1291b3553],
37	subjectivity	NN	O	subjectivity	prep_from	34	SENT_270	[p12l1314t3499r1698b3566],
38	.	.	O	.	_	0	SENT_270	[p12l1314t3499r1698b3566],

1	HER2	NN	O	her2	nn	3	SENT_271	[p12l111t3589r277b3639],
2	FISH	NN	O	fish	nn	3	SENT_271	[p12l295t3589r436b3640],
3	evaluation	NN	O	evaluation	nsubj	6	SENT_271	[p12l455t3586r790b3640],
4	did	VBD	O	do	aux	6	SENT_271	[p12l807t3586r906b3640],
5	not	RB	O	not	neg	6	SENT_271	[p12l925t3594r1029b3640],
6	show	VB	O	show	_	0	SENT_271	[p12l1045t3586r1215b3640],
7	any	DT	O	any	det	8	SENT_271	[p12l1230t3601r1343b3653],
8	relevance	NN	O	relevance	iobj	6	SENT_271	[p12l1359t3586r1662b3640],
9	in	IN	O	in	_	0	SENT_271	[p12l1681t3587r1740b3639],
10	our	PRP$	O	we	poss	11	SENT_271	[p12l1756t3601r1865b3640],
11	study	NN	O	study	prep_in	8	SENT_271	[p12l1881t3586r2067b3653],
12	,	,	O	,	_	0	SENT_271	[p12l1881t3586r2067b3653],
13	in	IN	O	in	_	0	SENT_271	[p12l2086t3587r2145b3639],
14	contrast	NN	O	contrast	prep_in	8	SENT_271	[p12l12t3680r272b3726],
15	with	IN	O	with	_	0	SENT_271	[p12l286t3672r434b3726],
16	Cappuzzo	NNP	PERSON	Cappuzzo	prep_with	14	SENT_271	[p12l451t3675r761b3740],
17	et	FW	O	et	nn	19	SENT_271	[p12l779t3680r838b3726],
18	al.	FW	O	al.	nn	19	SENT_271	[p12l854t3672r922b3727],
19	[	FW	O	[	dobj	6	SENT_271	[p12l943t3672r1026b3740],
20	11	CD	NUMBER	11	num	21	SENT_271	[p12l943t3672r1026b3740],
21	]	NN	O	]	npadvmod	6	SENT_271	[p12l1044t3672r1057b3740],
22	that	WDT	O	that	nsubj	23	SENT_271	[p12l1077t3672r1206b3726],
23	reported	VBD	O	report	rcmod	21	SENT_271	[p12l1222t3672r1497b3740],
24	that	IN	O	that	complm	31	SENT_271	[p12l1514t3672r1643b3726],
25	increased	VBN	O	increase	csubjpass	31	SENT_271	[p12l1659t3672r1963b3726],
26	HER2	NN	O	her2	nn	29	SENT_271	[p12l1979t3675r2145b3726],
27	gene	NN	O	gene	nn	29	SENT_271	[p12l6t3775r152b3827],
28	copy	NN	O	copy	nn	29	SENT_271	[p12l175t3775r325b3827],
29	number	NN	O	number	dobj	25	SENT_271	[p12l347t3759r602b3813],
30	is	VBZ	O	be	auxpass	31	SENT_271	[p12l624t3760r670b3813],
31	associated	VBN	O	associate	ccomp	23	SENT_271	[p12l694t3759r1025b3813],
32	with	IN	O	with	_	0	SENT_271	[p12l1047t3759r1195b3813],
33	response	NN	O	response	prep_with	31	SENT_271	[p12l1219t3775r1503b3827],
34	to	TO	O	to	_	0	SENT_271	[p12l1527t3767r1587b3813],
35	geﬁtinib	NN	O	geﬁtinib	nn	36	SENT_271	[p12l1610t3759r1877b3827],
36	therapy	NN	O	therapy	prep_to	31	SENT_271	[p12l1900t3759r2147b3827],
37	in	IN	O	in	_	0	SENT_271	[p13l12t23r71b76],
38	EGFR-positive	JJ	O	egfr-positive	amod	40	SENT_271	[p13l93t23r538b90],
39	NSCLC	NN	O	nsclc	nn	40	SENT_271	[p13l561t25r766b77],
40	patients	NNS	O	patient	prep_in	6	SENT_271	[p13l788t23r1062b90],
41	.	.	O	.	_	0	SENT_271	[p13l788t23r1062b90],

1	Nevertheless	RB	O	nevertheless	advmod	7	SENT_272	[p13l114t110r542b172],
2	,	,	O	,	_	0	SENT_272	[p13l114t110r542b172],
3	the	DT	O	the	det	5	SENT_272	[p13l564t110r665b164],
4	sample	NN	O	sample	nn	5	SENT_272	[p13l689t110r916b177],
5	size	NN	O	size	nsubj	7	SENT_272	[p13l939t110r1058b164],
6	may	MD	O	may	aux	7	SENT_272	[p13l1081t125r1217b177],
7	limit	VB	O	limit	_	0	SENT_272	[p13l1237t110r1388b164],
8	the	DT	O	the	det	9	SENT_272	[p13l1408t110r1510b164],
9	value	NN	O	value	dep	21	SENT_272	[p13l1530t110r1700b164],
10	of	IN	O	of	_	0	SENT_272	[p13l1723t109r1790b164],
11	our	PRP$	O	we	poss	12	SENT_272	[p13l1804t125r1912b164],
12	results	NNS	O	result	prep_of	9	SENT_272	[p13l1933t110r2144b164],
13	about	IN	O	about	_	0	SENT_272	[p13l12t197r194b251],
14	HER2	NN	O	her2	nn	15	SENT_272	[p13l220t200r389b250],
15	gene	NN	O	gene	prep_about	12	SENT_272	[p13l417t212r567b264],
16	(	CD	NUMBER	(	num	15	SENT_272	[p13l594t197r759b264],
17	only	RB	O	only	advmod	19	SENT_272	[p13l594t197r759b264],
18	11	CD	NUMBER	11	num	19	SENT_272	[p13l787t200r845b250],
19	patients	NNS	O	patient	dep	21	SENT_272	[p13l880t198r1137b264],
20	HER2	NN	O	her2	nn	21	SENT_272	[p13l1163t200r1329b250],
21	FISH	NN	O	fish	dep	30	SENT_272	[p13l1356t200r1497b251],
22	positive	JJ	O	positive	amod	21	SENT_272	[p13l1526t198r1775b264],
23	and	CC	O	and	_	0	SENT_272	[p13l1802t197r1918b251],
24	only	RB	O	only	quantmod	25	SENT_272	[p13l1946t197r2084b264],
25	8	CD	NUMBER	8	num	26	SENT_272	[p13l2109t200r2143b251],
26	patients	NNS	O	patient	conj_and	21	SENT_272	[p13l12t285r269b351],
27	EGFR	NN	ORGANIZATION	egfr	nn	30	SENT_272	[p13l290t287r449b338],
28	and	CC	O	and	_	0	SENT_272	[p13l470t284r586b338],
29	HER2	NN	O	her2	nn	30	SENT_272	[p13l607t287r772b337],
30	FISH	NN	O	fish	dep	7	SENT_272	[p13l795t287r936b338],
31	positive	JJ	O	positive	amod	32	SENT_272	[p13l960t284r1252b351],
32	)	NN	O	)	dep	30	SENT_272	[p13l960t284r1252b351],
33	.	.	O	.	_	0	SENT_272	[p13l960t284r1252b351],

1	Although	IN	O	although	mark	5	SENT_273	[p13l111t370r409b438],
2	available	JJ	O	available	amod	3	SENT_273	[p13l443t370r723b424],
3	data	NNS	O	datum	nsubj	5	SENT_273	[p13l759t370r896b424],
4	may	MD	O	may	aux	5	SENT_273	[p13l931t386r1067b438],
5	allow	VB	O	allow	advcl	18	SENT_273	[p13l1100t370r1274b424],
6	identiﬁcation	NN	O	identiﬁcation	dobj	5	SENT_273	[p13l1308t370r1738b424],
7	of	IN	O	of	_	0	SENT_273	[p13l1772t370r1839b424],
8	sensitive	JJ	O	sensitive	amod	9	SENT_273	[p13l1867t371r2145b424],
9	populations	NNS	O	population	prep_of	6	SENT_273	[p13l12t457r408b525],
10	,	,	O	,	_	0	SENT_273	[p13l12t457r408b525],
11	at	IN	O	at	_	0	SENT_273	[p13l448t465r508b511],
12	present	JJ	DATE	present	prep_at	5	SENT_273	[p13l546t465r801b525],
13	,	,	O	,	_	0	SENT_273	[p13l546t465r801b525],
14	K-ms	JJ	O	k-ms	amod	16	SENT_273	[p13l839t461r1000b511],
15	mutation	NN	O	mutation	nn	16	SENT_273	[p13l1039t458r1334b511],
16	test	NN	O	test	nsubj	18	SENT_273	[p13l1373t465r1490b511],
17	certainly	RB	O	certainly	advmod	18	SENT_273	[p13l1528t457r1810b525],
18	identiﬁes	VBZ	O	identiﬁes	_	0	SENT_273	[p13l1848t457r2144b511],
19	refractory	JJ	O	refractory	amod	21	SENT_273	[p13l12t544r328b612],
20	NSCLC	NN	O	nsclc	nn	21	SENT_273	[p13l344t547r549b599],
21	patients	NNS	O	patient	dobj	18	SENT_273	[p13l566t545r823b612],
22	[	IN	O	[	_	0	SENT_273	[p13l844t544r943b612],
23	9	CD	NUMBER	9	num	24	SENT_273	[p13l844t544r943b612],
24	]	NN	O	]	prep_[	18	SENT_273	[p13l844t544r943b612],
25	.	.	O	.	_	0	SENT_273	[p13l844t544r943b612],

1	Also	RB	O	also	advmod	12	SENT_274	[p13l959t544r1095b599],
2	in	IN	O	in	_	0	SENT_274	[p13l1113t545r1172b598],
3	our	PRP$	O	we	poss	4	SENT_274	[p13l1189t560r1297b599],
4	series	NN	O	series	prep_in	12	SENT_274	[p13l1313t545r1510b607],
5	,	,	O	,	_	0	SENT_274	[p13l1313t545r1510b607],
6	the	DT	O	the	det	8	SENT_274	[p13l1528t544r1629b599],
7	7	CD	NUMBER	7	num	8	SENT_274	[p13l1648t548r1681b598],
8	K-ras	NN	O	k-ra	nsubj	16	SENT_274	[p13l1697t548r1858b598],
9	mutated	VBN	O	mutate	partmod	8	SENT_274	[p13l1875t544r2144b599],
10	patients	NNS	O	patient	dobj	9	SENT_274	[p13l12t632r269b699],
11	were	VBD	O	be	cop	12	SENT_274	[p13l287t647r445b686],
12	non-responder	JJ	O	non-responder	_	0	SENT_274	[p13l465t631r945b699],
13	and	CC	O	and	_	0	SENT_274	[p13l961t632r1077b686],
14	did	VBD	O	do	aux	16	SENT_274	[p13l1096t632r1196b686],
15	not	RB	O	not	neg	16	SENT_274	[p13l1215t640r1319b686],
16	harbor	VB	O	harbor	conj_and	12	SENT_274	[p13l1337t632r1551b686],
17	concomitant	JJ	O	concomitant	amod	20	SENT_274	[p13l1568t632r1973b686],
18	EGFR	NN	ORGANIZATION	egfr	nn	20	SENT_274	[p13l1988t634r2146b686],
19	gene	NN	O	gene	nn	20	SENT_274	[p13l6t734r152b786],
20	mutation	NN	O	mutation	dobj	16	SENT_274	[p13l174t720r485b773],
21	.	.	O	.	_	0	SENT_274	[p13l174t720r485b773],

1	Our	PRP$	O	we	poss	2	SENT_275	[p13l114t808r232b859],
2	data	NNS	O	datum	nsubj	3	SENT_275	[p13l271t805r408b859],
3	suggest	VBP	O	suggest	dep	22	SENT_275	[p13l450t813r689b873],
4	that	IN	O	that	complm	11	SENT_275	[p13l728t805r857b859],
5	clinical	JJ	O	clinical	amod	8	SENT_275	[p13l897t805r1122b859],
6	and	CC	O	and	_	0	SENT_275	[p13l1164t805r1280b859],
7	molecular	JJ	O	molecular	amod	8	SENT_275	[p13l1322t805r1645b859],
8	characteristics	NNS	O	characteristic	nsubjpass	11	SENT_275	[p13l1684t805r2144b859],
9	should	MD	O	should	aux	11	SENT_275	[p13l13t893r226b947],
10	be	VB	O	be	auxpass	11	SENT_275	[p13l261t893r335b947],
11	used	VBN	O	use	ccomp	3	SENT_275	[p13l371t893r519b947],
12	in	IN	O	in	_	0	SENT_275	[p13l555t894r614b947],
13	combination	NN	O	combination	prep_in	11	SENT_275	[p13l649t893r1055b947],
14	for	IN	O	for	_	0	SENT_275	[p13l1090t893r1179b947],
15	the	DT	O	the	det	16	SENT_275	[p13l1211t893r1313b947],
16	evaluation	NN	O	evaluation	prep_for	13	SENT_275	[p13l1348t893r1684b947],
17	of	IN	O	of	_	0	SENT_275	[p13l1719t893r1785b947],
18	EGFR	NN	ORGANIZATION	egfr	prep_of	16	SENT_275	[p13l1813t896r1980b947],
19	TI	NNP	O	TI	nn	20	SENT_275	[p13l2009t897r2144b947],
20	(	NNP	O	(	nsubj	22	SENT_275	[p13l2009t897r2144b947],
21	Is	VBZ	O	be	cop	22	SENT_275	[p13l2009t897r2144b947],
22	efﬁcacy	NN	O	efﬁcacy	_	0	SENT_275	[p13l12t980r267b1048],
23	.	.	O	.	_	0	SENT_275	[p13l12t980r267b1048],

1	However	RB	O	however	advmod	6	SENT_276	[p13l298t984r595b1043],
2	,	,	O	,	_	0	SENT_276	[p13l298t984r595b1043],
3	our	PRP$	O	we	poss	5	SENT_276	[p13l626t996r735b1034],
4	prospective	JJ	O	prospective	amod	5	SENT_276	[p13l763t981r1132b1048],
5	analysis	NN	O	analysis	nsubj	6	SENT_276	[p13l1162t980r1414b1048],
6	has	VBZ	O	have	_	0	SENT_276	[p13l1446t980r1550b1034],
7	some	DT	O	some	det	8	SENT_276	[p13l1582t996r1750b1034],
8	limitations	NNS	O	limitation	dobj	6	SENT_276	[p13l1781t980r2144b1035],
9	.	.	O	.	_	0	SENT_276	[p13l1781t980r2144b1035],

1	Tissue	NN	O	tissue	nn	2	SENT_277	[p13l9t1068r209b1122],
2	acquisition	NN	O	acquisition	nsubj	4	SENT_277	[p13l262t1068r613b1135],
3	was	VBD	O	be	cop	4	SENT_277	[p13l664t1083r786b1122],
4	difﬁcult	JJ	O	difﬁcult	ccomp	26	SENT_277	[p13l840t1067r1090b1122],
5	and	CC	O	and	_	0	SENT_277	[p13l1141t1067r1257b1121],
6	in	IN	O	in	_	0	SENT_277	[p13l1311t1068r1369b1121],
7	many	JJ	O	many	amod	8	SENT_277	[p13l1422t1083r1599b1135],
8	cases	NNS	O	case	prep_in	14	SENT_277	[p13l1650t1083r1814b1122],
9	parafﬁnembedded	JJ	O	parafﬁnembedded	amod	11	SENT_277	[p13l1867t1067r2144b1135, p13l12t1155r351b1209],
10	tumor	NN	O	tumor	nn	11	SENT_277	[p13l382t1163r583b1209],
11	material	NN	O	material	nsubj	14	SENT_277	[p13l612t1155r878b1209],
12	was	VBD	O	be	cop	14	SENT_277	[p13l908t1170r1030b1209],
13	not	RB	O	not	neg	14	SENT_277	[p13l1063t1163r1167b1209],
14	sufﬁcient	JJ	O	sufﬁcient	ccomp	26	SENT_277	[p13l1198t1154r1496b1209],
15	for	IN	O	for	_	0	SENT_277	[p13l1527t1154r1615b1209],
16	determining	VBG	O	determine	prepc_for	14	SENT_277	[p13l1644t1155r2042b1222],
17	all	DT	O	all	det	19	SENT_277	[p13l2071t1155r2145b1209],
18	molecular	JJ	O	molecular	amod	19	SENT_277	[p13l12t1242r335b1296],
19	markers	NNS	O	marker	dobj	16	SENT_277	[p13l367t1242r643b1304],
20	,	,	O	,	_	0	SENT_277	[p13l367t1242r643b1304],
21	as	IN	O	as	_	0	SENT_277	[p13l677t1257r739b1296],
22	other	JJ	O	other	amod	23	SENT_277	[p13l774t1242r945b1296],
23	investigators	NNS	O	investigator	prep_as	26	SENT_277	[p13l977t1243r1385b1309],
24	have	VBP	O	have	aux	26	SENT_277	[p13l1420t1242r1567b1296],
25	already	RB	O	already	advmod	26	SENT_277	[p13l1600t1242r1837b1309],
26	reported	VBN	O	report	_	0	SENT_277	[p13l1869t1242r2144b1309],
27	[	NN	O	[	nsubj	26	SENT_277	[p13l15t1328r275b1396],
28	27	CD	NUMBER	27	number	29	SENT_277	[p13l15t1328r275b1396],
29	—	CD	NUMBER	—	dep	27	SENT_277	[p13l15t1328r275b1396],
30	29	CD	NUMBER	29	num	31	SENT_277	[p13l15t1328r275b1396],
31	]	NN	O	]	dep	29	SENT_277	[p13l15t1328r275b1396],
32	.	.	O	.	_	0	SENT_277	[p13l15t1328r275b1396],

1	Additionally	RB	O	additionally	advmod	8	SENT_278	[p13l307t1328r714b1396],
2	,	,	O	,	_	0	SENT_278	[p13l307t1328r714b1396],
3	our	PRP$	O	we	poss	5	SENT_278	[p13l749t1344r857b1382],
4	sample	NN	O	sample	nn	5	SENT_278	[p13l890t1328r1117b1396],
5	size	NN	O	size	nsubj	8	SENT_278	[p13l1152t1329r1271b1382],
6	was	VBD	O	be	cop	8	SENT_278	[p13l1303t1344r1426b1382],
7	rather	RB	O	rather	advmod	8	SENT_278	[p13l1461t1328r1657b1382],
8	small	JJ	O	small	_	0	SENT_278	[p13l1690t1328r1859b1382],
9	and	CC	O	and	_	0	SENT_278	[p13l1893t1328r2009b1382],
10	the	DT	O	the	det	11	SENT_278	[p13l2043t1328r2145b1382],
11	associations	NNS	O	association	nsubj	13	SENT_278	[p13l12t1416r398b1469],
12	here	RB	O	here	advmod	13	SENT_278	[p13l428t1415r567b1469],
13	reported	VBD	O	report	conj_and	8	SENT_278	[p13l595t1415r871b1483],
14	as	IN	O	as	_	0	SENT_278	[p13l899t1431r962b1469],
15	statistically	RB	O	statistically	advmod	16	SENT_278	[p13l991t1415r1357b1483],
16	signiﬁcant	JJ	O	signiﬁcant	amod	18	SENT_278	[p13l1385t1415r1718b1483],
17	need	NN	O	need	nn	18	SENT_278	[p13l1745t1415r1898b1469],
18	validation	NN	O	validation	prep_as	13	SENT_278	[p13l1925t1415r2144b1469, p13l11t1503r138b1556],
19	in	IN	O	in	_	0	SENT_278	[p13l174t1503r233b1556],
20	future	JJ	DATE	future	amod	21	SENT_278	[p13l270t1502r464b1557],
21	studies	NNS	O	study	prep_in	13	SENT_278	[p13l502t1502r743b1557],
22	.	.	O	.	_	0	SENT_278	[p13l502t1502r743b1557],

1	Finally	RB	O	finally	advmod	18	SENT_279	[p13l782t1502r1004b1570],
2	,	,	O	,	_	0	SENT_279	[p13l782t1502r1004b1570],
3	because	IN	O	because	mark	9	SENT_279	[p13l1041t1502r1296b1557],
4	this	DT	O	this	nsubj	9	SENT_279	[p13l1333t1502r1449b1557],
5	was	VBD	O	be	cop	9	SENT_279	[p13l1485t1518r1608b1557],
6	a	DT	O	a	det	9	SENT_279	[p13l1646t1518r1678b1557],
7	single	JJ	O	single	amod	9	SENT_279	[p13l1715t1502r1901b1570],
8	cohort	NN	O	cohort	nn	9	SENT_279	[p13l1938t1502r2146b1557],
9	study	NN	O	study	advcl	18	SENT_279	[p13l13t1589r189b1657],
10	without	IN	O	without	_	0	SENT_279	[p13l215t1589r472b1644],
11	a	DT	O	a	det	13	SENT_279	[p13l501t1605r533b1643],
12	control	NN	O	control	nn	13	SENT_279	[p13l562t1589r788b1644],
13	group	NN	O	group	prep_without	9	SENT_279	[p13l817t1605r1020b1657],
14	,	,	O	,	_	0	SENT_279	[p13l817t1605r1020b1657],
15	we	PRP	O	we	nsubj	18	SENT_279	[p13l1049t1605r1141b1644],
16	can	MD	O	can	aux	18	SENT_279	[p13l1172t1597r1389b1644],
17	not	RB	O	not	neg	18	SENT_279	[p13l1172t1597r1389b1644],
18	say	VB	O	say	_	0	SENT_279	[p13l1418t1605r1520b1657],
19	whether	IN	O	whether	complm	26	SENT_279	[p13l1546t1589r1820b1644],
20	the	DT	O	the	det	23	SENT_279	[p13l1847t1589r1948b1643],
21	identiﬁed	JJ	O	identiﬁed	amod	23	SENT_279	[p13l1979t1589r2144b1644, p13l11t1676r177b1731],
22	signiﬁcant	NN	O	signiﬁcant	nn	23	SENT_279	[p13l200t1676r533b1744],
23	variables	NNS	O	variable	nsubj	26	SENT_279	[p13l550t1676r836b1731],
24	are	VBP	O	be	cop	26	SENT_279	[p13l858t1692r954b1731],
25	truly	RB	O	truly	advmod	26	SENT_279	[p13l975t1676r1128b1744],
26	predictive	JJ	O	predictive	ccomp	18	SENT_279	[p13l1147t1677r1467b1744],
27	or	CC	O	or	_	0	SENT_279	[p13l1488t1692r1554b1731],
28	simply	RB	O	simply	advmod	29	SENT_279	[p13l1573t1676r1788b1744],
29	prognostic	JJ	O	prognostic	conj_or	26	SENT_279	[p13l1807t1677r2146b1744],
30	of	IN	O	of	_	0	SENT_279	[p13l12t1765r78b1819],
31	outcome	NN	O	outcome	prep_of	26	SENT_279	[p13l93t1773r388b1820],
32	.	.	O	.	_	0	SENT_279	[p13l93t1773r388b1820],

1	5	CD	NUMBER	5	_	0	SENT_280	[p13l11t1868r66b1919],
2	.	.	O	.	_	0	SENT_280	[p13l11t1868r66b1919],

1	Conclusion	NN	O	conclusion	_	0	SENT_281	[p13l112t1865r488b1919],

1	In	IN	O	in	_	0	SENT_282	[p13l114t2045r173b2096],
2	conclusion	NN	O	conclusion	prep_in	13	SENT_282	[p13l203t2042r562b2105],
3	,	,	O	,	_	0	SENT_282	[p13l203t2042r562b2105],
4	despite	IN	O	despite	_	0	SENT_282	[p13l592t2042r823b2110],
5	these	DT	O	these	det	6	SENT_282	[p13l853t2042r1023b2096],
6	limitations	NNS	O	limitation	prep_despite	13	SENT_282	[p13l1053t2042r1416b2104],
7	,	,	O	,	_	0	SENT_282	[p13l1053t2042r1416b2104],
8	in	IN	O	in	_	0	SENT_282	[p13l1447t2043r1506b2096],
9	our	PRP$	O	we	poss	10	SENT_282	[p13l1536t2058r1644b2096],
10	study	NN	O	study	prep_in	13	SENT_282	[p13l1673t2042r1849b2110],
11	we	PRP	O	we	nsubj	13	SENT_282	[p13l1875t2058r1968b2096],
12	have	VBP	O	have	aux	13	SENT_282	[p13l1998t2042r2144b2096],
13	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_282	[p13l12t2129r340b2183],
14	the	DT	O	the	det	16	SENT_282	[p13l360t2129r461b2183],
15	important	JJ	O	important	amod	16	SENT_282	[p13l481t2130r806b2197],
16	role	NN	O	role	dobj	13	SENT_282	[p13l824t2129r945b2183],
17	of	IN	O	of	_	0	SENT_282	[p13l965t2129r1031b2183],
18	EGFR	NN	ORGANIZATION	egfr	nn	20	SENT_282	[p13l1040t2132r1198b2183],
19	gene	NN	O	gene	nn	20	SENT_282	[p13l1211t2145r1357b2197],
20	mutation	NN	O	mutation	prep_of	16	SENT_282	[p13l1376t2130r1672b2183],
21	as	IN	O	as	mark	29	SENT_282	[p13l1691t2145r1752b2183],
22	predictor	NN	O	predictor	nsubj	29	SENT_282	[p13l1773t2129r2069b2197],
23	of	IN	O	of	_	0	SENT_282	[p13l2086t2129r2152b2183],
24	response	NN	O	response	prep_of	22	SENT_282	[p13l12t2232r296b2284],
25	to	TO	O	to	_	0	SENT_282	[p13l313t2224r374b2270],
26	EGFR	NN	ORGANIZATION	egfr	nn	28	SENT_282	[p13l392t2219r558b2270],
27	TI	NNP	O	TI	nn	28	SENT_282	[p13l570t2220r721b2271],
28	(	NNP	O	(	prep_to	24	SENT_282	[p13l570t2220r721b2271],
29	Is	VBZ	O	be	advcl	13	SENT_282	[p13l570t2220r721b2271],
30	.	.	O	.	_	0	SENT_282	[p13l570t2220r721b2271],

1	Moreover	RB	O	moreover	advmod	7	SENT_283	[p13l740t2220r1060b2279],
2	,	,	O	,	_	0	SENT_283	[p13l740t2220r1060b2279],
3	our	PRP$	O	we	poss	5	SENT_283	[p13l1078t2232r1186b2270],
4	molecular	JJ	O	molecular	amod	5	SENT_283	[p13l1202t2216r1525b2270],
5	analysis	NN	O	analysis	nsubj	7	SENT_283	[p13l1540t2216r1792b2284],
6	has	VBZ	O	have	aux	7	SENT_283	[p13l1811t2216r1915b2270],
7	shown	VBN	O	show	_	0	SENT_283	[p13l1935t2216r2145b2270],
8	that	IN	O	that	complm	16	SENT_283	[p13l11t2303r140b2357],
9	patient	NN	O	patient	nn	10	SENT_283	[p13l162t2304r391b2371],
10	selection	NN	O	selection	nsubjpass	16	SENT_283	[p13l414t2303r699b2358],
11	for	IN	O	for	_	0	SENT_283	[p13l723t2303r812b2358],
12	geﬁtinib	NN	O	geﬁtinib	nn	13	SENT_283	[p13l832t2303r1099b2371],
13	treatment	NN	O	treatment	prep_for	10	SENT_283	[p13l1122t2311r1444b2358],
14	may	MD	O	may	aux	16	SENT_283	[p13l1467t2319r1603b2371],
15	be	VB	O	be	auxpass	16	SENT_283	[p13l1624t2303r1698b2358],
16	optimized	VBN	O	optimize	ccomp	7	SENT_283	[p13l1723t2303r2047b2371],
17	by	IN	O	by	_	0	SENT_283	[p13l2070t2303r2147b2371],
18	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_283	[p13l9t2393r167b2445],
19	FISH	NN	O	fish	agent	16	SENT_283	[p13l201t2393r342b2445],
20	and	CC	O	and	_	0	SENT_283	[p13l376t2391r492b2445],
21	EGFR	NN	ORGANIZATION	egfr	nn	22	SENT_283	[p13l523t2393r681b2445],
22	intron	NN	O	intron	conj_and	19	SENT_283	[p13l715t2391r910b2445],
23	1	CD	NUMBER	1	num	24	SENT_283	[p13l947t2394r971b2444],
24	polymorphism	NN	O	polymorphism	dep	19	SENT_283	[p13l1013t2391r1501b2458],
25	.	.	O	.	_	0	SENT_283	[p13l1013t2391r1501b2458],

1	Future	JJ	DATE	future	amod	3	SENT_284	[p13l1536t2394r1741b2445],
2	prospective	JJ	O	prospective	amod	3	SENT_284	[p13l1775t2391r2144b2458],
3	studies	NNS	O	study	nsubj	11	SENT_284	[p13l12t2478r253b2540],
4	,	,	O	,	_	0	SENT_284	[p13l12t2478r253b2540],
5	with	IN	O	with	_	0	SENT_284	[p13l273t2478r420b2532],
6	optimal	JJ	O	optimal	amod	8	SENT_284	[p13l441t2478r686b2545],
7	tissue	NN	O	tissue	nn	8	SENT_284	[p13l707t2479r892b2532],
8	sampling	NN	O	sampling	prep_with	3	SENT_284	[p13l914t2478r1222b2545],
9	,	,	O	,	_	0	SENT_284	[p13l914t2478r1222b2545],
10	should	MD	O	should	aux	11	SENT_284	[p13l1244t2478r1457b2532],
11	include	VB	O	include	_	0	SENT_284	[p13l1479t2478r1713b2532],
12	these	DT	O	these	det	14	SENT_284	[p13l1733t2478r1902b2532],
13	molecular	JJ	O	molecular	amod	14	SENT_284	[p13l1924t2478r2144b2532, p13l11t2564r138b2618],
14	markers	NNS	O	marker	dobj	11	SENT_284	[p13l159t2564r418b2618],
15	together	RB	O	together	_	0	SENT_284	[p13l442t2564r714b2632],
16	with	IN	O	with	_	0	SENT_284	[p13l733t2564r881b2618],
17	other	JJ	O	other	amod	19	SENT_284	[p13l904t2564r1075b2618],
18	biological	JJ	O	biological	amod	19	SENT_284	[p13l1095t2564r1404b2632],
19	parameters	NNS	O	parameter	prep_together_with	11	SENT_284	[p13l1428t2572r1789b2632],
20	associated	VBN	O	associate	partmod	19	SENT_284	[p13l1813t2564r2144b2618],
21	with	IN	O	with	_	0	SENT_284	[p13l10t2651r158b2705],
22	resistant	JJ	O	resistant	amod	25	SENT_284	[p13l174t2652r451b2705],
23	or	CC	O	or	_	0	SENT_284	[p13l466t2667r532b2705],
24	sensitive	JJ	O	sensitive	amod	25	SENT_284	[p13l547t2652r825b2705],
25	mechanisms	NNS	O	mechanism	prep_with	20	SENT_284	[p13l842t2651r1242b2705],
26	to	TO	O	to	aux	28	SENT_284	[p13l1259t2659r1320b2705],
27	further	JJ	O	further	advmod	28	SENT_284	[p13l1338t2651r1564b2705],
28	improve	VB	O	improve	xcomp	20	SENT_284	[p13l1579t2652r1842b2719],
29	selection	NN	O	selection	dobj	28	SENT_284	[p13l1860t2651r2145b2705],
30	of	IN	O	of	_	0	SENT_284	[p13l12t2738r78b2792],
31	patient	NN	O	patient	prep_of	29	SENT_284	[p13l93t2739r321b2806],
32	treated	VBN	O	treat	partmod	31	SENT_284	[p13l341t2738r570b2793],
33	with	IN	O	with	_	0	SENT_284	[p13l591t2738r739b2792],
34	EGFR	NN	ORGANIZATION	egfr	prep_with	32	SENT_284	[p13l761t2741r928b2793],
35	TI	NNP	O	TI	nsubj	37	SENT_284	[p13l944t2742r1096b2793],
36	<	JJR	O	<	amod	35	SENT_284	[p13l944t2742r1096b2793],
37	Is	VBZ	O	be	dep	28	SENT_284	[p13l944t2742r1096b2793],
38	.	.	O	.	_	0	SENT_284	[p13l944t2742r1096b2793],

1	Conﬂict	NN	O	conﬂict	_	0	SENT_285	[p13l11t2959r272b3014],
2	of	IN	O	of	_	0	SENT_285	[p13l292t2959r363b3014],
3	interest	NN	O	interest	prep_of	1	SENT_285	[p13l379t2959r640b3014],

1	No	DT	O	no	det	2	SENT_286	[p13l114t3140r199b3191],
2	conﬂicts	NNS	O	conﬂicts	_	0	SENT_286	[p13l222t3137r488b3191],
3	of	IN	O	of	_	0	SENT_286	[p13l512t3137r578b3191],
4	interest	NN	O	interest	prep_of	2	SENT_286	[p13l593t3138r838b3191],
5	for	IN	O	for	_	0	SENT_286	[p13l859t3137r948b3191],
6	all	DT	O	all	det	7	SENT_286	[p13l968t3137r1042b3191],
7	authors	NNS	O	author	prep_for	2	SENT_286	[p13l1065t3137r1323b3192],
8	.	.	O	.	_	0	SENT_286	[p13l1065t3137r1323b3192],

1	References	NNS	O	reference	_	0	SENT_287	[p13l11t3345r375b3399],

1	[	NN	O	[	nn	5	SENT_288	[p14l37t63r101b118],
2	1	CD	NUMBER	1	num	5	SENT_288	[p14l37t63r101b118],
3	]	CD	NUMBER	]	num	5	SENT_288	[p14l37t63r101b118],
4	Bunn	NNP	PERSON	Bunn	nn	5	SENT_288	[p14l136t66r268b107],
5	Jr	NNP	PERSON	Jr	_	0	SENT_288	[p14l288t66r333b118],
6	PA	NN	PERSON	pa	dep	5	SENT_288	[p14l359t65r434b114],
7	,	,	O	,	_	0	SENT_288	[p14l359t65r434b114],
8	Franklin	NNP	PERSON	Franklin	nn	9	SENT_288	[p14l461t63r670b107],
9	WA	NNP	O	WA	appos	6	SENT_288	[p14l694t65r798b107],
10	.	.	O	.	_	0	SENT_288	[p14l694t65r798b107],

1	Epidermal	JJ	O	epidermal	amod	5	SENT_289	[p14l826t63r1088b118],
2	growth	NN	O	growth	nn	5	SENT_289	[p14l1115t63r1300b118],
3	factor	NN	O	factor	nn	5	SENT_289	[p14l1327t63r1474b107],
4	receptor	NN	O	receptor	nn	5	SENT_289	[p14l1499t70r1714b118],
5	expression	NN	O	expression	_	0	SENT_289	[p14l1739t64r2026b118],
6	,	,	O	,	_	0	SENT_289	[p14l1739t64r2026b118],
7	signal	NN	O	signal	nn	8	SENT_289	[p14l2054t64r2145b118, p14l136t129r211b172],
8	pathway	NN	O	pathway	conj_and	5	SENT_289	[p14l250t129r479b183],
9	,	,	O	,	_	0	SENT_289	[p14l250t129r479b183],
10	and	CC	O	and	_	0	SENT_289	[p14l518t129r610b172],
11	inhibitors	NNS	O	inhibitor	conj_and	5	SENT_289	[p14l649t129r896b172],
12	in	IN	O	in	_	0	SENT_289	[p14l934t129r981b172],
13	non	JJ	O	non	amod	18	SENT_289	[p14l1019t129r1278b172],
14	—	JJ	O	—	amod	18	SENT_289	[p14l1019t129r1278b172],
15	small	JJ	O	small	amod	18	SENT_289	[p14l1019t129r1278b172],
16	cell	NN	O	cell	nn	18	SENT_289	[p14l1316t129r1402b172],
17	lung	NN	O	lung	nn	18	SENT_289	[p14l1440t129r1552b183],
18	cancer	NN	O	cancer	prep_in	11	SENT_289	[p14l1589t141r1764b173],
19	.	.	O	.	_	0	SENT_289	[p14l1589t141r1764b173],

1	Semin	NNP	O	Semin	nn	2	SENT_290	[p14l1803t129r1961b172],
2	Oncol	NNP	O	Oncol	_	0	SENT_290	[p14l1999t129r2145b172],
3	2002	CD	DATE	2002	num	2	SENT_290	[p14l135t195r530b249],
4	;	:	O	;	_	0	SENT_290	[p14l135t195r530b249],
5	29	CD	NUMBER	29	number	6	SENT_290	[p14l135t195r530b249],
6	(	CD	NUMBER	(	dep	2	SENT_290	[p14l135t195r530b249],
7	Suppl	NNP	O	Suppl	dep	6	SENT_290	[p14l135t195r530b249],
8	.	.	O	.	_	0	SENT_290	[p14l135t195r530b249],

1	14	CD	NUMBER	14	_	0	SENT_291	[p14l551t195r824b249],
2	)	CD	NUMBER	)	number	3	SENT_291	[p14l551t195r824b249],
3	:38	CD	NUMBER	:38	dep	1	SENT_291	[p14l551t195r824b249],
4	—	NN	O	—	dep	3	SENT_291	[p14l551t195r824b249],
5	44	CD	NUMBER	44	num	4	SENT_291	[p14l551t195r824b249],
6	.	.	O	.	_	0	SENT_291	[p14l551t195r824b249],

1	[	NN	O	[	_	0	SENT_292	[p14l37t260r101b315],
2	2	CD	NUMBER	2	number	3	SENT_292	[p14l37t260r101b315],
3	]	CD	NUMBER	]	num	10	SENT_292	[p14l37t260r101b315],
4	Giaccone	NNP	PERSON	Giaccone	nn	10	SENT_292	[p14l136t261r367b304],
5	G.	NNP	PERSON	G.	nn	10	SENT_292	[p14l392t263r440b304],
6	Epidermal	NNP	PERSON	Epidermal	nn	10	SENT_292	[p14l465t260r728b315],
7	growth	NN	O	growth	nn	10	SENT_292	[p14l751t260r936b315],
8	factor	NN	O	factor	nn	10	SENT_292	[p14l961t260r1108b304],
9	receptor	NN	O	receptor	nn	10	SENT_292	[p14l1131t267r1345b315],
10	inhibitors	NNS	O	inhibitor	dep	1	SENT_292	[p14l1368t260r1616b304],
11	in	IN	O	in	_	0	SENT_292	[p14l1641t261r1688b304],
12	the	DT	O	the	det	13	SENT_292	[p14l1712t260r1793b304],
13	treatment	NN	O	treatment	prep_in	10	SENT_292	[p14l1817t267r2075b304],
14	of	IN	O	of	_	0	SENT_292	[p14l2099t260r2151b304],
15	non	JJ	O	non	amod	20	SENT_292	[p14l136t327r395b370],
16	—	JJ	O	—	amod	20	SENT_292	[p14l136t327r395b370],
17	small	JJ	O	small	amod	20	SENT_292	[p14l136t327r395b370],
18	cell	NN	O	cell	nn	20	SENT_292	[p14l413t327r499b370],
19	lung	NN	O	lung	nn	20	SENT_292	[p14l518t327r630b381],
20	cancer	NN	O	cancer	prep_of	13	SENT_292	[p14l647t330r856b381],
21	.	.	O	.	_	0	SENT_292	[p14l647t330r856b381],

1	J	NNP	O	J	nn	3	SENT_293	[p14l647t330r856b381],
2	Clin	NNP	O	Clin	nn	3	SENT_293	[p14l874t327r972b370],
3	Oncol	NNP	O	Oncol	_	0	SENT_293	[p14l989t327r1135b370],
4	2005	CD	DATE	2005	num	3	SENT_293	[p14l1153t329r1627b377],
5	;	:	O	;	_	0	SENT_293	[p14l1153t329r1627b377],
6	23:3235	CD	NUMBER	23:3235	number	7	SENT_293	[p14l1153t329r1627b377],
7	—	CD	NUMBER	—	dep	3	SENT_293	[p14l1153t329r1627b377],
8	42	CD	NUMBER	42	dep	7	SENT_293	[p14l1153t329r1627b377],
9	.	.	O	.	_	0	SENT_293	[p14l1153t329r1627b377],

1	[	NN	O	[	_	0	SENT_294	[p14l37t393r101b448],
2	3	CD	NUMBER	3	num	1	SENT_294	[p14l37t393r101b448],
3	]	CD	NUMBER	]	num	5	SENT_294	[p14l37t393r101b448],
4	Fukuoka	NNP	LOCATION	Fukuoka	nn	5	SENT_294	[p14l136t393r352b437],
5	M	NN	O	m	dep	1	SENT_294	[p14l386t396r447b443],
6	,	,	O	,	_	0	SENT_294	[p14l386t396r447b443],
7	Yano	NNP	PERSON	Yano	nn	8	SENT_294	[p14l480t396r604b437],
8	S	NNP	O	S	appos	5	SENT_294	[p14l639t395r677b443],
9	,	,	O	,	_	0	SENT_294	[p14l639t395r677b443],
10	Giaccone	NNP	PERSON	Giaccone	nn	11	SENT_294	[p14l712t394r943b437],
11	G	NNP	PERSON	G	appos	5	SENT_294	[p14l978t395r1026b444],
12	,	,	O	,	_	0	SENT_294	[p14l978t395r1026b444],
13	Tamura	NNP	PERSON	Tamura	nn	14	SENT_294	[p14l1059t396r1253b437],
14	T	NN	O	t	appos	5	SENT_294	[p14l1285t396r1324b443],
15	,	,	O	,	_	0	SENT_294	[p14l1285t396r1324b443],
16	Nakagawa	NNP	PERSON	Nakagawa	nn	17	SENT_294	[p14l1359t393r1620b448],
17	K	NNP	PERSON	K	appos	5	SENT_294	[p14l1654t396r1699b443],
18	,	,	O	,	_	0	SENT_294	[p14l1654t396r1699b443],
19	Douillard	NNP	ORGANIZATION	Douillard	nn	20	SENT_294	[p14l1735t393r1972b437],
20	JY	NN	O	jy	appos	5	SENT_294	[p14l2000t396r2064b448],
21	,	,	O	,	_	0	SENT_294	[p14l2000t396r2064b448],
22	et	FW	O	et	nn	23	SENT_294	[p14l2099t400r2146b437],
23	al.	FW	O	al.	appos	5	SENT_294	[p14l135t459r190b503],
24	.	.	O	.	_	0	SENT_294	[p14l135t459r190b503],

1	Multi-institutional	JJ	O	multi-institutional	nsubj	10	SENT_295	[p14l223t459r702b502],
2	randomized	VBN	O	randomize	partmod	1	SENT_295	[p14l735t459r1042b502],
3	phase	NN	O	phase	nn	5	SENT_295	[p14l1075t459r1222b513],
4	II	CD	NUMBER	ii	num	5	SENT_295	[p14l1255t461r1285b502],
5	trial	NN	O	trial	dobj	2	SENT_295	[p14l1317t459r1420b502],
6	of	IN	O	of	_	0	SENT_295	[p14l1453t459r1506b502],
7	geﬁtinib	NN	O	geﬁtinib	prep_of	5	SENT_295	[p14l1531t458r1744b513],
8	for	IN	O	for	prep	2	SENT_295	[p14l1777t458r1848b502],
9	previously	RB	DATE	previously	advmod	10	SENT_295	[p14l1879t459r2147b513],
10	treated	VBN	O	treat	_	0	SENT_295	[p14l135t525r317b569],
11	patients	NNS	O	patient	dobj	10	SENT_295	[p14l356t526r562b580],
12	with	IN	O	with	_	0	SENT_295	[p14l599t525r718b569],
13	advanced	JJ	O	advanced	amod	16	SENT_295	[p14l755t525r997b569],
14	non-small-cell	JJ	O	non-small-cell	amod	16	SENT_295	[p14l1036t525r1409b569],
15	lung	NN	O	lung	nn	16	SENT_295	[p14l1447t525r1560b580],
16	cancer	NN	O	cancer	prep_with	10	SENT_295	[p14l1597t538r1772b569],
17	.	.	O	.	_	0	SENT_295	[p14l1597t538r1772b569],

1	J	NNP	O	J	nn	3	SENT_296	[p14l1805t528r1825b580],
2	Clin	NNP	O	Clin	nn	3	SENT_296	[p14l1863t525r1961b569],
3	Oncol	NNP	O	Oncol	_	0	SENT_296	[p14l1999t525r2145b569],
4	2003	CD	DATE	2003	num	3	SENT_296	[p14l135t593r605b641],
5	;	:	O	;	_	0	SENT_296	[p14l135t593r605b641],
6	21:2237	CD	NUMBER	21:2237	number	7	SENT_296	[p14l135t593r605b641],
7	—	CD	NUMBER	—	dep	3	SENT_296	[p14l135t593r605b641],
8	46	CD	NUMBER	46	dep	7	SENT_296	[p14l135t593r605b641],
9	.	.	O	.	_	0	SENT_296	[p14l135t593r605b641],

1	[	NN	O	[	_	0	SENT_297	[p14l37t657r101b711],
2	4	CD	NUMBER	4	num	1	SENT_297	[p14l37t657r101b711],
3	]	CD	NUMBER	]	num	5	SENT_297	[p14l37t657r101b711],
4	Kris	NNP	PERSON	Kris	nn	5	SENT_297	[p14l136t658r233b701],
5	MG	NN	PERSON	mg	dep	1	SENT_297	[p14l272t659r373b707],
6	,	,	O	,	_	0	SENT_297	[p14l272t659r373b707],
7	Natale	NNP	ORGANIZATION	Natale	nn	8	SENT_297	[p14l413t657r575b701],
8	RB	NN	ORGANIZATION	rb	appos	5	SENT_297	[p14l614t660r691b707],
9	,	,	O	,	_	0	SENT_297	[p14l614t660r691b707],
10	Herbst	NNP	ORGANIZATION	Herbst	nn	11	SENT_297	[p14l731t657r901b701],
11	RS	NN	ORGANIZATION	r	appos	5	SENT_297	[p14l939t659r1012b707],
12	,	,	O	,	_	0	SENT_297	[p14l939t659r1012b707],
13	Lynch	NNP	PERSON	Lynch	nn	15	SENT_297	[p14l1051t657r1200b711],
14	Jr	NNP	PERSON	Jr	nn	15	SENT_297	[p14l1231t660r1276b711],
15	TJ	NNP	PERSON	TJ	appos	5	SENT_297	[p14l1311t660r1372b711],
16	,	,	O	,	_	0	SENT_297	[p14l1311t660r1372b711],
17	Prager	NNP	PERSON	Prager	nn	18	SENT_297	[p14l1411t660r1575b711],
18	D	NNP	O	D	appos	5	SENT_297	[p14l1612t660r1661b707],
19	,	,	O	,	_	0	SENT_297	[p14l1612t660r1661b707],
20	Belani	NNP	PERSON	Belani	nn	21	SENT_297	[p14l1701t657r1857b701],
21	CP	NNP	O	CP	appos	5	SENT_297	[p14l1896t659r1965b707],
22	,	,	O	,	_	0	SENT_297	[p14l1896t659r1965b707],
23	et	FW	O	et	nn	24	SENT_297	[p14l2005t663r2052b701],
24	al.	FW	O	al.	appos	5	SENT_297	[p14l2090t657r2144b701],
25	.	.	O	.	_	0	SENT_297	[p14l2090t657r2144b701],

1	Efﬁcacy	NN	O	efﬁcacy	_	0	SENT_298	[p14l136t722r334b777],
2	of	IN	O	of	_	0	SENT_298	[p14l360t722r413b766],
3	geﬁtinib	NN	O	geﬁtinib	prep_of	1	SENT_298	[p14l434t722r660b777],
4	,	,	O	,	_	0	SENT_298	[p14l434t722r660b777],
5	an	DT	O	a	det	6	SENT_298	[p14l689t735r749b766],
6	inhibitor	NN	O	inhibitor	appos	1	SENT_298	[p14l777t722r1002b766],
7	of	IN	O	of	_	0	SENT_298	[p14l1028t722r1081b766],
8	epidermal	JJ	O	epidermal	amod	13	SENT_298	[p14l1103t722r1364b777],
9	growth	NN	O	growth	nn	13	SENT_298	[p14l1391t722r1576b777],
10	factor	NN	O	factor	nn	13	SENT_298	[p14l1604t722r1752b766],
11	receptor	NN	O	receptor	nn	13	SENT_298	[p14l1779t729r1993b777],
12	tyrosine	NN	O	tyrosine	nn	13	SENT_298	[p14l2019t729r2145b777, p14l136t790r237b832],
13	kinase	NN	O	kinase	prep_of	6	SENT_298	[p14l263t789r438b839],
14	,	,	O	,	_	0	SENT_298	[p14l263t789r438b839],
15	in	IN	O	in	_	0	SENT_298	[p14l464t790r511b832],
16	symptomatic	JJ	O	symptomatic	amod	17	SENT_298	[p14l536t790r872b843],
17	patients	NNS	O	patient	prep_in	1	SENT_298	[p14l896t790r1102b843],
18	with	IN	O	with	_	0	SENT_298	[p14l1127t789r1245b832],
19	non	JJ	O	non	amod	24	SENT_298	[p14l1270t789r1529b832],
20	—	JJ	O	—	amod	24	SENT_298	[p14l1270t789r1529b832],
21	small	JJ	O	small	amod	24	SENT_298	[p14l1270t789r1529b832],
22	cell	NN	O	cell	nn	24	SENT_298	[p14l1555t789r1641b832],
23	lung	NN	O	lung	nn	24	SENT_298	[p14l1667t789r1779b843],
24	cancer	NN	O	cancer	prep_with	17	SENT_298	[p14l1803t801r1979b833],
25	.	.	O	.	_	0	SENT_298	[p14l1803t801r1979b833],

1	JAMA	NNP	O	JAMA	_	0	SENT_299	[p14l1998t791r2147b843],
2	2003	CD	DATE	2003	num	1	SENT_299	[p14l135t857r637b906],
3	;	:	O	;	_	0	SENT_299	[p14l135t857r637b906],
4	290:2149	CD	NUMBER	290:2149	number	5	SENT_299	[p14l135t857r637b906],
5	—	CD	NUMBER	—	dep	1	SENT_299	[p14l135t857r637b906],
6	58	CD	NUMBER	58	dep	5	SENT_299	[p14l135t857r637b906],
7	.	.	O	.	_	0	SENT_299	[p14l135t857r637b906],

1	[	NN	O	[	nn	4	SENT_300	[p14l37t920r101b975],
2	5	CD	NUMBER	5	num	4	SENT_300	[p14l37t920r101b975],
3	]	NN	O	]	nn	4	SENT_300	[p14l37t920r101b975],
4	Perez-Soler	NN	O	perez-soler	_	0	SENT_300	[p14l136t921r429b964],
5	R	NN	O	r	dep	4	SENT_300	[p14l445t923r489b971],
6	,	,	O	,	_	0	SENT_300	[p14l445t923r489b971],
7	Chachoua	NNP	O	Chachoua	nn	8	SENT_300	[p14l508t921r757b964],
8	A	NNP	O	A	appos	5	SENT_300	[p14l773t923r822b971],
9	,	,	O	,	_	0	SENT_300	[p14l773t923r822b971],
10	Hammond	NNP	ORGANIZATION	Hammond	nn	11	SENT_300	[p14l841t921r1112b964],
11	LA	NNP	ORGANIZATION	LA	appos	5	SENT_300	[p14l1131t923r1206b971],
12	,	,	O	,	_	0	SENT_300	[p14l1131t923r1206b971],
13	Rowinsky	NNP	PERSON	Rowinsky	nn	14	SENT_300	[p14l1225t921r1474b975],
14	EK	NNP	O	EK	appos	5	SENT_300	[p14l1491t923r1568b971],
15	,	,	O	,	_	0	SENT_300	[p14l1491t923r1568b971],
16	Huberman	NNP	PERSON	Huberman	nn	17	SENT_300	[p14l1587t921r1860b964],
17	M	NNP	O	M	appos	5	SENT_300	[p14l1879t923r1939b971],
18	,	,	O	,	_	0	SENT_300	[p14l1879t923r1939b971],
19	Karp	NNP	PERSON	Karp	nn	20	SENT_300	[p14l1959t923r2077b975],
20	D	NNP	O	D	appos	5	SENT_300	[p14l2096t923r2144b971],
21	,	,	O	,	_	0	SENT_300	[p14l2096t923r2144b971],
22	et	FW	O	et	nn	23	SENT_300	[p14l135t993r183b1031],
23	al.	FW	O	al.	appos	5	SENT_300	[p14l204t987r258b1031],
24	.	.	O	.	_	0	SENT_300	[p14l204t987r258b1031],

1	Determinants	NNS	O	determinant	_	0	SENT_301	[p14l281t988r632b1031],
2	of	IN	O	of	_	0	SENT_301	[p14l655t987r708b1031],
3	tumor	NN	O	tumor	nn	4	SENT_301	[p14l723t993r884b1031],
4	response	NN	O	response	prep_of	1	SENT_301	[p14l904t1000r1131b1041],
5	and	CC	O	and	_	0	SENT_301	[p14l1153t987r1246b1031],
6	survival	NN	O	survival	prep_of	1	SENT_301	[p14l1270t987r1469b1031],
7	with	IN	O	with	_	0	SENT_301	[p14l1489t987r1608b1031],
8	erlotinib	NN	O	erlotinib	prep_with	1	SENT_301	[p14l1630t987r1847b1031],
9	in	IN	O	in	_	0	SENT_301	[p14l1869t988r1917b1030],
10	patients	NNS	O	patient	prep_in	1	SENT_301	[p14l1939t988r2144b1041],
11	with	IN	O	with	_	0	SENT_301	[p14l134t1052r253b1096],
12	non	JJ	O	non	amod	17	SENT_301	[p14l270t1052r529b1096],
13	—	JJ	O	—	amod	17	SENT_301	[p14l270t1052r529b1096],
14	small	JJ	O	small	amod	17	SENT_301	[p14l270t1052r529b1096],
15	cell	NN	O	cell	nn	17	SENT_301	[p14l548t1052r634b1096],
16	lung	NN	O	lung	nn	17	SENT_301	[p14l652t1052r765b1107],
17	cancer	NN	O	cancer	prep_with	10	SENT_301	[p14l782t1055r990b1107],
18	.	.	O	.	_	0	SENT_301	[p14l782t1055r990b1107],

1	J	NNP	O	J	nn	3	SENT_302	[p14l782t1055r990b1107],
2	Clin	NNP	O	Clin	nn	3	SENT_302	[p14l1008t1053r1106b1096],
3	Oncol	NNP	O	Oncol	_	0	SENT_302	[p14l1124t1053r1270b1096],
4	2004	CD	DATE	2004	num	3	SENT_302	[p14l1288t1055r1756b1103],
5	;	:	O	;	_	0	SENT_302	[p14l1288t1055r1756b1103],
6	22:3238	CD	NUMBER	22:3238	number	7	SENT_302	[p14l1288t1055r1756b1103],
7	—	CD	NUMBER	—	dep	3	SENT_302	[p14l1288t1055r1756b1103],
8	47	CD	NUMBER	47	dep	7	SENT_302	[p14l1288t1055r1756b1103],
9	.	.	O	.	_	0	SENT_302	[p14l1288t1055r1756b1103],

1	[	NN	O	[	_	0	SENT_303	[p14l37t1119r101b1173],
2	6	CD	NUMBER	6	num	10	SENT_303	[p14l37t1119r101b1173],
3	]	CD	NUMBER	]	num	10	SENT_303	[p14l37t1119r101b1173],
4	Ciardiello	NNP	O	Ciardiello	nn	10	SENT_303	[p14l136t1119r379b1162],
5	F	NN	O	f	nn	10	SENT_303	[p14l407t1122r440b1169],
6	,	,	O	,	_	0	SENT_303	[p14l407t1122r440b1169],
7	Tortora	NNP	PERSON	Tortora	dep	10	SENT_303	[p14l465t1122r651b1162],
8	G.	NNP	O	G.	nn	10	SENT_303	[p14l677t1121r725b1163],
9	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_303	[p14l753t1121r886b1162],
10	antagonists	NNS	O	antagonist	dep	1	SENT_303	[p14l910t1120r1203b1173],
11	in	IN	O	in	_	0	SENT_303	[p14l1231t1119r1278b1162],
12	cancer	NN	O	cancer	nn	13	SENT_303	[p14l1304t1131r1472b1162],
13	treatment	NN	O	treatment	prep_in	10	SENT_303	[p14l1496t1125r1765b1163],
14	.	.	O	.	_	0	SENT_303	[p14l1496t1125r1765b1163],

1	N	NN	O	n	nn	2	SENT_304	[p14l1793t1122r1830b1162],
2	EnglJ	NN	O	englj	nsubj	3	SENT_304	[p14l1857t1119r2006b1173],
3	Med	VBD	O	med	_	0	SENT_304	[p14l2033t1119r2145b1162],

1	[	NN	O	[	nn	5	SENT_305	[p14l37t1251r101b1305],
2	7	CD	NUMBER	7	num	5	SENT_305	[p14l37t1251r101b1305],
3	]	CD	NUMBER	]	num	5	SENT_305	[p14l37t1251r101b1305],
4	Bunn	NNP	PERSON	Bunn	nn	5	SENT_305	[p14l136t1254r268b1294],
5	Jr	NNP	PERSON	Jr	_	0	SENT_305	[p14l283t1254r328b1305],
6	PA	NN	PERSON	pa	dep	5	SENT_305	[p14l348t1253r423b1301],
7	,	,	O	,	_	0	SENT_305	[p14l348t1253r423b1301],
8	Dziadziuszko	NNP	PERSON	Dziadziuszko	nn	9	SENT_305	[p14l446t1251r784b1294],
9	R	NNP	PERSON	R	appos	6	SENT_305	[p14l806t1254r850b1301],
10	,	,	O	,	_	0	SENT_305	[p14l806t1254r850b1301],
11	Varella	NNP	LOCATION	Varella	appos	6	SENT_305	[p14l870t1251r1237b1294],
12	.	.	O	.	_	0	SENT_305	[p14l870t1251r1237b1294],

1	—	NN	O	—	_	0	SENT_306	[p14l870t1251r1237b1294],
2	.	.	O	.	_	0	SENT_306	[p14l870t1251r1237b1294],

1	Garcia	NNP	PERSON	Garcia	nn	2	SENT_307	[p14l870t1251r1237b1294],
2	M	NNP	O	M	_	0	SENT_307	[p14l1259t1254r1320b1301],
3	,	,	O	,	_	0	SENT_307	[p14l1259t1254r1320b1301],
4	Franklin	NNP	PERSON	Franklin	nn	5	SENT_307	[p14l1342t1251r1551b1294],
5	WA	NNP	PERSON	WA	appos	2	SENT_307	[p14l1570t1253r1674b1301],
6	,	,	O	,	_	0	SENT_307	[p14l1570t1253r1674b1301],
7	Witta	NNP	LOCATION	Witta	nn	8	SENT_307	[p14l1694t1252r1840b1294],
8	SE	NN	LOCATION	se	appos	2	SENT_307	[p14l1861t1253r1931b1301],
9	,	,	O	,	_	0	SENT_307	[p14l1861t1253r1931b1301],
10	Kelly	NNP	PERSON	Kelly	nn	11	SENT_307	[p14l1953t1251r2080b1305],
11	K	NNP	O	K	appos	2	SENT_307	[p14l2100t1254r2144b1301],
12	,	,	O	,	_	0	SENT_307	[p14l2100t1254r2144b1301],
13	et	FW	O	et	nn	14	SENT_307	[p14l135t1324r183b1361],
14	al.	FW	O	al.	appos	2	SENT_307	[p14l207t1317r262b1361],
15	.	.	O	.	_	0	SENT_307	[p14l207t1317r262b1361],

1	Biological	JJ	O	biological	amod	2	SENT_308	[p14l288t1317r536b1372],
2	markers	NNS	O	marker	_	0	SENT_308	[p14l562t1317r769b1361],
3	for	IN	O	for	_	0	SENT_308	[p14l795t1317r867b1361],
4	non	JJ	O	non	amod	11	SENT_308	[p14l890t1317r1149b1361],
5	—	JJ	O	—	amod	11	SENT_308	[p14l890t1317r1149b1361],
6	small	JJ	O	small	amod	11	SENT_308	[p14l890t1317r1149b1361],
7	cell	NN	O	cell	nn	11	SENT_308	[p14l1175t1317r1261b1361],
8	lung	NN	O	lung	nn	11	SENT_308	[p14l1287t1317r1399b1372],
9	cancer	NN	O	cancer	nn	11	SENT_308	[p14l1424t1330r1591b1361],
10	patient	NN	O	patient	nn	11	SENT_308	[p14l1615t1318r1798b1372],
11	selection	NN	O	selection	prep_for	2	SENT_308	[p14l1822t1317r2050b1361],
12	for	IN	O	for	_	0	SENT_308	[p14l2075t1317r2147b1361],
13	epidermal	JJ	O	epidermal	amod	20	SENT_308	[p14l136t1383r396b1437],
14	growth	NN	O	growth	nn	20	SENT_308	[p14l410t1383r595b1437],
15	factor	NN	O	factor	nn	20	SENT_308	[p14l611t1382r758b1426],
16	receptor	NN	O	receptor	nn	20	SENT_308	[p14l772t1389r986b1437],
17	tyrosine	NN	O	tyrosine	nn	20	SENT_308	[p14l998t1383r1207b1437],
18	kinase	NN	O	kinase	nn	20	SENT_308	[p14l1223t1383r1384b1426],
19	inhibitor	NN	O	inhibitor	nn	20	SENT_308	[p14l1400t1383r1625b1426],
20	therapy	NN	O	therapy	prep_for	2	SENT_308	[p14l1637t1383r1843b1437],
21	.	.	O	.	_	0	SENT_308	[p14l1637t1383r1843b1437],

1	Clin	NNP	O	Clin	nn	3	SENT_309	[p14l1859t1383r1957b1426],
2	Cancer	NNP	O	Cancer	nn	3	SENT_309	[p14l1972t1385r2147b1426],
3	Res	NNP	O	Res	_	0	SENT_309	[p14l136t1452r219b1493],
4	2006	CD	DATE	2006	num	3	SENT_309	[p14l238t1451r677b1499],
5	;	:	O	;	_	0	SENT_309	[p14l238t1451r677b1499],
6	12:3652	CD	NUMBER	12:3652	number	7	SENT_309	[p14l238t1451r677b1499],
7	—	CD	NUMBER	—	dep	3	SENT_309	[p14l238t1451r677b1499],
8	6	CD	NUMBER	6	dep	7	SENT_309	[p14l238t1451r677b1499],
9	.	.	O	.	_	0	SENT_309	[p14l238t1451r677b1499],

1	[	NN	O	[	_	0	SENT_310	[p14l37t1514r101b1569],
2	8	CD	NUMBER	8	num	1	SENT_310	[p14l37t1514r101b1569],
3	]	CD	NUMBER	]	num	5	SENT_310	[p14l37t1514r101b1569],
4	Janne	NNP	PERSON	Janne	nn	5	SENT_310	[p14l129t1517r276b1569],
5	PA	NN	PERSON	pa	dep	1	SENT_310	[p14l289t1516r364b1565],
6	,	,	O	,	_	0	SENT_310	[p14l289t1516r364b1565],
7	EngelmanJA	NN	O	engelmanja	appos	5	SENT_310	[p14l378t1514r928b1569],
8	,	,	O	,	_	0	SENT_310	[p14l378t1514r928b1569],
9	Johnson	NNP	PERSON	Johnson	nsubj	10	SENT_310	[p14l378t1514r928b1569],
10	BE	VB	O	be	rcmod	1	SENT_310	[p14l940t1517r1014b1558],
11	.	.	O	.	_	0	SENT_310	[p14l940t1517r1014b1558],

1	Epidermal	JJ	O	epidermal	amod	5	SENT_311	[p14l1028t1514r1290b1569],
2	growth	NN	O	growth	nn	5	SENT_311	[p14l1302t1514r1487b1569],
3	factor	NN	O	factor	nn	5	SENT_311	[p14l1500t1514r1647b1558],
4	receptor	NN	O	receptor	nn	5	SENT_311	[p14l1658t1521r1873b1569],
5	mutations	NNS	O	mutation	_	0	SENT_311	[p14l1884t1515r2144b1558],
6	in	IN	O	in	_	0	SENT_311	[p14l136t1582r183b1624],
7	non	JJ	O	non	amod	12	SENT_311	[p14l202t1581r461b1624],
8	—	JJ	O	—	amod	12	SENT_311	[p14l202t1581r461b1624],
9	small	JJ	O	small	amod	12	SENT_311	[p14l202t1581r461b1624],
10	cell	NN	O	cell	nn	12	SENT_311	[p14l481t1581r567b1624],
11	lung	NN	O	lung	nn	12	SENT_311	[p14l587t1581r700b1635],
12	cancer	NN	O	cancer	prep_in	5	SENT_311	[p14l718t1593r899b1625],
13	:	:	O	:	_	0	SENT_311	[p14l718t1593r899b1625],
14	implications	NNS	O	implication	dep	5	SENT_311	[p14l922t1581r1239b1635],
15	for	IN	O	for	_	0	SENT_311	[p14l1259t1581r1331b1624],
16	treatment	NN	O	treatment	nn	19	SENT_311	[p14l1348t1587r1606b1624],
17	and	CC	O	and	_	0	SENT_311	[p14l1624t1581r1717b1624],
18	tumor	NN	O	tumor	nn	19	SENT_311	[p14l1736t1587r1896b1624],
19	biology	NN	O	biology	prep_for	14	SENT_311	[p14l1913t1581r2145b1635],
20	.	.	O	.	_	0	SENT_311	[p14l1913t1581r2145b1635],

1	J	NNP	O	J	nn	3	SENT_312	[p14l1913t1581r2145b1635],
2	Clin	NNP	O	Clin	nn	3	SENT_312	[p14l136t1647r234b1691],
3	Oncol	NNP	O	Oncol	_	0	SENT_312	[p14l252t1647r398b1691],
4	2005	CD	DATE	2005	num	3	SENT_312	[p14l416t1649r888b1697],
5	;	:	O	;	_	0	SENT_312	[p14l416t1649r888b1697],
6	23:3227	CD	NUMBER	23:3227	number	7	SENT_312	[p14l416t1649r888b1697],
7	—	CD	NUMBER	—	dep	3	SENT_312	[p14l416t1649r888b1697],
8	34	CD	NUMBER	34	dep	7	SENT_312	[p14l416t1649r888b1697],
9	.	.	O	.	_	0	SENT_312	[p14l416t1649r888b1697],

1	[	NN	O	[	nn	3	SENT_313	[p14l37t1712r101b1767],
2	9	CD	NUMBER	9	num	3	SENT_313	[p14l37t1712r101b1767],
3	]	NN	O	]	_	0	SENT_313	[p14l37t1712r101b1767],
4	Pao	NNP	O	Pao	nn	5	SENT_313	[p14l136t1715r224b1756],
5	W	NNP	O	W	dep	3	SENT_313	[p14l242t1715r309b1763],
6	,	,	O	,	_	0	SENT_313	[p14l242t1715r309b1763],
7	Wang	NNP	PERSON	Wang	nn	8	SENT_313	[p14l328t1715r478b1767],
8	TY	NNP	PERSON	TY	appos	5	SENT_313	[p14l495t1715r570b1763],
9	,	,	O	,	_	0	SENT_313	[p14l495t1715r570b1763],
10	Riely	NNP	PERSON	Riely	nn	11	SENT_313	[p14l592t1713r718b1767],
11	GJ	NNP	O	GJ	appos	5	SENT_313	[p14l737t1715r803b1767],
12	,	,	O	,	_	0	SENT_313	[p14l737t1715r803b1767],
13	Miller	NNP	ORGANIZATION	Miller	nn	14	SENT_313	[p14l825t1713r978b1756],
14	VA	NNP	ORGANIZATION	VA	appos	5	SENT_313	[p14l995t1715r1081b1763],
15	,	,	O	,	_	0	SENT_313	[p14l995t1715r1081b1763],
16	Pan	NNP	O	Pan	nn	17	SENT_313	[p14l1104t1715r1194b1756],
17	Q	NNP	O	Q	appos	5	SENT_313	[p14l1215t1715r1264b1765],
18	,	,	O	,	_	0	SENT_313	[p14l1215t1715r1264b1765],
19	Ladanyi	NNP	PERSON	Ladanyi	nn	20	SENT_313	[p14l1286t1713r1481b1767],
20	M	NNP	PERSON	M	appos	5	SENT_313	[p14l1503t1715r1564b1763],
21	,	,	O	,	_	0	SENT_313	[p14l1503t1715r1564b1763],
22	et	FW	O	et	nn	23	SENT_313	[p14l1585t1719r1633b1756],
23	al.	FW	O	al.	appos	5	SENT_313	[p14l1652t1713r1707b1757],
24	.	.	O	.	_	0	SENT_313	[p14l1652t1713r1707b1757],

1	KRAS	NNP	ORGANIZATION	KRAS	_	0	SENT_314	[p14l1729t1715r1862b1756],
2	mutations	NNS	O	mutation	dep	1	SENT_314	[p14l1884t1713r2144b1756],
3	and	CC	O	and	_	0	SENT_314	[p14l135t1779r228b1823],
4	primary	JJ	O	primary	amod	5	SENT_314	[p14l247t1780r454b1833],
5	resistance	NN	O	resistance	dep	1	SENT_314	[p14l472t1780r727b1823],
6	of	IN	O	of	_	0	SENT_314	[p14l746t1779r799b1823],
7	lung	NN	O	lung	nn	8	SENT_314	[p14l812t1779r924b1833],
8	adenocarcinomas	NNS	O	adenocarcinoma	prep_of	1	SENT_314	[p14l941t1779r1390b1823],
9	to	TO	O	to	_	0	SENT_314	[p14l1409t1785r1458b1823],
10	geﬁtinib	NN	O	geﬁtinib	prep_to	8	SENT_314	[p14l1476t1779r1689b1833],
11	or	CC	O	or	_	0	SENT_314	[p14l1708t1792r1761b1823],
12	erlotinib	NN	O	erlotinib	conj_or	10	SENT_314	[p14l1778t1779r2008b1823],
13	.	.	O	.	_	0	SENT_314	[p14l1778t1779r2008b1823],

1	PLoS	NNP	O	PLoS	nn	2	SENT_315	[p14l2028t1781r2145b1823],
2	Med	NNP	O	Med	_	0	SENT_315	[p14l136t1844r248b1888],
3	2005	CD	DATE	2005	num	5	SENT_315	[p14l266t1847r564b1895],
4	;	:	O	;	_	0	SENT_315	[p14l266t1847r564b1895],
5	2	CD	NUMBER	2	dep	2	SENT_315	[p14l266t1847r564b1895],
6	:	:	O	:	_	0	SENT_315	[p14l266t1847r564b1895],
7	e17	NN	O	e17	dep	2	SENT_315	[p14l266t1847r564b1895],
8	.	.	O	.	_	0	SENT_315	[p14l266t1847r564b1895],

1	[	NN	O	[	nn	4	SENT_316	[p14l8t1911r101b1965],
2	10	CD	NUMBER	10	num	4	SENT_316	[p14l8t1911r101b1965],
3	]	NN	O	]	nn	4	SENT_316	[p14l8t1911r101b1965],
4	Dziadziuszko	NN	PERSON	dziadziuszko	_	0	SENT_316	[p14l136t1911r474b1954],
5	R	NN	PERSON	r	dep	4	SENT_316	[p14l513t1914r556b1961],
6	,	,	O	,	_	0	SENT_316	[p14l513t1914r556b1961],
7	Hirsch	NNP	PERSON	Hirsch	nn	8	SENT_316	[p14l594t1911r758b1954],
8	FR	NN	O	fr	appos	5	SENT_316	[p14l795t1914r867b1961],
9	,	,	O	,	_	0	SENT_316	[p14l795t1914r867b1961],
10	Varella	NNP	LOCATION	Varella	appos	5	SENT_316	[p14l903t1911r1271b1954],
11	.	.	O	.	_	0	SENT_316	[p14l903t1911r1271b1954],

1	—	NN	O	—	_	0	SENT_317	[p14l903t1911r1271b1954],
2	.	.	O	.	_	0	SENT_317	[p14l903t1911r1271b1954],

1	Garcia	NNP	PERSON	Garcia	nn	2	SENT_318	[p14l903t1911r1271b1954],
2	M	NNP	O	M	_	0	SENT_318	[p14l1308t1914r1369b1961],
3	,	,	O	,	_	0	SENT_318	[p14l1308t1914r1369b1961],
4	Bunn	NNP	PERSON	Bunn	nn	6	SENT_318	[p14l1407t1914r1540b1954],
5	Jr	NNP	PERSON	Jr	nn	6	SENT_318	[p14l1570t1914r1615b1965],
6	PA.	NNP	PERSON	PA.	appos	2	SENT_318	[p14l1651t1913r1727b1955],
7	.	.	O	.	_	0	SENT_318	[p14l1651t1913r1727b1955],

1	Selecting	VBG	O	select	_	0	SENT_319	[p14l1765t1911r1997b1965],
2	lung	NN	O	lung	nn	4	SENT_319	[p14l2034t1911r2146b1965],
3	cancer	NN	O	cancer	nn	4	SENT_319	[p14l135t1989r303b2020],
4	patients	NNS	O	patient	dobj	1	SENT_319	[p14l351t1977r557b2031],
5	for	IN	O	for	prep	4	SENT_319	[p14l607t1976r677b2020],
6	treatment	NN	O	treatment	dep	23	SENT_319	[p14l724t1983r982b2020],
7	with	IN	O	with	_	0	SENT_319	[p14l1029t1977r1147b2020],
8	epidermal	JJ	O	epidermal	amod	14	SENT_319	[p14l1195t1976r1456b2031],
9	growth	NN	O	growth	nn	14	SENT_319	[p14l1504t1977r1689b2031],
10	factor	NN	O	factor	nn	14	SENT_319	[p14l1738t1976r1885b2020],
11	receptor	NN	O	receptor	nn	14	SENT_319	[p14l1933t1983r2147b2031],
12	tyrosine	NN	O	tyrosine	nn	14	SENT_319	[p14l135t2044r344b2097],
13	kinase	NN	O	kinase	nn	14	SENT_319	[p14l382t2043r544b2086],
14	inhibitors	NNS	O	inhibitor	prep_with	6	SENT_319	[p14l582t2043r829b2086],
15	by	IN	O	by	_	0	SENT_319	[p14l868t2043r928b2097],
16	immunohistochemistry	NN	O	immunohistochemistry	prep_by	14	SENT_319	[p14l965t2043r1572b2097],
17	and	CC	O	and	_	0	SENT_319	[p14l1608t2043r1700b2086],
18	ﬂuorescence	NN	O	ﬂuorescence	conj_and	16	SENT_319	[p14l1739t2043r2060b2086],
19	in	FW	O	in	nn	20	SENT_319	[p14l2099t2043r2146b2086],
20	situ	FW	O	situ	advmod	21	SENT_319	[p14l136t2110r229b2153],
21	hybridisation	NN	O	hybridisation	rcmod	16	SENT_319	[p14l263t2109r771b2164],
22	—	CD	NUMBER	—	num	21	SENT_319	[p14l263t2109r771b2164],
23	why	WRB	O	why	dep	5	SENT_319	[p14l263t2109r771b2164],
24	,	,	O	,	_	0	SENT_319	[p14l263t2109r771b2164],
25	when	WRB	O	when	dep	23	SENT_319	[p14l804t2109r960b2159],
26	,	,	O	,	_	0	SENT_319	[p14l804t2109r960b2159],
27	and	CC	O	and	advmod	4	SENT_319	[p14l994t2109r1087b2153],
28	how	WRB	O	how	dep	1	SENT_319	[p14l1122t2109r1260b2153],
29	?	.	O	?	_	0	SENT_319	[p14l1122t2109r1260b2153],

1	Clin	NNP	O	Clin	nn	3	SENT_320	[p14l1295t2109r1393b2153],
2	Cancer	NNP	O	Cancer	nn	3	SENT_320	[p14l1427t2111r1602b2153],
3	Res	NNP	O	Res	_	0	SENT_320	[p14l1634t2112r1718b2153],
4	2006	CD	DATE	2006	num	3	SENT_320	[p14l1752t2109r2144b2164],
5	;	:	O	;	_	0	SENT_320	[p14l1752t2109r2144b2164],
6	12	CD	NUMBER	12	number	7	SENT_320	[p14l1752t2109r2144b2164],
7	(	CD	NUMBER	(	dep	3	SENT_320	[p14l1752t2109r2144b2164],
8	Suppl	NNP	O	Suppl	dep	7	SENT_320	[p14l1752t2109r2144b2164],
9	.	.	O	.	_	0	SENT_320	[p14l1752t2109r2144b2164],

1	14	CD	NUMBER	14	_	0	SENT_321	[p14l138t2175r472b2229],
2	)	CD	NUMBER	)	number	3	SENT_321	[p14l138t2175r472b2229],
3	:4409	CD	NUMBER	:4409	dep	1	SENT_321	[p14l138t2175r472b2229],
4	—	CD	NUMBER	—	num	5	SENT_321	[p14l138t2175r472b2229],
5	15	CD	NUMBER	15	dep	3	SENT_321	[p14l138t2175r472b2229],
6	.	.	O	.	_	0	SENT_321	[p14l138t2175r472b2229],

1	[	NN	O	[	_	0	SENT_322	[p14l10t2241r101b2295],
2	11	CD	NUMBER	11	num	1	SENT_322	[p14l10t2241r101b2295],
3	]	CD	NUMBER	]	num	5	SENT_322	[p14l10t2241r101b2295],
4	Cappuzzo	NNP	O	Cappuzzo	nn	5	SENT_322	[p14l136t2243r384b2295],
5	F	NN	O	f	dep	1	SENT_322	[p14l398t2244r431b2291],
6	,	,	O	,	_	0	SENT_322	[p14l398t2244r431b2291],
7	Varella	NNP	LOCATION	Varella	appos	5	SENT_322	[p14l443t2241r811b2285],
8	.	.	O	.	_	0	SENT_322	[p14l443t2241r811b2285],

1	—	NN	O	—	_	0	SENT_323	[p14l443t2241r811b2285],
2	.	.	O	.	_	0	SENT_323	[p14l443t2241r811b2285],

1	Garcia	NNP	PERSON	Garcia	nn	2	SENT_324	[p14l443t2241r811b2285],
2	M	NNP	O	M	_	0	SENT_324	[p14l824t2244r885b2291],
3	,	,	O	,	_	0	SENT_324	[p14l824t2244r885b2291],
4	Shigematsu	NNP	PERSON	Shigematsu	nn	5	SENT_324	[p14l899t2241r1197b2295],
5	H	NNP	PERSON	H	appos	2	SENT_324	[p14l1210t2244r1261b2291],
6	,	,	O	,	_	0	SENT_324	[p14l1210t2244r1261b2291],
7	Domenichini	NNP	O	Domenichini	nn	11	SENT_324	[p14l1275t2241r1604b2285],
8	I	PRP	O	I	dep	11	SENT_324	[p14l1618t2244r1644b2291],
9	,	,	O	,	_	0	SENT_324	[p14l1618t2244r1644b2291],
10	Bartolini	NNP	PERSON	Bartolini	dep	11	SENT_324	[p14l1658t2241r1877b2285],
11	S	NNP	O	S	appos	2	SENT_324	[p14l1891t2243r1929b2291],
12	,	,	O	,	_	0	SENT_324	[p14l1891t2243r1929b2291],
13	Ceresoli	NNP	O	Ceresoli	nn	14	SENT_324	[p14l1943t2241r2145b2285],
14	GL	NNP	O	GL	appos	2	SENT_324	[p14l136t2309r212b2357],
15	,	,	O	,	_	0	SENT_324	[p14l136t2309r212b2357],
16	et	FW	O	et	nn	17	SENT_324	[p14l239t2313r286b2350],
17	al.	FW	O	al.	appos	2	SENT_324	[p14l311t2307r366b2350],
18	.	.	O	.	_	0	SENT_324	[p14l311t2307r366b2350],

1	Increased	VBN	O	increase	amod	3	SENT_325	[p14l393t2306r637b2350],
2	HER2	NN	O	her2	nn	3	SENT_325	[p14l664t2309r799b2350],
3	gene	NN	O	gene	nsubjpass	7	SENT_325	[p14l826t2319r946b2361],
4	copy	NN	O	copy	nn	5	SENT_325	[p14l972t2319r1092b2361],
5	number	NN	O	number	tmod	7	SENT_325	[p14l1117t2306r1321b2350],
6	is	VBZ	O	be	auxpass	7	SENT_325	[p14l1345t2307r1382b2350],
7	associated	VBN	O	associate	_	0	SENT_325	[p14l1409t2306r1674b2350],
8	with	IN	O	with	_	0	SENT_325	[p14l1699t2306r1817b2350],
9	response	NN	O	response	prep_with	7	SENT_325	[p14l1843t2319r2070b2361],
10	to	TO	O	to	_	0	SENT_325	[p14l2096t2313r2145b2350],
11	geﬁtinib	NN	O	geﬁtinib	nn	12	SENT_325	[p14l134t2373r348b2427],
12	therapy	NN	O	therapy	prep_to	7	SENT_325	[p14l370t2373r568b2427],
13	in	IN	O	in	_	0	SENT_325	[p14l589t2374r636b2416],
14	epidermal	JJ	O	epidermal	amod	18	SENT_325	[p14l659t2373r919b2427],
15	growth	NN	O	growth	nn	18	SENT_325	[p14l941t2373r1126b2427],
16	factor	NN	O	factor	nn	18	SENT_325	[p14l1148t2373r1296b2416],
17	receptor	NN	O	receptor	nn	18	SENT_325	[p14l1317t2374r1753b2427],
18	—	NN	O	—	prep_in	12	SENT_325	[p14l1317t2374r1753b2427],
19	positive	JJ	O	positive	amod	26	SENT_325	[p14l1317t2374r1753b2427],
20	non	JJ	O	non	amod	26	SENT_325	[p14l1777t2373r2036b2416],
21	—	NN	O	—	nn	26	SENT_325	[p14l1777t2373r2036b2416],
22	small	JJ	O	small	amod	26	SENT_325	[p14l1777t2373r2036b2416],
23	cell	NN	O	cell	nn	26	SENT_325	[p14l2059t2373r2145b2416],
24	lung	NN	O	lung	nn	26	SENT_325	[p14l136t2439r248b2494],
25	cancer	NN	O	cancer	nn	26	SENT_325	[p14l265t2452r433b2483],
26	patients	NNS	O	patient	dep	18	SENT_325	[p14l449t2440r701b2494],
27	.	.	O	.	_	0	SENT_325	[p14l449t2440r701b2494],

1	J	NNP	O	J	nn	3	SENT_326	[p14l449t2440r701b2494],
2	Clin	NNP	O	Clin	nn	3	SENT_326	[p14l719t2439r817b2483],
3	Oncol	NNP	O	Oncol	_	0	SENT_326	[p14l835t2439r981b2483],
4	2005	CD	DATE	2005	num	3	SENT_326	[p14l999t2441r1470b2489],
5	;	:	O	;	_	0	SENT_326	[p14l999t2441r1470b2489],
6	23:5007	CD	NUMBER	23:5007	number	7	SENT_326	[p14l999t2441r1470b2489],
7	—	CD	NUMBER	—	dep	3	SENT_326	[p14l999t2441r1470b2489],
8	18	CD	NUMBER	18	dep	7	SENT_326	[p14l999t2441r1470b2489],
9	.	.	O	.	_	0	SENT_326	[p14l999t2441r1470b2489],

1	[	NN	O	[	nn	5	SENT_327	[p14l7t2504r101b2559],
2	12	CD	NUMBER	12	num	5	SENT_327	[p14l7t2504r101b2559],
3	]	CD	NUMBER	]	num	5	SENT_327	[p14l7t2504r101b2559],
4	Han	NNP	O	Han	nn	5	SENT_327	[p14l136t2507r237b2548],
5	SW	NNP	O	SW	dep	28	SENT_327	[p14l261t2507r355b2555],
6	,	,	O	,	_	0	SENT_327	[p14l261t2507r355b2555],
7	Jeon	NNP	PERSON	Jeon	nn	8	SENT_327	[p14l372t2507r489b2559],
8	YK	NNP	PERSON	YK	appos	5	SENT_327	[p14l510t2507r592b2555],
9	,	,	O	,	_	0	SENT_327	[p14l510t2507r592b2555],
10	Lee	NNP	ORGANIZATION	Lee	nn	11	SENT_327	[p14l616t2507r699b2548],
11	KH	NNP	ORGANIZATION	KH	appos	5	SENT_327	[p14l724t2507r810b2555],
12	,	,	O	,	_	0	SENT_327	[p14l724t2507r810b2555],
13	Keam	NNP	PERSON	Keam	nn	14	SENT_327	[p14l835t2507r977b2548],
14	B	NNP	PERSON	B	appos	5	SENT_327	[p14l1000t2507r1042b2555],
15	,	,	O	,	_	0	SENT_327	[p14l1000t2507r1042b2555],
16	Hwang	NNP	PERSON	Hwang	nn	17	SENT_327	[p14l1067t2507r1247b2559],
17	PG	NNP	O	PG	appos	5	SENT_327	[p14l1270t2507r1349b2555],
18	,	,	O	,	_	0	SENT_327	[p14l1270t2507r1349b2555],
19	Oh	UH	O	oh	dep	20	SENT_327	[p14l1374t2505r1444b2548],
20	DY	NNP	O	DY	rcmod	17	SENT_327	[p14l1468t2507r1545b2555],
21	,	,	O	,	_	0	SENT_327	[p14l1468t2507r1545b2555],
22	et	FW	O	et	nn	24	SENT_327	[p14l1569t2511r1617b2548],
23	al.	FW	O	al.	nn	24	SENT_327	[p14l1639t2505r1694b2549],
24	lntron	NN	O	lntron	appos	5	SENT_327	[p14l1718t2507r1876b2548],
25	1	CD	NUMBER	1	num	28	SENT_327	[p14l1901t2507r1921b2548],
26	CA	NNP	O	CA	nn	28	SENT_327	[p14l1951t2507r2020b2548],
27	dinucleotide	NN	O	dinucleotide	nn	28	SENT_327	[p14l2041t2505r2145b2548, p14l135t2571r371b2615],
28	repeat	NN	O	repeat	_	0	SENT_327	[p14l402t2577r564b2625],
29	polymorphism	NN	O	polymorphism	dep	28	SENT_327	[p14l593t2571r972b2625],
30	and	CC	O	and	_	0	SENT_327	[p14l1002t2571r1094b2615],
31	mutations	NNS	O	mutation	conj_and	28	SENT_327	[p14l1126t2572r1386b2615],
32	of	IN	O	of	_	0	SENT_327	[p14l1417t2571r1470b2615],
33	epidermal	JJ	O	epidermal	amod	36	SENT_327	[p14l1494t2571r1755b2625],
34	growth	NN	O	growth	nn	36	SENT_327	[p14l1785t2571r1969b2625],
35	factor	NN	O	factor	nn	36	SENT_327	[p14l2000t2571r2147b2615],
36	receptor	NN	O	receptor	prep_of	31	SENT_327	[p14l136t2643r350b2691],
37	and	CC	O	and	_	0	SENT_327	[p14l370t2636r463b2680],
38	geﬁtinib	NN	O	geﬁtinib	nn	39	SENT_327	[p14l485t2636r698b2691],
39	responsiveness	NN	O	responsiveness	prep_of	31	SENT_327	[p14l721t2637r1107b2691],
40	in	IN	O	in	_	0	SENT_327	[p14l1130t2637r1177b2680],
41	non-small-cell	JJ	O	non-small-cell	amod	43	SENT_327	[p14l1199t2636r1572b2680],
42	lung	NN	O	lung	nn	43	SENT_327	[p14l1594t2636r1707b2691],
43	cancer	NN	O	cancer	prep_in	36	SENT_327	[p14l1728t2649r1903b2680],
44	.	.	O	.	_	0	SENT_327	[p14l1728t2649r1903b2680],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_328	[p14l1927t2636r2145b2680, p14l135t2709r336b2757],
2	Genomics	NNP	O	Genomics	_	0	SENT_328	[p14l353t2704r604b2746],
3	2007	CD	DATE	2007	num	2	SENT_328	[p14l623t2705r1016b2753],
4	;	:	O	;	_	0	SENT_328	[p14l623t2705r1016b2753],
5	17:313	CD	NUMBER	17:313	number	6	SENT_328	[p14l623t2705r1016b2753],
6	—	CD	NUMBER	—	dep	2	SENT_328	[p14l623t2705r1016b2753],
7	9	CD	NUMBER	9	dep	6	SENT_328	[p14l623t2705r1016b2753],
8	.	.	O	.	_	0	SENT_328	[p14l623t2705r1016b2753],

1	[	RB	O	[	advmod	3	SENT_329	[p14l8t2768r101b2823],
2	13	CD	NUMBER	13	number	3	SENT_329	[p14l8t2768r101b2823],
3	]	CD	NUMBER	]	_	0	SENT_329	[p14l8t2768r101b2823],
4	Ichihara	NNP	O	Ichihara	nn	5	SENT_329	[p14l136t2768r342b2812],
5	S	NN	O	s	dep	3	SENT_329	[p14l369t2771r406b2819],
6	,	,	O	,	_	0	SENT_329	[p14l369t2771r406b2819],
7	Toyooka	FW	LOCATION	toyooka	dep	3	SENT_329	[p14l432t2769r645b2823],
8	S	NN	LOCATION	s	dep	3	SENT_329	[p14l671t2771r709b2819],
9	,	,	O	,	_	0	SENT_329	[p14l671t2771r709b2819],
10	Fujiwara	NNP	PERSON	Fujiwara	nn	11	SENT_329	[p14l737t2769r957b2823],
11	Y	NN	PERSON	y	appos	8	SENT_329	[p14l982t2771r1023b2819],
12	,	,	O	,	_	0	SENT_329	[p14l982t2771r1023b2819],
13	Hotta	NNP	PERSON	Hotta	appos	3	SENT_329	[p14l1051t2771r1192b2812],
14	I	PRP	O	I	nsubj	15	SENT_329	[p14l1219t2771r1264b2819],
15	(	VBP	O	(	rcmod	13	SENT_329	[p14l1219t2771r1264b2819],
16	,	,	O	,	_	0	SENT_329	[p14l1219t2771r1264b2819],
17	Shigematsu	NNP	PERSON	Shigematsu	nn	18	SENT_329	[p14l1292t2768r1589b2823],
18	H	NNP	O	H	appos	13	SENT_329	[p14l1616t2771r1667b2819],
19	,	,	O	,	_	0	SENT_329	[p14l1616t2771r1667b2819],
20	Tokumo	NNP	O	Tokumo	nn	21	SENT_329	[p14l1692t2769r1900b2812],
21	M	NNP	O	M	appos	18	SENT_329	[p14l1928t2771r1989b2819],
22	,	,	O	,	_	0	SENT_329	[p14l1928t2771r1989b2819],
23	et	FW	O	et	nn	24	SENT_329	[p14l2016t2775r2064b2812],
24	al.	FW	O	al.	appos	18	SENT_329	[p14l2090t2768r2144b2812],
25	.	.	O	.	_	0	SENT_329	[p14l2090t2768r2144b2812],

1	The	DT	O	the	det	2	SENT_330	[p14l133t2835r226b2878],
2	impact	NN	O	impact	_	0	SENT_330	[p14l260t2836r436b2889],
3	of	IN	O	of	_	0	SENT_330	[p14l468t2835r521b2878],
4	epidermal	JJ	O	epidermal	amod	9	SENT_330	[p14l547t2835r807b2889],
5	growth	NN	O	growth	nn	9	SENT_330	[p14l839t2835r1024b2889],
6	factor	NN	O	factor	nn	9	SENT_330	[p14l1056t2835r1204b2878],
7	receptor	NN	O	receptor	nn	9	SENT_330	[p14l1235t2841r1449b2889],
8	gene	NN	O	gene	nn	9	SENT_330	[p14l1479t2847r1599b2889],
9	status	NN	O	status	prep_of	2	SENT_330	[p14l1632t2841r1782b2878],
10	on	IN	O	on	_	0	SENT_330	[p14l1815t2847r1878b2878],
11	geﬁtinibtreated	JJ	O	geﬁtinibtreated	amod	13	SENT_330	[p14l1909t2835r2145b2889, p14l135t2901r317b2945],
12	Japanese	JJ	MISC	japanese	amod	13	SENT_330	[p14l352t2904r582b2956],
13	patients	NNS	O	patient	prep_on	9	SENT_330	[p14l623t2902r829b2956],
14	with	IN	O	with	_	0	SENT_330	[p14l869t2901r987b2945],
15	non-small-cell	JJ	O	non-small-cell	amod	17	SENT_330	[p14l1027t2901r1400b2945],
16	lung	NN	O	lung	nn	17	SENT_330	[p14l1441t2901r1553b2956],
17	cancer	NN	O	cancer	prep_with	2	SENT_330	[p14l1592t2914r1768b2945],
18	.	.	O	.	_	0	SENT_330	[p14l1592t2914r1768b2945],

1	Int	NN	O	int	nn	3	SENT_331	[p14l1809t2904r1879b2945],
2	J	NN	O	j	nn	3	SENT_331	[p14l1911t2904r1932b2956],
3	Cancer	NN	O	cancer	_	0	SENT_331	[p14l1972t2903r2147b2945],
4	2007	CD	DATE	2007	dep	3	SENT_331	[p14l135t2969r628b3017],
5	;	:	O	;	_	0	SENT_331	[p14l135t2969r628b3017],
6	120:1239	CD	NUMBER	120:1239	number	7	SENT_331	[p14l135t2969r628b3017],
7	—	CD	NUMBER	—	dep	3	SENT_331	[p14l135t2969r628b3017],
8	47	CD	NUMBER	47	dep	7	SENT_331	[p14l135t2969r628b3017],
9	.	.	O	.	_	0	SENT_331	[p14l135t2969r628b3017],

1	[	RB	O	[	dep	5	SENT_332	[p14l8t3033r101b3087],
2	14	CD	NUMBER	14	num	5	SENT_332	[p14l8t3033r101b3087],
3	]	CD	NUMBER	]	num	5	SENT_332	[p14l8t3033r101b3087],
4	Liu	NNP	O	Liu	nn	5	SENT_332	[p14l136t3034r210b3077],
5	G	NNP	O	G	_	0	SENT_332	[p14l241t3035r289b3083],
6	,	,	O	,	_	0	SENT_332	[p14l241t3035r289b3083],
7	Gurubhagavatula	NNP	LOCATION	Gurubhagavatula	nn	8	SENT_332	[p14l321t3033r761b3087],
8	S	NNP	LOCATION	S	appos	5	SENT_332	[p14l792t3035r830b3083],
9	,	,	O	,	_	0	SENT_332	[p14l792t3035r830b3083],
10	Zhou	NNP	PERSON	Zhou	nn	11	SENT_332	[p14l860t3033r989b3077],
11	W	NNP	PERSON	W	appos	5	SENT_332	[p14l1018t3036r1084b3083],
12	,	,	O	,	_	0	SENT_332	[p14l1018t3036r1084b3083],
13	Wang	NNP	PERSON	Wang	nn	14	SENT_332	[p14l1113t3036r1263b3087],
14	Z	NNP	PERSON	Z	appos	11	SENT_332	[p14l1291t3036r1332b3083],
15	,	,	O	,	_	0	SENT_332	[p14l1291t3036r1332b3083],
16	Yeap	NNP	PERSON	Yeap	nn	17	SENT_332	[p14l1362t3036r1483b3087],
17	BY	NNP	O	BY	appos	11	SENT_332	[p14l1514t3036r1586b3083],
18	,	,	O	,	_	0	SENT_332	[p14l1514t3036r1586b3083],
19	Asomaning	NNP	O	Asomaning	nn	20	SENT_332	[p14l1615t3034r1907b3087],
20	K	NNP	O	K	appos	11	SENT_332	[p14l1937t3036r1981b3083],
21	,	,	O	,	_	0	SENT_332	[p14l1937t3036r1981b3083],
22	et	FW	O	et	nn	23	SENT_332	[p14l2013t3039r2060b3077],
23	al.	FW	O	al.	appos	11	SENT_332	[p14l2090t3033r2144b3077],
24	.	.	O	.	_	0	SENT_332	[p14l2090t3033r2144b3077],

1	Epidermal	JJ	O	epidermal	amod	5	SENT_333	[p14l136t3098r398b3153],
2	growth	NN	O	growth	nn	5	SENT_333	[p14l426t3099r611b3153],
3	factor	NN	O	factor	nn	5	SENT_333	[p14l640t3098r787b3142],
4	receptor	NN	O	receptor	nn	5	SENT_333	[p14l815t3105r1029b3153],
5	polymorphisms	NNS	O	polymorphism	nsubj	14	SENT_333	[p14l1057t3098r1459b3153],
6	and	CC	O	and	_	0	SENT_333	[p14l1489t3098r1581b3142],
7	clinical	JJ	O	clinical	amod	8	SENT_333	[p14l1610t3098r1791b3142],
8	outcomes	NNS	O	outcome	nsubj	14	SENT_333	[p14l1820t3105r2068b3142],
9	in	IN	O	in	_	0	SENT_333	[p14l2099t3099r2146b3142],
10	non-small-cell	JJ	O	non-small-cell	amod	13	SENT_333	[p14l136t3165r508b3208],
11	lung	NN	O	lung	nn	13	SENT_333	[p14l527t3165r640b3219],
12	cancer	NN	O	cancer	nn	13	SENT_333	[p14l656t3177r824b3208],
13	patients	NNS	O	patient	prep_in	8	SENT_333	[p14l840t3165r1046b3219],
14	treated	VBN	O	treat	_	0	SENT_333	[p14l1065t3165r1247b3208],
15	with	IN	O	with	_	0	SENT_333	[p14l1264t3165r1382b3208],
16	geﬁtinib	NN	O	geﬁtinib	prep_with	14	SENT_333	[p14l1399t3165r1625b3219],
17	.	.	O	.	_	0	SENT_333	[p14l1399t3165r1625b3219],

1	Pharmacogenomics	NNS	MISC	pharmacogenomic	_	0	SENT_334	[p14l1644t3165r2144b3219],
2	J	NNP	O	J	dep	1	SENT_334	[p14l129t3234r149b3286],
3	2008	CD	DATE	2008	num	2	SENT_334	[p14l167t3233r573b3282],
4	;	:	O	;	_	0	SENT_334	[p14l167t3233r573b3282],
5	8:129	CD	NUMBER	8:129	number	6	SENT_334	[p14l167t3233r573b3282],
6	—	CD	NUMBER	—	dep	1	SENT_334	[p14l167t3233r573b3282],
7	38	CD	NUMBER	38	dep	6	SENT_334	[p14l167t3233r573b3282],
8	.	.	O	.	_	0	SENT_334	[p14l167t3233r573b3282],

1	[	RB	O	[	advmod	2	SENT_335	[p14l8t3296r101b3351],
2	15	CD	NUMBER	15	_	0	SENT_335	[p14l8t3296r101b3351],
3	]	CD	NUMBER	]	num	5	SENT_335	[p14l8t3296r101b3351],
4	Therasse	NN	O	therasse	nn	5	SENT_335	[p14l133t3297r358b3340],
5	P	NN	O	p	dep	2	SENT_335	[p14l375t3299r410b3347],
6	,	,	O	,	_	0	SENT_335	[p14l375t3299r410b3347],
7	Arbuck	NNP	ORGANIZATION	Arbuck	nn	8	SENT_335	[p14l425t3297r609b3340],
8	SG	NNP	ORGANIZATION	SG	appos	5	SENT_335	[p14l624t3299r702b3347],
9	,	,	O	,	_	0	SENT_335	[p14l624t3299r702b3347],
10	Eisenhauer	NNP	PERSON	Eisenhauer	nn	11	SENT_335	[p14l719t3297r1004b3340],
11	EA	NN	PERSON	ea	appos	5	SENT_335	[p14l1019t3299r1097b3347],
12	,	,	O	,	_	0	SENT_335	[p14l1019t3299r1097b3347],
13	Wanders	NNP	O	Wanders	nn	14	SENT_335	[p14l1112t3297r1340b3340],
14	J	NNP	O	J	appos	5	SENT_335	[p14l1351t3299r1384b3351],
15	,	,	O	,	_	0	SENT_335	[p14l1351t3299r1384b3351],
16	Kaplan	NNP	PERSON	Kaplan	nn	17	SENT_335	[p14l1401t3297r1577b3351],
17	RS	NN	O	r	appos	5	SENT_335	[p14l1594t3299r1666b3347],
18	,	,	O	,	_	0	SENT_335	[p14l1594t3299r1666b3347],
19	Rubinstein	NN	PERSON	rubinstein	nn	20	SENT_335	[p14l1684t3297r1957b3340],
20	L	NN	O	l	appos	5	SENT_335	[p14l1973t3299r2010b3347],
21	,	,	O	,	_	0	SENT_335	[p14l1973t3299r2010b3347],
22	et	FW	O	et	nn	23	SENT_335	[p14l2027t3303r2075b3340],
23	al.	FW	O	al.	appos	5	SENT_335	[p14l2090t3297r2144b3341],
24	.	.	O	.	_	0	SENT_335	[p14l2090t3297r2144b3341],

1	New	NNP	O	New	nn	2	SENT_336	[p14l136t3366r251b3407],
2	guidelines	NNS	O	guideline	_	0	SENT_336	[p14l262t3363r525b3417],
3	to	TO	O	to	aux	4	SENT_336	[p14l538t3369r587b3407],
4	evaluate	VB	O	evaluate	infmod	2	SENT_336	[p14l600t3363r814b3407],
5	the	DT	O	the	det	6	SENT_336	[p14l827t3363r908b3407],
6	response	NN	O	response	dobj	4	SENT_336	[p14l921t3376r1149b3417],
7	to	TO	O	to	_	0	SENT_336	[p14l1161t3369r1210b3407],
8	treatment	NN	O	treatment	prep_to	4	SENT_336	[p14l1223t3369r1481b3407],
9	in	IN	O	in	_	0	SENT_336	[p14l1493t3364r1540b3406],
10	solid	JJ	O	solid	amod	11	SENT_336	[p14l1553t3363r1673b3407],
11	tumors	NNS	O	tumor	prep_in	8	SENT_336	[p14l1686t3369r1885b3407],
12	:	:	O	:	_	0	SENT_336	[p14l1686t3369r1885b3407],
13	European	JJ	ORGANIZATION	european	amod	14	SENT_336	[p14l1903t3366r2146b3417],
14	Organization	NNP	ORGANIZATION	Organization	dep	2	SENT_336	[p14l136t3429r467b3483],
15	for	IN	ORGANIZATION	for	_	0	SENT_336	[p14l488t3428r559b3472],
16	Research	NNP	ORGANIZATION	Research	prep_for	14	SENT_336	[p14l579t3429r805b3472],
17	and	CC	ORGANIZATION	and	_	0	SENT_336	[p14l826t3428r918b3472],
18	Treatment	NN	ORGANIZATION	treatment	dep	2	SENT_336	[p14l938t3431r1207b3472],
19	of	IN	ORGANIZATION	of	_	0	SENT_336	[p14l1227t3428r1280b3472],
20	Cancer	NN	ORGANIZATION	cancer	prep_of	18	SENT_336	[p14l1295t3431r1477b3479],
21	,	,	O	,	_	0	SENT_336	[p14l1295t3431r1477b3479],
22	National	NNP	ORGANIZATION	National	nn	24	SENT_336	[p14l1499t3428r1714b3472],
23	Cancer	NNP	ORGANIZATION	Cancer	nn	24	SENT_336	[p14l1736t3431r1911b3472],
24	Institute	NNP	ORGANIZATION	Institute	appos	20	SENT_336	[p14l1930t3429r2145b3472],
25	of	IN	O	of	_	0	SENT_336	[p14l136t3495r189b3539],
26	the	DT	O	the	det	28	SENT_336	[p14l208t3495r289b3539],
27	United	NNP	LOCATION	United	nn	28	SENT_336	[p14l315t3495r486b3539],
28	States	NNPS	LOCATION	States	prep_of	24	SENT_336	[p14l513t3497r674b3539],
29	.	.	O	.	_	0	SENT_336	[p14l513t3497r674b3539],

1	National	NNP	ORGANIZATION	National	nn	3	SENT_337	[p14l702t3495r917b3539],
2	Cancer	NNP	ORGANIZATION	Cancer	nn	3	SENT_337	[p14l944t3497r1119b3539],
3	Institute	NNP	ORGANIZATION	Institute	_	0	SENT_337	[p14l1143t3496r1358b3539],
4	of	IN	ORGANIZATION	of	_	0	SENT_337	[p14l1385t3495r1438b3539],
5	Canada	NNP	ORGANIZATION	Canada	prep_of	3	SENT_337	[p14l1458t3495r1696b3549],
6	.	.	O	.	_	0	SENT_337	[p14l1458t3495r1696b3549],

1	J	NNP	O	J	nn	4	SENT_338	[p14l1458t3495r1696b3549],
2	Natl	NNP	O	Natl	nn	4	SENT_338	[p14l1723t3495r1826b3539],
3	Cancer	NNP	O	Cancer	nn	4	SENT_338	[p14l1853t3497r2027b3539],
4	Inst	NNP	O	Inst	_	0	SENT_338	[p14l2052t3498r2146b3539],
5	2000	CD	DATE	2000	num	4	SENT_338	[p14l135t3563r575b3611],
6	;	:	O	;	_	0	SENT_338	[p14l135t3563r575b3611],
7	92:205	CD	NUMBER	92:205	number	8	SENT_338	[p14l135t3563r575b3611],
8	—	CD	NUMBER	—	dep	4	SENT_338	[p14l135t3563r575b3611],
9	16	CD	NUMBER	16	dep	8	SENT_338	[p14l135t3563r575b3611],
10	.	.	O	.	_	0	SENT_338	[p14l135t3563r575b3611],

1	[	NN	O	[	_	0	SENT_339	[p14l8t3627r101b3681],
2	16	CD	NUMBER	16	num	1	SENT_339	[p14l8t3627r101b3681],
3	]	NNP	O	]	nn	5	SENT_339	[p14l8t3627r101b3681],
4	Lynch	NNP	PERSON	Lynch	nn	5	SENT_339	[p14l136t3627r284b3681],
5	TJ	NNP	PERSON	TJ	dep	1	SENT_339	[p14l313t3630r373b3681],
6	,	,	O	,	_	0	SENT_339	[p14l313t3630r373b3681],
7	Bell	NNP	ORGANIZATION	Bell	nn	8	SENT_339	[p14l405t3627r498b3670],
8	DW	NNP	ORGANIZATION	DW	appos	5	SENT_339	[p14l530t3630r632b3677],
9	,	,	O	,	_	0	SENT_339	[p14l530t3630r632b3677],
10	Sordella	NNP	PERSON	Sordella	nn	11	SENT_339	[p14l665t3627r871b3670],
11	R	NNP	PERSON	R	appos	5	SENT_339	[p14l903t3630r946b3677],
12	,	,	O	,	_	0	SENT_339	[p14l903t3630r946b3677],
13	Gurubhagavatula	NNP	LOCATION	Gurubhagavatula	nn	14	SENT_339	[p14l978t3627r1418b3681],
14	S	NNP	LOCATION	S	appos	5	SENT_339	[p14l1449t3629r1487b3677],
15	,	,	O	,	_	0	SENT_339	[p14l1449t3629r1487b3677],
16	Okimoto	NNP	PERSON	Okimoto	nn	17	SENT_339	[p14l1520t3627r1740b3670],
17	RA	NN	O	ra	appos	5	SENT_339	[p14l1771t3629r1853b3677],
18	,	,	O	,	_	0	SENT_339	[p14l1771t3629r1853b3677],
19	Brannigan	NNP	PERSON	Brannigan	nn	20	SENT_339	[p14l1885t3628r2146b3681],
20	BW	NN	O	bw	appos	5	SENT_339	[p14l136t3696r232b3743],
21	,	,	O	,	_	0	SENT_339	[p14l136t3696r232b3743],
22	et	FW	O	et	nn	23	SENT_339	[p14l257t3700r305b3737],
23	al.	FW	O	al.	appos	5	SENT_339	[p14l327t3693r382b3737],
24	.	.	O	.	_	0	SENT_339	[p14l327t3693r382b3737],

1	Activating	VBG	O	activate	amod	2	SENT_340	[p14l405t3694r665b3748],
2	mutations	NNS	O	mutation	_	0	SENT_340	[p14l688t3694r949b3737],
3	in	IN	O	in	_	0	SENT_340	[p14l974t3694r1021b3736],
4	Epidermal	NNP	O	Epidermal	nn	6	SENT_340	[p14l1045t3693r1307b3748],
5	Growth	NNP	O	Growth	nn	6	SENT_340	[p14l1332t3693r1525b3737],
6	Factor	NN	O	factor	prep_in	2	SENT_340	[p14l1549t3696r1704b3737],
7	Receptor	NN	O	receptor	nn	9	SENT_340	[p14l1727t3696r1953b3748],
8	underlying	VBG	O	underlie	amod	9	SENT_340	[p14l1975t3693r2145b3737, p14l136t3759r261b3813],
9	responsiveness	NN	O	responsiveness	dep	2	SENT_340	[p14l284t3759r670b3813],
10	of	IN	O	of	_	0	SENT_340	[p14l694t3758r747b3802],
11	non-small-cell	JJ	O	non-small-cell	amod	13	SENT_340	[p14l764t3759r1136b3802],
12	lung	NN	O	lung	nn	13	SENT_340	[p14l1160t3759r1272b3813],
13	cancer	NN	O	cancer	prep_of	9	SENT_340	[p14l1294t3771r1462b3802],
14	to	TO	O	to	_	0	SENT_340	[p14l1483t3765r1531b3802],
15	geﬁtinib	NN	O	geﬁtinib	prep_to	13	SENT_340	[p14l1553t3758r1779b3813],
16	.	.	O	.	_	0	SENT_340	[p14l1553t3758r1779b3813],

1	N	NN	O	n	nn	2	SENT_341	[p14l1803t3761r1840b3802],
2	EnglJ	NN	O	englj	nsubj	3	SENT_341	[p14l1864t3759r2010b3813],
3	Med	VBD	O	med	_	0	SENT_341	[p14l2033t3759r2145b3802],

1	[	NN	O	[	nn	5	SENT_342	[p15l10t77r101b132],
2	17	CD	NUMBER	17	num	5	SENT_342	[p15l10t77r101b132],
3	]	CD	NUMBER	]	num	5	SENT_342	[p15l10t77r101b132],
4	Paez	NNP	O	Paez	nn	5	SENT_342	[p15l136t80r250b121],
5	JG	NNP	O	JG	_	0	SENT_342	[p15l264t80r336b132],
6	,	,	O	,	_	0	SENT_342	[p15l264t80r336b132],
7	Janne	NNP	PERSON	Janne	nn	8	SENT_342	[p15l351t80r498b132],
8	PA	NN	PERSON	pa	appos	5	SENT_342	[p15l519t79r594b128],
9	,	,	O	,	_	0	SENT_342	[p15l519t79r594b128],
10	Lee	NNP	PERSON	Lee	nn	11	SENT_342	[p15l616t80r699b121],
11	JC	NNP	PERSON	JC	appos	8	SENT_342	[p15l713t80r780b132],
12	,	,	O	,	_	0	SENT_342	[p15l713t80r780b132],
13	Tracy	NNP	PERSON	Tracy	nn	14	SENT_342	[p15l799t80r938b132],
14	S	NNP	PERSON	S	appos	8	SENT_342	[p15l957t80r995b128],
15	,	,	O	,	_	0	SENT_342	[p15l957t80r995b128],
16	Greulich	NNP	PERSON	Greulich	nn	17	SENT_342	[p15l1017t77r1233b121],
17	H	NNP	PERSON	H	appos	8	SENT_342	[p15l1254t80r1304b128],
18	,	,	O	,	_	0	SENT_342	[p15l1254t80r1304b128],
19	Gabriel	NNP	PERSON	Gabriel	nn	20	SENT_342	[p15l1325t77r1509b121],
20	S	NNP	PERSON	S	appos	8	SENT_342	[p15l1530t80r1568b128],
21	,	,	O	,	_	0	SENT_342	[p15l1530t80r1568b128],
22	et	FW	O	et	nn	23	SENT_342	[p15l1589t84r1637b121],
23	al.	FW	O	al.	appos	8	SENT_342	[p15l1656t77r1711b121],
24	.	.	O	.	_	0	SENT_342	[p15l1656t77r1711b121],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_343	[p15l1733t80r1866b121],
2	mutations	NNS	O	mutation	_	0	SENT_343	[p15l1884t78r2144b121],
3	in	IN	O	in	_	0	SENT_343	[p15l136t145r183b187],
4	lung	NN	O	lung	nn	5	SENT_343	[p15l203t144r316b198],
5	cancer	NN	O	cancer	prep_in	2	SENT_343	[p15l335t156r516b188],
6	:	:	O	:	_	0	SENT_343	[p15l335t156r516b188],
7	correlation	NN	O	correlation	dep	2	SENT_343	[p15l540t144r821b187],
8	with	IN	O	with	_	0	SENT_343	[p15l839t144r958b187],
9	clinical	JJ	O	clinical	amod	10	SENT_343	[p15l978t144r1158b187],
10	response	NN	O	response	prep_with	7	SENT_343	[p15l1179t156r1407b198],
11	to	TO	O	to	_	0	SENT_343	[p15l1427t150r1475b187],
12	geﬁtinib	NN	O	geﬁtinib	nn	13	SENT_343	[p15l1495t144r1708b198],
13	therapy	NN	O	therapy	prep_to	10	SENT_343	[p15l1728t144r1934b198],
14	.	.	O	.	_	0	SENT_343	[p15l1728t144r1934b198],

1	Science	NNP	O	Science	_	0	SENT_344	[p15l1955t145r2145b187],
2	2004	CD	DATE	2004	num	1	SENT_344	[p15l135t212r673b259],
3	;	:	O	;	_	0	SENT_344	[p15l135t212r673b259],
4	304:1497	CD	NUMBER	304:1497	number	5	SENT_344	[p15l135t212r673b259],
5	—	CD	NUMBER	—	dep	1	SENT_344	[p15l135t212r673b259],
6	500	CD	NUMBER	500	dep	5	SENT_344	[p15l135t212r673b259],
7	.	.	O	.	_	0	SENT_344	[p15l135t212r673b259],

1	360	CD	NUMBER	360	num	3	SENT_345	[p15l393t335r439b356],
2	M.	NN	NUMBER	m.	nn	3	SENT_345	[p15l1191t335r1220b356],
3	Tiseo	NNP	PERSON	Tiseo	_	0	SENT_345	[p15l1230t334r1289b356],
4	et	FW	O	et	nn	5	SENT_345	[p15l1298t337r1321b356],
5	al.	FW	O	al.	dep	3	SENT_345	[p15l1328t334r1353b356],
6	/	:	O	/	punct	3	SENT_345	[p15l1360t334r1372b361],
7	Lung	NN	O	lung	nn	8	SENT_345	[p15l1378t335r1438b361],
8	Cancer	NN	O	cancer	dep	3	SENT_345	[p15l1445t335r1528b356],
9	67	CD	NUMBER	67	number	10	SENT_345	[p15l1535t335r1565b356],
10	(	CD	NUMBER	(	num	11	SENT_345	[p15l1572t334r1653b361],
11	2010	CD	DATE	2010	dep	8	SENT_345	[p15l1572t334r1653b361],
12	)	CD	NUMBER	)	number	13	SENT_345	[p15l1572t334r1653b361],
13	355-360	CD	NUMBER	355-360	num	11	SENT_345	[p15l1660t335r1767b356],

1	[	NN	O	[	nn	5	SENT_346	[p15l11t484r103b538],
2	18	CD	NUMBER	18	num	5	SENT_346	[p15l11t484r103b538],
3	]	CD	NUMBER	]	num	5	SENT_346	[p15l11t484r103b538],
4	Pao	NNP	O	Pao	nn	5	SENT_346	[p15l138t487r226b528],
5	W	NNP	O	W	_	0	SENT_346	[p15l244t487r311b534],
6	,	,	O	,	_	0	SENT_346	[p15l244t487r311b534],
7	Miller	NNP	PERSON	Miller	nn	8	SENT_346	[p15l332t484r486b528],
8	V	NNP	O	V	appos	5	SENT_346	[p15l501t487r550b534],
9	,	,	O	,	_	0	SENT_346	[p15l501t487r550b534],
10	Zakowski	NNP	O	Zakowski	nn	11	SENT_346	[p15l570t484r811b528],
11	M	NNP	O	M	appos	8	SENT_346	[p15l832t487r892b534],
12	,	,	O	,	_	0	SENT_346	[p15l832t487r892b534],
13	Doherty	NNP	PERSON	Doherty	nn	14	SENT_346	[p15l913t484r1122b538],
14	J	NNP	PERSON	J	appos	8	SENT_346	[p15l1134t487r1167b538],
15	,	,	O	,	_	0	SENT_346	[p15l1134t487r1167b538],
16	Politi	NNP	PERSON	Politi	nn	17	SENT_346	[p15l1188t484r1319b528],
17	K	NNP	PERSON	K	appos	8	SENT_346	[p15l1340t487r1385b534],
18	,	,	O	,	_	0	SENT_346	[p15l1340t487r1385b534],
19	Sarkaria	NNP	O	Sarkaria	appos	8	SENT_346	[p15l1406t484r1613b528],
20	I	PRP	O	I	dep	19	SENT_346	[p15l1633t487r1659b534],
21	,	,	O	,	_	0	SENT_346	[p15l1633t487r1659b534],
22	et	FW	O	et	nn	23	SENT_346	[p15l1680t490r1727b528],
23	al.	FW	O	al.	appos	8	SENT_346	[p15l1746t484r1801b528],
24	.	.	O	.	_	0	SENT_346	[p15l1746t484r1801b528],

1	EGF	NN	ORGANIZATION	egf	nn	4	SENT_347	[p15l1822t486r1920b528],
2	receptor	NN	O	receptor	nn	4	SENT_347	[p15l1938t490r2153b538],
3	gene	NN	O	gene	nn	4	SENT_347	[p15l137t562r257b604],
4	mutations	NNS	O	mutation	nsubjpass	17	SENT_347	[p15l284t550r544b593],
5	are	VBP	O	be	cop	6	SENT_347	[p15l570t562r648b593],
6	common	JJ	O	common	_	0	SENT_347	[p15l673t562r900b593],
7	in	IN	O	in	_	0	SENT_347	[p15l926t550r973b593],
8	lung	NN	O	lung	nn	9	SENT_347	[p15l998t549r1111b604],
9	cancers	NNS	O	cancer	prep_in	6	SENT_347	[p15l1135t562r1326b593],
10	from	IN	O	from	_	0	SENT_347	[p15l1353t549r1474b593],
11	“	CD	NUMBER	“	prep_from	9	SENT_347	[p15l1500t552r1668b593],
12	never	RB	O	never	advmod	9	SENT_347	[p15l1500t552r1668b593],
13	smokers	NNS	O	smoker	dep	9	SENT_347	[p15l1692t549r1929b593],
14	”	CD	NUMBER	”	tmod	6	SENT_347	[p15l1692t549r1929b593],
15	and	CC	O	and	_	0	SENT_347	[p15l1955t549r2048b593],
16	are	VBP	O	be	auxpass	17	SENT_347	[p15l2074t562r2151b593],
17	associated	VBN	O	associate	conj_and	6	SENT_347	[p15l138t616r403b659],
18	with	IN	O	with	_	0	SENT_347	[p15l421t616r540b659],
19	sensitivity	NN	O	sensitivity	prep_with	17	SENT_347	[p15l560t617r825b670],
20	of	IN	O	of	_	0	SENT_347	[p15l843t616r896b659],
21	tumors	NNS	O	tumor	prep_of	19	SENT_347	[p15l909t622r1092b659],
22	to	TO	O	to	_	0	SENT_347	[p15l1112t622r1161b659],
23	geﬁtinib	NN	O	geﬁtinib	prep_to	17	SENT_347	[p15l1179t616r1393b670],
24	and	CC	O	and	_	0	SENT_347	[p15l1413t616r1506b659],
25	erlotinib	NN	O	erlotinib	conj_and	23	SENT_347	[p15l1526t616r1756b660],
26	.	.	O	.	_	0	SENT_347	[p15l1526t616r1756b660],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_348	[p15l1777t619r1887b659],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_348	[p15l1906t616r2009b659],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_348	[p15l2027t616r2151b659],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_348	[p15l138t683r207b726],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_348	[p15l225t684r331b726],
6	2004	CD	DATE	2004	num	5	SENT_348	[p15l346t684r582b733],
7	;	:	O	;	_	0	SENT_348	[p15l346t684r582b733],
8	101 213306	CD	NUMBER	101 213306	number	9	SENT_348	[p15l596t684r868b726],[p15l346t684r582b733],
9	-11	CD	NUMBER	-11	dep	5	SENT_348	[p15l596t684r868b726],
10	.	.	O	.	_	0	SENT_348	[p15l596t684r868b726],

1	[	NN	O	[	_	0	SENT_349	[p15l10t747r103b802],
2	19	CD	NUMBER	19	num	1	SENT_349	[p15l10t747r103b802],
3	]	CD	NUMBER	]	num	5	SENT_349	[p15l10t747r103b802],
4	Janne	NNP	ORGANIZATION	Janne	nn	5	SENT_349	[p15l131t750r279b802],
5	PA	NN	ORGANIZATION	pa	dep	1	SENT_349	[p15l301t750r376b798],
6	,	,	O	,	_	0	SENT_349	[p15l301t750r376b798],
7	Borras	NNP	ORGANIZATION	Borras	nn	8	SENT_349	[p15l398t750r559b791],
8	AM	NNP	ORGANIZATION	AM	appos	5	SENT_349	[p15l579t750r680b798],
9	,	,	O	,	_	0	SENT_349	[p15l579t750r680b798],
10	Kuang	NNP	PERSON	Kuang	nn	11	SENT_349	[p15l702t750r862b802],
11	Y	NN	PERSON	y	appos	5	SENT_349	[p15l880t750r921b798],
12	,	,	O	,	_	0	SENT_349	[p15l880t750r921b798],
13	Rogers	NNP	ORGANIZATION	Rogers	nn	14	SENT_349	[p15l944t750r1112b802],
14	AM	NNP	ORGANIZATION	AM	appos	5	SENT_349	[p15l1132t750r1232b798],
15	,	,	O	,	_	0	SENT_349	[p15l1132t750r1232b798],
16	Joshi	NNP	ORGANIZATION	Joshi	nn	17	SENT_349	[p15l1248t748r1376b802],
17	VA	NNP	ORGANIZATION	VA	appos	5	SENT_349	[p15l1396t749r1482b798],
18	,	,	O	,	_	0	SENT_349	[p15l1396t749r1482b798],
19	Liyanage	NNP	PERSON	Liyanage	nn	20	SENT_349	[p15l1504t748r1727b802],
20	H	NNP	O	H	appos	5	SENT_349	[p15l1748t750r1799b798],
21	,	,	O	,	_	0	SENT_349	[p15l1748t750r1799b798],
22	et	FW	O	et	nn	23	SENT_349	[p15l1821t754r1868b791],
23	al.	FW	O	al.	appos	5	SENT_349	[p15l1888t748r1943b792],
24	.	.	O	.	_	0	SENT_349	[p15l1888t748r1943b792],

1	A	DT	O	a	det	6	SENT_350	[p15l1963t750r2000b791],
2	rapid	JJ	O	rapid	amod	6	SENT_350	[p15l2020t748r2151b802],
3	and	CC	O	and	_	0	SENT_350	[p15l138t814r231b858],
4	sensitive	JJ	O	sensitive	amod	6	SENT_350	[p15l245t815r468b858],
5	enzymatic	JJ	O	enzymatic	amod	6	SENT_350	[p15l482t815r748b868],
6	method	NN	O	method	_	0	SENT_350	[p15l761t814r959b858],
7	for	IN	O	for	_	0	SENT_350	[p15l973t814r1045b858],
8	epidermal	JJ	O	epidermal	amod	13	SENT_350	[p15l1056t814r1317b868],
9	growth	NN	O	growth	nn	13	SENT_350	[p15l1330t814r1515b868],
10	factor	NN	O	factor	nn	13	SENT_350	[p15l1528t814r1676b858],
11	receptor	NN	O	receptor	nn	13	SENT_350	[p15l1688t820r1903b868],
12	mutation	NN	O	mutation	nn	13	SENT_350	[p15l1915t815r2152b858],
13	screening	NN	O	screening	prep_for	6	SENT_350	[p15l139t880r397b934],
14	.	.	O	.	_	0	SENT_350	[p15l139t880r397b934],

1	Clin	NNP	O	Clin	nn	3	SENT_351	[p15l416t879r514b923],
2	Cancer	NNP	O	Cancer	nn	3	SENT_351	[p15l532t882r707b923],
3	Res	NNP	O	Res	_	0	SENT_351	[p15l723t882r807b923],
4	2006	CD	DATE	2006	num	3	SENT_351	[p15l825t882r1230b930],
5	;	:	O	;	_	0	SENT_351	[p15l825t882r1230b930],
6	12:751	CD	NUMBER	12:751	number	7	SENT_351	[p15l825t882r1230b930],
7	—	CD	NUMBER	—	dep	3	SENT_351	[p15l825t882r1230b930],
8	8	CD	NUMBER	8	dep	7	SENT_351	[p15l825t882r1230b930],
9	.	.	O	.	_	0	SENT_351	[p15l825t882r1230b930],

1	[	RB	O	[	advmod	2	SENT_352	[p15l7t946r103b1000],
2	20	CD	NUMBER	20	_	0	SENT_352	[p15l7t946r103b1000],
3	]	CD	NUMBER	]	num	5	SENT_352	[p15l7t946r103b1000],
4	Cappuzzo	NNP	O	Cappuzzo	nn	5	SENT_352	[p15l138t948r387b1000],
5	F	NN	O	f	dep	2	SENT_352	[p15l403t949r437b996],
6	,	,	O	,	_	0	SENT_352	[p15l403t949r437b996],
7	Hirsch	NNP	PERSON	Hirsch	nn	8	SENT_352	[p15l454t946r619b990],
8	FR	NN	O	fr	appos	5	SENT_352	[p15l634t949r706b996],
9	,	,	O	,	_	0	SENT_352	[p15l634t949r706b996],
10	Rossi	NNP	PERSON	Rossi	nn	11	SENT_352	[p15l724t947r852b990],
11	E	NNP	O	E	appos	5	SENT_352	[p15l869t949r909b996],
12	,	,	O	,	_	0	SENT_352	[p15l869t949r909b996],
13	Bartolini	NNP	PERSON	Bartolini	nn	14	SENT_352	[p15l926t946r1146b990],
14	S	NNP	O	S	appos	5	SENT_352	[p15l1162t948r1200b996],
15	,	,	O	,	_	0	SENT_352	[p15l1162t948r1200b996],
16	Ceresoli	NNP	ORGANIZATION	Ceresoli	nn	17	SENT_352	[p15l1217t946r1420b990],
17	GL	NNP	ORGANIZATION	GL	appos	5	SENT_352	[p15l1436t948r1513b996],
18	,	,	O	,	_	0	SENT_352	[p15l1436t948r1513b996],
19	Bemis	NNP	PERSON	Bemis	nn	20	SENT_352	[p15l1530t947r1683b990],
20	L	NNP	PERSON	L	appos	5	SENT_352	[p15l1700t949r1737b996],
21	,	,	O	,	_	0	SENT_352	[p15l1700t949r1737b996],
22	et	FW	O	et	nn	23	SENT_352	[p15l1753t952r1801b990],
23	al.	FW	O	al.	appos	5	SENT_352	[p15l1816t946r1871b990],
24	.	.	O	.	_	0	SENT_352	[p15l1816t946r1871b990],

1	Epidermal	JJ	O	epidermal	amod	3	SENT_353	[p15l1888t946r2151b1000],
2	growth	NN	O	growth	nn	3	SENT_353	[p15l137t1012r322b1066],
3	factor	NN	O	factor	_	0	SENT_353	[p15l342t1011r489b1055],
4	receptor	NN	O	receptor	nn	5	SENT_353	[p15l507t1018r722b1066],
5	gene	NN	O	gene	dep	3	SENT_353	[p15l739t1024r859b1066],
6	and	CC	O	and	_	0	SENT_353	[p15l879t1011r972b1055],
7	protein	NN	O	protein	nn	10	SENT_353	[p15l992t1012r1177b1066],
8	and	CC	O	and	_	0	SENT_353	[p15l1196t1011r1289b1055],
9	geﬁtinib	NN	O	geﬁtinib	nn	10	SENT_353	[p15l1308t1011r1522b1066],
10	sensitivity	NN	O	sensitivity	dep	3	SENT_353	[p15l1542t1012r1807b1066],
11	in	IN	O	in	_	0	SENT_353	[p15l1825t1012r1872b1055],
12	non-small	JJ	O	non-small	amod	15	SENT_353	[p15l1891t1011r2151b1055],
13	cell	NN	O	cell	nn	15	SENT_353	[p15l138t1078r224b1121],
14	lung	NN	O	lung	nn	15	SENT_353	[p15l243t1078r356b1132],
15	cancer	NN	O	cancer	prep_in	3	SENT_353	[p15l373t1081r581b1132],
16	.	.	O	.	_	0	SENT_353	[p15l373t1081r581b1132],

1	J	NNP	O	J	nn	4	SENT_354	[p15l373t1081r581b1132],
2	Natl	NNP	O	Natl	nn	4	SENT_354	[p15l599t1078r702b1121],
3	Cancer	NNP	O	Cancer	nn	4	SENT_354	[p15l721t1080r896b1121],
4	Inst	NNP	O	Inst	_	0	SENT_354	[p15l912t1081r1008b1121],
5	2005	CD	DATE	2005	num	4	SENT_354	[p15l1024t1080r1462b1128],
6	;	:	O	;	_	0	SENT_354	[p15l1024t1080r1462b1128],
7	97:643	CD	NUMBER	97:643	number	8	SENT_354	[p15l1024t1080r1462b1128],
8	—	CD	NUMBER	—	dep	4	SENT_354	[p15l1024t1080r1462b1128],
9	55	CD	NUMBER	55	dep	8	SENT_354	[p15l1024t1080r1462b1128],
10	.	.	O	.	_	0	SENT_354	[p15l1024t1080r1462b1128],

1	[	NN	O	[	_	0	SENT_355	[p15l9t1144r103b1199],
2	21	CD	NUMBER	21	num	1	SENT_355	[p15l9t1144r103b1199],
3	]	CD	NUMBER	]	num	5	SENT_355	[p15l9t1144r103b1199],
4	Loprevite	NN	O	loprevite	nn	5	SENT_355	[p15l138t1145r377b1199],
5	M	NN	O	m	dep	1	SENT_355	[p15l394t1147r455b1194],
6	,	,	O	,	_	0	SENT_355	[p15l394t1147r455b1194],
7	Tiseo	NNP	O	Tiseo	nn	8	SENT_355	[p15l470t1145r604b1188],
8	M	NNP	O	M	appos	5	SENT_355	[p15l621t1147r682b1194],
9	,	,	O	,	_	0	SENT_355	[p15l621t1147r682b1194],
10	Chiaramondia	NNP	O	Chiaramondia	nn	11	SENT_355	[p15l699t1144r1060b1188],
11	M	NNP	O	M	appos	5	SENT_355	[p15l1077t1147r1137b1195],
12	,	,	O	,	_	0	SENT_355	[p15l1077t1147r1137b1195],
13	Capelletti	NNP	O	Capelletti	nn	14	SENT_355	[p15l1155t1144r1399b1199],
14	M	NNP	O	M	appos	5	SENT_355	[p15l1417t1147r1478b1194],
15	,	,	O	,	_	0	SENT_355	[p15l1417t1147r1478b1194],
16	Bozzetti	NNP	ORGANIZATION	Bozzetti	nn	17	SENT_355	[p15l1496t1145r1702b1188],
17	C	NNP	O	C	appos	5	SENT_355	[p15l1719t1146r1761b1194],
18	,	,	O	,	_	0	SENT_355	[p15l1719t1146r1761b1194],
19	Bortesi	NN	PERSON	bortesus	nn	20	SENT_355	[p15l1779t1145r1956b1188],
20	B	NN	O	b	appos	5	SENT_355	[p15l1973t1147r2015b1195],
21	,	,	O	,	_	0	SENT_355	[p15l1973t1147r2015b1195],
22	et	FW	O	et	nn	23	SENT_355	[p15l2033t1151r2080b1188],
23	al.	FW	O	al.	appos	5	SENT_355	[p15l2096t1144r2151b1188],
24	.	.	O	.	_	0	SENT_355	[p15l2096t1144r2151b1188],

1	Buccal	JJ	MISC	buccal	amod	3	SENT_356	[p15l138t1210r302b1253],
2	mucosa	NN	O	mucosa	nn	3	SENT_356	[p15l320t1222r516b1253],
3	cells	NNS	O	cell	nsubj	9	SENT_356	[p15l533t1210r644b1253],
4	as	IN	O	as	_	0	SENT_356	[p15l663t1222r712b1253],
5	“	NN	O	“	prep_as	3	SENT_356	[p15l731t1210r803b1253],
6	in	FW	O	in	prep	5	SENT_356	[p15l731t1210r803b1253],
7	vivo	FW	O	vivo	nn	8	SENT_356	[p15l818t1210r948b1253],
8	”	FW	O	”	pobj	6	SENT_356	[p15l818t1210r948b1253],
9	model	NN	O	model	_	0	SENT_356	[p15l967t1210r1126b1253],
10	to	TO	O	to	aux	11	SENT_356	[p15l1144t1216r1193b1253],
11	evaluate	VB	O	evaluate	xcomp	9	SENT_356	[p15l1211t1210r1425b1253],
12	geﬁtinib	NN	O	geﬁtinib	nn	13	SENT_356	[p15l1442t1209r1655b1264],
13	activity	NN	O	activity	dobj	11	SENT_356	[p15l1673t1210r1863b1264],
14	in	IN	O	in	_	0	SENT_356	[p15l1880t1210r1927b1253],
15	patients	NNS	O	patient	prep_in	11	SENT_356	[p15l1944t1210r2151b1264],
16	with	IN	O	with	_	0	SENT_356	[p15l137t1276r255b1320],
17	advanced	JJ	O	advanced	amod	21	SENT_356	[p15l273t1276r515b1320],
18	non-small	JJ	O	non-small	amod	21	SENT_356	[p15l534t1276r793b1320],
19	cell	NN	O	cell	nn	21	SENT_356	[p15l812t1276r898b1320],
20	lung	NN	O	lung	nn	21	SENT_356	[p15l917t1276r1030b1330],
21	cancer	NN	O	cancer	prep_with	15	SENT_356	[p15l1046t1289r1222b1320],
22	.	.	O	.	_	0	SENT_356	[p15l1046t1289r1222b1320],

1	Clin	NNP	O	Clin	nn	3	SENT_357	[p15l1241t1276r1340b1320],
2	Cancer	NNP	O	Cancer	nn	3	SENT_357	[p15l1357t1278r1533b1320],
3	Res	NNP	O	Res	_	0	SENT_357	[p15l1549t1279r1633b1320],
4	2007	CD	DATE	2007	num	3	SENT_357	[p15l1651t1278r2114b1326],
5	;	:	O	;	_	0	SENT_357	[p15l1651t1278r2114b1326],
6	13:6518	CD	NUMBER	13:6518	number	7	SENT_357	[p15l1651t1278r2114b1326],
7	—	CD	NUMBER	—	dep	3	SENT_357	[p15l1651t1278r2114b1326],
8	26	CD	NUMBER	26	dep	7	SENT_357	[p15l1651t1278r2114b1326],
9	.	.	O	.	_	0	SENT_357	[p15l1651t1278r2114b1326],

1	[	NN	O	[	_	0	SENT_358	[p15l7t1341r103b1396],
2	22	CD	NUMBER	22	num	1	SENT_358	[p15l7t1341r103b1396],
3	]	CD	NUMBER	]	num	5	SENT_358	[p15l7t1341r103b1396],
4	Mclnerney	NN	O	mclnerney	nn	5	SENT_358	[p15l138t1344r414b1396],
5	JM	NN	O	jm	dep	1	SENT_358	[p15l443t1344r528b1396],
6	,	,	O	,	_	0	SENT_358	[p15l443t1344r528b1396],
7	Wilson	NNP	PERSON	Wilson	nn	8	SENT_358	[p15l564t1341r747b1385],
8	MA	NNP	PERSON	MA	appos	5	SENT_358	[p15l783t1343r883b1392],
9	,	,	O	,	_	0	SENT_358	[p15l783t1343r883b1392],
10	Strand	NNP	ORGANIZATION	Strand	nn	11	SENT_358	[p15l921t1341r1085b1385],
11	KJ	NNP	ORGANIZATION	KJ	appos	5	SENT_358	[p15l1123t1344r1185b1396],
12	,	,	O	,	_	0	SENT_358	[p15l1123t1344r1185b1396],
13	Chrysogelos	NNP	ORGANIZATION	Chrysogelos	nn	14	SENT_358	[p15l1223t1341r1531b1396],
14	SA	NNP	ORGANIZATION	SA	appos	5	SENT_358	[p15l1569t1343r1644b1385],
15	.	.	O	.	_	0	SENT_358	[p15l1569t1343r1644b1385],

1	A	DT	O	a	det	5	SENT_359	[p15l1680t1343r1718b1385],
2	strong	JJ	O	strong	amod	5	SENT_359	[p15l1753t1348r1915b1396],
3	intronic	JJ	O	intronic	amod	5	SENT_359	[p15l1951t1342r2152b1385],
4	enhancer	NN	O	enhancer	nn	5	SENT_359	[p15l138t1408r377b1451],
5	element	NN	O	element	nsubj	12	SENT_359	[p15l388t1408r599b1451],
6	of	IN	O	of	_	0	SENT_359	[p15l610t1408r663b1451],
7	the	DT	O	the	det	9	SENT_359	[p15l668t1408r749b1451],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_359	[p15l762t1410r896b1451],
9	gene	NN	O	gene	prep_of	5	SENT_359	[p15l904t1420r1025b1462],
10	is	VBZ	O	be	cop	12	SENT_359	[p15l1038t1409r1075b1451],
11	preferentially	RB	O	preferentially	advmod	12	SENT_359	[p15l1088t1408r1437b1462],
12	active	JJ	O	active	_	0	SENT_359	[p15l1448t1409r1596b1451],
13	in	IN	O	in	_	0	SENT_359	[p15l1609t1409r1656b1451],
14	high	JJ	O	high	amod	15	SENT_359	[p15l1668t1408r1781b1462],
15	EGFR	NN	ORGANIZATION	egfr	prep_in	12	SENT_359	[p15l1793t1410r1926b1451],
16	expressing	VBG	O	express	xcomp	12	SENT_359	[p15l1936t1420r2151b1462, p15l138t1475r217b1529],
17	breast	NN	O	breast	nn	19	SENT_359	[p15l233t1474r391b1518],
18	cancer	NN	O	cancer	nn	19	SENT_359	[p15l408t1487r576b1518],
19	cells	NNS	O	cell	dobj	16	SENT_359	[p15l592t1474r749b1529],
20	.	.	O	.	_	0	SENT_359	[p15l592t1474r749b1529],

1	J	NN	O	j	nn	2	SENT_360	[p15l592t1474r749b1529],
2	Cell	NN	O	cell	_	0	SENT_360	[p15l767t1474r860b1518],
3	Biochem	NNP	O	Biochem	dep	2	SENT_360	[p15l879t1474r1101b1518],
4	2001	CD	DATE	2001	num	3	SENT_360	[p15l1119t1476r1239b1518],
5	;	:	O	;	_	0	SENT_360	[p15l1253t1476r1560b1525],
6	80:538	CD	NUMBER	80:538	number	7	SENT_360	[p15l1253t1476r1560b1525],
7	—	CD	NUMBER	—	dep	2	SENT_360	[p15l1253t1476r1560b1525],
8	49	CD	NUMBER	49	dep	7	SENT_360	[p15l1253t1476r1560b1525],
9	.	.	O	.	_	0	SENT_360	[p15l1253t1476r1560b1525],

1	[	NN	O	[	nn	4	SENT_361	[p15l7t1539r103b1594],
2	23	CD	NUMBER	23	num	4	SENT_361	[p15l7t1539r103b1594],
3	]	NN	O	]	nn	4	SENT_361	[p15l7t1539r103b1594],
4	Tiseo	NN	O	tiseo	_	0	SENT_361	[p15l136t1540r269b1583],
5	M	NN	O	m	dep	4	SENT_361	[p15l292t1542r352b1590],
6	,	,	O	,	_	0	SENT_361	[p15l292t1542r352b1590],
7	Capelletti	NN	O	capellettus	nn	8	SENT_361	[p15l375t1540r619b1594],
8	M	NN	O	m	appos	5	SENT_361	[p15l642t1542r703b1590],
9	,	,	O	,	_	0	SENT_361	[p15l642t1542r703b1590],
10	De	NNP	PERSON	De	nn	12	SENT_361	[p15l726t1542r792b1583],
11	Palma	NNP	PERSON	Palma	nn	12	SENT_361	[p15l814t1540r970b1583],
12	G	NNP	PERSON	G	appos	5	SENT_361	[p15l991t1542r1039b1590],
13	,	,	O	,	_	0	SENT_361	[p15l991t1542r1039b1590],
14	Franciosi	NNP	PERSON	Franciosi	nn	15	SENT_361	[p15l1062t1540r1289b1583],
15	V	NNP	PERSON	V	appos	5	SENT_361	[p15l1309t1542r1357b1590],
16	,	,	O	,	_	0	SENT_361	[p15l1309t1542r1357b1590],
17	Cavazzoni	NNP	MISC	Cavazzoni	nn	18	SENT_361	[p15l1380t1540r1636b1583],
18	A	NNP	MISC	A	appos	5	SENT_361	[p15l1656t1542r1705b1590],
19	,	,	O	,	_	0	SENT_361	[p15l1656t1542r1705b1590],
20	Mozzoni	NNP	PERSON	Mozzoni	nn	21	SENT_361	[p15l1728t1540r1947b1583],
21	P	NN	O	p	appos	5	SENT_361	[p15l1970t1542r2005b1590],
22	,	,	O	,	_	0	SENT_361	[p15l1970t1542r2005b1590],
23	et	FW	O	et	nn	24	SENT_361	[p15l2028t1546r2075b1583],
24	al.	FW	O	al.	appos	5	SENT_361	[p15l2096t1540r2151b1584],
25	.	.	O	.	_	0	SENT_361	[p15l2096t1540r2151b1584],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_362	[p15l138t1608r272b1650],
2	intron	NN	O	intron	nsubj	6	SENT_362	[p15l282t1607r488b1650],
3	—	CD	NUMBER	—	num	5	SENT_362	[p15l282t1607r488b1650],
4	1	CD	NUMBER	1	num	5	SENT_362	[p15l282t1607r488b1650],
5	polymorphism	NN	O	polymorphism	dep	2	SENT_362	[p15l506t1606r886b1660],
6	predicts	VBZ	O	predict	_	0	SENT_362	[p15l898t1606r1103b1660],
7	geﬁtinib	NN	O	geﬁtinib	nn	8	SENT_362	[p15l1115t1606r1329b1660],
8	outcome	NN	O	outcome	dobj	6	SENT_362	[p15l1341t1612r1565b1650],
9	in	IN	O	in	_	0	SENT_362	[p15l1577t1607r1625b1649],
10	advanced	JJ	O	advanced	amod	14	SENT_362	[p15l1636t1606r1879b1650],
11	non-small	JJ	O	non-small	amod	14	SENT_362	[p15l1891t1606r2151b1650],
12	cell	NN	O	cell	nn	14	SENT_362	[p15l138t1672r224b1715],
13	lung	NN	O	lung	nn	14	SENT_362	[p15l243t1672r356b1726],
14	cancer	NN	O	cancer	prep_in	8	SENT_362	[p15l373t1674r581b1726],
15	.	.	O	.	_	0	SENT_362	[p15l373t1674r581b1726],

1	J	NNP	O	J	nn	3	SENT_363	[p15l373t1674r581b1726],
2	Thoracic	NNP	O	Thoracic	nn	3	SENT_363	[p15l597t1672r816b1715],
3	Oncol	NNP	O	Oncol	_	0	SENT_363	[p15l834t1672r980b1715],
4	2008	CD	DATE	2008	num	3	SENT_363	[p15l998t1674r1421b1722],
5	;	:	O	;	_	0	SENT_363	[p15l998t1674r1421b1722],
6	3:1104	CD	NUMBER	3:1104	number	7	SENT_363	[p15l998t1674r1421b1722],
7	—	CD	NUMBER	—	dep	3	SENT_363	[p15l998t1674r1421b1722],
8	11	CD	NUMBER	11	dep	7	SENT_363	[p15l998t1674r1421b1722],
9	.	.	O	.	_	0	SENT_363	[p15l998t1674r1421b1722],

1	[	NN	O	[	_	0	SENT_364	[p15l7t1738r103b1792],
2	24	CD	NUMBER	24	number	3	SENT_364	[p15l7t1738r103b1792],
3	]	CD	NUMBER	]	num	5	SENT_364	[p15l7t1738r103b1792],
4	Perez-Soler	NN	O	perez-soler	nn	5	SENT_364	[p15l138t1738r432b1782],
5	R	NN	O	r	dep	1	SENT_364	[p15l460t1741r503b1788],
6	,	,	O	,	_	0	SENT_364	[p15l460t1741r503b1788],
7	Saltz	NNP	PERSON	Saltz	nn	8	SENT_364	[p15l534t1738r655b1782],
8	L.	NNP	PERSON	L.	nn	11	SENT_364	[p15l685t1741r722b1782],
9	Cutaneous	JJ	PERSON	cutaneous	amod	11	SENT_364	[p15l753t1740r1021b1782],
10	adverse	JJ	O	adverse	amod	11	SENT_364	[p15l1051t1738r1248b1782],
11	effects	NNS	O	effect	appos	1	SENT_364	[p15l1278t1738r1444b1782],
12	with	IN	O	with	_	0	SENT_364	[p15l1473t1738r1592b1782],
13	HER1/EGFR-targeted	JJ	O	her1/egfr-targeted	amod	14	SENT_364	[p15l1621t1738r2151b1792],
14	agents	NNS	O	agent	prep_with	11	SENT_364	[p15l138t1810r319b1858],
15	:	:	O	:	_	0	SENT_364	[p15l138t1810r319b1858],
16	is	VBZ	O	be	dep	14	SENT_364	[p15l342t1804r379b1847],
17	there	EX	O	there	expl	16	SENT_364	[p15l397t1803r530b1847],
18	a	DT	O	a	det	20	SENT_364	[p15l548t1816r574b1847],
19	silver	NN	O	silver	nn	20	SENT_364	[p15l593t1804r731b1847],
20	lining	NN	O	lining	nsubj	16	SENT_364	[p15l748t1803r955b1858],
21	?	.	O	?	_	0	SENT_364	[p15l748t1803r955b1858],

1	J	NNP	O	J	nn	3	SENT_365	[p15l748t1803r955b1858],
2	Clin	NNP	O	Clin	nn	3	SENT_365	[p15l973t1804r1072b1847],
3	Oncol	NNP	O	Oncol	_	0	SENT_365	[p15l1089t1803r1236b1847],
4	2005	CD	DATE	2005	num	3	SENT_365	[p15l1254t1806r1728b1854],
5	;	:	O	;	_	0	SENT_365	[p15l1254t1806r1728b1854],
6	23:5235	CD	NUMBER	23:5235	number	7	SENT_365	[p15l1254t1806r1728b1854],
7	—	CD	NUMBER	—	dep	3	SENT_365	[p15l1254t1806r1728b1854],
8	46	CD	NUMBER	46	dep	7	SENT_365	[p15l1254t1806r1728b1854],
9	.	.	O	.	_	0	SENT_365	[p15l1254t1806r1728b1854],

1	[	NN	O	[	nn	5	SENT_366	[p15l6t1870r103b1924],
2	25	CD	NUMBER	25	num	5	SENT_366	[p15l6t1870r103b1924],
3	]	CD	NUMBER	]	num	5	SENT_366	[p15l6t1870r103b1924],
4	Amador	NNP	O	Amador	nn	5	SENT_366	[p15l136t1870r343b1913],
5	ML	NNP	O	ML	_	0	SENT_366	[p15l361t1873r450b1920],
6	,	,	O	,	_	0	SENT_366	[p15l361t1873r450b1920],
7	Oppenheimer	NNP	ORGANIZATION	Oppenheimer	nn	8	SENT_366	[p15l470t1870r826b1924],
8	D	NNP	ORGANIZATION	D	appos	5	SENT_366	[p15l843t1873r892b1920],
9	,	,	O	,	_	0	SENT_366	[p15l843t1873r892b1920],
10	Perea	NNP	PERSON	Perea	nn	11	SENT_366	[p15l912t1873r1050b1913],
11	S	NNP	O	S	appos	8	SENT_366	[p15l1069t1872r1107b1920],
12	,	,	O	,	_	0	SENT_366	[p15l1069t1872r1107b1920],
13	Maitra	NNP	O	Maitra	nn	14	SENT_366	[p15l1127t1870r1295b1913],
14	A	NNP	O	A	appos	8	SENT_366	[p15l1311t1872r1360b1920],
15	,	,	O	,	_	0	SENT_366	[p15l1311t1872r1360b1920],
16	Cusatis	NNP	O	Cusatis	nn	17	SENT_366	[p15l1380t1871r1561b1913],
17	G	NNP	O	G	appos	8	SENT_366	[p15l1581t1872r1629b1920],
18	,	,	O	,	_	0	SENT_366	[p15l1581t1872r1629b1920],
19	lacobuzio-Donahue	NN	O	lacobuzio-donahue	nn	20	SENT_366	[p15l1649t1870r2151b1913],
20	C	NN	O	c	appos	8	SENT_366	[p15l138t1938r181b1986],
21	,	,	O	,	_	0	SENT_366	[p15l138t1938r181b1986],
22	et	FW	O	et	nn	23	SENT_366	[p15l207t1943r254b1980],
23	al.	FW	O	al.	appos	8	SENT_366	[p15l278t1936r333b1980],
24	.	.	O	.	_	0	SENT_366	[p15l278t1936r333b1980],

1	An	DT	O	a	det	8	SENT_367	[p15l357t1938r427b1979],
2	epidermal	JJ	O	epidermal	amod	8	SENT_367	[p15l452t1936r713b1991],
3	growth	NN	O	growth	nn	8	SENT_367	[p15l738t1936r923b1991],
4	factor	NN	O	factor	nn	8	SENT_367	[p15l948t1936r1096b1980],
5	receptor	NN	O	receptor	nn	8	SENT_367	[p15l1120t1943r1335b1991],
6	intron	NN	O	intron	nn	8	SENT_367	[p15l1359t1937r1516b1980],
7	1	CD	NUMBER	1	num	8	SENT_367	[p15l1543t1939r1563b1979],
8	polymorphism	NN	O	polymorphism	nsubj	9	SENT_367	[p15l1595t1936r1974b1991],
9	mediates	VBZ	O	mediate	_	0	SENT_367	[p15l1999t1936r2151b1980, p15l138t2008r238b2045],
10	response	NN	O	response	dobj	9	SENT_367	[p15l274t2014r501b2056],
11	to	TO	O	to	_	0	SENT_367	[p15l535t2008r584b2045],
12	epidermal	JJ	O	epidermal	amod	16	SENT_367	[p15l619t2002r880b2056],
13	growth	NN	O	growth	nn	16	SENT_367	[p15l914t2002r1099b2056],
14	factor	NN	O	factor	nn	16	SENT_367	[p15l1134t2002r1282b2045],
15	receptor	NN	O	receptor	nn	16	SENT_367	[p15l1315t2008r1530b2056],
16	inhibitors	NNS	O	inhibitor	prep_to	9	SENT_367	[p15l1562t2002r1823b2046],
17	.	.	O	.	_	0	SENT_367	[p15l1562t2002r1823b2046],

1	Cancer	NN	O	cancer	_	0	SENT_368	[p15l1859t2004r2034b2045],
2	Res	NNP	O	Res	dep	1	SENT_368	[p15l2067t2004r2151b2045],
3	2004:64:9139	CD	NUMBER	2004:64:9139	num	2	SENT_368	[p15l138t2070r609b2116],
4	—	CD	NUMBER	—	number	5	SENT_368	[p15l138t2070r609b2116],
5	43	CD	NUMBER	43	dep	2	SENT_368	[p15l138t2070r609b2116],
6	.	.	O	.	_	0	SENT_368	[p15l138t2070r609b2116],

1	[	NN	O	[	_	0	SENT_369	[p15l6t2134r103b2188],
2	26	CD	NUMBER	26	num	1	SENT_369	[p15l6t2134r103b2188],
3	]	CD	NUMBER	]	num	5	SENT_369	[p15l6t2134r103b2188],
4	Nomura	NNP	ORGANIZATION	Nomura	nn	5	SENT_369	[p15l138t2137r345b2178],
5	M	NN	ORGANIZATION	m	dep	1	SENT_369	[p15l364t2137r425b2184],
6	,	,	O	,	_	0	SENT_369	[p15l364t2137r425b2184],
7	Shigematsu	NN	PERSON	shigematsu	nn	8	SENT_369	[p15l445t2134r743b2188],
8	H	NN	PERSON	h	appos	5	SENT_369	[p15l762t2137r813b2184],
9	,	,	O	,	_	0	SENT_369	[p15l762t2137r813b2184],
10	Li	NNP	PERSON	Li	nn	11	SENT_369	[p15l833t2135r874b2177],
11	L	NNP	PERSON	L	appos	5	SENT_369	[p15l893t2137r930b2184],
12	,	,	O	,	_	0	SENT_369	[p15l893t2137r930b2184],
13	Suzuki	NNP	ORGANIZATION	Suzuki	nn	14	SENT_369	[p15l950t2134r1119b2178],
14	M	NNP	ORGANIZATION	M	appos	5	SENT_369	[p15l1139t2137r1200b2184],
15	,	,	O	,	_	0	SENT_369	[p15l1139t2137r1200b2184],
16	Takahashi	NNP	ORGANIZATION	Takahashi	nn	17	SENT_369	[p15l1218t2134r1474b2178],
17	T	NN	ORGANIZATION	t	appos	5	SENT_369	[p15l1491t2137r1530b2184],
18	,	,	O	,	_	0	SENT_369	[p15l1491t2137r1530b2184],
19	Estess	NNP	ORGANIZATION	Estess	nn	20	SENT_369	[p15l1550t2137r1702b2178],
20	P	NN	ORGANIZATION	p	appos	5	SENT_369	[p15l1722t2137r1757b2184],
21	,	,	O	,	_	0	SENT_369	[p15l1722t2137r1757b2184],
22	et	FW	O	et	nn	23	SENT_369	[p15l1777t2140r1825b2178],
23	al.	FW	O	al.	appos	5	SENT_369	[p15l1842t2134r1898b2178],
24	.	.	O	.	_	0	SENT_369	[p15l1842t2134r1898b2178],

1	Polymorphism	NN	O	polymorphism	_	0	SENT_370	[p15l1918t2134r2151b2188, p15l138t2199r309b2254],
2	,	,	O	,	_	0	SENT_370	[p15l1918t2134r2151b2188, p15l138t2199r309b2254],
3	mutations	NNS	O	mutation	appos	1	SENT_370	[p15l325t2200r586b2243],
4	and	CC	O	and	_	0	SENT_370	[p15l602t2199r694b2243],
5	ampliﬁcation	NN	O	ampliﬁcation	appos	1	SENT_370	[p15l710t2199r1051b2254],
6	of	IN	O	of	_	0	SENT_370	[p15l1066t2199r1119b2243],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_370	[p15l1128t2202r1261b2243],
8	gene	NN	O	gene	prep_of	3	SENT_370	[p15l1273t2212r1393b2254],
9	in	IN	O	in	_	0	SENT_370	[p15l1409t2200r1456b2243],
10	non-small	JJ	O	non-small	amod	13	SENT_370	[p15l1471t2199r1730b2243],
11	cell	NN	O	cell	nn	13	SENT_370	[p15l1746t2199r1832b2243],
12	lung	NN	O	lung	nn	13	SENT_370	[p15l1848t2199r1961b2254],
13	cancer	NN	O	cancer	prep_in	8	SENT_370	[p15l1974t2212r2150b2243],
14	.	.	O	.	_	0	SENT_370	[p15l1974t2212r2150b2243],

1	PLOS	NNP	O	PLOS	nsubj	2	SENT_371	[p15l138t2268r264b2309],
2	Med	VBD	O	med	_	0	SENT_371	[p15l283t2266r395b2309],
3	2007	CD	DATE	2007	dobj	2	SENT_371	[p15l413t2268r809b2316],
4	;	:	O	;	_	0	SENT_371	[p15l413t2268r809b2316],
5	4:715	CD	NUMBER	4:715	number	6	SENT_371	[p15l413t2268r809b2316],
6	—	CD	NUMBER	—	dep	3	SENT_371	[p15l413t2268r809b2316],
7	27	CD	NUMBER	27	dep	6	SENT_371	[p15l413t2268r809b2316],
8	.	.	O	.	_	0	SENT_371	[p15l413t2268r809b2316],

1	[	NN	O	[	_	0	SENT_372	[p15l8t2332r103b2387],
2	27	CD	NUMBER	27	num	1	SENT_372	[p15l8t2332r103b2387],
3	]	CD	NUMBER	]	num	5	SENT_372	[p15l8t2332r103b2387],
4	Tsao	NNP	PERSON	Tsao	nn	5	SENT_372	[p15l136t2335r249b2376],
5	MS	NN	O	m	dep	1	SENT_372	[p15l273t2334r364b2382],
6	,	,	O	,	_	0	SENT_372	[p15l273t2334r364b2382],
7	Sakurada	NNP	ORGANIZATION	Sakurada	nn	8	SENT_372	[p15l388t2332r623b2376],
8	A	NNP	ORGANIZATION	A	appos	5	SENT_372	[p15l644t2334r693b2382],
9	,	,	O	,	_	0	SENT_372	[p15l644t2334r693b2382],
10	Cutz	NNP	O	Cutz	nn	11	SENT_372	[p15l717t2335r830b2376],
11	JC	NNP	O	JC	appos	5	SENT_372	[p15l847t2334r914b2387],
12	,	,	O	,	_	0	SENT_372	[p15l847t2334r914b2387],
13	Zhu	NNP	PERSON	Zhu	nn	14	SENT_372	[p15l937t2332r1034b2376],
14	CQ	NNP	O	CQ	appos	5	SENT_372	[p15l1057t2334r1140b2385],
15	,	,	O	,	_	0	SENT_372	[p15l1057t2334r1140b2385],
16	Kamel	NNP	PERSON	Kamel	appos	5	SENT_372	[p15l1165t2332r1462b2376],
17	.	.	O	.	_	0	SENT_372	[p15l1165t2332r1462b2376],

1	—	NN	O	—	_	0	SENT_373	[p15l1165t2332r1462b2376],
2	.	.	O	.	_	0	SENT_373	[p15l1165t2332r1462b2376],

1	Reid	NNP	PERSON	Reid	nn	2	SENT_374	[p15l1165t2332r1462b2376],
2	S	NNP	O	S	_	0	SENT_374	[p15l1486t2334r1524b2382],
3	,	,	O	,	_	0	SENT_374	[p15l1486t2334r1524b2382],
4	Squire	NNP	PERSON	Squire	nn	5	SENT_374	[p15l1548t2333r1709b2387],
5	J	NNP	PERSON	J	appos	2	SENT_374	[p15l1726t2335r1758b2387],
6	,	,	O	,	_	0	SENT_374	[p15l1726t2335r1758b2387],
7	et	FW	O	et	nn	8	SENT_374	[p15l1782t2339r1830b2376],
8	al.	FW	O	al.	appos	5	SENT_374	[p15l1852t2332r1907b2376],
9	.	.	O	.	_	0	SENT_374	[p15l1852t2332r1907b2376],

1	Erlotinib	NNP	O	Erlotinib	_	0	SENT_375	[p15l1931t2332r2151b2376],
2	in	IN	O	in	_	0	SENT_375	[p15l138t2398r185b2441],
3	lung	NN	O	lung	nn	4	SENT_375	[p15l211t2398r324b2452],
4	cancer	NN	O	cancer	prep_in	1	SENT_375	[p15l349t2398r825b2441],
5	—	CD	NUMBER	—	number	6	SENT_375	[p15l349t2398r825b2441],
6	molecular	JJ	O	molecular	dep	1	SENT_375	[p15l349t2398r825b2441],
7	and	CC	O	and	_	0	SENT_375	[p15l849t2398r942b2441],
8	clinical	JJ	O	clinical	amod	9	SENT_375	[p15l968t2398r1149b2441],
9	predictors	NNS	O	predictor	dep	1	SENT_375	[p15l1176t2398r1436b2452],
10	of	IN	O	of	_	0	SENT_375	[p15l1462t2398r1516b2441],
11	outcome	NN	O	outcome	prep_of	6	SENT_375	[p15l1536t2404r1772b2442],
12	.	.	O	.	_	0	SENT_375	[p15l1536t2404r1772b2442],

1	N	NN	O	n	nn	2	SENT_376	[p15l1799t2400r1836b2441],
2	EnglJ	NN	O	englj	nsubj	3	SENT_376	[p15l1863t2398r2012b2452],
3	Med	VBD	O	med	_	0	SENT_376	[p15l2039t2398r2151b2441],
4	2005	CD	DATE	2005	dobj	3	SENT_376	[p15l138t2466r609b2514],
5	;	:	O	;	_	0	SENT_376	[p15l138t2466r609b2514],
6	353:133	CD	NUMBER	353:133	number	7	SENT_376	[p15l138t2466r609b2514],
7	—	CD	NUMBER	—	dep	4	SENT_376	[p15l138t2466r609b2514],
8	44	CD	NUMBER	44	dep	7	SENT_376	[p15l138t2466r609b2514],
9	.	.	O	.	_	0	SENT_376	[p15l138t2466r609b2514],

1	[	NN	O	[	_	0	SENT_377	[p15l6t2529r103b2584],
2	28	CD	NUMBER	28	num	1	SENT_377	[p15l6t2529r103b2584],
3	]	CD	NUMBER	]	num	5	SENT_377	[p15l6t2529r103b2584],
4	Hirsch	NNP	PERSON	Hirsch	nn	5	SENT_377	[p15l138t2529r302b2573],
5	FR	NN	O	fr	dep	1	SENT_377	[p15l343t2532r415b2580],
6	,	,	O	,	_	0	SENT_377	[p15l343t2532r415b2580],
7	Varella	NNP	PERSON	Varella	appos	5	SENT_377	[p15l454t2529r822b2573],
8	.	.	O	.	_	0	SENT_377	[p15l454t2529r822b2573],

1	—	NN	O	—	_	0	SENT_378	[p15l454t2529r822b2573],
2	.	.	O	.	_	0	SENT_378	[p15l454t2529r822b2573],

1	Garcia	NNP	PERSON	Garcia	nn	2	SENT_379	[p15l454t2529r822b2573],
2	M	NNP	O	M	_	0	SENT_379	[p15l863t2532r924b2580],
3	,	,	O	,	_	0	SENT_379	[p15l863t2532r924b2580],
4	Bunn	NNP	PERSON	Bunn	nn	6	SENT_379	[p15l966t2532r1098b2573],
5	Jr	NNP	PERSON	Jr	nn	6	SENT_379	[p15l1132t2532r1177b2584],
6	PA	NN	PERSON	pa	appos	2	SENT_379	[p15l1217t2531r1292b2580],
7	,	,	O	,	_	0	SENT_379	[p15l1217t2531r1292b2580],
8	Franklin	NNP	PERSON	Franklin	nn	9	SENT_379	[p15l1333t2529r1542b2573],
9	WA	NNP	PERSON	WA	appos	6	SENT_379	[p15l1580t2531r1685b2580],
10	,	,	O	,	_	0	SENT_379	[p15l1580t2531r1685b2580],
11	Dziadziuszko	NNP	PERSON	Dziadziuszko	nn	12	SENT_379	[p15l1727t2529r2066b2573],
12	R	NNP	PERSON	R	appos	6	SENT_379	[p15l2108t2532r2150b2580],
13	,	,	O	,	_	0	SENT_379	[p15l2108t2532r2150b2580],
14	Thatcher	NNP	PERSON	Thatcher	nn	15	SENT_379	[p15l135t2596r365b2640],
15	N	NNP	O	N	appos	6	SENT_379	[p15l386t2599r436b2646],
16	,	,	O	,	_	0	SENT_379	[p15l386t2599r436b2646],
17	et	FW	O	et	nn	18	SENT_379	[p15l460t2602r507b2640],
18	al.	FW	O	al.	appos	6	SENT_379	[p15l528t2596r583b2640],
19	.	.	O	.	_	0	SENT_379	[p15l528t2596r583b2640],

1	Molecular	JJ	O	molecular	amod	2	SENT_380	[p15l607t2596r866b2640],
2	predictors	NNS	O	predictor	nsubj	12	SENT_380	[p15l887t2596r1147b2650],
3	of	IN	O	of	_	0	SENT_380	[p15l1171t2596r1224b2640],
4	outcome	NN	O	outcome	prep_of	2	SENT_380	[p15l1240t2602r1464b2640],
5	with	IN	O	with	_	0	SENT_380	[p15l1486t2596r1604b2640],
6	geﬁtinib	NN	O	geﬁtinib	prep_with	4	SENT_380	[p15l1625t2596r1839b2650],
7	in	IN	O	in	_	0	SENT_380	[p15l1862t2597r1909b2639],
8	phase	NN	O	phase	nn	11	SENT_380	[p15l1932t2596r2080b2650],
9	III	CD	NUMBER	iii	num	11	SENT_380	[p15l2103t2599r2150b2639],
10	placebo	NN	O	placebo	nn	11	SENT_380	[p15l138t2661r624b2716],
11	—	NN	O	—	prep_in	6	SENT_380	[p15l138t2661r624b2716],
12	controlled	JJ	O	controlled	_	0	SENT_380	[p15l138t2661r624b2716],
13	study	NN	O	study	dobj	12	SENT_380	[p15l645t2661r786b2716],
14	in	IN	O	in	_	0	SENT_380	[p15l805t2662r851b2705],
15	advanced	JJ	O	advanced	amod	18	SENT_380	[p15l870t2661r1113b2705],
16	non-small-cell	JJ	O	non-small-cell	amod	18	SENT_380	[p15l1133t2661r1506b2705],
17	lung	NN	O	lung	nn	18	SENT_380	[p15l1527t2661r1639b2716],
18	cancer	NN	O	cancer	prep_in	13	SENT_380	[p15l1657t2664r1867b2716],
19	.	.	O	.	_	0	SENT_380	[p15l1657t2664r1867b2716],

1	J	NNP	O	J	nn	3	SENT_381	[p15l1657t2664r1867b2716],
2	Clin	NNP	O	Clin	nn	3	SENT_381	[p15l1887t2661r1986b2705],
3	Oncol	NNP	O	Oncol	_	0	SENT_381	[p15l2005t2661r2151b2705],
4	2006	CD	DATE	2006	num	3	SENT_381	[p15l138t2730r613b2778],
5	;	:	O	;	_	0	SENT_381	[p15l138t2730r613b2778],
6	24:5034	CD	NUMBER	24:5034	number	7	SENT_381	[p15l138t2730r613b2778],
7	—	CD	NUMBER	—	dep	3	SENT_381	[p15l138t2730r613b2778],
8	42	CD	NUMBER	42	dep	7	SENT_381	[p15l138t2730r613b2778],
9	.	.	O	.	_	0	SENT_381	[p15l138t2730r613b2778],

1	[	NN	O	[	nn	5	SENT_382	[p15l6t2794r103b2849],
2	29	CD	NUMBER	29	num	5	SENT_382	[p15l6t2794r103b2849],
3	]	CD	NUMBER	]	num	5	SENT_382	[p15l6t2794r103b2849],
4	Zhu	NNP	PERSON	Zhu	nn	5	SENT_382	[p15l137t2794r234b2838],
5	CQ	NNP	O	CQ	_	0	SENT_382	[p15l261t2796r344b2847],
6	,	,	O	,	_	0	SENT_382	[p15l261t2796r344b2847],
7	da	NNP	O	da	nn	10	SENT_382	[p15l373t2794r432b2838],
8	Cunha	NNP	ORGANIZATION	Cunha	nn	10	SENT_382	[p15l459t2794r621b2838],
9	Santos	NNP	ORGANIZATION	Santos	nn	10	SENT_382	[p15l649t2796r814b2838],
10	G	NNP	ORGANIZATION	G	appos	5	SENT_382	[p15l843t2796r891b2844],
11	,	,	O	,	_	0	SENT_382	[p15l843t2796r891b2844],
12	Ding	NNP	PERSON	Ding	nn	13	SENT_382	[p15l919t2795r1038b2849],
13	K	NNP	PERSON	K	appos	10	SENT_382	[p15l1065t2797r1110b2844],
14	,	,	O	,	_	0	SENT_382	[p15l1065t2797r1110b2844],
15	Sakurada	NNP	ORGANIZATION	Sakurada	nn	16	SENT_382	[p15l1138t2794r1373b2838],
16	A	NNP	ORGANIZATION	A	appos	10	SENT_382	[p15l1399t2796r1447b2844],
17	,	,	O	,	_	0	SENT_382	[p15l1399t2796r1447b2844],
18	Cutz	NNP	O	Cutz	nn	19	SENT_382	[p15l1476t2796r1589b2838],
19	JC	NNP	O	JC	appos	10	SENT_382	[p15l1610t2796r1677b2849],
20	,	,	O	,	_	0	SENT_382	[p15l1610t2796r1677b2849],
21	Liu	NNP	PERSON	Liu	nn	22	SENT_382	[p15l1705t2795r1780b2838],
22	N	NNP	O	N	appos	10	SENT_382	[p15l1808t2797r1858b2844],
23	,	,	O	,	_	0	SENT_382	[p15l1808t2797r1858b2844],
24	et	FW	O	et	nn	25	SENT_382	[p15l1886t2801r1933b2838],
25	al.	FW	O	al.	appos	10	SENT_382	[p15l1960t2794r2014b2838],
26	.	.	O	.	_	0	SENT_382	[p15l1960t2794r2014b2838],

1	Role	NN	O	role	_	0	SENT_383	[p15l2043t2794r2151b2838],
2	of	IN	O	of	_	0	SENT_383	[p15l138t2859r191b2903],
3	l	NN	O	l	prep_of	1	SENT_383	[p15l209t2862r342b2903],
4	(	CD	NUMBER	(	num	3	SENT_383	[p15l209t2862r342b2903],
5	RAS	NN	O	ra	nsubj	13	SENT_383	[p15l209t2862r342b2903],
6	and	CC	O	and	_	0	SENT_383	[p15l367t2860r460b2903],
7	EGFR	NN	ORGANIZATION	egfr	nsubj	13	SENT_383	[p15l484t2862r618b2903],
8	as	IN	O	as	_	0	SENT_383	[p15l639t2872r689b2903],
9	biomarkers	NNS	O	biomarker	prep_as	5	SENT_383	[p15l713t2860r1004b2903],
10	of	IN	O	of	_	0	SENT_383	[p15l1029t2859r1082b2903],
11	response	NN	O	response	prep_of	9	SENT_383	[p15l1100t2872r1327b2914],
12	to	TO	O	to	aux	13	SENT_383	[p15l1351t2866r1400b2903],
13	erlotinib	VB	O	erlotinib	infmod	3	SENT_383	[p15l1424t2860r1642b2903],
14	in	IN	O	in	_	0	SENT_383	[p15l1667t2860r1714b2903],
15	National	NNP	ORGANIZATION	National	nn	17	SENT_383	[p15l1738t2860r1953b2903],
16	Cancer	NNP	ORGANIZATION	Cancer	nn	17	SENT_383	[p15l1978t2862r2153b2903],
17	Institute	NNP	ORGANIZATION	Institute	prep_in	13	SENT_383	[p15l138t2927r353b2970],
18	of	IN	ORGANIZATION	of	_	0	SENT_383	[p15l380t2926r433b2970],
19	Canada	NNP	ORGANIZATION	Canada	prep_of	17	SENT_383	[p15l454t2926r640b2970],
20	Clinical	JJ	ORGANIZATION	clinical	amod	24	SENT_383	[p15l667t2926r854b2970],
21	Trials	NNPS	ORGANIZATION	Trials	nn	24	SENT_383	[p15l879t2926r1019b2970],
22	Group	NNP	ORGANIZATION	Group	nn	24	SENT_383	[p15l1046t2928r1204b2980],
23	Study	NNP	ORGANIZATION	Study	nn	24	SENT_383	[p15l1231t2926r1377b2980],
24	BR	NNP	O	BR	tmod	13	SENT_383	[p15l1402t2928r1592b2980],
25	.21	CD	NUMBER	.21	dep	24	SENT_383	[p15l1402t2928r1592b2980],
26	.	.	O	.	_	0	SENT_383	[p15l1402t2928r1592b2980],

1	J	NNP	O	J	nn	3	SENT_384	[p15l1402t2928r1592b2980],
2	Clin	NNP	O	Clin	nn	3	SENT_384	[p15l1619t2926r1718b2970],
3	Oncol	NNP	O	Oncol	_	0	SENT_384	[p15l1744t2926r1890b2970],
4	2008	CD	DATE	2008	num	3	SENT_384	[p15l1918t2928r2147b2976],
5	;	:	O	;	_	0	SENT_384	[p15l1918t2928r2147b2976],
6	26	CD	NUMBER	26	num	8	SENT_384	[p15l1918t2928r2147b2976],
7	:	:	O	:	_	0	SENT_384	[p15l1918t2928r2147b2976],
8	4268-75	CD	NUMBER	4268-75	dep	3	SENT_384	[p15l136t2995r376b3036],
9	.	.	O	.	_	0	SENT_384	[p15l136t2995r376b3036],

1	[	RB	O	[	advmod	2	SENT_385	[p15l6t3059r103b3113],
2	30	CD	NUMBER	30	_	0	SENT_385	[p15l6t3059r103b3113],
3	]	CD	NUMBER	]	num	5	SENT_385	[p15l6t3059r103b3113],
4	Parra	NNP	O	Parra	nn	5	SENT_385	[p15l138t3062r270b3102],
5	HS	NN	O	h	dep	2	SENT_385	[p15l293t3061r373b3109],
6	,	,	O	,	_	0	SENT_385	[p15l293t3061r373b3109],
7	Cavina	NNP	PERSON	Cavina	nn	8	SENT_385	[p15l397t3060r567b3102],
8	R	NNP	PERSON	R	appos	5	SENT_385	[p15l590t3062r633b3109],
9	,	,	O	,	_	0	SENT_385	[p15l590t3062r633b3109],
10	Latteri	NNP	O	Latteri	nn	11	SENT_385	[p15l658t3060r822b3102],
11	F	NN	O	f	appos	5	SENT_385	[p15l846t3062r880b3109],
12	,	,	O	,	_	0	SENT_385	[p15l846t3062r880b3109],
13	Campagnoli	NNP	PERSON	Campagnoli	nn	14	SENT_385	[p15l904t3059r1209b3113],
14	E	NNP	O	E	appos	5	SENT_385	[p15l1233t3062r1273b3109],
15	,	,	O	,	_	0	SENT_385	[p15l1233t3062r1273b3109],
16	Morenghi	NNP	O	Morenghi	nn	17	SENT_385	[p15l1297t3059r1546b3113],
17	E	NNP	O	E	appos	5	SENT_385	[p15l1570t3062r1610b3109],
18	,	,	O	,	_	0	SENT_385	[p15l1570t3062r1610b3109],
19	Torri	NNP	PERSON	Torri	nn	20	SENT_385	[p15l1632t3060r1753b3102],
20	W	NNP	PERSON	W	appos	5	SENT_385	[p15l1775t3062r1841b3109],
21	,	,	O	,	_	0	SENT_385	[p15l1775t3062r1841b3109],
22	et	FW	O	et	nn	23	SENT_385	[p15l1866t3065r1913b3102],
23	al.	FW	O	al.	appos	5	SENT_385	[p15l1935t3059r1990b3103],
24	.	.	O	.	_	0	SENT_385	[p15l1935t3059r1990b3103],

1	Analysis	NN	O	analysis	_	0	SENT_386	[p15l2012t3059r2151b3102, p15l136t3126r231b3180],
2	of	IN	O	of	_	0	SENT_386	[p15l254t3125r307b3169],
3	epidermal	JJ	O	epidermal	amod	7	SENT_386	[p15l323t3125r584b3180],
4	growth	NN	O	growth	nn	7	SENT_386	[p15l605t3125r791b3180],
5	factor	NN	O	factor	nn	7	SENT_386	[p15l813t3125r960b3169],
6	receptor	NN	O	receptor	nn	7	SENT_386	[p15l981t3132r1196b3180],
7	expression	NN	O	expression	prep_of	1	SENT_386	[p15l1216t3126r1492b3180],
8	as	IN	O	as	_	0	SENT_386	[p15l1514t3138r1564b3169],
9	a	DT	O	a	det	11	SENT_386	[p15l1587t3138r1612b3169],
10	predictive	JJ	O	predictive	amod	11	SENT_386	[p15l1635t3125r1890b3180],
11	factor	NN	O	factor	prep_as	7	SENT_386	[p15l1913t3125r2061b3169],
12	for	IN	O	for	_	0	SENT_386	[p15l2081t3125r2153b3169],
13	response	NN	O	response	prep_for	11	SENT_386	[p15l138t3203r366b3245],
14	to	TO	O	to	aux	15	SENT_386	[p15l382t3197r431b3234],
15	geﬁtinib	VB	O	geﬁtinib	infmod	1	SENT_386	[p15l447t3190r661b3245],
16	(	CD	NUMBER	(	number	17	SENT_386	[p15l678t3191r905b3245],
17	“	CD	NUMBER	“	dobj	15	SENT_386	[p15l678t3191r905b3245],
18	Iressa	NNP	MISC	Iressa	nn	19	SENT_386	[p15l678t3191r905b3245],
19	”	NN	O	”	dep	17	SENT_386	[p15l678t3191r905b3245],
20	,	,	O	,	_	0	SENT_386	[p15l678t3191r905b3245],
21	ZD1839	NN	O	zd1839	nn	22	SENT_386	[p15l922t3191r1138b3245],
22	)	NN	O	)	appos	17	SENT_386	[p15l922t3191r1138b3245],
23	in	IN	O	in	_	0	SENT_386	[p15l1156t3191r1203b3234],
24	non-small-cell	JJ	O	non-small-cell	amod	26	SENT_386	[p15l1220t3191r1593b3234],
25	lung	NN	O	lung	nn	26	SENT_386	[p15l1611t3191r1724b3245],
26	cancer	NN	O	cancer	prep_in	22	SENT_386	[p15l1740t3203r1916b3235],
27	.	.	O	.	_	0	SENT_386	[p15l1740t3203r1916b3235],

1	BrJ	NN	O	brj	nn	2	SENT_387	[p15l1934t3193r2017b3245],
2	Cancer	NN	O	cancer	_	0	SENT_387	[p15l2035t3193r2151b3234, p15l138t3270r216b3301],
3	2004	CD	DATE	2004	dep	2	SENT_387	[p15l232t3259r670b3307],
4	;	:	O	;	_	0	SENT_387	[p15l232t3259r670b3307],
5	91:208	CD	NUMBER	91:208	number	6	SENT_387	[p15l232t3259r670b3307],
6	—	CD	NUMBER	—	dep	2	SENT_387	[p15l232t3259r670b3307],
7	12	CD	NUMBER	12	dep	6	SENT_387	[p15l232t3259r670b3307],
8	.	.	O	.	_	0	SENT_387	[p15l232t3259r670b3307],

1	[	NN	O	[	nn	5	SENT_388	[p15l9t3322r103b3377],
2	31	CD	NUMBER	31	num	5	SENT_388	[p15l9t3322r103b3377],
3	]	CD	NUMBER	]	num	5	SENT_388	[p15l9t3322r103b3377],
4	Bailey	NNP	PERSON	Bailey	nn	5	SENT_388	[p15l138t3323r292b3377],
5	L	NNP	PERSON	L	_	0	SENT_388	[p15l305t3325r486b3377],
6	,	,	O	,	_	0	SENT_388	[p15l305t3325r486b3377],
7	Janas	NNP	PERSON	Janas	nn	8	SENT_388	[p15l305t3325r486b3377],
8	M	NNP	O	M	appos	5	SENT_388	[p15l501t3325r562b3373],
9	,	,	O	,	_	0	SENT_388	[p15l501t3325r562b3373],
10	Schmidt	NNP	PERSON	Schmidt	nn	11	SENT_388	[p15l576t3323r788b3366],
11	N	NNP	O	N	appos	5	SENT_388	[p15l800t3325r850b3373],
12	,	,	O	,	_	0	SENT_388	[p15l800t3325r850b3373],
13	Bindslev	NNP	PERSON	Bindslev	nn	14	SENT_388	[p15l864t3323r1082b3366],
14	N	NNP	O	N	appos	5	SENT_388	[p15l1095t3325r1144b3373],
15	,	,	O	,	_	0	SENT_388	[p15l1095t3325r1144b3373],
16	Wolf	NNP	PERSON	Wolf	nn	17	SENT_388	[p15l1156t3322r1285b3366],
17	M	NN	O	m	appos	5	SENT_388	[p15l1292t3325r1353b3373],
18	,	,	O	,	_	0	SENT_388	[p15l1292t3325r1353b3373],
19	GrousJ	NN	O	grousj	appos	5	SENT_388	[p15l1368t3325r1556b3377],
20	,	,	O	,	_	0	SENT_388	[p15l1368t3325r1556b3377],
21	As1	NN	O	as1	appos	5	SENT_388	[p15l1568t3323r1759b3377],
22	<	JJR	O	<	amod	23	SENT_388	[p15l1568t3323r1759b3377],
23	aaJ	NN	O	aaj	dep	21	SENT_388	[p15l1568t3323r1759b3377],
24	,	,	O	,	_	0	SENT_388	[p15l1568t3323r1759b3377],
25	Herbst	NNP	ORGANIZATION	Herbst	nn	26	SENT_388	[p15l1774t3323r1944b3366],
26	R	NNP	ORGANIZATION	R	appos	5	SENT_388	[p15l1957t3323r2151b3377, p15l138t3402r226b3433],
27	,	,	O	,	_	0	SENT_388	[p15l1957t3323r2151b3377, p15l138t3402r226b3433],
28	Johnson	NNP	PERSON	Johnson	nn	29	SENT_388	[p15l1957t3323r2151b3377, p15l138t3402r226b3433],
29	DH	NNP	O	DH	nsubj	56	SENT_388	[p15l251t3392r342b3439],
30	,	,	O	,	_	0	SENT_388	[p15l251t3392r342b3439],
31	Giaccone	NNP	PERSON	Giaccone	nn	33	SENT_388	[p15l369t3390r600b3433],
32	G.	NNP	O	G.	nn	33	SENT_388	[p15l626t3391r675b3433],
33	Evaluation	NN	O	evaluation	dep	40	SENT_388	[p15l702t3389r973b3433],
34	of	IN	O	of	_	0	SENT_388	[p15l998t3389r1051b3433],
35	epidermal	JJ	O	epidermal	amod	37	SENT_388	[p15l1071t3389r1331b3443],
36	growth	NN	O	growth	nn	37	SENT_388	[p15l1357t3389r1542b3443],
37	factor	NN	O	factor	prep_of	33	SENT_388	[p15l1567t3389r1715b3433],
38	receptor	NN	O	receptor	dep	40	SENT_388	[p15l1739t3395r1954b3443],
39	(	CD	NUMBER	(	num	38	SENT_388	[p15l1978t3389r2151b3443],
40	EGFR	NN	ORGANIZATION	egfr	dep	52	SENT_388	[p15l1978t3389r2151b3443],
41	)	RB	O	)	advmod	40	SENT_388	[p15l1978t3389r2151b3443],
42	as	IN	O	as	_	0	SENT_388	[p15l138t3467r187b3498],
43	a	DT	O	a	det	45	SENT_388	[p15l215t3467r241b3498],
44	predictive	JJ	O	predictive	amod	45	SENT_388	[p15l268t3454r523b3509],
45	marker	NN	O	marker	prep_as	40	SENT_388	[p15l551t3454r736b3498],
46	in	IN	O	in	_	0	SENT_388	[p15l762t3455r809b3498],
47	patients	NNS	O	patient	prep_in	45	SENT_388	[p15l836t3455r1042b3509],
48	with	IN	O	with	_	0	SENT_388	[p15l1068t3455r1187b3498],
49	non-small	JJ	O	non-small	amod	51	SENT_388	[p15l1214t3454r1473b3498],
50	cell	NN	O	cell	nn	51	SENT_388	[p15l1500t3454r1586b3498],
51	lung	NN	O	lung	prep_with	47	SENT_388	[p15l1614t3454r1727b3509],
52	cancer	NN	O	cancer	dep	54	SENT_388	[p15l1752t3467r1920b3498],
53	(	CD	NUMBER	(	num	52	SENT_388	[p15l1945t3454r2151b3509],
54	NSCLC	NN	O	nsclc	dep	29	SENT_388	[p15l1945t3454r2151b3509],
55	)	CD	NUMBER	)	num	54	SENT_388	[p15l1945t3454r2151b3509],
56	receiving	VBG	O	receive	dep	5	SENT_388	[p15l138t3522r372b3575],
57	ﬁrst-line	JJ	O	ﬁrst-line	amod	58	SENT_388	[p15l403t3521r624b3564],
58	geﬁtinib	NN	O	geﬁtinib	dobj	56	SENT_388	[p15l656t3521r870b3575],
59	combined	VBN	O	combine	prep	56	SENT_388	[p15l903t3521r1157b3564],
60	with	IN	O	with	pcomp	59	SENT_388	[p15l1189t3521r1308b3564],
61	platinum-based	JJ	O	platinum-based	amod	63	SENT_388	[p15l1340t3521r1748b3575],
62	chemotherapy	NN	O	chemotherapy	nn	63	SENT_388	[p15l1781t3521r2153b3575],
63	(	NN	O	(	pobj	60	SENT_388	[p15l138t3587r364b3641],
64	abstract	JJ	O	abstract	amod	63	SENT_388	[p15l138t3587r364b3641],
65	7013	CD	NUMBER	7013	number	66	SENT_388	[p15l407t3587r560b3641],
66	)	CD	NUMBER	)	dep	64	SENT_388	[p15l407t3587r560b3641],
67	.	.	O	.	_	0	SENT_388	[p15l407t3587r560b3641],

1	J	NNP	O	J	nn	3	SENT_389	[p15l598t3590r618b3642],
2	Clin	NNP	O	Clin	nn	3	SENT_389	[p15l662t3587r760b3631],
3	Oncol	NNP	O	Oncol	_	0	SENT_389	[p15l804t3587r950b3631],
4	2004	CD	DATE	2004	dep	3	SENT_389	[p15l994t3589r1136b3631],
5	.	.	O	.	_	0	SENT_389	[p15l994t3589r1136b3631],

1	ASCO	NNP	ORGANIZATION	ASCO	nsubj	3	SENT_390	[p15l1179t3589r1317b3631],
2	Annual	JJ	SET	annual	amod	1	SENT_390	[p15l1359t3587r1542b3631],
3	Meeting	VBG	O	meet	_	0	SENT_390	[p15l1587t3588r1799b3642],
4	Proceedings	NNP	O	Proceedings	dobj	3	SENT_390	[p15l1841t3587r2150b3642],
5	22:618	CD	NUMBER	22:618	num	4	SENT_390	[p15l138t3656r323b3698],
6	.	.	O	.	_	0	SENT_390	[p15l138t3656r323b3698],

